[
    "This phase 3 clinical trial aims to evaluate the effectiveness of aprepitant, dexamethasone, granisetron hydrochloride, palonosetron hydrochloride, prochlorperazine, and placebo in managing nausea in cancer patients undergoing chemotherapy, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for patients diagnosed with schizophrenia, testing the efficacy of three different doses of the drug mp-214. The inclusion criteria include obtaining written informed consent, meeting the DSM-IV-TR criteria for schizophrenia, and having normal physical examination, laboratory, vital signs, and/or ECG results. The exclusion criteria include patients with schizoaffective disorder, schizophreniform disorder, other psychotic disorders other than schizophrenia, or bipolar I or II disorder.",
    "This phase 3 trial is testing the effectiveness of istradefylline, a drug used to treat Parkinson's disease, in patients who have completed previous studies and meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes and coronary artery bypass grafting, testing the effectiveness of rosiglitazone or placebo in reducing the risk of restenosis in saphenous vein grafts.",
    "This sample is a phase 2/phase 3 trial for patients with esophageal cancer or adenocarcinoma, testing the effectiveness of nimotuzumab, cisplatin, and fluorouracil in combination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for breast neoplasms, testing the drugs lapatinib, letrozole, and placebo, with eligibility criteria including post-menopausal females with ER+ and/or PgR+ tumors and ECOG Performance Status of 0 or 1.",
    "In this phase 3 trial, the drug combination of asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, etoposide, ifosfamide, mercaptopurine, methotrexate, prednisone, thioguanine, vincristine sulfate, and vindesine will be tested for the treatment of histologically confirmed acute lymphoblastic leukemia (ALL), with specific eligibility criteria for patients.",
    "This sample is a phase 3 trial for patients with chronic renal anemia, testing the drugs methoxy polyethylene glycol-epoetin beta and epoetin alfa, with inclusion criteria including regular hemodialysis for at least 3 months and exclusion criteria such as recent red blood cell transfusion and poorly controlled hypertension.",
    "This sample is a phase 3 trial for patients with age-related macular degeneration and choroidal neovascularization, testing the drug ranibizumab. The eligibility criteria include age over 50, specific diagnosis and lesion characteristics, and a certain level of visual acuity.",
    "This sample is a phase 2/phase 3 trial testing the use of propranolol, a beta-blocker, in patients with acute ischemic MCA-territory stroke, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for epilepsy, testing the drug lamotrigine, with inclusion criteria including a confident diagnosis of epilepsy and currently being treated with one or two antiepileptic medications, and exclusion criteria including a history of hypersensitivity to lamotrigine and progressive diseases that would interfere with the study objectives.",
    "This sample is a phase 3 trial for rheumatoid arthritis patients who have completed a previous study and have been diagnosed with the disease for over a year. The study aims to evaluate the effectiveness of abatacept, non-biologic disease modifying anti-rheumatic drug (dmard), and anti-tumor necrosing factor (tnf) therapy in these patients who have previously received an anti-TNF therapy for at least 3 months.",
    "This sample is a phase 3 clinical trial for patients with locally advanced or metastatic renal cell carcinoma, testing the effectiveness of pazopanib and sunitinib as treatment options. The eligibility criteria include having no prior systemic therapy for advanced or metastatic RCC, an ECOG PS of 0 or 1, and adequate organ system functions.",
    "This sample is a phase 3 clinical trial for the treatment of benign prostatic hypertrophy using cetrorelix pamoate, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to investigate the effectiveness of repaglinide and short-acting insulin in treating newly diagnosed diabetes mellitus in patients with cystic fibrosis, while excluding those with diabetic keto-acidosis, already treated diabetes mellitus, severe liver insufficiency, and other specific conditions.",
    "This sample is a phase 3 clinical trial for chemotherapy-induced nausea and vomiting, testing the effectiveness of aprepitant, ondansetron, dexamethasone, fosaprepitant dimeglumine, and placebos as comparators, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for head and neck cancer, testing the drugs cisplatin and fluorouracil, with eligibility criteria including specific disease characteristics and patient characteristics.",
    "This sample is a phase 2/phase 3 trial for patients with HIV infection and chronic hepatitis B, testing the effectiveness of Truvada (emtricitabine + tenofovir df) in combination with other criteria such as stable ARV, CD4 count, and viral load.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the efficacy of tiotropium respimat compared to placebo respimat, with inclusion criteria including patients aged 18-75 with a 12-week history of asthma, confirmed diagnosis, and specific lung function requirements, and exclusion criteria including significant diseases, recent cardiac events, lung diseases other than asthma, and use of certain medications.",
    "This sample is a phase 3 clinical trial for osteoarthritis of the knee, testing the effectiveness of ketoprofen in diractin\u00ae compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of human insulin inhalation powder and insulin glargine in combination with oral antihyperglycemic medications, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug simvastatin, with eligibility criteria including age, disease severity, medical condition, language proficiency, and exclusion criteria related to cardiovascular health, liver disease, neoplastic disease, and psychiatric disorders.",
    "This sample is a phase 3 trial testing the effectiveness of telmisartan and amlodipine combination therapy in patients with essential hypertension who have not responded adequately to amlodipine monotherapy.",
    "This sample is a phase 3 clinical trial for patients with prostate cancer that has spread to the bone, testing the drugs zd4054 and placebo. The eligibility criteria include confirmed diagnosis of prostate cancer, increasing PSA levels, and no or mild pain from prostate cancer. Exclusion criteria include current use of opiates, previous chemotherapy treatment, heart failure or recent myocardial infraction, and a history of epilepsy or seizures.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis who have had an inadequate response to methotrexate, and it will test the effectiveness of methotrexate, ocrelizumab, and placebo as potential treatments.",
    "This sample is a phase 3 clinical trial for the treatment of migraine disorders, testing the efficacy of a combination product (sumatriptan succinate/naproxen sodium) compared to a placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for ulcerative colitis, testing the effectiveness of azathioprine (aza) and placebo drugs, with specific eligibility criteria including age, disease severity, previous treatments, and tuberculosis screening.",
    "This sample is a phase 3 clinical trial for epilepsy patients, testing the effectiveness of lamotrigine and levetiracetam as anticonvulsant drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial for patients with stage IIIB or IV non-small cell lung cancer, testing the effectiveness of vorinostat and comparing it to paclitaxel, carboplatin, and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for rheumatoid arthritis, testing the efficacy of tocilizumab and disease-modifying antirheumatic drugs (DMARDs) in adult participants who have had an inadequate response to current DMARD therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic pain in the knee or hip joint, testing the effectiveness of tramadol hcl er and celecoxib as alternative analgesics to acetaminophen, NSAIDs, and COX-2 selective inhibitors.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD). The trial aims to evaluate the effectiveness of formoterol fumurate inhalation solution and ipratropium bromide and albuterol sulfate inhalation solution in treating COPD. The eligibility criteria include a COPD diagnosis, a history of smoking, and meeting lung function requirements.",
    "This sample is a phase 3 clinical trial for patients with chronic kidney disease, testing the effectiveness of the drugs placebo and ast-120 in improving kidney function and reducing proteinuria, with specific eligibility criteria for inclusion and exclusion.",
    "This phase 3 clinical trial aims to evaluate the efficacy of semuloparin sodium, a potential anticoagulant, in preventing venous thromboembolism in cancer patients undergoing chemotherapy for metastatic or locally advanced solid tumors of the lung, pancreas, stomach, colon/rectum, bladder, or ovary.",
    "This sample is a phase 3 clinical trial for patients with ulcerative colitis, testing the effectiveness of mesalazine (asacol\u00ae) in maintaining remission, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with essential hypertension, testing the effectiveness of various drugs including amlodipine, olmesartan medoxomil, amlodipine+valsartan, and hydrochlorothiazide, with specific inclusion and exclusion criteria for both the core study and extension phases.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes, testing the drugs rivoglitazone, pioglitazone, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer patients who have progressed after platinum-based chemotherapy, and it is testing the drug icotinib as a potential treatment option. The eligibility criteria include confirmed diagnosis, specific disease stage, performance status, measurable lesion, and adequate hematologic and biochemical values. Patients with symptomatic brain metastases, previous treatment with drugs targeting EGFR, or a history of interstitial lung disease are excluded from the study.",
    "This sample is a phase 2/phase 3 trial for patients with chronic hepatitis C, testing the efficacy of nitazoxanide, ribavirin, and peginterferon-alfa-2a in combination therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of acute ischemic stroke using the drugs ancrod (viprinex) and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with cystic fibrosis, testing the effectiveness of mp-376 (levofloxacin solution for inhalation) and tis (tobramycin inhalation solution) in improving lung function and reducing respiratory infections. The study has specific inclusion and exclusion criteria, and patients enrolled in the study may have the opportunity to participate in an open label extension.",
    "This sample is a phase 3 clinical trial for bladder cancer patients who have undergone radical cystectomy, and it aims to evaluate the effectiveness of cisplatin, doxorubicin hydrochloride, methotrexate, and vinblastine in preventing the recurrence of bladder cancer.",
    "This sample is a phase 3 trial for the treatment of type 2 diabetes, testing the drugs saxagliptin, metformin, and placebo, with inclusion criteria of inadequate blood sugar control and exclusion criteria of previous diabetes treatment and current treatment with other blood sugar-lowering medications.",
    "This sample is a phase 3 clinical trial for major depressive disorder (MDD) in patients aged 66 years or older, using the drug quetiapine. The inclusion criteria require a documented clinical diagnosis of MDD, while exclusion criteria include the presence of dementia or other mental disorders, uncontrolled hypertension, substance or alcohol abuse, and a current or past diagnosis of cancer or stroke.",
    "This sample is a phase 3 trial for congestive heart failure, testing the effectiveness of irbesartan and placebo in patients aged 60 years and older with symptoms consistent with NYHA class II-IV, and various abnormalities indicating heart disease, with exclusion criteria including recent heart-related events and surgeries, life-threatening arrhythmia, stroke, serious lung disease, and other factors limiting life expectancy.",
    "This sample is a phase 3 trial for HIV infections, testing the drugs nevirapine bid, nevirapine qd, and atazanavir, with inclusion criteria including HIV-1 infection, no previous antiretroviral treatment, specific CD4+ counts, and adequate renal function, and exclusion criteria including active drug abuse, hepatic cirrhosis, and certain pregnancy and medical history factors.",
    "This sample is a phase 3 clinical trial for the treatment of allergic rhinitis and asthma, comparing the effectiveness of mometasone furoate nasal spray (mfns) to a placebo nasal spray, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin, pioglitazone, and metformin as treatment options, with specific inclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for atopic dermatitis, testing the effectiveness of pimecrolimus and topical corticosteroids in infants aged 3 to <12 months with mild-to-moderate disease, and includes specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma and plasma cell neoplasm, testing the effectiveness of thalidomide and zoledronic acid as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 3 clinical trial for the drug balaglitazone in patients with type 2 diabetes mellitus who are currently being treated with insulin, and it includes specific inclusion and exclusion criteria for participation in the study.",
    "This sample is a phase 3 clinical trial for patients with chronic hepatitis B, testing the effectiveness of lam group and adv group drugs in treating the disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of benign prostatic hyperplasia (BPH) using the drugs tadalafil and placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the effectiveness of IV vancomycin plus IV aztreonam and ceftaroline in treating skin and skin structure infections caused by bacterial infections, specifically those involving deeper soft tissue or requiring significant surgical intervention, or cellulitis or abscess on lower extremity occurring in subjects with diabetes mellitus or peripheral vascular disease.",
    "This sample is a phase 3 trial for neuropathic pain, testing the effectiveness of pregabalin (lyrica) and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for major depressive disorder with psychotic features, testing the effectiveness of mifepristone and placebo as potential drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of complicated intra-abdominal infection (cIAI) using the drugs cxa-201 and metronidazole or meropenem, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial testing the effectiveness of ketamine/amitriptyline np-h cream in reducing peripheral neuropathy in patients with a history of cancer and pain, numbness, or tingling in the hands or feet following chemotherapy.",
    "This sample is a phase 3 clinical trial for patients with open-angle glaucoma or ocular hypertension, testing the effectiveness of brinzolamide 1% / timolol 0.5% fixed combination ophthalmic suspension, brinzolamide 1% ophthalmic suspension, and timolol 0.5% ophthalmic solution in lowering intraocular pressure. The study has specific inclusion and exclusion criteria, and participants must meet certain eligibility requirements.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin, canagliflozin, metformin, and sulphonylurea in controlling blood glucose levels within specific criteria.",
    "This phase 3 trial is investigating the effectiveness of eflornithine and sulindac in preventing the recurrence of precancerous colon polyps in patients with a history of surgically resected adenomatous polyps, with specific eligibility criteria and restrictions on concurrent medications and medical conditions.",
    "This sample is a phase 3 clinical trial for the treatment of venous thromboembolism using semuloparin sodium, enoxaparin, and placebo drugs, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of quetiapine fumarate as a treatment option. The inclusion criteria include having a documented clinical diagnosis of major depressive disorder and being able to provide informed consent, while the exclusion criteria include a history of non-compliance, lack of response to previous quetiapine treatment, and recent participation in a clinical trial.",
    "This sample is a phase 3 clinical trial for patients with a diagnosis of cerebral infraction, testing the drug aggrenox capsule, and the eligibility criteria include having a known onset of cerebral infraction between 1 week and 6 months before enrollment, being 50 years or older, and having at least two of the specified risk factors such as diabetes, hypertension, smoking, obesity, previous vascular disease, end-organ damage, or hyperlipidemia.",
    "This sample is a phase 3 clinical trial for the treatment of cystic fibrosis and Burkholderia infections, using the drugs azli and placebo, with eligibility criteria including age, genetic mutations, chronic infection, and pulmonary function.",
    "This sample is a phase 3 clinical trial for the treatment of sleep initiation and maintenance disorders and insomnia, using the drugs eplivanserin (sr46349) and placebo, with eligibility criteria including a diagnosis of primary insomnia and disturbance of sleep maintenance.",
    "This sample is a phase 3 trial for postmenopausal women experiencing vasomotor symptoms and hot flashes, testing the effectiveness of various drugs including 0.5mg drsp / 0.5mg e2 (bay86-4891) and estradiol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) using methylphenidate HCl as the drug, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 3 trial for patients with persistent asthma, testing the effectiveness of montelukast sodium and placebo in reducing symptoms during allergy season, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial called ACTIVE, which aims to evaluate the effectiveness of clopidogrel (sr25990c) compared to a placebo in patients with atrial fibrillation and a high risk of vascular events, who either have a contraindication to use an oral anticoagulant treatment or are unwilling to take it. The eligibility criteria include evidence of atrial fibrillation, high risk of vascular events, and contraindication or unwillingness to take an oral anticoagulant treatment. Exclusion criteria include various medical conditions, such as recent coronary stent procedure, requirement for oral anticoagulant, intolerance to ASA or clopidogrel, and others.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of various drugs including sitagliptin phosphate, metformin hydrochloride, pioglitazone, and placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using atomoxetine hydrochloride as the drug, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for kidney transplantation, testing the effectiveness of drugs such as everolimus, mycophenolate mofetil, basiliximab, cyclosporine a, and corticosteroid, with specific eligibility criteria for patients.",
    "This phase 3 trial aims to evaluate the effectiveness of ace inhibition, intensified blood pressure control, and add-on angiotensin receptor blockade in children with chronic renal failure, hypertension, acquired kidney disease, and congenital kidney disease, who meet specific inclusion criteria such as age 3-18 years and moderate state of renal failure.",
    "This sample is a phase 3 clinical trial for patients with metastatic prostate cancer that is unresponsive to hormone therapy, testing the effectiveness of chemotherapy (taxotere and prednisone) in treating the disease.",
    "This sample is a phase 3 trial testing the drug \"exanta\" for patients undergoing hip replacement surgery to prevent thromboembolism, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for osteoporosis, testing the drugs lasofoxifene, raloxifene, and placebo, with inclusion criteria of postmenopausal women with low bone density and exclusion criteria of presence of metabolic bone disease, fractures, blood clots, recent cancer, and certain medication use.",
    "This phase 3 trial aims to investigate the effectiveness of intravenous magnesium in patients undergoing coronary artery bypass surgery with or without valve procedure, who are scheduled for on-pump or cardiopulmonary bypass protocol, and have coronary artery disease or valvular heart disease.",
    "This sample is a phase 2/phase 3 trial for patients with house dust mite induced persistent mild to moderate asthma, testing the effectiveness of various drugs including salbutamol inhaler, budesonide/formoterol inhaler, prednisone tablet, desloratadine tablet, and budesonide nasal spray, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the efficacy of LY2216684, an investigational drug, in combination with selective serotonin reuptake inhibitors (SSRIs) for the treatment of major depressive disorder (MDD) in patients who have had a partial response to SSRIs.",
    "This sample is a phase 3 clinical trial for liver cancer, testing the drugs carboplatin, cisplatin, and doxorubicin hydrochloride, with eligibility criteria including specific disease characteristics and patient characteristics.",
    "This phase 3 trial is testing the effectiveness of drugs (placebo, e2007) in patients with Parkinson's disease who have predictable motor fluctuations, and meet specific inclusion criteria, such as a good response to levodopa and a rating of II-IV on the Hoehn & Yahr scale in an OFF state.",
    "This phase 3 clinical trial is testing the effectiveness of spd489 (lisdexamfetamine dimesylate) compared to a placebo in treating major depressive disorder (MDD) in adults aged 18-65, with specific inclusion and exclusion criteria, such as having a MADRS total score of 24 or higher and not having responded to previous antidepressant treatments.",
    "This sample is a phase 3 trial for patients with hyponatremia and congestive heart failure, testing the effectiveness of lixivaptan and placebo drugs.",
    "This phase 3 trial is investigating the use of aliskiren, a drug used to treat hypertension, in patients with type 2 diabetes mellitus and cardiovascular disease, who also have reduced kidney function. The study has specific inclusion and exclusion criteria, including the requirement for concomitant treatment with either an Angiotensin-converting-enzyme-inhibitor (ACEi) or an Angiotensin-receptor-blocker (ARB) but not both.",
    "This sample is a phase 3 clinical trial for patients with chronic pancreatitis, testing the effectiveness of triamcinolone and bupivicaine alone in relieving chronic pancreatic-type abdominal pain, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of biphasic insulin aspart 30 and metformin in controlling blood glucose levels, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for individuals with type 2 diabetes, testing the effectiveness of dapagliflozin and metformin xr in improving glycemic control. The inclusion criteria include age, duration of diabetes treatment, C-peptide levels, body mass index, and serum creatinine levels, while the exclusion criteria include liver and kidney function, creatine kinase levels, and the presence of severe uncontrolled diabetes or other serious medical conditions.",
    "This sample is a phase 3 trial for contraception, testing the drugs cdb-2914 and levonorgestrel, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial testing the drug lacosamide for the treatment of partial epilepsies and partial onset seizures, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the drug zonisamide in the treatment of partial seizures, with specific inclusion and exclusion criteria for subjects, including age range, weight, medical history, and drug sensitivities.",
    "This sample is a phase 2/phase 3 trial that focuses on diabetic patients aged 55 and above with diseases such as diabetes, myocardial infraction, and cardiovascular disease. The study aims to test the effectiveness of natural source vitamin E 400iu/day as a treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with reflux esophagitis, testing the effectiveness of esomeprazole and omeprazole in treating the condition, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients undergoing liver transplantation, focusing on the use of tacrolimus as an immunosuppressive drug, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with essential hypertension who have not reached their blood pressure goal with previous antihypertensive medications. The study will test the effectiveness of losartan potassium (+) hydrochlorothiazide in treating hypertension.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of perindopril-indapamide and gliclazide mr-based glucose lowering drugs in reducing the risk of cardiovascular disease in older patients with a history of major macrovascular or microvascular disease, or other major risk factors for vascular disease.",
    "This sample is a phase 3 clinical trial for patients with multiple sclerosis, testing the effectiveness of dalfampridine-er in improving walking impairment, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of overactive bladder, testing the effectiveness of alkalinized xylocaine and placebo drugs, with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 3 clinical trial for patients with moderate to moderately severe chronic active ulcerative colitis (UC) who have not responded to currently available therapies. The study will test the effectiveness of cobitolimod compared to a placebo in reducing symptoms and improving disease management.",
    "This phase 3 trial aims to evaluate the effectiveness of aripiprazole and placebo in treating serious behavioral problems in individuals with autistic disorder, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for low back pain, testing the effectiveness of active theramine and active naproxen compared to naproxen and theramine-like placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of saxagliptin, metformin, placebo, and pioglitazone in controlling blood sugar levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with central retinal vein occlusion and macular edema, testing the effectiveness of ranibizumab in improving visual acuity and reducing macular edema.",
    "This phase 3 trial aims to evaluate the effectiveness of liraglutide and placebo in treating type 2 diabetes and obesity, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of octreotide acetate and tamoxifen citrate drugs in combination with surgery, radiotherapy, and chemotherapy as treatment options, with specific eligibility criteria for postmenopausal women.",
    "This sample is a phase 3 clinical trial for chronic pain, osteoarthritis, and low back pain, testing the efficacy of fentanyl compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with metastatic breast cancer, testing the effectiveness of gemcitabine, herceptin, and capecitabine (xeloda) as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 trial is investigating the effectiveness of alendronate and denosumab in treating postmenopausal women with osteoporosis or osteopenia, with specific eligibility criteria including T-score values, thyroid function, liver function, renal function, and exclusion of certain diseases and conditions.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin and metformin combination therapy compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for liver transplantation patients with confirmed hepatitis C virus (HCV) status, testing the efficacy of different immunosuppressive regimens including tacrolimus and everolimus, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of cervical dystonia using a placebo drug, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of tiotropium + olodaterol and olodaterol drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of glimepiride and linagliptin compared to placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for deep venous thrombosis, testing the drugs idrabiotaparinux sodium, idraparinux sodium, avidin, and placebo (for avidin), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the drug ipragliflozin, with specific inclusion and exclusion criteria related to diabetes, renal disease, cardiovascular health, pregnancy, and previous participation in other studies.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of capecitabine, bevacizumab, and irinotecan as chemotherapy drugs, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 3 clinical trial for patients with unresectable and/or metastatic renal cell carcinoma, testing the effectiveness of sorafenib (Nexavar) as a systemic therapy, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of carboplatin and paclitaxel in treating patients with unresectable stage IIIA or IIIB non-small cell lung cancer, and the eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 clinical trial for kidney transplantation and chronic kidney failure, testing the drugs cyclosporine, belatacept li, and belatacept mi, with specific inclusion and exclusion criteria for the subjects.",
    "This sample is a phase 3 clinical trial for patients with advanced or recurrent malignant melanoma, testing the effectiveness of dacarbazine, fotemustine, and interferon alfa-2b as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for non-small cell lung cancer patients with specific histologies, testing the drugs cp 751,871 (figitumumab) and erlotinib, with inclusion and exclusion criteria specified.",
    "This sample is a phase 3 clinical trial for Crohn's Disease, testing the effectiveness of infliximab and azathioprine in patients who meet specific inclusion criteria, such as having a diagnosis of Crohn's Disease for at least 6 weeks and moderate to severe disease activity.",
    "This sample is a phase 3 clinical trial for asthma, testing the effectiveness of fluticasone propionate, fluticasone furoate, and placebo in patients with a pre-bronchodilator FEV1 of 40-90% predicted and a reversibility FEV1 of at least 12% and 200mLs. The study has specific inclusion and exclusion criteria, and participants must have been on an inhaled corticosteroid for at least 4 weeks prior to the first visit.",
    "This sample is a phase 3 clinical trial for patients with Friedreich's ataxia, testing the drug idebenone, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of lopinavir/ritonavir tablets combined with nucleoside/nucleotide reverse transcriptase inhibitors in antiretroviral-experienced adults with HIV-1 infection who are currently failing their antiretroviral regimen.",
    "This sample is a phase 3 trial for rheumatoid arthritis, testing the effectiveness of mra(tocilizumab), mra placebo, mtx, and mtx placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of various inhalation powders and a placebo in improving lung function and reducing symptoms. The eligibility criteria include being an outpatient, having a clinical history of COPD, and meeting certain age and lung function requirements.",
    "This phase 3 clinical trial is testing a combination of drugs including asparaginase, cyclophosphamide, cytarabine, and others, for the treatment of lymphoblastic lymphoma, with specific eligibility criteria for patients.",
    "This sample is a phase 3 clinical trial for postmenopausal osteoporosis, testing the drugs menatetranone and alfacalcidol, with inclusion criteria including postmenopausal women with low bone density and exclusion criteria including certain medical conditions and recent use of specific medications.",
    "This sample is a phase 3 trial for tobacco dependence and smoking cessation, testing the effectiveness of nicotine patch, placebo, and varenicline as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of human immunodeficiency virus (HIV) infection, testing the efficacy of drugs such as dolutegravir, atripla, and abacavir/lamivudine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with gastroesophageal reflux disease (GERD), testing the drug pantoprazole, and includes eligibility criteria such as age, consent, and exclusion criteria related to other medications and pregnancy.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of exenatide and placebo in improving glycemic control, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of tocilizumab 162 mg, a drug used to treat rheumatoid arthritis, compared to a placebo, in adult patients with moderate to severe rheumatoid arthritis who have been on stable disease-modifying anti-rheumatic drugs for at least 8 weeks.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of er niacin/laropiprant compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) and stable airway obstruction. The trial is testing the efficacy of aclidinium bromide/formoterol fumarate, aclidinium bromide, formoterol fumarate, and placebo in treating COPD symptoms. The eligibility criteria include age, smoking history, lung function measurements, and overall health. The exclusion criteria include recent hospitalization, respiratory infections, cardiovascular conditions, and other medical conditions that may interfere with the study.",
    "This sample is a phase 3 trial for liver transplantation, focusing on patients receiving a liver graft from a cadaveric donor with compatible blood type, and the drug being tested is tacrolimus. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 clinical trial for patients 65 years or older with Gram-positive complicated Skin and Soft Tissue Infections (cSSTIs), testing the effectiveness of daptomycin and vancomycin or semi-synthetic penicillins (ssps) as parenteral antimicrobial therapy.",
    "This sample is a phase 3 clinical trial for patients with metastatic breast cancer, testing the effectiveness of pegylated liposomal doxorubicin and capecitabine as treatment options, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of bdp hfa, a nasal aerosol, compared to placebo in treating seasonal allergic rhinitis (SAR) in children aged 6 to 11 years with a history of SAR to tree/grass pollen. The eligibility criteria include a documented history of SAR, sensitivity to seasonal allergens, and exclusion criteria such as nasal pathology, respiratory infections, and active asthma requiring treatment with corticosteroids.",
    "This phase 3 trial aims to evaluate the use of esmolol, a beta-blocker, in high-risk non-cardiovascular surgeries, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 3 clinical trial for the treatment of cystic fibrosis and lung infection caused by pseudomonas aeruginosa. The trial will test the efficacy of the drug azli compared to a placebo, and participants must meet specific eligibility criteria to be included in the study.",
    "This sample is a phase 3 clinical trial for osteoarthritis of the hand, testing the effectiveness of diclofenac sodium gel 1% as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of various drugs including Combivent CFC-MDI and Combivent Respimat, with eligibility criteria including age, smoking history, and spirometric criteria.",
    "This sample is a phase 3 trial for chronic hepatitis C infection, testing the drugs abt-450/r/abt-267, abt-333, ribavirin, and placebo for ribavirin, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of insulin degludec/liraglutide, insulin degludec, and liraglutide in treating type 2 diabetes, with specific eligibility criteria for subjects including HbA1c levels, age, and previous medication usage.",
    "This sample is a phase 3 trial for the treatment of clostridium infections and diarrhea, using the drugs par-101/opt-80 and vancomycin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for women with breast cancer, testing the effects of melatonin and placebo on post-operative sleep quality and depression levels.",
    "This sample is a phase 3 trial for the treatment of pneumonia using amoxicillin and benzyl penicillin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with cirrhosis, hepatic encephalopathy, and hyponatremia, testing the drug tolvaptan to determine its effectiveness in treating these conditions. The inclusion criteria include specific diagnostic criteria for cirrhosis and HE, as well as requirements for mental status and serum sodium levels. The exclusion criteria include uncontrolled HE, recent alcohol or drug abuse, contraindications to MRI examination, and other medical conditions.",
    "This sample is a phase 3 trial testing the use of modafinil in patients with sleepiness attributed to opioids, with specific inclusion and exclusion criteria, and the study excludes patients with hypersensitivity to modafinil, renal impairment, hepatic dysfunction, known history of cardiovascular disease, and patients taking certain medications.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of various drugs including atrovent respimat, combivent mdi, combivent respimat, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic heart failure, testing the effectiveness of olmesartan medoxomil, an angiotensin II receptor blocker, in combination with angiotensin converting enzyme inhibitors and/or beta-blockers. The eligibility criteria include specific NYHA class, age range, and stable patients with certain medications. Exclusion criteria include renal dysfunction, drug hypersensitivity, severe liver dysfunction, and other medical conditions.",
    "This sample is a phase 2/phase 3 trial for patients with pancreatic cancer, testing the effectiveness of fluorouracil, gemcitabine hydrochloride, irinotecan hydrochloride, leucovorin calcium, and oxaliplatin as treatment options. The eligibility criteria include specific disease characteristics, age range, performance status, hematopoietic and hepatic function, and absence of certain medical conditions.",
    "This sample is a phase 2/phase 3 clinical trial for the treatment of influenza using nitazoxanide and placebo, with specific eligibility criteria including age, symptoms, confirmation of infection, and exclusion criteria such as severity of illness, high risk of complications, prior treatment with nitazoxanide, and other pre-existing chronic infections.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using the drug nrp104, with specific eligibility criteria including age, medical assessments, ECG parameters, and meeting DSM-IV-TR criteria for ADHD diagnosis.",
    "This sample is a phase 3 clinical trial for patients with inoperable stage III non-small cell lung cancer (NSCLC), testing the efficacy of radical radiotherapy treatment combined with platinum-based chemotherapy. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 clinical trial for patients with small cell lung cancer (SCLC) that have not responded to or have progressed after first-line therapy. The trial is testing the drug picoplatin as a potential treatment option. The eligibility criteria include specific disease diagnosis, prior chemotherapy regimen, radiological evidence, ECOG performance status, and various laboratory values.",
    "This sample is a phase 3 trial for age-related macular degeneration, testing the drug bevacizumab, with inclusion criteria including na\u00efve subfoveal choroidal neovascularization and best-corrected visual acuity less than 20/200.",
    "This sample is a phase 3 clinical trial for the treatment of open-angle glaucoma and ocular hypertension using brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension, brinzolamide ophthalmic suspension, 1%, and brimonidine tartrate ophthalmic solution, 0.2%. The eligibility criteria include a diagnosis of open-angle glaucoma or ocular hypertension, specific intraocular pressure range, and exclusion criteria such as other forms of glaucoma, severe central vision loss, and ocular trauma or infection within certain timeframes.",
    "This sample is a phase 3 clinical trial for patients with bipolar disorders and manic episodes, testing the effectiveness of risperidone oral tablets in treating the condition, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial testing the use of gabapentin in patients undergoing elective surgery for open unilateral inguinal herniorraphy, with specific inclusion and exclusion criteria, and targeting diseases related to pain, analgesia, and inguinal hernia.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of different drug combinations (cisplatin, ifosfamide, gemcitabine and cisplatin, docetaxel) based on specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of olodaterol (bi 1744) and placebo in improving lung function and exercise capacity. The inclusion criteria include a diagnosis of COPD, age between 40 and 75, and a smoking history of more than 10-pack years. The exclusion criteria include certain medical conditions, such as asthma, thyrotoxicosis, and recent myocardial infraction, as well as limitations in exercise performance and pregnancy.",
    "This phase 3 trial is testing the combination of galiximab and rituximab versus rituximab with placebo in patients with relapsed or progressive non-Hodgkin's lymphoma, and the eligibility criteria include age, histological confirmation, measurable disease, and acceptable organ function.",
    "This sample is a phase 2/phase 3 clinical trial for patients with idiopathic pulmonary fibrosis, testing the efficacy of bosentan and placebo drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of lixisenatide (ave0010) in combination with basal insulin and metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for asthma, testing the effectiveness of montelukast and placebo in non-smoking participants aged 6 to 14 years with chronic asthma and a history of asthma exacerbation associated with a cold within the past year.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the drugs ly2963016, lantus, and oams, with eligibility criteria including specific disease diagnostic criteria, prior use of oral diabetes medications, specific Hemoglobin A1c values, and a maximum body mass index, while excluding patients with certain liver, cardiac, or gastrointestinal diseases, active cancer, excessive insulin resistance or hypersensitivity to Lantus, recent severe low blood sugar episodes, recent use of other insulin, or use of other diabetes medicines not approved to be taken with insulin.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec/insulin aspart and biphasic insulin aspart 30 in controlling blood sugar levels, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for chronic insomnia, testing the effectiveness of the drug ramelteon compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for Lennox-Gastaut syndrome, testing the effectiveness of rufinamide and placebo in participants who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients diagnosed with multiple myeloma, testing the drug bortezomib. The eligibility criteria include specific disease diagnosis, performance status, blood counts, renal function, and contraception use. Exclusion criteria include hypersensitivity to the drug, pregnancy or breastfeeding, recent myocardial infraction, and recent use of other investigational or anti-myeloma therapies.",
    "This phase 3 clinical trial is testing the effectiveness of aflibercept and folfiri drugs in combination with placebo for the treatment of colorectal neoplasms and neoplasm metastasis that are not amenable to potentially curative treatment, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of urinary incontinence, detrusor overactivity, and urinary urgency using botulinum toxin A injections in the bladder detrusor muscle, with eligibility criteria including refractory symptoms and 6 or more urge incontinence episodes on a 3-day bladder diary.",
    "This sample is a phase 3 clinical trial for patients with symptomatic multiple myeloma, testing the effectiveness of various drugs such as dexamethasone, cisplatin, and adriamycin, along with eligibility criteria including age, performance score, and negative HIV serology.",
    "This sample is a phase 3 clinical trial for lupus nephritis, testing the effectiveness of tacrolimus, leflunomide, and prednisone in patients who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with moderately active flare of ulcerative colitis, testing the effectiveness of mesalamine as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with Cushing's disease, testing the drug pasireotide as a potential treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using lurasidone, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for allergic rhinoconjunctivitis, testing the drugs grazax + aerius and grazax + placebo, with inclusion criteria including a clinical history of grass pollen induced allergic rhinoconjunctivitis and a positive skin prick test response to Phleum pratense.",
    "This sample is a phase 3 clinical trial for patients with breast, lung, or prostate cancer, testing the effectiveness of zoledronic acid and sm-153 in combination with chemotherapy or hormonal therapy, with specific eligibility criteria including prior diagnosis, bone scan results, blood count, and performance status.",
    "This sample is a phase 3 trial for the treatment of human immunodeficiency virus (HIV) infection, testing the drugs dolutegravir and raltegravir, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the effectiveness of human insulin inhalation powder, injectable insulin, and insulin glargine in treating the disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with cystic fibrosis and pseudomonas aeruginosa infection, testing the drug azli. The inclusion criteria include a diagnosis of CF, positive lower respiratory tract culture for PA, and clinical stability, while the exclusion criteria include recent use of antipseudomonal antibiotics, history of lung transplantation, and hypersensitivity to aztreonam or beta-agonists.",
    "This sample is a phase 3 clinical trial for hypoactive sexual desire disorder (HSDD) in postmenopausal females, testing the effectiveness of testosterone gel and placebo gel as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for individuals with type 2 diabetes, testing the effectiveness of dapagliflozin and metformin in improving glycemic control, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for major depressive disorder, testing the drugs vortioxetine and venlafaxine extended release, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the treatment of bipolar disorder, testing the drugs asenapine and olanzapine, with inclusion criteria requiring completion of previous studies and exclusion criteria excluding patients with unstable medical conditions or significant laboratory abnormalities.",
    "This sample is a phase 3 trial for patients with hypertension, testing the efficacy and safety of long-term administration of amlodipine, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of lonidamine in treating benign prostatic hyperplasia and enlarged prostate in males aged 50-80 years, with specific inclusion and exclusion criteria, such as prostate volume, urinary tract infections, cardiac, renal or hepatic diseases, and prior treatments.",
    "This sample is a phase 3 trial for the treatment of idiopathic restless legs syndrome using the drug rotigotine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial that aims to evaluate the effectiveness of ati-5923 and coumadin (warfarin) in patients with various cardiovascular diseases, including atrial fibrillation, atrial flutter, venous thromboembolic disease, myocardial infraction, and cardiomyopathy, who require chronic anticoagulation. The eligibility criteria include specific indications for warfarin anticoagulation, age greater than 18, and willingness to comply with the study protocol. The exclusion criteria include contraindications to anticoagulation, active bleeding, concomitant use of other anticoagulant or antiplatelet agents, and certain medical conditions.",
    "This sample is a phase 3 trial for patients with painful diabetic neuropathy, testing the drug pregabalin. The inclusion criteria include patients who completed a 13-week treatment in a previous study, while the exclusion criteria include patients who experienced serious adverse events or treatment non-compliance in the previous study.",
    "This sample is a phase 3 trial for heart failure patients, testing the drugs rolofylline and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of the drug linagliptin compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the drug tolvaptan, which aims to treat hyponatremia in clinically euvolemic or hypervolemic states, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with renal failure and tremors, testing the effectiveness of the drugs Prograf and LCP-tacro in reducing tremors caused by the use of Prograf or generic tacrolimus for kidney transplant.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of multiple drugs including budesonide/formoterol pmdi, budesonide pmdi, and formoterol turbuhaler, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of dabigatran etexilate and warfarin in treating thromboembolism, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is investigating the effectiveness of opc-34712 + adt and placebo + adt in treating major depressive disorder, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with chronic renal failure and chronic kidney disease, testing the effectiveness of peginesatide and epoetin alfa in maintaining hemoglobin levels within a specific range, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for HIV infections and acquired immunodeficiency syndrome (AIDS), testing the drugs vicriviroc and placebo, with eligibility criteria including documented HIV-1 infection, resistance to certain drug classes, and willingness to use contraception.",
    "The sample is a phase 3 clinical trial for Crohn's disease, testing the effectiveness of infliximab or placebo in treating patients with single or multiple draining fistulas, and excluding those with complications requiring surgery or positive stool culture.",
    "This sample is a phase 3 clinical trial testing the effectiveness of chlorhexidine, a topical antiseptic solution, in preventing infections in pregnant women delivering at Chris Hani Baragwanath Hospital or its satellite clinics in Soweto, who meet certain inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of schizophrenia using the drugs asenapine and olanzapine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with bipolar I disorder and acute agitation, testing the efficacy of inhaled loxapine 5 mg and 10 mg compared to an inhaled placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of migraine, testing the drugs telcagepant and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for endometriosis, testing the drugs Visanne and placebo, with inclusion criteria being female patients with endometriosis-associated pelvic pain, and exclusion criteria including pregnant or lactating women, history or suspicion of hormone dependent tumor, therapy resistant endometriosis, need for primary surgical treatment, and any other conditions which forbid participation.",
    "This sample is a phase 3 clinical trial for patients with osteoarthritis of the knee and coagulopathy, testing the effectiveness of the drug Pennsaid in reducing knee pain.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes mellitus, testing the effectiveness of Generex Oral-Lyn\u2122 and regular human insulin in managing the disease. The inclusion criteria include age, duration of diabetes, insulin dosage, BMI, HbA1c levels, and willingness to follow dietary guidelines and monitor blood glucose. The exclusion criteria include various medical conditions, history of severe hypoglycemia, high blood pressure, recent illness, and substance abuse.",
    "This sample is a phase 2/phase 3 trial for rheumatoid arthritis, testing the effectiveness of prednisone in combination with methotrexate for patients who are inadequate responders to TNF-alpha antagonists or methotrexate alone. The eligibility criteria include age 18-80, specific disease criteria, adequate renal function, negative pregnancy test, and stable corticosteroid dose. Exclusion criteria include other inflammatory arthritis, abnormal blood counts, liver abnormalities, positive viral serology, recent treatment with TNF-alpha antagonists or investigational agents, and history of severe allergic reactions or infections.",
    "This sample is a phase 3 clinical trial for the drug semuloparin sodium, which is being tested for its effectiveness in preventing venous thromboembolism in patients undergoing surgery for fracture of the upper third of the femur. The eligibility criteria include exclusion of patients with a history of deep vein thrombosis or pulmonary embolism, high risk of bleeding, hypersensitivity to heparins, contraindication to venography, end-stage renal disease, or on dialysis.",
    "In this phase 3 trial, patients with acute symptoms of Bipolar I Disorder will be tested with aripiprazole, a drug used to treat mental disorders.",
    "This sample is a phase 3 trial for patients with moderate to severe hypertension, testing the effectiveness of different drug combinations (valsartan + amlodipine, valsartan + hctz, amlodipine + hctz, valsartan + amlodipine + hctz) in reducing blood pressure. The inclusion criteria require specific blood pressure ranges, while the exclusion criteria include patients on multiple antihypertensive drugs or with arm circumference over 42 cm.",
    "This sample is a phase 3 trial for the treatment of type 2 diabetes mellitus, testing the drug lixisenatide (ave0010) against a placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for overactive bladder syndrome, testing the drugs fesoterodine and placebo in men aged 40 years and above who have persistent symptoms of OAB. The inclusion criteria include urinary frequency and micturition-related urgency episodes, while the exclusion criteria include contraindication to fesoterodine and previous history of urinary retention.",
    "This sample is a phase 3 clinical trial for patients with chronic kidney disease, testing the drug eplerenone to determine its effectiveness in reducing blood pressure in patients with an estimated glomerular filtration rate between 15-60 ml/min/1.73 m2. The inclusion criteria include age between 18-80 years, signed informed consent, and a blood pressure of \u2265130/80 mmHg or undergoing anti-hypertensive treatment. The exclusion criteria include high potassium levels, allergies to the drug, treatment with spironolactone or certain other medications, inborn errors of metabolism, pregnancy or lactation, and other severe chronic illnesses.",
    "This sample is a phase 3 trial for patients with chronic hepatitis C and liver fibrosis, testing the drugs pentoxyphilline and tocopherol, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the use of vyvanse (lisdexamfetamine dimesylate) in the treatment of attention deficit hyperactivity disorder (ADHD) and attention deficit disorders with hyperactivity, with specific inclusion and exclusion criteria for subjects participating in the study.",
    "This phase 3 trial aims to evaluate the effectiveness of azilsartan medoxomil, with or without chlorthalidone and other non-angiotensin II receptor blocker antihypertensive medications, compared to placebo, in participants with essential hypertension. The eligibility criteria include specific blood pressure ranges, exclusion of certain medications, and the absence of hypersensitivity to AII receptor blockers.",
    "This sample is a phase 3 clinical trial for patients with hypertension, testing the effectiveness of the drug combination ramipril and hydrochlorothiazide in lowering blood pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of dapagliflozin and placebo in combination with insulin therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with unspecified adult solid tumors and weight changes, testing the effectiveness of megestrol acetate and oxandrolone 20 mg in improving weight loss and nutritional requirements.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of fluticasone propionate/formoterol fumarate 100/10 and fluticasone propionate 100 in reducing symptoms, with eligibility criteria including a history of asthma, specific lung function measurements, and exclusion criteria such as recent systemic corticosteroid use or significant pulmonary disease.",
    "This sample is a phase 3 clinical trial studying the effectiveness of trimethoprim-sulfamethoxazole and placebo in treating vesicoureteral reflux and urinary tract infections in children aged 2 months to 6 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with diffuse large B-cell non-Hodgkin's lymphoma, testing the effectiveness of the CHOP regimen as a treatment option.",
    "This sample is a phase 3 clinical trial for postmenopausal females with oestrogen and/or progesterone receptor positive breast cancer, testing the effectiveness of fulvestrant and anastrozole as systemic endocrine therapy for advanced or recurrent disease.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung carcinoma, testing the effectiveness of pemetrexed, gemcitabine, and cisplatin as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for hepatocellular carcinoma (HCC) patients, testing the effectiveness of sirolimus, a drug used in immunosuppressive therapy, in combination with other drugs, for the treatment of HCC. The eligibility criteria include age, histological confirmation of HCC, and exclusion criteria such as hypersensitivity to sirolimus, certain medical conditions, and non-HCC malignancies.",
    "This sample is a phase 2/phase 3 trial for patients with colorectal carcinoma and liver metastases, testing the effectiveness of folfox6 cycles 1-3, folfox6 cycles 4 onwards, and bevacizumab cycles 3 onwards as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of restless legs syndrome using ropinirole extended release (xr) in subjects who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with ulcerative colitis, testing the effectiveness of mesalazine slow-release granules and mesalazine liquid enema as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for hepatocellular carcinoma, testing the drugs sunitinib malate and sorafenib, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for obesity, testing the drugs vi-0521, topiramate, and phentermine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic lymphocytic leukemia (CLL), testing the effectiveness of idelalisib, rituximab, and a placebo in treating the disease. The trial includes adult subjects with previously treated recurrent CLL who have measurable lymphadenopathy and require therapy for CLL, but are currently not fit to receive cytotoxic therapy due to chemotherapy-induced bone marrow damage or comorbidities.",
    "This sample is a phase 3 trial for HIV-1 infected adults, testing the efficacy of dolutegravir, darunavir, and ritonavir in combination therapy, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of enoxaparin and apixaban, along with their matching placebos, in preventing deep vein thrombosis and pulmonary embolism in patients undergoing hip replacement surgery, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of epilepsy with partial seizures, using lamotrigine as the study drug, and includes eligibility criteria such as age, seizure history, and background antiepileptic drug treatment.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of aclidinium bromide, tiotropium, and placebo in improving lung function. The inclusion criteria include age, COPD severity, and smoking history, while the exclusion criteria include no history of asthma and no recent exacerbations.",
    "This sample is a phase 3 clinical trial for pain management, where the drug being tested is 4975 and the placebo, and the eligibility criteria include patients planning to undergo a specific type of foot surgery.",
    "This sample is a phase 3 clinical trial for graft versus host disease, testing the effectiveness of methylprednisolone and placebo as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with asthma, testing the effectiveness of formoterol/fluticasone and foraseq\u00ae drugs in combination with inhaled corticosteroids, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with psoriatic arthritis, testing the effectiveness of intensive management or tight control compared to standard management. The inclusion criteria include patients with less than 24 months disease duration, active disease, and adequate blood count and hepatobiliary function. Exclusion criteria include previous treatment with DMARDs, pregnancy or planning pregnancy, and recent use of investigational agents.",
    "This sample is a phase 3 clinical trial for the drug rebamipide in patients with keratoconjunctivitis sicca (dry eye), with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial is testing the effectiveness of a placebo and 0.15% azelastine hydrochloride in treating moderate to severe seasonal allergic rhinitis in patients 12 years and older, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the drug candesartan to determine its effectiveness in reducing blood pressure in patients with diabetic retinopathy.",
    "This sample is a phase 3 trial testing the effectiveness of valganciclovir and ganciclovir in treating cytomegalovirus infections in patients receiving allogeneic peripheral blood stem cell transplant, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for lipodystrophy and HIV infections, testing the drugs tesamorelin and placebo for tesamorelin, with inclusion criteria including completion of a previous study and signed informed consent, and exclusion criteria including fasting blood glucose levels.",
    "This phase 3 trial focuses on patients with asthma and lung diseases, testing the effectiveness of drugs such as albuterol, colchicine, adrenal cortex hormones, and adrenergic-beta agonists, with specific eligibility criteria varying for each study.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of various combinations of glimepiride and atorvastatin in reducing HbA1c levels and fasting blood glucose, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of quetiapine fumarate as a treatment option, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for non-Hodgkin's lymphoma, testing the effectiveness of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone/prednisolone as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial for patients with thromboembolism, testing the effectiveness of warfarin and dabigatran etexilate as anticoagulant therapy, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for patients with overactive bladder, testing the drug fesoterodine fumarate, and includes inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial for breast cancer patients, testing the drug letrozole, an aromatase inhibitor, with specific eligibility criteria including ER and/or PgR positive tumors, postmenopausal status, and adequate organ function.",
    "This phase 3 trial aims to evaluate the effectiveness of sitagliptin, glipizide, and their respective placebos in patients with type 2 diabetes mellitus and moderate or severe renal insufficiency, while excluding those with type 1 diabetes, active liver disease, or on dialysis.",
    "This phase 3 trial is investigating the effectiveness of sumatriptan succinate / naproxen sodium and placebo in treating migraine without aura, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using methylphenidate 20 mg long-acting capsules as the drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for pediatric patients with refractory partial onset seizures, testing the effectiveness of levetiracetam as an anti-epileptic drug.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the drug ipragliflozin, and includes eligibility criteria such as HbA1c value, BMI range, and exclusion criteria such as type 1 diabetes and renal or cardiovascular diseases.",
    "This sample is a phase 3 trial for patients with schizophrenia and acute agitation, testing the effectiveness of inhaled loxapine and placebo as potential treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with essential hypertension, testing the effectiveness of fimasartan and fimasartan/hctz combination in reducing blood pressure, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis (RA) testing the effectiveness of abatacept and methotrexate (MTX) in patients who have discontinued all biologics and disease-modifying antirheumatic drugs (DMARDs) except for MTX.",
    "This sample is a phase 3 clinical trial for the treatment of psoriasis vulgaris using topical medications, specifically leo 90105 (calcipotriol + betamethasone dipropionate) and dovonex\u00ae (calcipotriol). The study includes eligibility criteria such as a minimum m-PASI score and a target lesion size, and excludes patients with certain skin conditions or who are pregnant or breastfeeding.",
    "This sample is a phase 3 trial for the treatment of schizophrenia using ziprasidone oral capsules, with specific inclusion and exclusion criteria, and the study is based on a previous double-blind treatment study.",
    "This sample is a phase 3 trial for patients with ocular hypertension, testing the effectiveness of the drug bimatoprost/timolol fixed combination in lowering intraocular pressure (IOP) in both eyes, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with B-cell chronic lymphocytic leukemia (CLL), testing the effectiveness of rituximab, cyclophosphamide, and fludarabine phosphate as treatment options, with specific eligibility criteria and patient characteristics outlined.",
    "This sample is a phase 3 trial for patients with acute coronary syndrome, testing the drugs ticagrelor and clopidogrel, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with recurrent uterine corpus carcinoma and other related stages, testing the effectiveness of carboplatin, cisplatin, doxorubicin hydrochloride, and paclitaxel in combination with radiation therapy for potential cure.",
    "This sample is a phase 3 clinical trial for the treatment of diabetic macular edema using infliximab and placebo drugs, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of quetiapine fumarate (Seroquel) SR, an antipsychotic drug, in treating patients with Bipolar Disorder, specifically those with manic or mixed episodes, and who have been admitted to the hospital for the first 4 days of study treatment. The study has specific inclusion and exclusion criteria, including a documented diagnosis of Bipolar Disorder and the absence of certain conditions such as substance abuse or dependence.",
    "This sample is a phase 3 clinical trial for the treatment of epilepsy, testing the drugs zonisamide and carbamazepine, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the efficacy of docetaxel, capecitabine, epirubicin, and cyclophosphamide as adjuvant chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the efficacy of an antidepressant drug (antidepressant + spd489) compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for fibromyalgia, testing the drug pregabalin, with inclusion criteria based on ACR criteria for fibromyalgia and exclusion criteria related to previous adverse events.",
    "This sample is a phase 3 trial for the treatment of cystic fibrosis using tobramycin, with inclusion criteria including successful completion of a core study, at least 6 years of age, and both males and females eligible.",
    "This sample is a phase 2/phase 3 trial for patients with colorectal cancer, testing the drugs cpt-11 and ts-1, as well as cpt-11, 5-fu, and l-lv, with specific eligibility criteria including prior chemotherapy, no prior irinotecan administration, and certain health parameters.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the effectiveness of cisplatin, etoposide, and docetaxel as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 3 trial for patients with atrial fibrillation, testing the efficacy of sr34006 (idraparinux sodium) injection and vitamin K antagonist (warfarin or acenocoumarol) tablets as long-term therapy, with specific eligibility criteria including risk factors and exclusion criteria such as bleeding risk and participation in other studies.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of pramlintide in combination with insulin therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with acute coronary syndrome, testing the effectiveness of clopidogrel, prasugrel, and commercially-available aspirin in preventing adverse cardiovascular events. The eligibility criteria include having had a recent unstable angina/non-ST-elevation myocardial infraction event and not planning to undergo percutaneous coronary intervention or coronary artery bypass graft.",
    "This sample is a phase 3 clinical trial for patients with prostate cancer, testing the effectiveness of drugs such as docetaxel, estramustine phosphate sodium, ketoconazole, and therapeutic hydrocortisone, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) patients, testing the efficacy of mometasone furoate/formoterol (mf/f) combination and mometasone furoate mdi (mf mdi) compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the drug NKTR-118 (also known as naloxegol) and placebo in patients with opioid-induced constipation (OIC). The inclusion criteria include having confirmed OIC symptoms and being on a stable opioid regimen, while the exclusion criteria include cancer-related pain and certain medical conditions.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C infection using drugs such as abt-450/r/abt-267, abt-333, ribavirin, and placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for bipolar disorder, testing the effectiveness of ziprasidone hcl (oral) as a less metabolically disruptive antipsychotic medication, with specific inclusion and exclusion criteria related to metabolic risk factors and contraindications.",
    "This sample is a phase 3 trial testing the drugs sevelamer carbonate and placebo in patients with hyperparathyroidism and chronic kidney disease, with specific inclusion and exclusion criteria related to eGFR and primary parathyroid disease.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of adriamycin, cyclophosphamide, and taxol drugs, with specific eligibility criteria including tumor size, lymph node status, HER2 positivity, and various medical conditions.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec in combination with metformin and other oral antidiabetic drugs, with specific eligibility criteria including HbA1c levels, BMI, and exclusion criteria such as recent use of GLP-1 receptor agonists and life-threatening diseases.",
    "This sample is a phase 3 clinical trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD). The study aims to evaluate the efficacy of the drug nva237 compared to a placebo in improving lung function. The inclusion criteria include patients with a smoking history of at least 10 pack years and a post-bronchodilator FEV1 between 40% and 70% of the predicted normal. The exclusion criteria include pregnant or nursing women, patients with recent COPD exacerbation or lower respiratory tract infection, and patients with certain cardiovascular abnormalities.",
    "This phase 3 trial is investigating the effectiveness of the drugs hzt-501 and ibuprofen in patients with osteoarthritis, rheumatoid arthritis, chronic low back pain, chronic regional pain syndrome, and chronic soft tissue pain who are expected to require daily administration of an NSAID for at least the coming 6 months and have completed a previous 24-week treatment period. The study has specific inclusion and exclusion criteria, including the absence of certain medical conditions and meeting the criteria of previous protocols.",
    "This sample is a phase 3 clinical trial for the treatment of advanced melanoma using the drugs gsk2118436 and dacarbazine (dtic), targeting patients with BRAF mutation positive melanoma who are treatment naive and have measurable disease according to RECIST 1.1 criteria.",
    "This sample is a phase 3 trial for HIV infections, testing the effectiveness of darunavir and ritonavir as antiretroviral treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of indacaterol and placebo to indacaterol in treating the disease. The eligibility criteria include a diagnosis of COPD, a smoking history of at least 10 pack-years, and specific lung function measurements. Various exclusion criteria are also listed.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the drug exemestane, with eligibility criteria including increased risk factors for breast cancer and postmenopausal women over the age of 35, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 trial for major depressive disorder, testing the drug vortioxetine (lu aa21004), with inclusion criteria including completion of a short-term treatment study for major depressive episode, and exclusion criteria including any current psychiatric disorder other than MDD, non-use of effective contraception for female patients of childbearing potential, and use of any psychoactive medication.",
    "This sample is a phase 3 clinical trial for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by Gram-positive pathogens, using single-dose iv oritavancin diphosphate and iv vancomycin as the study drugs, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the effectiveness of tocilizumab and DMARDs compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for HIV-associated neuropathic pain, testing the effectiveness of pregabalin and placebo in reducing moderate to severe pain in subjects with confirmed HIV infection, while excluding pregnant or breastfeeding females, street drug or alcohol abusers, and subjects on certain medications.",
    "This sample is a phase 3 trial for the treatment of psoriasis, testing the drugs cp-690,550 and placebo/cp-690,550, with eligibility criteria including a diagnosis of moderate to severe plaque psoriasis and a Psoriasis Area and Severity Index (PASI) score of 12.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec/insulin aspart in combination with metformin and other oral anti-diabetic drugs. The inclusion criteria include having a diagnosis of type 2 diabetes for at least 24 weeks, being insulin na\u00efve, and having a HbA1c level between 7.0-10.0%. The exclusion criteria include recent use of GLP-1 receptor agonists, recurrent severe hypoglycemia, and known hypersensitivity to trial products.",
    "This phase 3 trial is testing the effectiveness of a fixed combination ophthalmic solution containing bimatoprost and timolol in treating ocular hypertension and glaucoma, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the drug tiotropium. The inclusion criteria include being at least 40 years old, having a smoking history of more than 10 pack-years, and having a Forced Expiratory Volume in 1 Second (FEV1) less than 60% predicted. The exclusion criteria include a recent history of cardiac issues, asthma or allergic conditions, malignancy requiring treatment within the past 5 years, life-threatening pulmonary obstruction, cystic fibrosis, clinically evident bronchiectasis, known active tuberculosis, and known hypersensitivity to anticholinergic drugs.",
    "This sample is a phase 3 clinical trial for the treatment of hypercholesterolemia and dyslipidemia, testing the drugs abt-335 and rosuvastatin calcium, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the treatment of schizophrenia, focusing on patients with a diagnosis of paranoid, disorganized, catatonic, residual, or undifferentiated subtype with persistent negative symptoms. The study includes the drugs asenapine and olanzapine, and the inclusion criteria require a caregiver. Exclusion criteria include uncontrolled medical conditions and other psychiatric disorders.",
    "This sample is a phase 3 clinical trial for the treatment of migraine with or without aura, testing the effectiveness of drugs such as maxalt 10mg mlt plus caffeine 75mg and maxalt 10mg mlt plus placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for renal transplantation, testing the drug enteric-coated mycophenolate sodium (ec-mps), with inclusion criteria including recipients of de novo cadaveric, living unrelated or living related kidney transplants, and exclusion criteria including more than one previous renal transplantation and patients receiving a kidney from a non-heart beating donor.",
    "This sample is a phase 3 trial for participants with chronic hepatitis C genotype 4, testing the efficacy of drugs such as bms-790052, pegylated-interferon alfa 2a, and ribavirin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of lixisenatide, exenatide, and metformin in controlling blood sugar levels, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of Exparel 266 mg, a local anesthetic, compared to a placebo in reducing postoperative pain in patients undergoing thoracotomy, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for adults with chronic hepatitis B, testing the effectiveness of pegylated interferon alpha-2b in patients who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This sample is a phase 3 clinical trial for iron deficiency anemia, testing the drugs ferumoxytol and iron sucrose in participants with specific inclusion and exclusion criteria, such as low hemoglobin and transferrin saturation levels, history of unsatisfactory oral iron therapy, and no allergies to IV iron.",
    "The sample is a phase 3 trial studying the effectiveness of prednisolone and mycophenolate mofetil, as well as prednisolone and tacrolimus, in treating lupus nephritis and membranous glomerulonephritis, with eligibility criteria including abnormal urine protein excretion and biopsy-proven membranous lupus nephritis.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of various drugs including gsk573719/gw642444 and tiotropium bromide, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the effectiveness of folate, methotrexate, methylprednisolone, placebo, and rituximab in treating rheumatoid arthritis in adult patients who are naive to methotrexate treatment.",
    "This sample is a phase 3 clinical trial testing the effectiveness of topiramate and placebo in treating partial seizure disorder, epilepsy, and seizures in infants aged 1-24 months who are receiving regular enteral feedings and weigh between 3.5 and 15 kg. The study has specific inclusion and exclusion criteria, and the goal is to evaluate the efficacy of topiramate as an antiepileptic drug.",
    "This sample is a phase 3 trial for patients with advanced renal cell carcinoma, testing the drug Nexavar (sorafenib) as a single agent treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with moderate to severe idiopathic Parkinson's disease, testing the efficacy of preladenant and rasagiline as potential treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with breast cancer, testing the effectiveness of docetaxel and gemcitabine in treating unresectable, locally recurrent, or metastatic disease, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for locally advanced breast cancer, testing the drugs trastuzumab, doxorubicin, paclitaxel, and cmf, with inclusion criteria of female patients aged 18 or older and exclusion criteria of previous therapy for any invasive malignancy.",
    "This sample is a phase 3 trial for the treatment of bacterial pneumonia, testing the effectiveness of ceftaroline fosamil for injection, ceftriaxone, and placebo, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 3 trial for rheumatoid arthritis patients who have experienced a disease flare after initial response to infliximab, and it aims to evaluate the efficacy and safety of different dosing schedules of infliximab.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of omalizumab, placebo, and fluticasone as treatments, with specific eligibility criteria including age, weight, IgE levels, asthma diagnosis, positive skin test, and lung function.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the effectiveness of different drug combinations including abatacept, infliximab, and placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for the treatment of overactive bladder using normal saline (placebo) in patients with neurogenic overactive bladder due to spinal cord injury or multiple sclerosis, who have had an inadequate response to anticholinergic medication.",
    "This sample is a phase 3 clinical trial for non-small-cell lung carcinoma, testing the efficacy of sorafenib + paclitaxel + carboplatin compared to placebo + paclitaxel + carboplatin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with generalized anxiety disorder, testing the effectiveness of quetiapine fumarate and escitalopram oxylate as potential drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of chronic lymphocytic leukemia using obinutuzumab, rituximab, and chlorambucil, with specific eligibility criteria including age, disease type, and previous treatment history.",
    "This sample is a phase 3 clinical trial for patients with Crohn's disease, testing the effectiveness of clarithromycin and placebo in combination with prednisolone or budesonide, azathioprine, and 5-ASA preparation, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for restless legs syndrome, testing the drug rotigotine, with inclusion criteria of idiopathic RLS and exclusion criteria of secondary RLS, history of sleep disturbances, and symptomatic orthostatic hypotension.",
    "This phase 3 trial aims to evaluate the effectiveness of valsartan and enalapril, two drugs commonly used to treat hypertension, in children and adolescents aged 6-17 with a documented history of hypertension. The study includes specific inclusion and exclusion criteria, such as age, weight, blood pressure measurements, and the absence of certain medical conditions.",
    "This sample is a phase 3 trial for trauma patients with ongoing significant hemorrhage, testing the effectiveness of tranexamic acid and sodium chloride 0.9% in reducing blood loss. The eligibility criteria include patients with low blood pressure or high heart rate within 8 hours of injury, while exclusion criteria include patients with clear indications or contraindications for antifibrinolytic therapy.",
    "In this phase 3 trial, the drug montelukast sodium is being tested for its effectiveness in treating episodic asthma in patients aged 6 months to 5 years, with exclusion criteria including patients who are not in otherwise good health and patients with persistent asthma.",
    "This sample is a phase 3 clinical trial for patients with partial epilepsy and partial seizures, where the drug being tested is levetiracetam, and the eligibility criteria include age range, weight range, and specific diagnostic and treatment requirements.",
    "This sample is a phase 3 clinical trial for kidney transplantation, testing the drugs tacrolimus, mycophenolate mofetil, and steroids, with inclusion criteria including patients aged 60 or older and exclusion criteria such as previous organ transplants or significant infections.",
    "This sample is a phase 3 trial for patients with refractory epilepsy, testing the effectiveness of Keppra\u00ae extended release formulation - XR compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 1 diabetes, testing the effectiveness of insulin degludec, insulin detemir, and insulin aspart in controlling blood sugar levels, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial studying the effects of dehydroepiandrosterone and placebo on women aged 40-65 years with decreased desire or interest in sexual activity, with inclusion criteria including being postmenopausal, sexually active, and having a BMI of 18-34 kg/m2.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C, testing the efficacy of eltrombopag and placebo drugs in combination with peginterferon and ribavirin antiviral therapy, with specific eligibility criteria for subjects to participate in the study.",
    "This sample is a phase 3 trial for major depressive disorder, testing the drugs DVS-233 SR and venlafaxine ER, with inclusion criteria including outpatients and sexually active individuals using contraception, and exclusion criteria including previous treatment with DVS-233 SR or venlafaxine and hypersensitivity to venlafaxine.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer (NSCLC) who have failed prior treatments. The study is testing the efficacy of talactoferrin and placebo drugs in patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for children with asthma, testing the effectiveness of different doses of map0010 and a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial testing the drugs telmisartan and bisoprolol versus placebo in patients with diabetes mellitus, heart failure, and coronary artery disease. The eligibility criteria include age > 18 years, known diabetes mellitus > 6 months, increased Nt-proBNP above 125pg/ml, and informed consent. Exclusion criteria include other diseases with a life expectancy below 1 year, chronic infection or malignant disease, women in childbearing age without contraceptive, history of cardiac disease, systemic cortisone treatment, and patients on chronic or acute hemodialysis, ultrafiltration, or peritoneal dialysis.",
    "This sample is a phase 3 clinical trial for the treatment of proctitis, a disease affecting the rectum, using drugs such as mesalamine and canasa, as well as a placebo, with specific eligibility criteria for participants.",
    "This phase 3 trial aims to evaluate the effectiveness of donepezil, a drug used for Alzheimer's disease, compared to a placebo in reducing sedation caused by opiates in patients with advanced cancer.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of the drug qva149 compared to a placebo, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial testing the use of Lamictal in the treatment of post-herpetic neuralgia, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for the drug vilazodone in patients with major depressive disorder, with specific inclusion and exclusion criteria, and the study aims to assess the drug's efficacy in treating the disorder.",
    "This sample is a phase 3 clinical trial for multiple sclerosis, testing the efficacy of glatiramer acetate (db) and glatiramer acetate (ol) compared to a placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 trial for heartburn, testing the effectiveness of esomeprazole as a heartburn medication, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the drugs bifeprunox and quetiapine, with the inclusion criteria being a diagnosis of schizophrenia, age between 18-65 years, and no recent hospitalization for an exacerbation of schizophrenia.",
    "This phase 3 trial is investigating the effectiveness of smc021 oral calcitonin and smc021 placebo in treating knee osteoarthritis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for patients with non-small cell lung cancer (NSCLC) and includes eligibility criteria related to disease characteristics, patient characteristics, and prior concurrent therapy. The trial will test the effectiveness of carboplatin, cediranib maleate, and paclitaxel as potential treatments for NSCLC.",
    "This phase 3 trial is testing the effectiveness of moxifloxacin and ertapenem intravenous drugs in treating hospitalized men and women with confirmed or suspected intra abdominal infection, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 3 clinical trial for gastric cancer, testing the drugs capecitabine and oxaliplatin in adult participants who have undergone potentially curative tumor resection and have not received prior chemotherapy or radiotherapy.",
    "This sample is a phase 3 trial testing the drugs apixaban and enoxaparin for the treatment of venous thrombosis and pulmonary embolism in patients with congestive heart failure, acute respiratory failure, infection, acute rheumatic disorder, and inflammatory bowel disease. The eligibility criteria include age 40 or older, exclusion of patients with venous thromboembolism, active bleeding or high risk of bleeding, inability to take oral medication, and ongoing treatment with anticoagulants or antiplatelets other than aspirin at a dose \u2264 165 mg/day.",
    "This sample is a phase 3 trial for the treatment of hyperlipidemia using a placebo drug, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 clinical trial is investigating the use of memantine, a drug used to treat Alzheimer's disease, in patients with brain metastases from various solid tumor malignancies, who have stable systemic disease and meet specific eligibility criteria.",
    "This phase 3 trial is testing the drug bosentan for the treatment of pulmonary hypertension and sickle cell anemia, with specific eligibility criteria including completion of a previous study, negative pregnancy test, and use of reliable contraception methods.",
    "This sample is a phase 3 trial for patients with pulmonary embolism, testing the drugs rivaroxaban and enoxaparin in combination with VKA, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of ferinject \u00ae (ferric carboxymaltose) and normal saline (0.9%) in treating stable symptomatic chronic heart failure (CHF) patients with low left ventricular ejection fraction (LVEF) and iron deficiency, based on specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the drugs vildagliptin am, vildagliptin pm, and placebo, with inclusion criteria including being on metformin for at least three months and having a stable dose, and exclusion criteria including pregnancy, lactation, and significant diabetic complications.",
    "This sample is a phase 3 clinical trial for adolescents with schizophrenia, testing the effectiveness of risperidone as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of psoriasis, testing the drugs placebo and ustekinumab, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with acute or primary HIV-1 infection, testing the effectiveness of multiple drug combinations including raltegravir, maraviroc, darunavir, ritonavir, and tenofovir/emtricitabine, with specific inclusion and exclusion criteria.",
    "In this phase 3 trial, the drugs being tested are edoxaban and enoxaparin sodium for the prevention of venous thromboembolism in patients undergoing unilateral total hip arthroplasty, with exclusion criteria including subjects with risks of hemorrhage, thromboembolic risks, weighing less than 40 kg, and those who are pregnant or suspect pregnancy.",
    "This sample is a phase 3 clinical trial studying the effects of omega-3 fatty acids (fish oil supplements) versus placebo on patients who have experienced a heart attack in the 2 to 4 weeks before study entry, with exclusion criteria including metallic implants, active cancer, and significant kidney dysfunction.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of various drugs, including indacaterol and salmeterol/fluticasone, in treating moderate-to-severe chronic obstructive pulmonary disease (COPD) in patients aged \u226540 years with a smoking history of at least 20 pack years and specific lung function criteria.",
    "This sample is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) using the drugs \"nwp09\" and \"placebo\" to assess the safety and efficacy of pharmacologic treatment in children aged 6 to 12 years.",
    "This sample is a phase 3 clinical trial for HIV infections, testing the effectiveness of various drug combinations including tenofovir/emtricitabine and nevirapine, and tenofovir/emtricitabine/efavirenz, among others, on HIV-1 infected patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic myelogenous leukemia, testing the effectiveness of nilotinib and imatinib drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for lung cancer, non-small cell, testing the drug hycamtin, oral capsules, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin glargine, insulin glulisine, metformin, and insulin secretagogue drugs in combination with basal insulin and other oral antidiabetic medications. The eligibility criteria include being a type 2 diabetic with a BMI \u2264 40 kg/m\u00b2 and HbA1c > 7%, and exclusion criteria include type 1 diabetes, certain treatments, and various medical conditions.",
    "This sample is a phase 3 clinical trial for postmenopausal women with osteoporosis, testing the effectiveness of denosumab compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with metastatic breast cancer, testing the effectiveness of drugs such as g-csf, trastuzumab, and vinorelbine, with specific eligibility criteria including confirmation of breast carcinoma, HER-2/neu overexpression, and adequate cardiac function.",
    "This sample is a phase 3 clinical trial for the drug brivaracetam tablets, bolus, and infusion, which aims to evaluate the efficacy and safety of the drug in treating epilepsy patients who are uncontrolled while being treated with 1 to 2 permitted concomitant antiepileptic drugs (AEDs). The study includes specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 trial for patients diagnosed with gastroesophageal reflux, testing the drugs lafutidine and famotidine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for bipolar depression, testing the effectiveness of quetiapine fumarate (seroquel) extended release compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with acute coronary syndromes, testing the switch from fondaparinux to bivalirudin or unfractionated heparin as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of psoriasis vulgaris using various drugs such as calcipotriol plus betamethasone and betamethasone-17,21-dipropionate, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the effectiveness of ospemifene 60 mg, a drug used to treat vaginal atrophy, compared to a placebo, in menopausal women with moderate or severe symptoms of vaginal atrophy.",
    "This sample is a phase 3 trial for patients with idiopathic pulmonary fibrosis, testing the drug bosentan, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of gemcitabine, capecitabine, and vinorelbine in treating breast cancer patients who have progressed after combination treatment of a taxane and an anthracycline, and meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for epilepsy patients, testing the effectiveness of brivaracetam in reducing the frequency of partial onset seizures.",
    "This phase 3 trial is testing the effectiveness of metformin and cj-30001/cj-30002 in treating Type 2 Diabetes Mellitus, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 trial aims to evaluate the effectiveness of tadalafil, placebo, and finasteride in treating benign prostatic hyperplasia and enlarged prostate, with specific eligibility criteria for participants, such as not having taken certain treatments within a specified duration and having bladder outlet obstruction.",
    "This sample is a phase 3 trial for kidney transplantation, focusing on the use of drugs like prograf-xl, prograf, and mmf, with specific eligibility criteria for patients, including exclusion criteria such as previous organ transplants, HIV seropositivity, and significant liver disease.",
    "This sample is a phase 3 trial for obesity, testing the drugs vi-0521 and placebo matched phentermine/topiramate, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for metastatic breast cancer patients who have progressed on prior aromatase inhibitor therapy, and it aims to evaluate the efficacy of exemestane and everolimus in combination as a treatment option.",
    "This sample is a phase 3 clinical trial for prostate cancer patients who are asymptomatic and meet specific disease characteristics, such as histologically confirmed prostate cancer and no metastatic disease, and patient characteristics, such as age 80 and under and WHO performance status 0-2. The trial will test the drugs bicalutamide and goserelin acetate for their effectiveness in treating prostate cancer.",
    "This sample is a phase 3 trial for overactive bladder, testing the drugs fesoterodine fumarate, placebo, and tolterodine tartrate, with inclusion criteria of urinary frequency and urgency urinary incontinence, and exclusion criteria of contraindications to fesoterodine use, significant hepatic and renal disease, and OAB symptoms caused by neurological conditions or known pathologies of urinary tract.",
    "This sample is a phase 3 clinical trial for pediatric patients with rhinitis, testing the effectiveness of levocetirizine in treating symptoms such as rhinorrhea, nasal congestion, and sneezing, with specific eligibility criteria including age range, QTc interval, and liver function.",
    "This sample is a phase 2/phase 3 trial for patients with active rheumatoid arthritis who have an incomplete response to methotrexate. The study will test the efficacy of ce-224,535, a drug, compared to a placebo in treating the disease.",
    "This phase 3 trial is investigating the effectiveness of zoledronic acid, placebo, and teriparatide in postmenopausal women with osteoporosis, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of budesonide/formoterol pmdi and formoterol turbuhaler in reducing COPD exacerbations, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial for patients with venous thromboembolism, testing the drug fondaparinux sodium, and includes eligibility criteria such as age \u2265 18 years old and having at least one risk factor for VTE.",
    "This sample is a phase 3 trial studying the effects of cangrelor, clopidogrel, and post-cangrelor clopidogrel on patients with atherosclerosis undergoing percutaneous coronary intervention (PCI) for stable angina, non-ST-segment elevation acute coronary syndrome (NSTE-ACS), or ST-segment elevation myocardial infraction (STEMI). The eligibility criteria include being at least 18 years old, having recent diagnostic angiography demonstrating atherosclerosis, and providing written informed consent. Exclusion criteria include recent use of P2Y12 inhibitors, eptifibatide, tirofiban, or abciximab, receipt of fibrinolytic therapy, increased bleeding risk, and currently receiving warfarin or experiencing active bleeding.",
    "This sample is a phase 3 trial for patients with primary hypertension, testing the effectiveness of candesartan cilexetil, hydrochlorothiazide, and candesartan/hct 32/25 mg in reducing mean sitting DBP, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for seasonal allergic rhinitis, testing the effectiveness of drugs such as bilastine and desloratadine compared to a placebo, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 3 trial for osteoporosis, testing the effectiveness of zoledronic acid and placebo, with specific inclusion and exclusion criteria, such as previous participation in the HORIZON-Pivotal Fracture Study and exclusion for poor kidney, eye, or liver health.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of biphasic insulin aspart, insulin detemir, and insulin aspart in combination with metformin, a sulphonylurea, or a combination of both, for patients who are insulin naive and have a BMI below or equal to 40.0 kg/m2, with HbA1c levels between 7.0% and 10%. The study excludes patients with proliferative retinopathy, recurrent major hypoglycemia, cardiac problems, uncontrolled hypertension, and impaired hepatic or renal function.",
    "This sample is a phase 3 trial for patients with symptomatic heart failure who have intolerance to first-line medication, and it will test the effectiveness of losartan 50 mg and losartan 150 mg as alternative and/or additional drug treatment.",
    "This sample is a phase 3 trial for prostate cancer, testing the drugs amg 162 and placebo, with eligibility criteria that include specific icd-10 codes for the disease.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of vildagliptin and placebo in reducing HbA1c levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for locally advanced or metastatic HER2-positive breast cancer, testing the drugs docetaxel, vinorelbine, and trastuzumab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with hypertension, testing the combination pill of losartan and hydrochlorothiazide as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with aneurysmal subarachnoid hemorrhage, testing the efficacy of the drug clazosentan compared to a placebo in preventing cerebral vasospasm.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of risperidone and ziprasidone as treatments. The inclusion criteria require hospitalized patients with a minimum PANSS score of 60, while the exclusion criteria include previous intolerance or lack of response to risperidone.",
    "This sample is a phase 3 clinical trial for women with platinum-sensitive recurrent ovarian cancer, testing the drug topotecan. The inclusion criteria include age, disease status, and performance status, while the exclusion criteria include chemotherapy history, timing of disease progression, radiation, hypersensitivity to certain drugs, infection, and pregnancy or breastfeeding.",
    "This sample is a phase 3 clinical trial for patients with breast cancer, fatigue, and gastrointestinal cancer, testing the effectiveness of methylphenidate compared to a placebo in reducing fatigue symptoms.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer, testing the drugs alimta or taxotere and erlotinib [tarceva], with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of drugs such as placebo, canagliflozin, sitagliptin, and metformin immediate release, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of foster\u00ae 100/6 \u00b5g/unit dose and seretide accuhaler\u00ae 500/50 \u00b5g/actuation in improving lung function and reducing exacerbations. Eligible patients must be aged \u2265 40 years, have a smoking history of at least 10 pack years, and meet specific lung function criteria.",
    "This sample is a phase 3 trial for HIV infection and hyperlipidemia, testing the effectiveness of atazanavir and the current antiretroviral regimen in patients with specific eligibility criteria, including HIV-1 RNA levels, CD4 count, and stable antiretroviral regimen.",
    "This sample is a phase 3 trial for prostatitis, testing the drugs alfuzosin and placebo, with inclusion criteria including male participants over 18 years old experiencing pelvic discomfort for at least six weeks, and exclusion criteria including previous use of certain alpha-adrenergic receptor blockers and history of certain medical conditions or surgeries.",
    "This sample is a phase 3 trial for patients with moderate essential hypertension, testing the effectiveness of valsartan + amlodipine in reducing blood pressure.",
    "This phase 3 clinical trial is testing the effectiveness of carboplatin, gemcitabine hydrochloride, and paclitaxel in treating patients with non-small cell lung cancer who have recurrent disease or distant metastases, and meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for patients with metastatic breast cancer and hypercalcemia of malignancy, testing the effectiveness of ibandronate sodium, zoledronic acid, and zolendronic acid in treating multiple bone metastases. The eligibility criteria include having histologically proven breast cancer, newly diagnosed bone metastases, and an ECOG performance status of 0-2.",
    "This phase 3 clinical trial is investigating the efficacy of ranibizumab injections and sham injections in treating macular edema and retinal vein occlusion, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of spasticity in multiple sclerosis patients using Sativex, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 clinical trial is testing the effectiveness of 5-fluorouracil, capecitabine, and cisplatin in treating advanced and/or metastatic gastric cancer in adults aged 18 to 75 years with at least 1 measurable lesion.",
    "This phase 3 trial is investigating the efficacy of the drug tc-5214 compared to a placebo in patients with major depressive disorder (MDD) who have had an inadequate response to one antidepressant. The study aims to assess the safety and effectiveness of tc-5214 as an adjunctive treatment for MDD.",
    "This sample is a phase 3 trial for breast neoplasms and hormone-dependent neoplasms, testing the drugs atamestane, toremifene, and letrozole, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for major depressive disorder, testing the effectiveness of antidepressant + placebo and antidepressant + aripiprazole in patients who have had an inadequate response to one to three antidepressants.",
    "This sample is a phase 2/phase 3 trial for HIV infections, testing the effectiveness of various antiretroviral drugs (nrtis, nnrtis, and pis) in HIV-infected individuals aged 30 days to 18 years, who have not previously received HAART or anti-HIV drugs for more than 56 consecutive days after birth, and meet other inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with epithelial ovarian cancer, peritoneal primary carcinoma, or fallopian tube cancer, testing the effectiveness of carboplatin and paclitaxel drugs in combination with eligibility criteria including specific histologic diagnoses, blood count and liver function requirements, and exclusion criteria such as",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of drugs such as indacaterol and glycopyrronium (qva149) and fluticasone/salmeterol, compared to placebos, based on specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs dimebon and placebo on patients with mild-to-moderate Alzheimer's disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of different drug treatments including placebo, tiotropium + olodaterol, tiotropium, and olodaterol, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 trial is testing the drug gefitinib in patients with non-small cell lung cancer who have not progressed after prior chemotherapy, and have no active interstitial lung disease or other concurrent anticancer therapy.",
    "This sample is a phase 3 trial for bipolar disorder, testing the effectiveness of olanzapine, haloperidol, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for osteoarthritis, testing the effectiveness of hydrocodone/acetaminophen extended release and placebo in managing pain, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for restless legs syndrome, testing the drug ropinirole extended release (xr), with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the treatment of pulmonary hypertension using the drug tadalafil, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of systemic lupus erythematosus, testing the drugs premarin and provera in postmenopausal women with inactive or stable disease.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis, testing the efficacy of methotrexate and tocilizumab in combination with stable doses of corticosteroids and excluding patients with certain medical conditions and prior treatments.",
    "This sample is a phase 3 trial studying the effectiveness of intravitreal triamcinolone injection in treating macular edema associated with central retinal vein occlusion and branch retinal vein occlusion.",
    "This sample is a phase 3 clinical trial for the treatment of perennial allergic rhinitis (PAR) using ciclesonide nasal aerosol and placebo, with eligibility criteria including a history of PAR and sensitivity to allergens known to induce PAR.",
    "This phase 3 trial is testing the effectiveness of erlotinib hydrochloride and matched placebo in treating advanced non-small cell lung cancer patients who are not suitable for first-line chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of exenatide and insulin glargine in combination therapy, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of losartan potassium + hydrochlorothiazide + amlodipine besylate, losartan potassium, and amlodipine besylate in treating essential hypertension, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for HIV-1 patients, testing the effectiveness of the drugs tmc278 and efavirenz in combination with nucleoside/nucleotide reverse transcriptase inhibitors, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of autistic disorder, testing the effectiveness of fluoxetine and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of human insulin inhalation powder and insulin in insulin-naive patients who are non-smokers, with specific inclusion and exclusion criteria.",
    "This phase 3 trial focuses on testing the effectiveness of tiotropium inhalation solution, a medication used for chronic obstructive pulmonary disease (COPD), in patients with pulmonary disease.",
    "This sample is a phase 3 trial for patients with epilepsy, specifically partial epilepsy, using the drug levetiracetam. The inclusion criteria include patients who completed a previous trial and wish to continue treatment with the drug, while the exclusion criteria include patients who did not participate in the previous trial or were not compliant with the study requirements.",
    "This phase 3 trial is investigating the effectiveness of duloxetine hydrochloride in treating patients with painful sensory chemotherapy-induced peripheral neuropathy resulting from prior treatment with single-agent taxane or platinum agents, and who meet specific eligibility criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of lixisenatide (ave0010) in combination with metformin compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of lc15-0444 and sitagliptin in combination with metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of aclidinium bromide/formoterol fixed-dose combination (FDC), aclidinium bromide, formoterol fumarate, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for a drug called IDEA-033, which aims to treat joint pain, musculoskeletal pain, stiffness, and soft tissue inflammation in designated target areas. The eligibility criteria include being at least 18 years old, refraining from chronic usage of NSAIDs or other analgesics, and having healthy skin in the target areas. Exclusion criteria include hypersensitivity to IDEA-033 or other NSAIDs, history of coagulation disorders or peptic ulcers, and clinically significant renal, hepatic, or gastric disease.",
    "This sample is a phase 3 trial for patients with hypercholesterolemia, testing the effectiveness of various drugs including ezetimibe/simvastatin, niacin, and their combinations, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the efficacy of rivastigmine capsule and rivastigmine transdermal patch in treating Parkinson's disease dementia, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with colorectal and liver neoplasms, testing the effectiveness of irinotecan + 5 fu + folinic acid and folinic acid + 5 fu drugs in combination with surgical resection of liver metastasis(es) as the inclusion criteria, while excluding patients with prior hepatic radiation or resection, prior radiofrequency ablation or cryoablation, and prior chemotherapy for metastatic disease.",
    "This phase 3 trial is investigating the efficacy of vortioxetine in patients with major depressive disorder, with specific inclusion and exclusion criteria, and the study aims to assess the drug's effectiveness in treating recurrent MDD.",
    "This sample is a phase 2/phase 3 trial for asthma, testing the drugs rosiglitazone, theophylline, beclomethasone, and inhaled beclomethasone and oral theophylline, with eligibility criteria including age, smoking history, asthma diagnosis, and lung function requirements.",
    "This sample is a phase 2/phase 3 trial for the treatment of multiple sclerosis using duloxetine and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with major depression, testing the drug risperidone, and includes inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the efficacy of vortioxetine compared to placebo, with inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for bipolar disorder, testing the effectiveness of ziprasidone oral capsules, with specific inclusion and exclusion criteria related to a previous double-blind treatment study.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the drugs carbidopa/levodopa/entacapone and immediate release carbidopa/levodopa. The eligibility criteria include a clinical diagnosis of idiopathic Parkinson's disease and a diagnosis of Parkinson's disease for no more than 5 years.",
    "This sample is a phase 3 trial for the drug sildenafil citrate (uk-92,480) in patients with pulmonary hypertension, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia or schizoaffective disorder, testing the efficacy and safety of switching to lurasidone hcl as an antipsychotic medication.",
    "This sample is a phase 2/phase 3 trial for breast neoplasm, testing the effectiveness of paclitaxel weekly in combination with capecitabine and docetaxel every 3 weeks in combination with capecitabine, with eligibility criteria including morphologically proven breast carcinoma, measurable and/or evaluable disease, age 18 years or older, and adequate cardiac, hematological, renal, and hepatic functions.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin lispro protamine suspension and insulin glargine in combination with oral antihyperglycemic medications. The eligibility criteria include having type 2 diabetes for at least 1 year, being 18 years or older, and having a hemoglobin A1c between 7.5% and 10.0%.",
    "This sample is a phase 3 trial for smoking cessation, testing the effectiveness of varenicline tartrate and placebo in helping current cigarette smokers between the ages of 18 and 75 years, who are motivated to stop smoking. The study has specific inclusion and exclusion criteria, and the diseases being targeted are not mentioned.",
    "This sample is a phase 3 trial for the treatment of social anxiety disorder using the drug quetiapine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with head and neck cancer and squamous cell carcinoma, testing the drug erlotinib. The inclusion criteria include having metastatic, recurrent, or persistent cancer, while the exclusion criteria include prior chemotherapy and recent chemotherapy or radiotherapy.",
    "This sample is a phase 3 trial testing the drugs edoxaban and enoxaparin sodium for the treatment of venous thromboembolism in patients undergoing unilateral total knee arthroplasty, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for breast cancer patients who have undergone complete resection of the primary tumor, and it aims to evaluate the effectiveness of a combination of drugs including cyclophosphamide, docetaxel, epirubicin hydrochloride, fluorouracil, goserelin acetate, and tamoxifen citrate in preventing the recurrence of breast cancer.",
    "This sample is a phase 3 clinical trial for patients with newly diagnosed acute myeloid leukemia (AML), testing the efficacy of ara-c, mitoxantrone, daunorubicin, and thioguanin as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of diabetic peripheral neuropathy using the drug pregabalin, with inclusion criteria including a diagnosis of painful diabetic peripheral neuropathy and pain on walking, and exclusion criteria including inability to walk 50 feet on a flat surface and pain on walking due to conditions other than diabetic peripheral neuropathy.",
    "This sample is a phase 2/phase 3 trial for anal cancer, testing the drugs cisplatin, fluorouracil, and mitomycin c, with eligibility criteria including histologically confirmed squamous cell anal carcinoma and specific tumor characteristics.",
    "This sample is a phase 3 clinical trial for patients with prostate cancer, testing the effectiveness of leuprolide acetate formulations A and B in continuous androgen deprivation treatment. The eligibility criteria include specific disease stage, rising PSA levels, and Eastern Cooperative Oncology Group performance status. Exclusion criteria include certain medical conditions, recent prostate cancer therapies, and use of certain medications.",
    "This sample is a phase 3 trial for the treatment of diabetes mellitus using pioglitazone and metformin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the efficacy of fluorouracil, doxorubicin, cyclophosphamide, and paclitaxel as adjuvant chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of hospital-acquired pneumonia using levofloxacin and piperacillin/tazobactam, with specific inclusion and exclusion criteria for enrollment.",
    "This sample is a phase 3 clinical trial for patients with chronic lymphocytic leukemia, testing the effectiveness of fludarabine and cyclophosphamide as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2/phase 3 trial for lupus nephritis, testing the drugs atacicept, mycophenolate mofetil, placebo, and corticosteroids, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with hypercholesterolemia, testing the effectiveness of atorvastatin and ezetimibe in reducing LDL-C levels in patients on background lipid-lowering therapy.",
    "This sample is a phase 3 clinical trial for the treatment of pulmonary arterial hypertension in children, using sildenafil citrate and placebo drugs, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial for patients with Parkinson's disease, testing the efficacy of rasagiline mesylate as a continued therapy option, with specific inclusion and exclusion criteria based on previous evaluations.",
    "This sample is a phase 3 trial for patients with acute heart failure, testing the efficacy of tezosentan compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the drug candesartan to determine its effectiveness in reducing blood pressure and improving retinal health.",
    "This sample is a phase 3 trial for patients with mild to moderate hypertension, testing the effectiveness of various drugs including amlodipine and manidipine, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of indacaterol and placebo in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who have a smoking history of at least 10 pack-years and meet specific lung function criteria.",
    "This sample is a phase 2/phase 3 trial for patients with Philadelphia chromosome positive accelerated or blast phase chronic myeloid leukemia, testing the drug panobinostat. The eligibility criteria include prior treatment with at least two BCR-ABL tyrosine kinase inhibitors and resistance to the most recent therapy. Exclusion criteria include being a candidate for hematopoietic stem cell transplantation and impaired cardiac function.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis B using the drug lamivudine, with specific eligibility criteria including liver biopsy acceptance, certain grades of hepatitis, and viral load thresholds.",
    "This sample is a phase 3 clinical trial for patients with chronic hepatitis B, testing the effectiveness of telbivudine and adefovir dipivoxil drugs in reducing viral breakthrough, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 clinical trial for patients with chronic sinusitis and nasal polyps, testing the effectiveness of S8 sinus implant and mometasone furoate nasal spray in reducing symptoms and improving quality of life.",
    "This sample is a phase 3 trial for the treatment of benign prostatic hyperplasia and lower urinary tract symptoms, using various drugs including placebo tamsulosin hydrochloride ocas 0.4 mg and tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with hyperphosphatemia and end-stage renal disease, testing the effectiveness of ferric citrate as a phosphate binder for patients on hemodialysis or peritoneal dialysis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of low back pain using the drugs thiocolchicoside+ketoprofen and thiocolchicoside, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with breast cancer, testing the drugs exemestane and anastrozole, and the eligibility criteria include having confirmed breast cancer and being inoperable or having metastatic progressive or locally recurrent breast cancer.",
    "This sample is a phase 3 clinical trial for patients with diabetes mellitus type 2, testing the effectiveness of the drugs placebo and taspoglutide in reducing HbA1c levels and BMI, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the efficacy of rivaroxaban and placebo in treating venous thromboembolism, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for rheumatoid arthritis patients who have inadequate response to methotrexate, and the study is testing the efficacy of rituximab in treating the disease.",
    "This sample is a phase 3 trial for a drug called oxycodone naloxone prolonged release tablets (oxn) to treat moderate to severe pain caused by opioids, specifically targeting constipation as a side effect. The study includes inclusion and exclusion criteria, and the diseases being studied are pain-related.",
    "This phase 3 trial aims to evaluate the effectiveness of didanosine, lamivudine, and efavirenz, as well as didanosine, lamivudine, and nevirapine, in treating tuberculosis and human immunodeficiency virus infections in patients who meet specific inclusion criteria, such as being newly diagnosed with sputum smear positive tuberculosis and having a CD4 cell count less than 250 cells/mm3.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin glargine new formulation and insulin glargine in combination with oral antihyperglycemic drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of seasonal allergic rhinitis using different concentrations and dose volumes of epinastine nasal spray, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of sepsis using drotrecogin alfa (activated) and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with pain associated with cancer or cancer treatment, testing the effectiveness of the drug bema\u2122 compared to a placebo, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of atorvastatin, a statin drug, in treating patients with atrial fibrillation and inflammation, while considering various eligibility criteria and exclusion factors.",
    "This sample is a phase 3 clinical trial for patients with type II diabetes mellitus, testing the drugs vildagliptin and glimepiride in combination with stable metformin treatment, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is investigating the use of capecitabine in patients with histologically confirmed biliary tract cancer who have undergone radical surgical approaches, and meet specific eligibility criteria related to their disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of liraglutide, glimepiride, and placebo in treating type 2 diabetes patients who have not responded to diet and lifestyle changes or metformin monotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with relapsed ovarian, fallopian tube, or primary peritoneal cancer, testing the effectiveness of paclitaxel, saracatinib, and a matched placebo as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 trial is testing the efficacy of inhaled mannitol compared to a placebo in patients with cystic fibrosis, and the eligibility criteria include having a confirmed diagnosis of cystic fibrosis, being aged > 6 years old, and having FEV1 >40% and < 90% predicted.",
    "This phase 3 clinical trial aims to evaluate the efficacy of the drug \"cov795\" compared to a placebo in patients undergoing a primary unilateral first metatarsal bunionectomy for the treatment of postoperative pain. The eligibility criteria include being 18 to 75 years old, having a body mass index \u226433 kg/m2, and being in generally good health.",
    "This sample is a phase 2/phase 3 trial for the treatment of type 2 diabetes mellitus using alogliptin and pioglitazone, with eligibility criteria including completion of a previous study, understanding and compliance with protocol requirements, and exclusion criteria related to hepatic impairment, renal impairment, and cardiac failure.",
    "This phase 3 trial aims to evaluate the effectiveness of clevidipine, a calcium channel blocker, in reducing systolic blood pressure in patients with hypertension undergoing cardiac surgery.",
    "This sample is a phase 3 clinical trial for amyotrophic lateral sclerosis (ALSO) patients, testing the drugs dexpramipexole and placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with idiopathic pulmonary fibrosis (IPF) testing the efficacy of bosentan, an endothelin receptor antagonist, compared to a placebo. The inclusion criteria include a proven diagnosis of IPF within the last 3 years, while the exclusion criteria include various conditions and medications that may interfere with the study.",
    "This sample is a phase 2/phase 3 trial for tobacco dependence, testing the effectiveness of s-adenosyl-l-methionine (SAMe) as a treatment option, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is investigating the effectiveness of rotigotine, a non-ergot dopamine agonist, in treating advanced Parkinson's disease patients who are experiencing motor fluctuations and nocturias, and are already on a stable dose of levodopa and a non-ergot dopamine agonist.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of vortioxetine, duloxetine, and placebo as treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with essential hypertension, testing the effectiveness of aliskiren, amlodipine, and hydrochlorothiazide as treatment options, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of liraglutide, a drug used to treat type 2 diabetes, compared to a placebo, in patients with type 2 diabetes who are already on stable basal insulin analogue dose and metformin. The trial will assess the impact of liraglutide on HbA1c levels, body mass index, and other eligibility criteria.",
    "This sample is a phase 3 trial for the treatment of painful diabetic neuropathy using the drug lacosamide, with inclusion criteria being patients with painful diabetic neuropathy and exclusion criteria being patients with liver enzyme abnormalities, impaired renal function, cardiac abnormalities, and pregnant or nursing females.",
    "This sample is a phase 3 clinical trial for acute schizophrenia, testing the effectiveness of er oros paliperidone and olanzapine as treatment. The inclusion criteria include having a DSM-IV diagnosis of schizophrenia, a specific PANSS score range, and meeting certain requirements for contraception. The exclusion criteria include having a diagnosis other than schizophrenia, inability to swallow the study drug whole, and recent use of certain medications or therapies.",
    "This sample is a phase 3 trial for the drug NKTR-118 (also known as naloxegol) and placebo in patients with opioid-induced constipation (OIC) who are on a stable maintenance opioid regimen. The study aims to evaluate the efficacy of NKTR-118 in improving bowel movements compared to placebo.",
    "This sample is a phase 3 clinical trial for cystic fibrosis patients with Pseudomonas aeruginosa infection, testing the effectiveness of tobramycin inhalation powder as a treatment option. The inclusion criteria include a confirmed diagnosis of cystic fibrosis, age between 6 and 21 years, and FEV1 within a specific range, while the exclusion criteria include hypersensitivity to aminoglycosides or inhaled antibiotics.",
    "In this phase 3 trial, the drug being tested is ciprofloxacin for men with an elevated prostate specific antigen (PSA) and normal digital rectal exam, who have elected to proceed with a diagnostic 12-core prostate biopsy. The inclusion criteria include being 18 years or older, while the exclusion criteria include previous prostate biopsy, history of prostate cancer, urinary tract infections or prostatitis within one year of study entry, antibiotic use within one month prior to PSA level, pyuria or bacteruria on urinalysis, and allergy to fluoroquinolones.",
    "This phase 3 trial aims to evaluate the effectiveness of simvastatin in patients with cardiovascular disease, with specific inclusion and exclusion criteria, and the drugs being tested include simvastatin 20 mg daily, simvastatin 80 mg daily, and placebo.",
    "This sample is a phase 3 clinical trial for breast cancer, testing the drugs gemcitabine, docetaxel, and capecitabine, with specific eligibility criteria for patients with locally advanced and/or metastatic disease.",
    "This sample is a phase 3 clinical trial for patients with invasive breast cancer that overexpresses ErbB2, testing the effectiveness of lapatinib, paclitaxel, and trastuzumab in combination, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of bipolar disorder using the drug quetiapine, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) in subjects of Asian ancestry, using the drugs fluticasone furoate/vilanterol and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C, focusing on Japanese participants who have failed to respond to prior IFN-based therapy. The study will test the efficacy of vaniprevir and ribavirin as potential drugs for this population.",
    "The sample is a phase 3 trial for the treatment of migraine, with the drugs frovatriptan and placebo being tested, and the inclusion criteria being pre-menopausal females diagnosed with MRM who fit the criteria for 'difficult to treat'.",
    "This sample is a phase 3 clinical trial for osteoarthritis, specifically targeting osteoarthritis of the hip, and it involves the drugs naproxcinod, naproxen, and placebo. The eligibility criteria include being a chronic user of NSAIDs or acetaminophen, discontinuing analgesic therapy, and having certain exclusion criteria such as uncontrolled hypertension or diabetes.",
    "This sample is a phase 3 clinical trial for the treatment of post-stroke spasticity and cerebrovascular accident using the drugs gsk1358820 and placebo, with specific eligibility criteria for patients to be included in the study.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the drugs SPM 962, ropinirole, and placebo, with eligibility criteria including a diagnosis of Parkinson's disease, specific age range, specific disease severity, and specific symptoms not well controlled with L-dopa.",
    "The sample is a phase 3 clinical trial for patients with glaucoma or ocular hypertension, testing the effectiveness of the drug brimonidine in lowering intraocular pressure (IOP) in both eyes, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the drugs erlotinib (tarceva) and pemetrexed (alimta), with eligibility criteria including confirmed adenocarcinoma, stage IIIB/IV, failure to prior chemotherapy, and other specific requirements.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of docetaxel, mitoxantrone, and prednisone in treating patients with prostate neoplasms, who meet specific eligibility criteria including histologically proven prostate adenocarcinoma, documented progressive disease, and normal organ function.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of insulin degludec in combination with oral antidiabetic drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for major depressive disorder, testing the effectiveness of various drugs including quetiapine, amitriptyline, and fluoxetine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for lupus erythematosus and lupus nephritis, testing the effectiveness of infliximab compared to placebo in patients with biopsy-proven membranous glomerulonephritis, who have proteinuria despite adequate therapy with ACE inhibitors and steroids.",
    "This sample is a phase 3 clinical trial for the treatment of chronic lymphocytic leukemia using obinutuzumab, rituximab, and chlorambucil, with specific eligibility criteria including age, documented CD20+ B-Cell Chronic Lymphocytic Lymphoma, and previously untreated CLL requiring treatment.",
    "This phase 3 trial aims to evaluate the effectiveness of iogen (molecular iodine) in treating fibrocystic disease of the breast, fibrocystic changes of the breast, fibrocystic mastopathy, and pain in premenopausal females between the ages of 18 and 50, who have a history of clinical breast pain and meet specific inclusion criteria.",
    "This sample is a phase 3 trial for chronic hepatitis B, testing the drugs entecavir, tenofovir, adefovir, and lamivudine, with eligibility criteria including evidence of lamivudine resistance and specific liver function criteria.",
    "This sample is a phase 3 clinical trial for patients with locally advanced or metastatic colorectal cancer, testing the effectiveness of fluorouracil and leucovorin calcium as treatment options. The eligibility criteria include specific disease characteristics and patient characteristics such as age, performance status, and hematopoietic and renal function. Prior chemotherapy, endocrine therapy, radiotherapy, and surgery are allowed.",
    "This sample is a phase 3 trial for the treatment of scalp psoriasis using various corticosteroid drugs, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 3 clinical trial for patients with idiopathic Parkinson's disease, testing the efficacy of piribedil and pramipexole or ropinirole in reducing daytime sleepiness, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for individuals with type 2 diabetes mellitus who intend to fast during Ramadan, testing the effectiveness of sitagliptin, sulfonylurea, and metformin in managing blood glucose levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of hypercholesterolemia, testing the drugs ezetimibe (+) simvastatin, rosuvastatin calcium, and placebos, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec and insulin glargine in combination with metformin or other diabetes medications, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with extensive stage small cell lung cancer (SCLC), testing the effectiveness of cisplatin, etoposide, and irinotecan hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, age, performance status, hematopoietic and hepatic function, renal function, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 clinical trial for children with allergic rhinitis, testing the effectiveness of cetirizine in treating symptoms. The eligibility criteria include excluding children with drug hypersensitivity, complications, and those who have taken certain medications within a specific timeframe.",
    "This sample is a phase 3 clinical trial for the treatment of sleep initiation and maintenance disorders using the drugs volinanserin and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for gastric cancer patients, testing the effectiveness of cisplatin, fluorouracil, and leucovorin calcium as treatment options, with specific eligibility criteria including age, performance status, hematopoietic, hepatic, renal, and cardiovascular conditions, as well as prior concurrent therapies.",
    "This sample is a phase 3 trial for cystic fibrosis patients, testing the effectiveness of denufosol tetrasodium inhalation solution and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the efficacy of denosumab and placebo in ambulatory Korean postmenopausal women with osteoporosis, aged 60 to 90 years old, who have a bone mineral density consistent with a T-score less than -2.5 and greater than or equal to -4.0 at the lumbar spine or total hip.",
    "This sample is a phase 3 clinical trial for prostate cancer patients who have undergone prior pelvic radiotherapy, with eligibility criteria including rising prostate-specific antigen levels, negative metastatic disease evidence, and a life expectancy of more than 5 years. The study will test the effectiveness of drugs such as bicalutamide, buserelin, cyproterone acetate, flutamide, goserelin, leuprolide acetate, and nilutamide.",
    "This sample is a phase 3 trial for patients with open angle glaucoma or ocular hypertension, testing the effectiveness of drugs like Xalacom, Xalatan, and Timolol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for hypertension, testing the effectiveness of azilsartan medoxomil and placebo in participants with essential hypertension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis, testing the effectiveness of methotrexate, placebo, and tocilizumab in combination with stable methotrexate therapy, for patients who have had an inadequate response to current anti-rheumatic therapies, including MTX and anti-TNF therapies.",
    "This sample is a phase 3 trial for patients aged 66 years or older with Generalised Anxiety Disorder (GAD), testing the effectiveness of quetiapine xr and placebo in treating anxiety disorders, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for epilepsy patients, testing the effectiveness of the drug USL255 compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for epilepsy patients with partial-onset seizures, testing the effectiveness of lacosamide and levetiracetam as adjunctive treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of macular degeneration and choroidal neovascularization using verteoporfin photodynamic therapy, ranibizumab, and their respective placebos. The eligibility criteria include age 50 or older and subfoveal choroidal neovascularization due to age-related macular degeneration.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the effectiveness of galantamine and placebo in outpatients with mild to moderately-severe AD, who have a responsible caregiver, and excluding patients with other neurodegenerative disorders or certain coexisting diseases.",
    "This sample is a phase 2/phase 3 trial testing the use of propranolol, a beta blocker, in children under the age of 10 with recurrent respiratory papillomatosis, a disease characterized by the growth of benign tumors in the respiratory tract. The study aims to determine the safety and efficacy of propranolol in reducing the need for surgical interventions in these children.",
    "This sample is a phase 3 clinical trial for patients with HER-2 negative adenocarcinoma of the breast, testing the effectiveness of bevacizumab and taxane-based chemotherapy as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for children and adolescents with familial hypercholesterolaemia, testing the effectiveness of rosuvastatin calcium in reducing cholesterol levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C, testing the efficacy of a combination of drugs including infliximab, pegylated interferon alfa-2b, and ribavirin, with specific eligibility criteria for subjects to be included in the study.",
    "This sample is a phase 3 trial for myasthenia gravis, testing the drugs tacrolimus and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of rasagiline and placebo in patients with idiopathic Parkinson's disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the effectiveness of the drug rotigotine in patients who have had PD for more than 3 years and have symptoms not adequately controlled by L-dopa. The study has specific inclusion and exclusion criteria, and aims to evaluate the drug's impact on PD symptoms and quality of life.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of lurasidone, and includes specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with refractory status epilepticus, testing the effectiveness of propofol and thiopental/pentobarbital for coma induction, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for smoking cessation, testing the drug dianicline, with inclusion criteria of outpatients over the legal age smoking at least 10 cigarettes per day for at least 2 months, and exclusion criteria including insufficient level of motivation, another participant in the household, and patients with current psychotic disorder or major depressive disorder.",
    "This sample is a phase 3 clinical trial for pulmonary fibrosis, testing the drugs placebo and bibf 1120, with inclusion criteria including age, IPF diagnosis, HRCT pattern, and lung function requirements, and exclusion criteria including liver function, lung transplantation, bleeding and thrombotic risks, and recent use of certain medications.",
    "This sample is a phase 3 trial for gastroesophageal reflux disease, testing the effectiveness of lansoprazole microgranules suspension and placebo in reducing reflux symptoms in infants, with specific inclusion and exclusion criteria for participation.",
    "This sample is a phase 3 trial for adults with moderate to severe rheumatoid arthritis (RA) who have not been treated with methotrexate. The study aims to evaluate the efficacy of cp-690,550, a disease-modifying antirheumatic drug, in reducing RA symptoms. The inclusion criteria include specific diagnostic criteria for RA and active disease indicators, while the exclusion criteria include various medical conditions and history of infections or malignancies.",
    "This sample is a phase 3 clinical trial for patients with Parkinson's disease who are not satisfactorily controlled on ropinirole, and it aims to evaluate the effectiveness of rotigotine as a treatment option.",
    "This sample is a phase 3 clinical trial for patients with head and neck cancer, mucositis, oral complications of radiation therapy, and pain, where the drug being tested is doxepin hydrochloride, and the eligibility criteria include age, histologic proof of malignancy, oral pain related to mucositis, ability to complete questionnaires, ECOG Performance Status, and willingness to return for follow-up.",
    "This phase 3 trial aims to evaluate the effectiveness of cabazitaxel, mitoxantrone, and prednisone in treating refractory prostate neoplasms, with specific eligibility criteria including confirmed adenocarcinoma, disease progression, and Eastern Cooperative Oncology Group performance status.",
    "This phase 3 trial is testing the effectiveness of reslizumab, a drug used to treat eosinophilic asthma, compared to a placebo, in patients with a previous diagnosis of asthma who have had at least one asthma exacerbation requiring corticosteroid use in the past year, and meet other eligibility criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of lisinopril and atenolol in reducing blood pressure in patients with chronic hemodialysis, hypertension, and left ventricular hypertrophy, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of perennial allergic rhinitis using fluticasone furoate, with specific inclusion and exclusion criteria, and various assessments and tests required for eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of migraine disorders using the drug np101 - sumatriptan iontophoretic transdermal patch, with a placebo control group, and includes eligibility criteria such as age range, diagnosis of migraine headache, and good health status.",
    "This sample is a phase 3 trial for individuals with potential HIV exposure, testing the effectiveness of darunavir/ritonavir, lopinavir in fixed combination with ritonavir, zidovudine, nrtis, and efavirenz as HIV postexposure prophylaxis.",
    "This phase 3 trial is testing the efficacy of desoximetasone spray 0.25% compared to placebo in treating stable plaque psoriasis involving at least 10% of the body surface area, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial is investigating the effectiveness of mirabegron and solifenacin succinate in treating overactive urinary bladder in patients who have previously received antimuscarinic agents, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with restless legs syndrome, testing the drug xp13512 (gsk1838262) as a potential treatment. The inclusion criteria include having primary RLS symptoms, a minimum frequency of symptoms, and specific severity scores. Exclusion criteria include certain sleep disorders, neurologic diseases, abnormal laboratory results, and pregnancy.",
    "This sample is a phase 3 clinical trial for the treatment of bipolar disorder using the drug aripiprazole, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for the treatment of osteoporosis using the drug lasofoxifene, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for cytomegalovirus infections in adult lung transplant recipients, testing the effectiveness of valganciclovir as a treatment option, with specific inclusion and exclusion criteria for each phase.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of teriparatide and placebo in Japanese patients aged 55 or older with osteoporosis who are at high risk for fracture. The study will exclude patients with a history of metabolic bone disorders other than primary osteoporosis, history of malignant neoplasm in the past 5 years (except for treated skin cancers), and severe or chronically disabling conditions other than osteoporosis.",
    "This sample is a phase 3 clinical trial for patients with stage I or II thoracic esophageal cancer, testing the effectiveness of cisplatin and fluorouracil as treatment options, with specific eligibility criteria related to the disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 3 trial for the treatment of respiratory distress syndrome of prematurity and bronchopulmonary dysplasia using the drugs infasurf and sham, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the drugs saxagliptin and sitagliptin in combination with metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of fluticasone propionate/formoterol fumarate and other drugs in reducing symptoms and improving lung function, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial testing the drug rimonabant and placebo for patients with cardiovascular disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic hepatitis C. The study aims to evaluate the effectiveness of telaprevir, pegylated interferon alfa-2a, and ribavirin in patients who failed previous therapy. The inclusion criteria include being a control group patient from a previous study, completing all assessments, and using effective birth control. Exclusion criteria include receiving other HCV therapy, having decompensated liver disease or pancreatitis, requiring systemic corticosteroids, and having a history of non-compliance or unsafe treatment.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of mifepristone and its different dosages in treating major depressive disorder with psychotic features, using patients aged 18 to 75 years who are able to provide informed consent, while excluding those with major medical problems, previous participation in a mifepristone clinical trial, or a history of allergic reactions to mifepristone.",
    "This sample is a phase 3 trial for venous thrombosis, testing the drugs rivaroxaban and enoxaparin followed by vka, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of schizophrenia using the drugs blonanserin and risperidone. The study includes eligibility criteria such as meeting DSM-IV-TR criteria for schizophrenia, age between 18 and 65, PANSS total score \u226570 and \u2264120, and willingness to comply with the study protocol. Exclusion criteria include recent treatment with other investigational products or long-acting drugs for schizophrenia, as well as a history of treatment with clozapine.",
    "This sample is a phase 3 trial for patients with partial seizures and epilepsies, testing the effectiveness of pregabalin and placebo as an add-on treatment for patients currently taking 1 to 3 anti-epilepsy medicines at stable dosages.",
    "This sample is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) using the drug atomoxetine, with specific inclusion and exclusion criteria for patients aged 8 to 10 years old.",
    "This sample is a phase 3 trial for breast cancer patients, testing the drugs capecitabine (Xeloda) and taxotere. The eligibility criteria include female patients aged 18-70 with adenocarcinoma of the breast and no evidence of metastatic disease.",
    "This sample is a phase 3 trial for chronic hepatitis B, testing the effectiveness of pegylated interferon alpha 2b in patients with specific eligibility criteria, including baseline HBV DNA levels and liver stiffness measurements.",
    "This sample is a phase 3 trial for multiple sclerosis patients who have completed the BENEFIT study, testing the effectiveness of interferon beta-1b (betaseron, bay86-5046) in preventing the development of clinically definite multiple sclerosis (CDMS).",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin phosphate and placebo as add-on therapy to glimepiride, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for leukemia and lymphoma patients, testing the effectiveness of a combination of drugs including asparaginase, cyclophosphamide, and vincristine sulfate, among others, with specific eligibility criteria based on disease characteristics and patient characteristics.",
    "This sample is a phase 3 clinical trial for the treatment of diabetic retinopathy and diabetic macular edema, using drugs such as triamcinolone acetonide, ranibizumab, and sham injection, with specific eligibility criteria for study eye inclusion.",
    "This sample is a phase 3 clinical trial for patients with metastatic prostate cancer, testing the effectiveness of risedronate and placebo drugs in combination with androgen deprivation therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the efficacy of darbepoetin alfa, a drug used to treat anemia, versus a placebo in patients with stage 3-5 chronic kidney disease (CKD) who are not on dialysis and are over 70 years old. The trial aims to evaluate the impact of darbepoetin alfa on hemoglobin levels and transferrin saturation in these patients.",
    "This sample is a phase 3 clinical trial for gout, testing the drugs febuxostat and allopurinol, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of prostatic hyperplasia using dutasteride and placebo, with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 2/phase 3 trial for asthma patients, testing the drugs vr506 and placebo, with inclusion criteria including age, documented clinical history of asthma, and ability to use the new inhaler correctly, and exclusion criteria including regular use of topical steroids, recent respiratory tract infection, and history of lung cancer.",
    "This sample is a phase 3 trial for Crohn's disease, testing the drugs gsk1605786a and placebo, with eligibility criteria including achieving clinical response in a previous study and stable doses of Crohn's disease medications.",
    "This sample is a phase 3 trial testing the effectiveness of enoxaparin + placebo and apixaban + placebo in preventing deep vein thrombosis and pulmonary embolism in patients scheduled for knee replacement surgery, with specific eligibility criteria and exclusion criteria related to bleeding disorders and anticoagulation.",
    "This sample is a phase 3 clinical trial for kidney diseases, testing the effectiveness of enteric-coated mycophenolate sodium, tacrolimus, and corticosteroids in kidney transplant patients with specific eligibility criteria.",
    "This sample is a phase 2/phase 3 trial for patients with metastatic breast cancer and bone metastases, testing the effectiveness of zoledronic acid in improving outcomes. The eligibility criteria include having signed informed consent, being female and 18 years or older, having histologically confirmed invasive breast cancer with bone metastases, having an ECOG Performance Status of 0 to 2, and having a life expectancy of more than 3 months.",
    "This sample is a phase 3 clinical trial for ovarian cancer patients, testing the effectiveness of carboplatin, cyclophosphamide, mitoxantrone hydrochloride, and paclitaxel drugs in combination with chemotherapy, with specific eligibility criteria for patients including disease stage, response to chemotherapy, age, performance status, hematopoietic and hepatic function, and prior therapy history.",
    "This sample is a phase 3 clinical trial for patients with stage III or IV ovarian epithelial, fallopian tube, or primary peritoneal cancer, testing the effectiveness of tamoxifen citrate and thalidomide as treatment options. The eligibility criteria include specific disease stage, prior chemotherapy regimen, normal CA 125 levels, and various health parameters.",
    "This sample is a phase 3 trial for major depressive disorder, testing the effectiveness of levomilnacipran er and placebo as treatments, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the efficacy of zoledronic acid and placebo in treating male osteoporosis, with specific inclusion and exclusion criteria outlined in the study.",
    "This sample is a phase 3 trial for the treatment of dry eye, using dexamethasone phosphate ophthalmic solution and sodium citrate buffer solution, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for previously untreated metastatic colon or rectal cancer, testing the effectiveness of bevacizumab and fluoropyrimidine-based chemotherapy as a first-line treatment.",
    "This sample is a phase 3 clinical trial for individuals with Down syndrome and Alzheimer's disease, testing the effectiveness of vitamin E, multivitamin, and placebo in improving cognitive function, with specific inclusion and exclusion criteria for participation.",
    "This sample is a phase 3 clinical trial for chemotherapy-induced nausea and vomiting (CINV), testing the effectiveness of comparator drugs (fosaprepitant dimeglumine, aprepitant, dexamethasone, ondansetron) in combination with cisplatin chemotherapy, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of aclidinium bromide compared to a placebo, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for infants who are small for gestational age, testing the effectiveness of genotropin and control (no treatment) in promoting growth.",
    "This sample is a phase 3 clinical trial for the treatment of complicated urinary tract infection (cUTI) and pyelonephritis. The study will test the effectiveness of the drugs cxa-201 and levofloxacin in patients who meet specific inclusion criteria, such as having pyuria and clinical signs/symptoms of cUTI.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec and sitagliptin in combination with other oral antidiabetic drugs, with specific eligibility criteria including duration of diabetes, ongoing treatment, BMI, and HbA1c levels.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia and psychotic disorders, testing the effectiveness of risperidone as a continuous treatment option, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of torcetrapib/atorvastatin and atorvastatin in treating hypercholesterolemia and hyperlipidemia, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for Parkinson's disease and dyskinesias, testing the drug ropinirole controlled-release (Requip CR) for restless leg syndrome, with specific inclusion and exclusion criteria related to levodopa therapy and cognitive function.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of lidocaine patches in treating persistent neuropathic pain following surgical procedures for cancer diagnosis or treatment, with specific eligibility criteria including pain rating, size of painful area, and absence of certain conditions or medications.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using the drug paliperidone er, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for asthma, testing the drugs alk hdm ait placebo, alk hdm ait 6 du, and alk hdm ait 12 du, with eligibility criteria including a history of house dust mite induced asthma, use of inhaled corticosteroids, reversible airway obstruction, suitable level of asthma control, and positive skin prick test and specific IgE response to Der pte and/or Der far.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer, testing consolidation chemotherapy with docetaxel plus cisplatin and ccrt arm without consolidation chemotherapy as treatment options, with specific eligibility criteria including histological confirmation, measurable disease, stage IIIA or IIIB, ECOG performance status 0-1, and various laboratory values within normal limits.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of granulocyte colony-stimulating factor plus plerixafor and granulocyte colony-stimulating factor plus placebo in combination with other chemotherapy drugs, with specific eligibility criteria for inclusion and exclusion.",
    "This phase 3 trial is investigating the use of enoxaparin and apixaban, along with matching placebos, in patients undergoing knee replacement surgery to prevent deep vein thrombosis and pulmonary embolism. The eligibility criteria include specific surgical requirements and exclude patients with bleeding disorders, coagulopathy, active bleeding, recent surgery or trauma, hepatobiliary disease, and other contraindications.",
    "This sample is a phase 3 trial for the drug brivaracetam in patients with well-characterized focal epilepsy or epileptic syndrome, who have at least 2 but not exceeding 40 partial onset seizures per 4 weeks.",
    "This sample is a phase 3 clinical trial for patients with unresectable non-small cell lung cancer (NSCLC), testing the effectiveness of carboplatin and cisplatin as treatment options, with specific eligibility criteria outlined.",
    "This phase 3 clinical trial aims to evaluate the efficacy of placebo, palifermin, and cisplatin chemotherapy in combination with radiotherapy for the treatment of newly diagnosed, locally advanced stage head and neck cancer. The trial includes patients with histologically documented squamous cell carcinoma involving the oral cavity, oropharynx, nasopharynx, hypopharynx, or larynx, and who meet specific eligibility criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of paclitaxel in achieving complete remission in patients with advanced ovarian, fallopian tube, or primary peritoneal cancer who have undergone tumor debulking and platinum-based combination chemotherapy.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec/insulin aspart and biphasic insulin aspart 30 in controlling blood sugar levels, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for postmenopausal women with estrogen and/or progesterone receptor positive breast cancer, testing the effectiveness of letrozole as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for newly diagnosed multiple myeloma patients, testing the efficacy of lenalidomide, melphalan, prednisone, aspirin, and placebo in induction and maintenance therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for ulcerative colitis, testing the drugs spd476 and asacol, with inclusion criteria including previous diagnosis of ulcerative colitis in remission and exclusion criteria such as proctitis and hypersensitivity to salicylates.",
    "This sample is a phase 3 trial for diabetes mellitus, testing the drugs alogliptin and insulin, with inclusion criteria including being an outpatient and signing an informed consent form, and exclusion criteria including having serious cardiac, cerebrovascular, pancreatic, or hematological diseases.",
    "This sample is a phase 3 trial for renal transplantation, testing the drugs everolimus + cyclosporine, everolimus + enteric-coated mycophenolate sodium (ec-mps), and steroids, with inclusion criteria requiring patients to have completed a previous study and exclusion criteria including premature study discontinuation and recent acute rejection.",
    "This sample is a phase 3 clinical trial for female patients with locally recurrent or metastatic breast cancer, testing the efficacy of vinflunine plus capecitabine and capecitabine as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the effectiveness of anti-thymocyte globulin, cyclophosphamide, cyclosporine, methotrexate, and methylprednisolone in treating diseases such as graft versus host disease, leukemia, and lymphoma, with specific eligibility criteria for patients.",
    "This sample is a phase 3 trial for the treatment of generalized anxiety disorder (GAD) using the drugs pd 0332334 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the drug vortioxetine versus placebo in patients with major depressive disorder, with specific inclusion and exclusion criteria, and various assessments and measurements to determine eligibility and suitability for the study.",
    "This phase 3 trial aims to evaluate the effectiveness of topiramate and placebo in treating Tourette Syndrome, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 trial for venous thromboembolism, testing the effectiveness of rivaroxaban and enoxaparin as anticoagulant drugs in patients undergoing elective total hip replacement surgery, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with acute myeloid leukemia (AML) who have received previous induction/re-induction regimens, testing the drugs elacytarabine and investigator's choice, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is investigating the use of methylphenidate hydrochloride in patients with various brain tumors, including glioblastoma multiforme and meningioma, who are undergoing cranial radiotherapy. Eligible patients must be 18 years or older, have a Karnofsky performance status of 70-100%, and a life expectancy of at least 3 months. They should also meet certain hematopoietic criteria and not have any serious medical or psychiatric illnesses that would prevent study participation. Prior or concurrent chemotherapy and concurrent steroids are allowed, but certain medications for attention deficit disorder, anxiety disorder, schizophrenia, or substance abuse are not permitted.",
    "This sample is a phase 2/phase 3 trial for patients with non-small cell lung carcinoma, testing the efficacy of 1st line chemotherapy in combination with TG4010 immunotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for patients with ocular hypertension or glaucoma, testing the effectiveness of brimonidine 0.2%/timolol 0.5% fixed combination ophthalmic solution and concurrent brimonidine 0.2% and 0.5% timolol in lowering intraocular pressure (IOP).",
    "This sample is a phase 3 clinical trial for patients with gastroesophageal reflux disease (GERD) who have responded to standard PPI therapy in the past 12 months. The study aims to evaluate the efficacy of the drugs Zegerid and Losec in reducing heartburn episodes. The inclusion criteria include being between 18 and 75 years old, having a history of frequent heartburn, and providing written informed consent. Exclusion criteria include age <18 or >75, intake of certain medications, history of acid-lowering surgery, and presence of severe renal or hepatic insufficiency.",
    "This sample is a phase 3 clinical trial for the treatment of bipolar disorder and mood disorders using the drug paliperidone extended-release, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the drugs bifeprunox, placebo, and quetiapine, with inclusion criteria including a primary diagnosis of schizophrenia and stable medication for 8 weeks prior to screening.",
    "This sample is a phase 3 trial for patients with acute coronary syndrome and coronary artery disease, testing the effectiveness of atorvastatin in treating non-ST-segment elevation acute myocardial infraction with severe and diffuse coronary artery disease not amenable to conventional revascularization techniques.",
    "This phase 3 clinical trial is testing the effectiveness of cisplatin, ifosfamide, paclitaxel, and vinblastine in treating patients with extragonadal germ cell tumors and testicular germ cell tumors who have evidence of metastatic disease and have previously been treated with etoposide and cisplatin.",
    "This sample is a phase 3 trial for asthma treatment in children aged 6-14 years, using montelukast sodium and a placebo as the comparator drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of budesonide/formoterol turbuhaler, budesonide turbuhaler (pulmicort), and terbutaline turbuhaler in reducing symptoms. The inclusion criteria include a diagnosis of asthma for at least 6 months and prescribed daily use of glucocorticosteroids for at least 3 months prior to the study. Exclusion criteria include recent respiratory infection, intake of oral, rectal, or parenteral glucocorticosteroids, and any significant disease or disorder that may jeopardize patient safety.",
    "This sample is a phase 3 clinical trial for the treatment of seasonal allergic rhinitis using mometasone furoate nasal spray and placebo, with inclusion criteria including a positive skin-prick test response to an appropriate seasonal allergen and exclusion criteria such as a history of anaphylaxis, asthma requiring chronic corticosteroid use, and allergies to nasal sprays.",
    "This sample is a phase 3 clinical trial for patients with hypertension, testing the effectiveness of different doses of irbesartan/amlodipine combination drugs in controlling blood pressure. The eligibility criteria include age, previous treatment, blood pressure levels, and exclusion criteria such as contraindications, hepatic or renal impairment, and pregnancy.",
    "This sample is a phase 3 clinical trial for the treatment of psoriasis, testing the drugs voclosporin, ciclosporin, and placebo, with eligibility criteria including a diagnosis of stable plaque psoriasis and previous failure of systemic treatment.",
    "This sample is a phase 3 clinical trial for patients with rectal cancer, specifically T3 or T4 disease, testing the drug tegafur and uracil. The eligibility criteria include specific disease characteristics, performance status, hematopoietic and renal function, and prior treatment history.",
    "This sample is a phase 3 clinical trial for patients with small cell lung cancer (SCLC) who have had prior platinum-based chemotherapy, and it aims to evaluate the efficacy of amrubicin and topotecan as treatment options. The eligibility criteria include histological or cytological diagnosis of SCLC, radiographically documented progression after first-line treatment, and no more than 1 prior chemotherapy regimen.",
    "This sample is a phase 3 trial for kidney transplantation, testing the drugs alemtuzumab and tacrolimus, with eligibility criteria including age 18-65, endstage renal failure with no previous transplantation, cadaveric donor, and exclusion criteria such as pregnant or nursing women, multi-organ transplant recipients, and previous treatment with Campath-1H.",
    "This sample is a phase 3 trial for the drug caspofungin acetate, testing its effectiveness in treating invasive candidiasis, with specific inclusion and exclusion criteria provided.",
    "This sample is a phase 3 clinical trial for patients with chronic liver disease, testing the efficacy of eltrombopag in managing the risk of bleeding associated with invasive procedures.",
    "The sample is a phase 3 trial for the treatment of bipolar disorder, testing the drugs asenapine and olanzapine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of gastroesophageal reflux disease (GERD) using dexlansoprazole and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for systemic lupus erythematosus, testing the efficacy of belimumab at different doses compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for metastatic breast cancer patients, testing the efficacy of pertuzumab, trastuzumab, and docetaxel in combination with placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for breast cancer patients, testing the drugs zd9393 (zoladex) 10.8 mg and zd9393 (zoladex) 3.6 mg, with eligibility criteria including pre-menopausal females with hormone sensitivity and confirmation of breast cancer.",
    "This sample is a phase 3 clinical trial for patients with metastatic pancreatic cancer, testing the drug bevacizumab (Avastin) to determine its effectiveness in treating the disease. The inclusion criteria include being an adult patient with good liver, kidney, and bone marrow function, while the exclusion criteria include previous systemic treatment for metastatic pancreatic cancer and current or recent treatment with another investigational drug.",
    "This sample is a phase 2/phase 3 trial for the drug cx516 (ampakine) in patients with schizophrenia, with specific inclusion and exclusion criteria, such as a stable dose of clozapine, olanzapine or risperidone for at least 6 months.",
    "This sample is a phase 3 trial for the treatment of liver disease in patients with a history of chronic alcoholism, using the drugs s-adenosylmethionine and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with coronary heart disease, testing the effectiveness of dalcetrapib, evidence-based medical care for acute coronary syndrome, and placebo in improving dyslipidemia management, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of dapagliflozin and metformin as compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with fallopian tube cancer or ovarian cancer, testing the drugs TCG and TC, with eligibility criteria including histologically confirmed diagnosis, recent surgery, specific age and performance status requirements, and various medical condition exclusions.",
    "This sample is a phase 3 clinical trial for patients with retinal vein occlusion and macular edema, testing the effectiveness of the drug Ozurdex in improving visual acuity and reducing retinal thickness. The study includes eligibility criteria such as prior treatment with anti-VEGF injections, specific visual acuity range, and exclusion criteria such as glaucoma history and pregnancy.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of cyclophosphamide, docetaxel, gemcitabine, paclitaxel, and doxorubicin in combination with eligibility criteria for patient selection.",
    "This sample is a phase 3 trial for adults with HBeAg-negative chronic hepatitis B, testing the efficacy of pegylated interferon alfa-2a and lamivudine as potential treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with moderate to severe asthma, testing the effectiveness of budesonide/formoterol (symbicort) pmdi and budesonide hfa pmdi as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for psoriasis, testing the efficacy of \"u0267 foam\" and \"vehicle foam\" as potential treatments, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial testing the effectiveness of human insulin inhalation powder and injected insulin in treating patients with diabetes mellitus, asthma, and chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the effectiveness of carboplatin and paclitaxel as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia with quetiapine xr, targeting patients aged 18 to 60 with a diagnosis of schizophrenia and associated cannabis abuse and/or psychotic disorders through cannabis.",
    "This sample is a phase 3 clinical trial for the treatment of lupus erythematosus and lupus nephritis, using abetimus sodium and/or placebo solution, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the treatment of hyperlipidemia using fenofibrate/simvastatin and atorvastatin, with inclusion criteria of mixed dyslipidemia and exclusion criteria of hypersensitivity to the drugs, pregnancy or lactation, contra-indication to the drugs, and unstable or severe cardiac disease.",
    "This sample is a phase 3 clinical trial for liver transplantation, testing the drugs Prograf and MR4, with eligibility criteria including negative pregnancy test, end-stage liver failure, and exclusion criteria such as previous organ transplant, allergies to certain antibiotics, and substance abuse.",
    "This sample is a phase 3 clinical trial for patients with Parkinson's disease, testing the efficacy of safinamide as an add-on therapy to levodopa, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients scheduled for elective Cardiac or Thoracic Surgery, testing the drugs desirudin and heparin for the prevention of deep venous thrombosis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C, testing the drugs alisporivir, peginterferon alfa-2a, ribavirin, and a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for psoriasis, testing the effectiveness of adalimumab and mtx drugs compared to placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This phase 3 clinical trial aims to evaluate the efficacy of albumin-bound paclitaxel, paclitaxel, and carboplatin in treating stage IIIB or IV non-small cell lung carcinoma (NSCLC) patients who have not received prior chemotherapy for metastatic disease. The study includes eligibility criteria such as radiographically-documented measurable disease, specific blood counts and chemistry levels, expected survival of greater than 12 weeks, and an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. Exclusion criteria include active brain metastases, pre-existing peripheral neuropathy of Grade 2, 3, or 4, recent radiotherapy, concurrent illness, recent treatment with investigational drugs, history of allergy or hypersensitivity to study drugs, serious medical risk factors, and enrollment in other clinical protocols or investigational trials involving experimental therapy.",
    "This sample is a phase 3 trial for patients with acromegaly who have inadequately controlled the disease with octreotide LAR or lanreotide ATG, and it aims to evaluate the efficacy of pasireotide, octreotide lar 30mg, and lanreotide atg 120mg in combination therapy.",
    "This sample is a phase 3 trial for the drug flibanserin, which is being tested for the treatment of sexual dysfunctions, psychological, specifically hypoactive sexual desire disorder (HSDD) in premenopausal women. The eligibility criteria include age, diagnosis of HSDD, willingness to engage in sexual activity, use of an electronic diary, stable relationship, use of contraception, and ability to give informed consent. Exclusion criteria include recent medication use, history of drug dependence or abuse, previous participation in clinical trials, certain sexual disorders, menopause or hysterectomy, and pregnancy or breastfeeding.",
    "This sample is a phase 3 clinical trial for patients with osteoarthritis of the knee, testing the effectiveness of the drugs pg201 tablet and celebrex capsule in reducing pain and improving symptoms. The eligibility criteria include age, radiographic classification criteria, duration of symptoms, previous medication use, and pain levels.",
    "This sample is a phase 3 clinical trial for patients with gastrointestinal stromal tumors (GIST) who are currently receiving imatinib mesylate and have good physical functioning. The study aims to assess the efficacy of imatinib mesylate in treating unresectable and/or metastatic GIST.",
    "This sample is a phase 3 trial for patients with chronic hepatitis C infection (genotype 1), testing the effectiveness of telaprevir, peg-ifn-alfa-2a, ribavirin, and placebo as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of saxagliptin and placebo in improving glycaemic control. The inclusion criteria include inadequate glycaemic control despite being on metformin and sulfonylurea, while the exclusion criteria include prior use of insulin, DDP4 inhibitors, GLP-1 analogues, and other oral anti-diabetic agents.",
    "This sample is a phase 3 trial for seasonal allergic rhinitis, testing the effectiveness of olopatadine hydrochloride nasal spray 0.6% and vehicle as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of linagliptin and placebo in reducing HbA1c levels in patients aged 70 years and older, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the drug istradefylline (kw-6002), and includes eligibility criteria such as specific disease criteria, levodopa/carbidopa usage, and age requirements.",
    "This sample is a phase 3 clinical trial for patients with Parkinson's disease, testing the effectiveness of the drugs placebo and azilect\u00ae in reducing motor fluctuations in patients taking levodopa therapy.",
    "This sample is a phase 3 clinical trial for patients with prostate cancer, testing the effectiveness of zoledronic acid in preventing bone loss in patients undergoing androgen deprivation therapy (ADT) for at least 12 months. The inclusion criteria include patients with a confirmed diagnosis of prostate cancer, a baseline BMD T-score <-2.0, and a life expectancy of at least 12 months. The exclusion criteria include patients with bone metastases, prior bisphosphonate therapy in the past 6 months, and certain medical conditions that may confound the evaluation or prevent compliance to the protocol.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of celecoxib and placebo as palliative chemotherapy treatment, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for invasive breast cancer, testing the effectiveness of a combination of drugs including doxorubicin, cyclophosphamide, paclitaxel, trastuzumab, and lapatinib, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of migraine headaches using sumatriptan and placebo drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the treatment of major depressive disorder, testing the efficacy of desvenlafaxine succinate sustained-release (dvs sr), duloxetine, and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 clinical trial for atopic dermatitis, testing the drug fexofenadine/allegra (m016455), with inclusion criteria of patients aged 6 months through 11 years and exclusion criteria related to itching scores and specific affected areas.",
    "This sample is a phase 3 trial for postmenopausal women with breast cancer or osteoporosis, testing the effectiveness of alendronate sodium, calcium gluconate, and risedronate sodium in preventing osteoporosis. The eligibility criteria include specific disease characteristics and patient characteristics, and exclude certain prior and concurrent therapies.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of indacaterol, salmeterol, and placebo in improving lung function and symptoms. The inclusion criteria include a diagnosis of moderate-to-severe COPD, a smoking history of at least 20 pack-years, and specific lung function measurements. Exclusion criteria include recent hospitalization for a COPD exacerbation, long-term oxygen therapy, respiratory tract infection, concomitant pulmonary disease, history of asthma, and certain medical conditions.",
    "This sample is a phase 3 trial for the treatment of psoriasis using the drugs abt-874 and methotrexate, with specific inclusion and exclusion criteria based on the diagnosis and previous exposure to anti-IL 12.",
    "This sample is a phase 3 trial for participants with mixed hyperlipidemia, testing the drugs mk-0524a, atorvastatin, and simvastatin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for kidney transplantation, testing drugs such as fk506mr, prograf, mycophenolate mofetil, methylprednisolone, and prednisolone, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for individuals with impaired glucose tolerance, impaired fasting glucose, or early type 2 diabetes, testing the effectiveness of insulin glargine, omega-3 polyunsaturated fatty acids, and placebo in reducing cardiovascular risk factors.",
    "This sample is a phase 3 clinical trial for patients with ulcerative colitis, testing the effectiveness of drugs such as budesonide-mmx\u00ae and asacol\u00ae 400 mg, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of major depressive disorder, testing the drugs vortioxetine, duloxetine, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of drugs such as budesonide/formoterol (Symbicort), budesonide (Pulmicort), and terbutaline sulfate (Bricasol), with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of a-002 and varespladib methyl, compared to placebo, in reducing the risk of acute coronary syndrome in subjects with unstable angina, non-ST-segment elevation myocardial infraction (NSTEMI), or ST-segment elevation myocardial infraction (STEMI) who have at least one risk factor such as diabetes mellitus, metabolic syndrome, history of cerebrovascular disease, peripheral vascular disease, previous CABG, previous documented myocardial infraction, or previous coronary revascularization.",
    "The sample is a phase 3 clinical trial for participants with type 2 diabetes mellitus, testing the effectiveness of a new formulation of insulin glargine (hoe901-u300) compared to lantus (insulin glargine) in controlling blood glucose levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for advanced non-small cell lung cancer, testing the effectiveness of docetaxel, vinorelbine, gemcitabine, and capecitabine as treatment options, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of the drug bi 10773 and sitagliptin compared to placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of alogliptin, metformin, and pioglitazone in improving glycemic control, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of aliskiren, ramipril, hydrochlorothiazide, and amlodipine in treating essential hypertension in patients aged 65 and above, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for chemotherapy-induced nausea and vomiting, testing the effectiveness of aprepitant and ondansetron as antiemetic drugs in pediatric patients receiving emetogenic chemotherapy.",
    "This sample is a phase 3 clinical trial for the treatment of sleep initiation and maintenance disorders using the drugs volinanserin and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for head and neck cancer, testing the drugs placebo and erlotinib, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial for patients with advanced renal cell carcinoma (RCC), testing the effectiveness of bevacizumab, temsirolimus, and interferon-alfa 9mu as potential treatments. The eligibility criteria include having histologically confirmed RCC, measurable lesions, and no prior systemic treatment for RCC.",
    "This sample is a phase 2/phase 3 trial for patients with multiple myeloma, testing the drugs tanespimycin and bortezomib, and includes eligibility criteria such as prior treatment regimens, no prior use of certain inhibitors, and no known infections.",
    "This sample is a phase 3 trial for patients with atrial fibrillation, testing the effectiveness of rivaroxaban, warfarin, and their placebos as anticoagulants, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of various drugs including pioglitazone and linagliptin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for anaplastic thyroid cancer, testing the drugs ca4p, paclitaxel, and carboplatin, with specific eligibility criteria for patients to be included or excluded from the study.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes and overt nephropathy, testing the effectiveness of the drug bosentan in combination with angiotensin II receptor blockers in reducing albumin excretion.",
    "This sample is a phase 3 trial for infertility treatment, testing the effectiveness of placebo drugs (sch 900962 and recfsh) on women aged 35 to 42 with regular menstrual cycles and no endocrine abnormalities, ovarian hyperstimulation syndrome, or polycystic ovary syndrome.",
    "This sample is a phase 3 clinical trial testing the effectiveness of ramosetron and ondansetron in preventing nausea and vomiting in cancer patients undergoing highly emetogenic chemotherapy, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for HIV and hepatitis C patients, testing the effectiveness of lpv/r, peg-ifna 2a, ribavirin, and nucs in combination with stable HAART including r/LPV for > 6 months, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for fibromyalgia, testing the drug pregabalin, where patients must have met the inclusion criteria for a previous fibromyalgia study and received pregabalin/placebo under double-blind conditions.",
    "This sample is a phase 3 clinical trial for children with atopic dermatitis, testing the drugs broncho-vaxom and placebo - cap, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the drug \"elpenhaler active - diskus placebo\" in patients aged 18-65 with a diagnosis of asthma for at least 6 months, specific lung function criteria, stable asthma for 4 weeks, and other eligibility criteria.",
    "This sample is a phase 3 clinical trial for the treatment of hypercholesterolemia using lapaquistat acetate and stable statin therapy, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for non-prior chemotherapy treated advanced gastric adenocarcinoma, testing the drugs s-1, s-1 plus cddp, and 5-fu plus cddp, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients scheduled to undergo total hip arthroplasty, testing the effectiveness of enoxaparin and dabigatran etexilate in preventing venous thromboembolism, with specific eligibility and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with high-risk rhabdomyosarcoma or ectomesenchymoma, testing the effectiveness of cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, irinotecan hydrochloride, and vincristine sulfate as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 3 clinical trial for relapsing-remitting multiple sclerosis, testing the efficacy of glatiramer acetate (ga) compared to placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for breast neoplasms, testing the drugs capecitabine and sunitinib malate, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for smoking cessation, testing the effectiveness of placebo and varenicline tartarate drugs in subjects with mild to moderate COPD, who are current cigarette smokers and have not attempted to quit smoking in the past 3 months.",
    "This sample is a phase 3 trial for the treatment of moderate to severe plaque-type psoriasis using secukinumab 150 mg and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with inflammatory bowel disease and intestinal fistula, testing the drug ast-120, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with abdominal pain, testing the effectiveness of hyoscine butylbromide and placebo in relieving symptoms, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for low back pain, testing the effectiveness of tramadol hcl/acetaminophen extended release and placebo drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for patients with intermediate- or high-grade malignant soft tissue sarcoma, testing the effectiveness of the drugs doxorubicin hydrochloride and trabectedin, with eligibility criteria including previously untreated disease, confirmed disease progression, and specific patient characteristics.",
    "This sample is a phase 3 clinical trial for patients with persistent bronchial asthma, testing the effectiveness of ciclesonide (xrp1526) in improving lung function and reducing asthma exacerbations.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using methylphenidate hydrochloride and placebo as drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is investigating the efficacy of ly2216684 (edivoxetine) and selective serotonin reuptake inhibitors (SSRIs) in treating major depressive disorder (MDD) in adults who have had a partial response to SSRIs, with specific inclusion and exclusion criteria outlined in the study.",
    "This sample is a phase 3 clinical trial for hypertension, testing the drugs azilsartan medoxomil and chlorthalidone, with eligibility criteria including specific blood pressure ranges and exclusion criteria such as recent history of cardiovascular events or renal dysfunction.",
    "This sample is a phase 3 trial for asthma, testing the effectiveness of fluticasone propionate/formoterol fumarate and other drugs in patients with specific eligibility criteria, including a history of asthma, documented use of inhaled corticosteroids, and reversible symptoms of asthma.",
    "This sample is a phase 3 trial for HIV infections, testing the drug maraviroc, with specific inclusion and exclusion criteria for subjects.",
    "This phase 3 clinical trial aims to investigate the effects of paricalcitol and placebo on patients with coronary artery disease, chronic kidney disease, hypovitaminosis D, and secondary hyperparathyroidism, with specific eligibility criteria including age, medical history, and laboratory values.",
    "This sample is a phase 3 trial testing the drugs sirolimus, cyclosporine, mycophenolate mofetil, corticosteroids, and daclizumab in patients undergoing kidney transplantation for graft vs host disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for glaucoma, testing the drugs t2345 and prostaglandin, with inclusion criteria being adult patients diagnosed with glaucoma and exclusion criteria being patients under 18.",
    "This sample is a phase 2/phase 3 trial for patients with Parkinson's disease experiencing troublesome dyskinesia following levodopa dosing, and the drug being tested is ads-5102 (extended release amantadine hcl).",
    "This sample is a phase 3 trial for non-constipation irritable bowel syndrome, testing the effectiveness of rifaximin and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with non-valvular atrial fibrillation, testing the drugs du-176b 15mg, du-176b 30mg, and du-176b 60mg, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the effectiveness of chondroitin sulphate (condrosan) compared to a placebo in patients with primary osteoarthritis of the knee, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for a drug called alo-01, which combines morphine sulfate and naltrexone hydrochloride, to treat chronic moderate to severe pain caused by nonmalignant conditions. The eligibility criteria include being 18-70 years old and refraining from taking any other opioid medications during the study period.",
    "This sample is a phase 3 trial for patients with locally advanced or metastatic breast neoplasms, testing the drugs sunitinib + capecitabine and capecitabine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients at risk of venous thromboembolic events, testing the effectiveness of rivaroxaban, enoxaparin, and their placebos in preventing these events in patients with various acute medical conditions and additional risk factors for VTE.",
    "This sample is a phase 3 clinical trial for the treatment of acute bacterial rhinosinusitis (ABRS) using amoxicillin-potassium clavulanate combination, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of fluorouracil, irinotecan hydrochloride, and leucovorin calcium as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 3 trial for patients with acute coronary syndrome, testing the drugs bivalirudin and heparin, with specific inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 3 clinical trial for patients with metastatic breast cancer, testing the efficacy of bevacizumab, placebo, and standard chemotherapy as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 trial is investigating the effectiveness of levodopa carbidopa intestinal gel (lcig) and levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets in treating advanced Parkinson's disease patients who experience severe motor fluctuations despite optimized treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for chemotherapy-induced nausea and vomiting, testing the effectiveness of palonosetron, ondansetron, and placebo drugs, with specific eligibility criteria for patients including age, weight, disease confirmation, and absence of certain medical conditions or medication use.",
    "This phase 3 trial aims to evaluate the effectiveness of buprenorphine compared to placebo in treating moderate to severe low back pain, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for advanced breast cancer, testing the effectiveness of drugs such as sunitinib, paclitaxel, and bevacizumab, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for rheumatoid arthritis patients who are intolerant to methotrexate (MTX) and have inadequate response to other disease-modifying antirheumatic drugs (DMARDs) or biologics. The study aims to evaluate the efficacy and safety of abatacept as a treatment option.",
    "This sample is a phase 3 clinical trial for the treatment of acute lymphoblastic leukemia (ALL) using a combination of drugs including dexamethasone, asparaginase, cyclophosphamide, and others, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with essential hypertension, testing the efficacy of azilsartan medoxomil and valsartan as potential treatments, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with breast neoplasm, testing the effectiveness of taxol and tocosol paclitaxel drugs in treating stage IV (M1) disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis, testing the effectiveness of rituximab and anti-inflammatory drugs as a treatment option, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to assess the efficacy of cg5503 ir (tapentadol), an analgesic medication, in patients with chronic osteoarthritis of the hip or knee who require daily doses of analgesics for pain relief.",
    "This sample is a phase 3 clinical trial testing the drug tezosentan versus placebo in patients undergoing cardiac surgery with pulmonary hypertension, and it includes eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 3 trial for patients with venous thromboembolism, testing the drugs 15mg du-176b, 30mg du-176b, and fondaparinux, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for restless legs syndrome, testing the drug asp8825, with inclusion criteria based on diagnosis and symptom severity, and exclusion criteria including recent use of certain medications and specific medical conditions.",
    "This sample is a phase 3 trial for obesity and type 2 diabetes mellitus, testing the drugs taranabant and placebo, with specific inclusion and exclusion criteria related to BMI, HbA1c, psychiatric history, blood pressure, antihyperglycemic agent use, and triglyceride levels.",
    "This sample is a phase 2/phase 3 trial for patients with diffuse large B-cell or peripheral T-cell non-Hodgkin's lymphoma, testing the effectiveness of various drugs including chop regimen, epoch regimen, cyclophosphamide, doxorubicin hydrochloride, etoposide, prednisone, and vincristine sulfate, with specific eligibility criteria including age, performance status, hematopoietic, hepatic, renal, cardiovascular, and other factors.",
    "This sample is a phase 3 clinical trial for patients with gastric cancer, testing the efficacy of placebo and paclitaxel as second-line therapy after disease progression following platinum/fluoropyrimidine doublet with or without anthracycline.",
    "This sample is a phase 3 clinical trial for patients with ulcerative colitis, testing the effectiveness of abatacept (aba) compared to a placebo, for those who have had an inadequate response or intolerance to standard ulcerative colitis treatment.",
    "This sample is a phase 3 clinical trial for patients with metastatic breast cancer, testing the use of epoetin alfa to treat anemia caused by chemotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C using consensus interferon and ribavirin, with specific eligibility criteria including HCV genotype 1, liver biopsy confirmation, and various laboratory results.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of mepolizumab, placebo, and oral corticosteroids in reducing symptoms and improving lung function. The eligibility criteria include requirements for regular use of systemic and inhaled corticosteroids, evidence of eosinophilic asthma, and persistent airflow obstruction.",
    "This sample is a phase 3 trial for patients with schizophrenia or bipolar I disorder, testing the drug quetiapine fumarate, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to investigate the effectiveness of rosiglitazone, a drug used to treat insulin resistance, in patients with chronic kidney disease (CKD) stage 4 and a BMI \u2264 30, who have fasting glucose levels below 7 mmol/l. The study has specific inclusion and exclusion criteria, including excluding patients with diabetes mellitus using insulin, significant co-morbidities, significant cardiovascular co-morbidities, allergy to PPAR's, cardiac disease with marked limitation of functional capacity, use of immunosuppressant agents, history of renal transplant, hepatic insufficiency, history of alcohol abuse or excessive alcohol use, and female patients who are pregnant, intend to become pregnant within the study period, or are lactating.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of cariprazine and aripiprazole compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with esophageal and gastric cancer, testing the effectiveness of cisplatin, epirubicin hydrochloride, fluorouracil, and leucovorin calcium as treatment options, with specific eligibility criteria and required initial laboratory values.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of capecitabine, cyclophosphamide, docetaxel, doxorubicin hydrochloride, and gemcitabine hydrochloride as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 3 trial for breast cancer patients who are not suitable for surgery or radiotherapy alone, and it tests the effectiveness of taxane, avastin, and xeloda drugs in combination as a treatment option.",
    "This sample is a phase 3 trial for patients with left-sided uncomplicated diverticular disease, testing the effectiveness of mesalazine and placebo in reducing symptoms. The eligibility criteria include a confirmed diagnosis of diverticular disease, recent attack responding to antibiotics, and elevated C-reactive protein levels. Exclusion criteria include complicated diverticular disease, previous colonic surgery, and presence of other gastrointestinal diseases.",
    "This sample is a phase 3 clinical trial for chronic hepatitis B patients who have developed resistance to lamivudine and are receiving adefovir dipivoxil treatment. The trial will test the efficacy of drugs such as tdf, ftc/tdf, tdf placebo, and ftc/tdf placebo in treating the disease.",
    "This sample is a phase 3 clinical trial for metastatic melanoma, testing the drugs dacarbazine and temozolomide, with specific inclusion and exclusion criteria for potential study participants.",
    "This sample is a phase 3 clinical trial for patients with partial epilepsy, testing the efficacy of a modified release formulation of oxcarbazepine (oxc mr) and an immediate release formulation of oxcarbazepine (oxc ir) as an add-on treatment option. The eligibility criteria include stable treatment with oxcarbazepine, a minimum of 2 refractory seizures, weight between 50 kg and < 100 kg, and Caucasian ethnicity. Exclusion criteria include certain medical conditions, history of psychiatric illness or substance abuse, and use of specific medications.",
    "This sample is a phase 3 clinical trial for patients with coronary artery disease, postprandial hyperglycemia, and vitamin D deficiency, testing the effectiveness of vitamin D supplementation in reducing the risk of cardiovascular events.",
    "This sample is a phase 3 clinical trial for patients with sleep initiation and maintenance disorders and insomnia, testing the effectiveness of the drug eplivanserin compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for the treatment of seasonal allergic rhinitis using the drugs montelukast and placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is evaluating the safety of azilsartan medoxomil and chlorthalidone and olmesartan medoxomil and hydrochlorothiazide in patients with moderate renal impairment and hypertension, who are currently on stable therapy with 2 or 3 antihypertensive medications. The eligibility criteria include specific blood pressure ranges, estimated glomerular filtration rate, age, contraception use, and ability to comply with the protocol. Exclusion criteria include recent history of cardiovascular events, renal dysfunction, cancer, poorly-controlled diabetes, liver disease, and hypersensitivity to certain medications.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the drug bi 10773, and the eligibility criteria include specific requirements for previous treatment, HbA1c levels, age, BMI, and exclusion criteria such as uncontrolled hyperglycemia, liver disease, impaired renal function, and history of cancer.",
    "This sample is a phase 3 clinical trial for colorectal cancer patients, testing the effectiveness of cyclosporine and irinotecan hydrochloride drugs in combination with cetuximab, with specific eligibility criteria for patients, including disease characteristics and patient characteristics.",
    "This phase 3 trial is testing the effectiveness of epoetin beta and placebo in lung cancer or gynecologic cancer patients undergoing platinum-based chemotherapy, with the goal of increasing hemoglobin concentration (Hb) in patients with anemia.",
    "This sample is a phase 3 clinical trial for amyotrophic lateral sclerosis (ALSO) patients, testing the drugs mci-186 and placebo of mci-186, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for kidney transplantation, testing the drugs Prograf and MR4, with inclusion criteria such as receiving the first oral dose of the study drug prior to transplant and exclusion criteria including previous organ transplants, ABO incompatible donor kidney, and current malignancy.",
    "This sample is a phase 3 clinical trial for the treatment of blepharospasm using incobotulinumtoxina (xeomin) and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with head and neck cancer, testing the effectiveness of cisplatin, docetaxel, fluorouracil, and paclitaxel in combination with re-irradiation for unresectable disease. The eligibility criteria include specific disease characteristics, prior radiotherapy, and various patient characteristics.",
    "This sample is a phase 3 clinical trial for participants with hypercholesterolemia, testing the effectiveness of alirocumab, ezetimibe, and placebos in reducing LDL-C levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial that aims to evaluate the effectiveness of NGX-4010, a capsaicin patch, in treating painful HIV-associated distal symmetric polyneuropathy. The trial includes patients with documented HIV-1 infection and specific symptoms, and excludes those with certain medical conditions or recent medication use.",
    "This phase 3 clinical trial is testing the effectiveness of carboplatin and paclitaxel in treating non-small cell lung cancer patients who meet specific disease characteristics and patient eligibility criteria.",
    "This sample is a phase 3 clinical trial testing the effectiveness of modafinil and placebo in treating apathy and Alzheimer's disease, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using aripiprazole im depot and placebo drugs, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for patients with ovarian neoplasms, testing the drugs caelyx and paclitaxel hcl, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for childhood acute lymphoblastic leukemia (ALL) patients in second hematologic remission or greater who have relapsed, and it includes drugs such as cyclophosphamide, cyclosporine, etoposide, methotrexate, busulfan, and mesna as part of the treatment criteria.",
    "This sample is a phase 3 trial for patients with gastrointestinal stromal tumors who have progressed on imatinib, and it will test the effectiveness of sunitinib malate and imatinib mesylate as potential treatments.",
    "This sample is a phase 3 clinical trial for the treatment of gout, testing the drugs lesinurad and placebo, with eligibility criteria including a diagnosis of gout, sUA level \u2265 6.5 mg/dL, and intolerance or contraindication to allopurinol or febuxostat.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the effectiveness of DHA (docosahexaenoic acid) compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with diabetes mellitus, testing the effectiveness of insulin glargine and insulin glulisine in combination with other medications, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of pulmonary hypertension using the drugs bosentan and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of glaucoma and ocular hypertension using brimonidine ophthalmic solution 0.1% and 0.2%, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of epilepsy using the drug brivaracetam, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for patients with sarcoma, testing the effectiveness of imatinib mesylate and imatinib drugs in reducing tumor recurrence in patients with resectable GIST, with specific eligibility criteria including tumor size, mitotic count, and organ function.",
    "This sample is a phase 3 trial for the treatment of psoriasis using the drug etanercept, targeting adults with clinically stable plaque psoriasis involving at least 10% of the body surface and a minimum Psoriasis Area and Severity Index (PASI) score of 10 at screening.",
    "This sample is a phase 3 trial for the treatment of hyperlipidemia and mixed dyslipidemia using niacin er/simvastatin tablets and atorvastatin, with specific inclusion and exclusion criteria related to laboratory values and medical history.",
    "This sample is a phase 3 clinical trial for the treatment of PTSD and sleep disorders using the drug prazosin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for acute ischemic stroke, testing the use of a placebo drug. The inclusion criteria include having symptoms within 6 hours and a baseline NIHSS score above 5, while exclusion criteria include factors like hypertension, low fibrinogen level, and recent use of thrombolytic agents or surgery.",
    "This sample is a phase 3 trial for post-menopausal women with Urogenital ageing (UGA) and recurrent urinary tract infections, testing the effectiveness of estradiol, 25 mcg, in reducing the frequency of UTIs.",
    "This sample is a phase 3 trial for patients with rheumatoid arthritis who have had an inadequate response to anti-TNF-alpha agents, and are currently receiving either leflunomide or methotrexate. The study aims to evaluate the efficacy of ocrelizumab and placebo in reducing joint inflammation and improving symptoms.",
    "This sample is a phase 3 trial for schizoaffective disorder and psychotic disorder, testing the effectiveness of paliperidone er and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of schizophrenia, with the drugs asenapine, placebo, and olanzapine being tested, and the eligibility criteria including currently suffering from an acute exacerbation of schizophrenia.",
    "This phase 3 trial is focused on major depressive disorder and will be testing the drugs mk0869 and aprepitant, as well as a placebo comparator, to evaluate their effectiveness in treating the disorder.",
    "This sample is a phase 3 trial for patients with rheumatoid arthritis, testing the effectiveness of rituximab in combination with methotrexate for those who have had an inadequate response or intolerance to etanercept, infliximab, or adalimumab.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of linagliptin and placebo in achieving glycaemic control, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for basal cell carcinoma, testing the effectiveness of imiquimod 5% cream, with inclusion criteria being basal cell carcinoma and exclusion criteria being psoriasis.",
    "This sample is a phase 3 trial for major depressive disorder, testing the effectiveness of vortioxetine and agomelatine as an alternative to serotonin reuptake inhibitor (SRI) antidepressants, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial testing the drugs cisplatin, gemcitabine hydrochloride, and oxaliplatin for the treatment of extrahepatic bile duct cancer, gallbladder cancer, and liver cancer, with specific eligibility criteria for patients.",
    "This sample is a phase 3 clinical trial for patients with stage I or II primary operable breast cancer, testing the drug fulvestrant, and includes eligibility criteria such as hormone receptor status, age, sex, menopausal status, and prior concurrent therapy.",
    "This sample is a phase 3 clinical trial for endometrial cancer patients who have undergone total hysterectomy and bilateral salpingo-oophorectomy, and it aims to evaluate the efficacy of conjugated estrogens as a treatment option.",
    "This sample is a phase 3 clinical trial for patients with gastric adenocarcinoma, testing the effectiveness of capecitabine and oxaliplatin as post-surgery treatment, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the effectiveness of oravescent fentanyl citrate in managing breakthrough pain episodes in patients with cancer, who are opioid tolerant and have a histologically documented diagnosis of a malignant solid tumor or hematological malignancy.",
    "This sample is a phase 3 trial for bipolar disorder and mood disorders, testing the effectiveness of drugs such as placebo, quetiapine, and paliperidone er, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the effectiveness of tiotropium+salmeterol, salmeterol, and tiotropium in treating moderate to severe chronic obstructive pulmonary disease (COPD) in patients aged 40 and above, who are current or ex-smokers with a smoking history of at least 10 pack-years.",
    "This sample is a phase 3 trial for Crohn's Disease, testing the drugs abatacept and placebo, with eligibility criteria including being 18 years or older, having had Crohn's Disease for at least 3 months, and having an inadequate response or intolerance to other treatments.",
    "This sample is a phase 3 trial for fibromyalgia, testing the effectiveness of milnacipran 100mg compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with hepatocellular carcinoma, testing the drugs abt-869 and sorafenib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of perennial allergic rhinitis using bepotastine besilate and placebo, with specific inclusion and exclusion criteria for patients aged 7-15 years.",
    "This sample is a phase 3 trial for the treatment of human immunodeficiency virus (HIV) infection using the drugs fosamprenavir and ritonavir, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for HIV infections, testing the efficacy of tipranavir, darunavir, and ritonavir in treatment-experienced patients with resistance to multiple protease inhibitors, and requiring specific criteria for inclusion.",
    "This sample is a phase 3 trial for diabetic retinopathy, testing the drug octreotide acetate in microspheres, with specific inclusion and exclusion criteria for participation.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin, rosiglitazone, metformin, and glipizide as compared to a placebo, for patients who are inadequately controlled while taking two oral antidiabetic medications.",
    "This sample is a phase 3 trial for venous thromboembolism, testing the drugs fondaparinux and enoxaparin, with inclusion criteria including the ability to provide informed consent and exclusion criteria such as active bleeding and thrombolytic or anticoagulant treatment during the current hospitalization.",
    "This phase 3 trial is testing the effectiveness of golimumab, placebo, and methotrexate in treating rheumatoid arthritis patients who have been diagnosed for at least 6 months, are on a stable dose of methotrexate for 4 weeks, and have at least 4 swollen and 4 tender joints.",
    "This sample is a phase 3 trial testing the effectiveness of ezetimibe (plus simvastatin) versus placebo (plus simvastatin) in patients with heterozygous familial hypercholesterolemia, with specific inclusion and exclusion criteria. The diseases being studied are atherosclerosis, hypercholesterolemia, and hyperlipoproteinemia type II, with corresponding ICD-10 codes provided.",
    "This sample is a phase 3 clinical trial for postmenopausal women with breast cancer and osteoporosis, testing the effectiveness of letrozole and zoledronic acid in preventing fractures and improving bone density.",
    "This sample is a phase 3 clinical trial testing the drugs ibandronate and zoledronic acid for patients with malignant bone disease and moderate to severe pain, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients diagnosed with partial epilepsy, testing the effectiveness of pregabalin and lamotrigine drugs in reducing the frequency of seizures.",
    "This phase 3 trial is investigating the use of darbepoetin alfa and placebo in patients with kidney disease, diabetes mellitus, and anemia, with specific eligibility criteria including hemoglobin levels, chronic kidney disease history, eGFR, and Tsat levels.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of aclidinium bromide compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of bipolar disorder using quetiapine fumarate, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 clinical trial aims to evaluate the efficacy of fimasartan and candesartan cilexetil, two angiotensin II antagonists, in treating mild to moderate essential hypertension patients, while excluding those with severe hypertension, secondary hypertension, significant investigations, severe heart disease, severe diabetes mellitus, severe cerebrovascular disease, wasting disease, autoimmune disease, connective tissue disease, severe or malignancy retinopathy, hepatitis B or C or HIV positive reaction, alcohol or drug abuse history, allergic reaction to any angiotensin II antagonist, chronic inflammation disease, childbearing and breastfeeding women, and those who have taken medicine within 12 weeks or are participating in other clinical trials.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using methylphenidate transdermal system (MTS) as the drug, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for cervical cancer patients, testing the drug cisplatin, with specific eligibility criteria including age, stage of cancer, blood count, liver function, and absence of certain medical conditions.",
    "This sample is a phase 3 clinical trial for patients with metastatic prostate cancer, testing the drugs calcitriol and docetaxel, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for carpal tunnel syndrome, testing the effectiveness of gabapentin as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for osteoarthritis, testing the effectiveness of buprenorphine transdermal patch and placebo in managing moderate to severe pain, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with pancreatic cancer, testing the effectiveness of gemcitabine, capecitabine, and erlotinib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the drug bi 10773 and sitagliptin 100mg, along with placebos, to evaluate their effectiveness in treating the disease. The eligibility criteria include patients who completed a previous trial and meet certain health requirements, while excluding those with liver or renal disease, contraindications to certain medications, and other conditions that may jeopardize their safety during the trial.",
    "This sample is a phase 3 clinical trial for patients with advanced hepatocellular carcinoma (HCC) testing the effectiveness of sorafenib (Nexavar, Bay43-9006) compared to a placebo, with eligibility criteria including having a life expectancy of at least 12 weeks, histologically or cytologically documented HCC, and an Eastern Co-operative Oncology Group (ECOG) Performance Status of 0, 1, or 2.",
    "This sample is a phase 3 clinical trial for the drug resatorvid and placebo in patients with sepsis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of paliperidone palmitate as a switch from previous antipsychotic treatment. The study includes inclusion and exclusion criteria, and aims to evaluate the safety and efficacy of the drug in treating schizophrenia.",
    "This sample is a phase 3 clinical trial for patients with hyperlipidemia, testing the effectiveness of pitavastatin and atorvastatin in reducing LDL-C levels, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of muscle wasting and non-small cell lung cancer using the drugs gtx-024 and placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for patients with human immunodeficiency virus (HIV) infections, testing the effectiveness of atazanavir + ritonavir as a treatment option. The inclusion criteria include being on antiretroviral treatment for the previous 6 months, absence of virologic failure, and HIV RNA < 50 copies/mL. The exclusion criteria include presence of newly diagnosed HIV-related opportunistic infection, active disease conditions, and CD4 < 100 cells/mm3.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of the drug fluticasone propionate/salmeterol combination diskus in treating the disease. The inclusion criteria require a diagnosis of COPD, while the exclusion criteria exclude patients with asthma or other uncontrolled respiratory disorders.",
    "This sample is a phase 3 clinical trial for patients with advanced non-small cell lung cancer, testing the effectiveness of gemcitabine and cisplatin as chemotherapy drugs, with specific eligibility criteria for inclusion and exclusion.",
    "This phase 3 trial is investigating the efficacy of alga dunaliella bardawil and placebo in treating psoriasis, with inclusion criteria including a diagnosis of plaque or guttate psoriasis, a Psoriasis Area and Severity Index (PASI) score of \u226512 or psoriasis covering \u226510% of body surface area (BSA), and a Psoriasis severity of at least moderate.",
    "This sample is a phase 3 trial studying the effectiveness of fidaxomicin, vancomycin, and a matching placebo in treating clostridium infections and diarrhea, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with untreated squamous cell carcinoma or adenocarcinoma of the thoracic esophagus or gastro-esophageal junction, testing the effectiveness of cisplatin and fluorouracil as treatment options.",
    "This sample is a phase 3 trial for the drug ferumoxytol, which is being tested for the treatment of iron deficiency anemia, and includes eligibility criteria such as previous participation in a related study and exclusion criteria such as previous serious adverse events or pregnancy.",
    "This sample is a phase 3 trial testing the effectiveness of azithromycin versus placebo in patients over 40 years old with chronic cough and chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for diabetes mellitus, type 2, testing the drugs ly2189265, sitagliptin, placebo solution, placebo tablet, and metformin, with inclusion criteria including a minimum duration of diabetes, specific treatment regimens, HbA1c values, BMI range, stable weight, and negative pregnancy test for females of childbearing potential, and exclusion criteria including type 1 diabetes, recent use of GLP-1 analog or insulin, gastric emptying abnormality, use of weight loss medications, cardiovascular events, poorly controlled hypertension, abnormal ECG readings, liver disease, elevated ALT levels, impaired kidney function, uncontrolled diabetes or endocrine/autoimmune abnormalities, history of organ transplant, chronic use of glucocorticoid therapy, active or untreated malignancy, and use of CNS stimulants.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of azithromycin and placebo drugs, with specific inclusion and exclusion criteria, aiming to enroll a broad sample of adult patients with physician-diagnosed asthma.",
    "This sample is a phase 3 clinical trial for multiple sclerosis, specifically relapsing-remitting disease, testing the effectiveness of cladribine 5.25 mg/kg and cladribine 3.5 mg/kg as potential treatments. The study includes eligibility criteria such as age, disease classification, relapse history, MRI results, EDSS score, weight range, and contraception requirements. Exclusion criteria include progressive forms of MS, prior use of certain drugs, leukopenia, prior or current use of specific therapies, compromised immune function, history of malignancy, and various other medical conditions.",
    "This sample is a phase 3 clinical trial for patients with metastatic breast cancer, testing the effectiveness of docetaxel, lapatinib ditosylate, and paclitaxel in combination with eligibility criteria including HER2/neu overexpression and various patient characteristics.",
    "This sample is a phase 3 clinical trial for patients with acquired immunodeficiency syndrome (AIDS) or HIV infections, testing the efficacy of the drugs nnrti, ftc/tdf, and stribild in combination with an antiretroviral regimen, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with moderate persistent asthma, testing the effectiveness of beclomethasone plus formoterol and fluticasone plus salmeterol in controlling asthma symptoms, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients undergoing abdominal hysterectomy, testing the effectiveness of morphine and cg5503 ir drugs in managing postoperative pain, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for knee osteoarthritis, testing the efficacy of glucosamine sulfate /chondroitin sulfate and cosamin ds\u00ae as potential treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with pulmonary hypertension, testing the drug bosentan. The inclusion criteria include patients with a documented history of sickle cell disease, symptomatic PAH, and specific hemoglobin genotype and levels. The exclusion criteria include various medical conditions and treatments, such as liver disease, cardiac disease, and recent treatment with other investigational drugs or certain medications.",
    "This sample is a phase 3 trial for chronic hepatitis C patients, testing the efficacy of ribavirin in combination with other drugs, with specific eligibility criteria including age, liver disease status, previous treatment history, and contraception requirements.",
    "This sample is a phase 3 trial for the treatment of overactive bladder using the drugs mirabegron and placebo, with inclusion criteria including symptoms of overactive bladder for at least 3 months and experiencing a certain frequency of micturition and urgency episodes, while exclusion criteria include various medical conditions and contraindications for the drugs.",
    "This sample is a phase 3 trial for patients with osteoarthritis and postoperative pain, testing the effectiveness of pregabalin and placebo in managing pain after total knee arthroplasty.",
    "This sample is a phase 3 trial for patients with breast cancer receiving anthracycline-based chemotherapy, testing the use of esomeprazole to manage nausea as a side effect of the treatment.",
    "This sample is a phase 3 trial for patients with hypertension, testing the drugs telmisartan and telmisartan/hctz, with eligibility criteria including a history of mild-to-moderate essential hypertension and the ability to provide written informed consent.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C using the drugs sofosbuvir, rbv, and peg, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus and high HbA1c levels, testing the effectiveness of dapagliflozin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the use of somatropin and placebo in patients with chronic kidney disease and end-stage renal disease, with specific inclusion and exclusion criteria outlined in the study.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) using the drugs ff/gw642444 inhalation powder and gw642444 inhalation powder, with eligibility criteria including being an outpatient, having a COPD diagnosis, and a history of COPD exacerbations.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin glargine, ly2189265, and insulin lispro in managing blood glucose levels, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of vildagliptin in combination with metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for lupus nephritis, testing the effectiveness of drugs such as mycophenolate mofetil, cyclophosphamide, azathioprine, and corticosteroid in patients with systemic lupus erythematosus and active nephritis.",
    "This sample is a phase 3 trial for patients with genotype 1 hepatitis C infection who have previously received peginterferon-based therapy and relapsed within 1 year. The study will test the effectiveness of the drugs tmc435, placebo, peginterferon alpha-2a, and ribavirin in treating the disease.",
    "This phase 3 trial is testing the effectiveness of carmustine, cyclophosphamide, dacarbazine, doxorubicin hydrochloride, etoposide, and vinblastine in treating stage III or IV Hodgkin's disease in patients aged 15 to 65, with specific disease characteristics and patient characteristics.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of dapagliflozin, glimepiride, metformin hydrochloride, pioglitazone hydrochloride, and rosiglitazone in combination with a stable sulphonylurea monotherapy dose for improving glycaemic control.",
    "This phase 3 trial aims to evaluate the effectiveness of omalizumab (Xolair), placebo, corticosteroids, and long-acting beta-agonists in treating inadequately controlled asthma in patients aged 12 to 75 years with a history of moderate to severe asthma, positive response to aeroallergen, and previous asthma exacerbations requiring systemic corticosteroid rescue.",
    "This sample is a phase 3 trial for patients with ocular hypertension or open-angle glaucoma who have been using latanoprost 0.005% as their prior medication, and it aims to evaluate the ocular surface related symptoms and/or signs with the drug tafluprost.",
    "This sample is a phase 3 clinical trial for patients with epilepsy, specifically those with partial seizures, and the drug being tested is lamictal extended-release. The eligibility criteria include having a diagnosis of epilepsy with partial seizures for more than 24 weeks, experiencing at least 8 partial seizures during an 8-week Baseline Phase, and currently receiving treatment with a stable regimen of one or two antiepileptic drugs for at least four weeks.",
    "This phase 3 trial is testing the effectiveness of the folfiri regimen, capecitabine, celecoxib, fluorouracil, irinotecan hydrochloride, and leucovorin calcium in treating patients with metastatic colorectal cancer who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for the treatment of proctitis and proctosigmoiditis using budesonide and placebo, with specific eligibility criteria including confirmed diagnosis, disease extent, and baseline disease activity index.",
    "This phase 3 trial is testing the effectiveness of budesonide/formoterol, budesonide, and theophylline in treating asthma, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin aspart and glibenclamide in controlling blood sugar levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the effectiveness of insulin detemir, insulin aspart, insulin nph, and human soluble insulin in managing blood glucose levels, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of larotaxel, 5-fluorouracil, and capecitabine in treating advanced pancreatic neoplasms that have been previously treated with a gemcitabine-based regimen, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of telmisartan/amlodipine fixed combination drugs in patients with essential hypertension who did not respond to previous treatment with amlodipine, and the eligibility criteria include age, blood pressure control, and exclusion of certain medical conditions.",
    "This sample is a phase 3 clinical trial for high risk stage III melanoma, testing the drugs ipilimumab and placebo, with eligibility criteria including age \u2265 18 years, complete resection of melanoma, disease-free status, ECOG PS 0 or 1, and randomization within 12 weeks of surgery.",
    "This sample is a phase 3 trial for dry eye syndromes, testing the effectiveness of carboxymethylcellulose based eye drop formulations and lubricant eye drops, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of sorafenib, placebo, gemcitabine, and cisplatin in treating non-small-cell lung carcinoma, with specific eligibility criteria including age, disease stage, measurable lesions, and various laboratory requirements.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of docetaxel, leuprolide, and bicalutamide in combination for the treatment of prostate adenocarcinoma, with specific eligibility criteria including confirmed diagnosis, biochemical progression of disease, adequate organ function, and willingness to comply with study procedures.",
    "This sample is a phase 3 clinical trial that aims to test the effectiveness of sertraline, an antidepressant drug, compared to a placebo pill in treating depression in patients with a history of coronary heart disease. The eligibility criteria include specific symptoms of depression, documented history of heart disease, and exclusion criteria such as recent heart attack, certain psychiatric disorders, and current use of certain medications.",
    "This sample is a phase 3 clinical trial for the treatment of bipolar disorder, anxiety disorders, and substance use disorders using quetiapine xr and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with newly diagnosed acute promyelocytic leukemia (APL), testing the efficacy of a combination of drugs including arsenic trioxide, idarubicin, mercaptopurine, methotrexate, and all-trans retinoic acid, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with atrial fibrillation, testing the effectiveness of valsartan compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 trial aims to evaluate the effectiveness of topiramate compared to placebo in treating bipolar disorder, affective disorders, psychotic, and mood disorders in children with a DSM-IV diagnosis of Bipolar I Disorder, with inclusion criteria including a YMRS score greater than or equal to 20, general good health, and the ability to swallow tablets.",
    "This sample is a phase 3 trial for HIV-infected individuals with specific eligibility criteria, including prior antiretroviral resistance and stable antiretroviral regimen, to test the drug gw873140.",
    "This sample is a phase 3 clinical trial for kidney transplant recipients, testing the effectiveness of two drug combinations (everolimus and tacrolimus, mycophenolate mofetil and tacrolimus) in preventing organ rejection, with specific eligibility criteria for participants.",
    "This phase 3 trial aims to evaluate the effectiveness of olmesartan medoxomil, a drug used to treat hypertension, in patients with metabolic syndrome and hypertension, based on specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for patients with breast cancer and metastasis, focusing on those who overexpress HER2-NEU. The study aims to evaluate the efficacy of trastuzumab and other chemotherapy drugs in association with trastuzumab as a first-line treatment for visceral metastasis. The inclusion criteria include specific disease characteristics, good general conditions, age range, life expectancy, and absence of certain conditions. The exclusion criteria involve contraindications, prior treatments, geographical constraints, and other serious pathologies.",
    "This sample is a phase 3 trial for HIV patients who have experienced drug resistance or antiretroviral failure, and are currently on a protease inhibitor (PI) regimen with enfuvirtide. The study aims to evaluate the efficacy of darunavir and ritonavir in replacing enfuvirtide in the treatment regimen.",
    "This sample is a phase 3 trial for patients with end stage renal disease, testing the use of heparin as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with hypertension, testing the drugs telmisartan and ramipril, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for de novo kidney transplant recipients and renal transplantation patients, testing the drugs everolimus, cyclosporine, and prednison (continuous steroids) with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with glioblastoma multiforme, testing the drugs il13-pe38qqr and prolifespan 20 with carmustine implant (gliadel\u00ae wafer), with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for ulcerative colitis, testing the efficacy of asacol 400 mg in maintaining remission in pediatric patients aged 5-17 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with open-angle glaucoma or ocular hypertension, testing the drugs Xalacom and unfixed latanoprost and timolol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of Raynaud's and scleroderma using the drug fasudil, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with resectable adenocarcinoma of the rectum, testing the effectiveness of fluorouracil and leucovorin calcium in combination, with specific eligibility criteria including age, performance status, hematopoietic and renal function, and no prior biologic, chemotherapy, endocrine therapy, radiotherapy, or surgery for adenocarcinoma of the rectum.",
    "This sample is a phase 3 clinical trial for female patients with metastatic breast cancer, testing the effectiveness of vinflunine and alkylating agents as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with hormone refractory prostate cancer, testing the effectiveness of satraplatin and prednisone as a second-line chemotherapy treatment option. The eligibility criteria include having stage D2 metastatic prostate cancer, progression after one prior chemotherapy, and adequate bone marrow, hepatic, and renal functions.",
    "This phase 3 clinical trial is testing the effectiveness of leucovorin, oxaliplatin, and 5-fluorouracil in treating patients with pancreatic neoplasms who have previously received gemcitabine-based chemotherapy, and have measurable locally advanced or metastatic disease.",
    "This sample is a phase 3 clinical trial for the treatment of overactive urinary bladder in children, using solifenacin succinate suspension and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using the drug quetiapine xr, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for multiple myeloma, CLL/SLL, non-Hodgkin's lymphoma, Waldenstroms, and mantle cell lymphoma, using the drug fludarabine, with specific eligibility criteria for patients.",
    "This sample is a phase 3 clinical trial for the drug ranirestat in patients with diabetic neuropathy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for metastatic hormone-sensitive prostate cancer, testing the effectiveness of androgen-deprivation therapy and docetaxel as drugs, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 3 trial for allergic asthma, testing the drugs depigoid, omalizumab, and placebo, with inclusion criteria including age, weight, IgE levels, diagnosis, and FEV1, and exclusion criteria including pregnancy, concurrent diseases, and ingredient hypersensitivity.",
    "This sample is a phase 3 trial for cystic fibrosis, testing the drugs denufosol tetrasodium inhalation solution and placebo, with inclusion criteria including confirmed diagnosis of cystic fibrosis and FEV1 within a specific range.",
    "This sample is a phase 2/phase 3 trial for pancreatic cancer, testing the drug rubitecan, with inclusion criteria including non-resectable adenocarcinoma of the pancreas and exclusion criteria including active infections and scheduled surgery within 8 weeks.",
    "This sample is a phase 3 clinical trial for patients with left-sided uncomplicated diverticular disease, testing the effectiveness of mesalazine and placebo in reducing symptoms. The eligibility criteria include a confirmed diagnosis of diverticular disease, presence of at least one diverticulum, recent response to antibiotics or dietary modification, and elevated C-reactive protein levels. Exclusion criteria include complicated diverticular disease, right-sided diverticulitis, previous colonic surgery, and various other conditions.",
    "This sample is a phase 3 clinical trial for osteoarthritis knee pain, testing the effectiveness of duloxetine and placebo as potential drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of exenatide and placebo in combination with metformin and/or a thiazolidinedione, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for patients with open-angle glaucoma or ocular hypertension who are insufficiently controlled on monotherapy or are currently on multiple IOP-lowering medications. The trial will test the effectiveness of brinzolamide 1%/brimonidine tartrate 0.2% fixed combination ophthalmic suspension, brinzolamide 1% ophthalmic suspension, and brimonidine tartrate 0.2% ophthalmic solution in reducing intraocular pressure.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of dapagliflozin, metformin, and pioglitazone in improving glycemic control, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of exenatide and rosiglitazone in treating type 2 diabetes mellitus, with specific eligibility criteria including HbA1c levels and BMI ranges.",
    "This sample is a phase 3 trial for asthma, testing the efficacy of mometasone furoate/formoterol fumarate combination mdi, mometasone furoate mdi, formoterol fumarate, and placebo, with specific eligibility criteria for participants.",
    "This phase 3 clinical trial is investigating the effectiveness of folate, methotrexate, methylprednisolone, placebo, and rituximab in treating adult patients with rheumatoid arthritis who have not responded adequately to methotrexate alone.",
    "This sample is a phase 3 trial for nicotine addiction, testing the effectiveness of varenicline, placebo, and transdermal nicotine as smoking cessation treatments, with specific eligibility criteria and exclusion criteria related to smoking behavior, alcohol/drug use, medical conditions, and psychiatric conditions.",
    "This sample is a phase 2/phase 3 trial for tuberculosis and HIV infections, testing the effectiveness of nevirapine based therapy, efavirenz based therapy, and rifampicin (rmp) ethambutol (e) isoniazid (h) pyrazinamid (z) in patients with CD4 cell count < 250 cell/mm3 and who are na\u00efve of HAART. The study has specific inclusion and exclusion criteria, including age, TB treatment history, and pregnancy status.",
    "This sample is a phase 3 clinical trial for patients with relapsing-remitting multiple sclerosis, testing the effectiveness of glatiramer acetate (ga) 40 mg and glatiramer acetate 20 mg in reducing relapses and enhancing lesions in MRI scans.",
    "This sample is a phase 3 trial for subjects with schizophrenia or schizoaffective disorder who have completed 12 months of treatment under protocol 25517. The study will test the effectiveness of asenapine and olanzapine in treating these conditions.",
    "This sample is a phase 3 trial for asthma, testing the drugs fluticasone furoate/gw642444 and fluticasone furoate, with eligibility criteria including clinical diagnosis of asthma, reversibility FEV1, and history of asthma exacerbations, among others.",
    "This phase 3 trial aims to investigate the effectiveness of aliskiren and losartan in treating patients with essential hypertension, left ventricular hypertrophy, and overweight, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for pneumonia, testing the effectiveness of levofloxacin and nemonoxacin as oral drugs for patients with community-acquired pneumonia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of paliperidone er as a treatment option. The inclusion criteria include a DSM-IV diagnosis of schizophrenia, experiencing an acute schizophrenic episode, and agreeing to be hospitalized for a minimum of 14 days. The exclusion criteria include having a diagnosis other than schizophrenia, substance dependence within 6 months, and a history of lack of response to risperidone when acutely psychotic.",
    "This sample is a phase 3 clinical trial for patients with macular edema resulting from retinal vein occlusion, testing the effectiveness of 700 \u00b5g and 350 \u00b5g dexamethasone in improving visual acuity, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the drugs asp1941 and placebo. The inclusion criteria include specific disease, exercise program or stable diet, certain GFR and HbA1C values, and a specific BMI range. The exclusion criteria include type 1 diabetes, certain complications, recent insulin use, certain chronic diseases, and various other conditions.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of aclidinium bromide 200 \u00b5g and 400 \u00b5g in improving lung function and reducing symptoms. The inclusion criteria include a diagnosis of moderate to severe COPD and being a current or former smoker, while the exclusion criteria include recent hospitalization for COPD exacerbation, respiratory tract infection, and other respiratory or cardiovascular conditions.",
    "This sample is a phase 3 clinical trial for patients with diabetes mellitus and macular edema, testing the effectiveness of ranibizumab and sham injection in improving visual acuity and reducing retinal thickening.",
    "This sample is a phase 3 trial for patients with mild to moderate asthma, testing the drug budesonide/formoterol turbuhaler. The inclusion criteria include a diagnosis of asthma and daily use of inhaled GCS, while the exclusion criteria include regular need for >4 inhalations of a short-acting b2-agonist/day and known or suspected hypersensitivity to the investigational drugs.",
    "This sample is a phase 3 clinical trial for patients with idiopathic Parkinson's disease, testing the efficacy of pramipexole immediate release and extended release tablets in reducing off-time periods, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is focused on prostate cancer patients and aims to evaluate the effectiveness of drugs such as bicalutamide, leuprolide, goserelin, and flutamide in combination with radiation therapy, with specific eligibility criteria for patient selection.",
    "This sample is a phase 3 trial for women with menorrhagia (heavy menstrual bleeding) and aims to test the effectiveness of tranexamic acid tablets and placebo tablets in reducing bleeding.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin phosphate and placebo as additional treatment options to diet/exercise therapy and metformin monotherapy.",
    "This sample is a phase 3 clinical trial for patients with pulmonary fibrosis, testing the drugs placebo and bibf 1120, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for the drug lapatinib, targeting head and neck neoplasms, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of a simplified diabetes regimen and intensive diabetes management using human insulin inhalation powder. The eligibility criteria include having type 2 diabetes for at least 6 months, specific HbA1c levels, and being a candidate for insulin therapy. Exclusion criteria include pregnancy, smoking, history of severe hypoglycemia, recent pneumonia diagnosis, and certain medical conditions.",
    "This sample is a phase 3 trial for patients with persistent asthma not optimally controlled on high doses of ICS or medium dose of ICS+LABA, testing the drugs chf1535 200/6 \u00b5g and bdp 100 \u00b5g, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with refractory multiple myeloma, testing the drug plerixafor for stem cell mobilization prior to possible allogeneic stem cell transplant. The inclusion criteria include a diagnosis of MM, previous lenalidomide therapy, and specific blood counts, while exclusion criteria include prior transplantation and recent lenalidomide use.",
    "This phase 3 trial aims to evaluate the effectiveness of gabapentin in reducing hot flashes in women with breast cancer, who are ineligible for estrogen therapy due to age or risk factors.",
    "This sample is a phase 3 clinical trial for patients diagnosed with schizophrenia, testing the effectiveness of er oros paliperidone, placebo, and olanzapine as treatments, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of type 2 diabetes using bromocriptine mesylate, with specific eligibility criteria including a diagnosis of type 2 diabetes for at least six months, age between 18-75, stable metformin treatment, and specific HbA1c and fasting plasma glucose measurements.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs \"23 mg sr in study 326\" and \"10 mg ir in study 326\", with inclusion criteria including written informed consent, completion of a previous study without adverse reactions, and well-controlled co-morbid medical conditions. Exclusion criteria include the absence of a caregiver, certain medical conditions, and the use of prohibited medications.",
    "This sample is a phase 3 trial for the treatment of eosinophilic asthma using the drugs reslizumab and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 clinical trial is testing the effectiveness of rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin, and prednisone in treating diffuse large B-cell lymphoma in patients aged 60 to 65 years with specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of the drug bi 10773 in combination with metformin or sulfonylurea, with specific eligibility criteria including HbA1c levels, age, BMI, and exclusion criteria such as uncontrolled hyperglycemia, liver disease, impaired renal function, and history of cancer.",
    "This sample is a phase 3 clinical trial for lupus nephritis and systemic lupus erythematosus, testing the effectiveness of corticosteroids, cyclophosphamide, mycophenolate mofetil, ocrelizumab, azathioprine, and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is testing the effectiveness of bi 10773, a drug, in patients with type 2 diabetes and hypertension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer (NSCLC) patients with malignant pleural effusion or stage IV disease. The study aims to evaluate the efficacy of cetuximab + cisplatin + vinorelbine and cisplatin + vinorelbine as treatment options. The inclusion criteria include confirmed NSCLC diagnosis, EGFR expression on tumor tissue, and presence of measurable index lesions. Exclusion criteria include previous exposure to certain therapies, previous chemotherapy for NSCLC, brain metastasis, and other specific conditions.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis, testing the effectiveness of methotrexate and tocilizumab in treating the disease, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of dry eye, using 3% de-089 ophthalmic solution and 0.1% sodium hyaluronate ophthalmic solution, with inclusion criteria including keratoconjunctival disorder confirmed with vital dye staining and abnormal Schirmer score results.",
    "This sample is a phase 3 trial for erosive esophagitis patients who have not responded to standard-dose or higher-than-standard-dose PPI therapy, and it will test the efficacy of tak-438 in controlling the condition.",
    "This phase 3 trial is testing the effectiveness of ibuprofen/famotidine and ibuprofen in treating ulcers, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for the drug cilomilast in patients with chronic obstructive pulmonary disease (COPD), with inclusion criteria of a COPD diagnosis and a history of cigarette smoking, and exclusion criteria of significant heart or lung disease not associated with COPD and significant stomach or intestinal disease.",
    "This sample is a phase 3 trial testing the drug estradiol in postmenopausal women with menopause and postmenopausal vaginal atrophy, with the inclusion criteria being postmenopausal women whose last menstruation was at least two years previously.",
    "This sample is a phase 3 clinical trial for patients with multiple sclerosis and fatigue, testing the effectiveness of high dose aspirin, low dose aspirin, and placebo in reducing fatigue symptoms, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2/phase 3 trial for patients with unipolar depression, testing the effectiveness of escitalopram and pindolol as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with acquired immunodeficiency syndrome (AIDS) or HIV infection, testing the drug maraviroc for those who have limited treatment options due to resistance or intolerance, and have failed to achieve virologic suppression on their current regimen. The study includes specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 trial is testing the efficacy of placebo (for ramucirumab) and docetaxel in treating non-small cell lung cancer patients who have experienced disease progression after platinum-based chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of various drugs including placebo, tiotropium, olodaterol, and combinations of these drugs, based on specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for patients with plaque-type psoriasis, testing the effectiveness of ustekinumab and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for metastatic colorectal cancer, testing the drugs erlotinib (tarceva) and bevacizumab (avastin), with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for breast cancer patients who have undergone mastectomy or lumpectomy, and it aims to evaluate the effectiveness of cyclophosphamide, doxorubicin hydrochloride, octreotide pamoate, and tamoxifen citrate in preventing tumor recurrence.",
    "This sample is a phase 3 clinical trial studying the effectiveness of rivaroxaban and warfarin in patients with atrial fibrillation, stroke, and embolism, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with asthma, testing the effectiveness of the drugs symbicort and budesonide in combination with inhaled corticosteroids, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for primary biliary cirrhosis, testing the efficacy of obeticholic acid (oca) compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is investigating the use of anastrozole and placebo in postmenopausal women with a high risk of breast cancer based on age and family history, and who meet specific eligibility criteria.",
    "This sample is a phase 3 trial for patients with essential hypertension, testing the drugs lcz696, amlodipine, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the drug epoetin alfa for the treatment of anemia in patients with cancer, with specific eligibility criteria including age, body weight, ECOG score, and hemoglobin levels.",
    "This sample is a phase 2/phase 3 trial for allergic rhinitis, testing the efficacy of house dust mites allergen extract tablets and placebo tablets, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with esophagus cancer, testing the effectiveness of cisplatin and 5-fluorouracil in treating the disease, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for the treatment of knee pain due to osteoarthritis, using the drugs duloxetine and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of benign prostatic hypertrophy, testing the drugs cetrorelix and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for schizophrenia patients who have completed a short-term trial and meet specific criteria, and it involves the drugs haloperidol and asenapine.",
    "This sample is a phase 3 clinical trial for the treatment of diabetic neuropathy, painful, using drugs such as placebo and pregabalin, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the effectiveness of pemetrexed, gemcitabine, and cisplatin in treating non-squamous non-small cell lung cancer (NSCLC) patients with stage IIIB or IV disease, who have not received prior systemic chemotherapy for lung cancer.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec/insulin aspart in combination with metformin and other oral anti-diabetic drugs, with specific eligibility criteria including HbA1c levels between 7.0-10.0% and a BMI below or equal to 40.0 kg/m^2.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) using multiple drugs, including gsk 573719 and gw642444, and has specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by Gram-positive pathogens, using single-dose iv oritavancin diphosphate and iv vancomycin as the study drugs, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for the treatment of seasonal allergic rhinitis using azelastine hydrochloride nasal spray, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 trial is testing the efficacy of aripiprazole and placebo in treating bipolar I disorder, with specific inclusion and exclusion criteria for subjects, and the study aims to demonstrate drug efficacy based on CGI-BP Change From Preceding Phase scores.",
    "This sample is a phase 3 clinical trial for patients with systemic lupus erythematosus, testing the efficacy of switching to myfortic and continuing azathioprine as maintenance therapy, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the effectiveness of bevacizumab, carboplatin, paclitaxel, and placebo in treating locally advanced, metastatic, or recurrent non-small cell lung cancer, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with ovarian cancer, fallopian tube cancer, and primary peritoneal cavity cancer who have achieved complete remission with normal CA 125 after first-line platinum-containing chemotherapy. The study will test the effectiveness of chemotherapy in these patients.",
    "This sample is a phase 3 clinical trial for patients with metastatic breast cancer (MBC), testing the effectiveness of gemcitabine, docetaxel, and paclitaxel as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for non-small-cell lung cancer, testing the drug zoledronic acid 4 mg, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for epilepsy patients, testing the effectiveness of the drug brivaracetam compared to a placebo, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of drugs including velcade, thalidomide, and dexamethasone, as well as velcade, melphalan, and dexamethasone, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for gastrointestinal stromal tumors, testing the drugs regorafenib, placebo, and best supportive care, with eligibility criteria including prior treatment with imatinib and sunitinib, measurable lesions, and Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.",
    "This sample is a phase 3 trial for HIV-1 infection, testing the efficacy of atazanavir/ritonavir monotherapy in HIV-infected patients who have achieved virological suppression with previous antiretroviral therapy.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the drugs viaject\u2122 and regular human insulin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the drugs asa404, placebo, carboplatin, and paclitaxel, with eligibility criteria including histologically confirmed lung cancer, stage IIIb or IV disease, no prior systemic antineoplastic treatment, and specific lab values within range.",
    "This phase 3 trial is investigating the effectiveness of arbaclofen placarbil in treating spasticity in patients with multiple sclerosis, with inclusion criteria including specific disease criteria, Ashworth Score Scale score, EDSS rating, and stable MS treatment, while exclusion criteria include certain neurological disorders, muscle contractures, recent relapses, and specific medications.",
    "This phase 3 trial is investigating the effectiveness of capecitabine, erlotinib hydrochloride, and gemcitabine hydrochloride in treating locally advanced, unresectable pancreatic cancer patients who are not eligible for curative resection, and meet specific disease and patient criteria.",
    "This sample is a phase 3 trial testing the effectiveness of carvedilol mr, atenolol, and lisinopril in treating left ventricular hypertrophy in patients with hypertension, excluding those with certain medical conditions and using beta-2-agonists.",
    "This sample is a phase 3 trial for osteogenesis imperfecta, testing the efficacy of risedronate sodium (actonel) compared to a placebo, with inclusion criteria including an OI diagnosis and increased risk of fracture, and exclusion criteria including recent bisphosphonate use.",
    "This phase 3 trial is testing the effectiveness of tadalafil, a drug used to treat pulmonary hypertension, in patients with various forms of the disease, including idiopathic, collagen vascular disease-related, anorexigen use-related, and atrial septal defect-associated. The study includes eligibility criteria such as age, body weight, previous treatment with bosentan, and specific hemodynamic measurements. Exclusion criteria include pregnancy, certain types of PAH, left-sided heart disease, recent atrial septostomy, and use of certain medications within a specified timeframe.",
    "The sample is a phase 3 clinical trial for participants with type 2 diabetes mellitus, testing the effectiveness of two drugs, lantus (insulin glargine) and hoe901-u300 (new formulation of insulin glargine), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of sitagliptin phosphate compared to a placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is focused on osteoarthritis and aims to evaluate the effectiveness of glucosamine, chondroitin sulfate, glucosamine and chondroitin sulfate combined, and celecoxib in patients aged 40 years and above, with clinical and radiographic osteoarthritis symptomatic for at least six months.",
    "This sample is a phase 3 clinical trial for the treatment of cystic fibrosis using the drug ivacaftor, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial testing the effectiveness of montelukast, a drug used to treat upper respiratory tract infections, in children aged 1 to 5 years old without significant health problems. The study has specific inclusion and exclusion criteria, and aims to evaluate the impact of montelukast on wheezing and reactive airway disease.",
    "This sample is a phase 3 clinical trial for patients with non-small-cell lung carcinoma, testing the effectiveness of gemcitabine and cisplatin as a chemotherapy treatment. The eligibility criteria include specific disease stage, age, performance status, and various health parameters.",
    "This phase 3 trial is testing the effectiveness of pramipexole, a drug used to treat Parkinson's disease, compared to a placebo in patients with early idiopathic Parkinson's disease who meet specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of atamestane, toremifene, letrozole, aromatase inhibition, and estrogen receptor blocker in postmenopausal women with locally recurrent, locally advanced, or metastatic breast neoplasms, who have not received prior hormonal therapy, and meet specific eligibility criteria.",
    "This phase 3 clinical trial aims to evaluate the efficacy of mometasone furoate nasal spray (mfns) compared to a matching placebo nasal spray in subjects with allergic rhinitis, who have a positive skin prick test response to an appropriate seasonal allergen and are clinically symptomatic. The study includes inclusion and exclusion criteria, such as age, history of severe local reactions, upper respiratory tract infections, previous participation in other clinical studies, and pregnancy status.",
    "This sample is a phase 3 clinical trial for primary insomnia, testing the drugs suvorexant high dose (hd), suvorexant low dose (ld), and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the efficacy of the drug 323U66 SR in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 trial for inhaled insulin in patients with diabetes mellitus type 2 who have failed two or more oral anti-diabetic agents, with exclusion criteria including asthma, COPD, and smoking.",
    "This sample is a phase 3 clinical trial for the treatment of osteoporosis in postmenopausal women with back pain and spinal fractures, using drugs such as teriparatide and risedronate, along with a placebo, and with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for breast cancer patients with HER2-negative disease, evaluating the effectiveness of letrozole, bevacizumab, and fulvestrant as first-line treatment, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for subjects with partial seizures, who have been unresponsive to previous antiepileptic drugs. The study will test the effectiveness of pregabalin and levetiracetam in reducing seizure frequency.",
    "This sample is a phase 3 clinical trial for patients with proliferative diabetic retinopathy and diabetic macular edema, testing the effectiveness of ranibizumab and triamcinolone acetonide in combination with panretinal photocoagulation. The eligibility criteria include age, diagnosis of diabetes mellitus, specific retinopathy and macular edema conditions, visual acuity, and other medical factors.",
    "This sample is a phase 3 clinical trial for the treatment of bipolar disorder using the drug quetiapine, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of olanzapine and olanzapine pamoate depot as alternative medications for those who have an unsatisfactory response to their current medication or are experiencing negative effects. The inclusion criteria include a clinical diagnosis of schizophrenia and previous episodes of clinical worsening, while the exclusion criteria include active suicidal tendencies, pregnancy or nursing, and certain medical conditions.",
    "This sample is a phase 3 trial for schizophrenia, testing the effectiveness of placebo and ziprasidone oral capsules as treatments, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial aims to evaluate the efficacy of azilsartan medoxomil, a drug used for hypertension, in combination with metformin for patients with type 2 diabetes mellitus and inadequate glycemic control.",
    "This sample is a phase 2/phase 3 trial testing the effectiveness of levetiracetam and lorazepam in treating seizures, with inclusion criteria of having seizures and exclusion criteria of pregnancy, renal failure, and hepatic impairment.",
    "This phase 3 trial is testing the effectiveness of a placebo for sch 39641 in treating ragweed-induced allergic rhinoconjunctivitis, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of psoriasis vulgaris, testing the drugs leo 90100 and vehicle, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for HIV infections, testing the effectiveness of multiple drugs including enfuvirtide, raltegravir, darunavir, tipranavir, etravirine, and maraviroc, with specific eligibility criteria for participants.",
    "This sample is a phase 2/phase 3 trial for nicotine dependence, testing the effectiveness of extended treatment in adolescents aged 14-18 who smoke at least 10 cigarettes per day and have made at least one quit attempt in the previous 6 months. The study has inclusion and exclusion criteria related to age, smoking habits, mental health disorders, drug use, pregnancy, and current medication.",
    "This sample is a phase 3 clinical trial for gastric cancer, testing the drug uft (uracil, tegafur), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the drug alogliptin, and includes eligibility criteria such as specific controlled phase III studies the patients must have completed, certain liver and kidney function requirements, and restrictions on other medications.",
    "This sample is a phase 3 clinical trial for patients with prostatic neoplasms, testing the effectiveness of docetaxel + estramustine + hydrocortisone and docetaxel + prednisone as treatments. The eligibility criteria include confirmation of prostate adenocarcinoma, advanced stage of the disease, previous hormone treatment, low testosterone levels, and good hematological, liver, and kidney function. Exclusion criteria include previous chemotherapy or second-line hormone therapy, previous radiotherapy, recent malignant processes, concomitant serious diseases, and contraindications for treatment with estramustine.",
    "This phase 3 clinical trial aims to investigate the effectiveness of phylloquinone (k1) and menatetranone (mk4) in treating osteoporosis in postmenopausal females who are ambulatory, community dwelling, and meet various eligibility criteria.",
    "This sample is a phase 3 trial for patients with mixed dyslipidemia, testing the drugs abt-335 and placebo, with inclusion criteria of patients with qualifying cIMT thickness and exclusion criteria of certain chronic or unstable medical conditions, unstable dose of medications, pregnant or lactating women, and poorly controlled diabetes mellitus.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of exenatide once weekly and insulin detemir in combination with metformin and/or sulphonylurea, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the drug Stribild in patients with acquired immunodeficiency syndrome (AIDS) or HIV infections, who are virologically stable on their current antiretroviral regimen. The study aims to assess the safety and efficacy of Stribild as a potential treatment option.",
    "This sample is a phase 3 clinical trial testing the effectiveness of IV dalbavancin and vancomycin/linezolid in treating major abscess, surgical site infection, traumatic wound infection, or cellulitis caused by Gram-positive bacteria, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with cardiovascular diseases, peripheral vascular diseases, and atherosclerosis. The drug being tested is cilostazol, and the eligibility criteria include symptoms of intermittent claudication and positive noninvasive evaluation for significant aortoiliac PAD.",
    "This sample is a phase 3 trial testing the effectiveness of tapentadol extended release (ER) in treating pain, osteoarthritis, and low back pain, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of postoperative pain and bunions, using the drugs COV155 and placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for neoplasms, specifically prostate cancer, testing the effectiveness of dutasteride and placebo drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of montelukast and salmeterol/fluticasone propionate inhalation powder in improving lung function and reducing symptoms. The eligibility criteria include a diagnosis of asthma for at least 6 months, specific lung function measurements, and restrictions on previous medication use.",
    "This phase 3 trial is investigating the effectiveness of irinotecan, leucovorin, 5-fluorouracil, docetaxel, cisplatin and leucovorin, 5-fluorouracil drugs in treating patients with adenocarcinoma of the stomach or gastroesophageal junction, who have undergone surgery with curative intent, and meet specific eligibility criteria.",
    "This sample is a phase 3 trial for patients with hypertension and metabolic disorder, testing the effectiveness of losartan potassium (+) hydrochlorothiazide in controlling blood pressure and improving lipid abnormalities.",
    "This phase 3 clinical trial aims to evaluate the efficacy of alfuzosin and placebo in patients with neurogenic urinary bladder, specifically those with elevated detrusor Leak Point Pressure (LPP) of neuropathic etiology and Detrusor LPP \u2265 40 cm H2O and < 100 cm H2O, while excluding patients with certain urological surgeries, urethral dilatation, recent \u03b1-blocker therapy, detrusor injections of botulinum toxin, and other urological diseases/conditions.",
    "This sample is a phase 3 clinical trial for the treatment of overactive bladder, testing the drugs mirabegron and tolterodine, along with placebos, and includes eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for patients with colorectal cancer and metastatic cancer, testing the effectiveness of capecitabine, floxuridine, and oxaliplatin in combination with surgery or ablation as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of ly2216684, a drug for major depressive disorder (MDD), in patients who have had a partial response to selective serotonin reuptake inhibitor (SSRI) treatment, and have met certain inclusion criteria.",
    "This sample is a phase 3 trial that focuses on subjects with central neuropathic pain after stroke or multiple sclerosis. The drug being tested is pregabalin, and the eligibility criteria include a minimum pain WAS score and a certain time since the onset of pain.",
    "This sample is a phase 2/phase 3 trial for rheumatoid arthritis patients, testing the effectiveness of rosuvastatin and placebo in reducing symptoms. The inclusion criteria include disease duration of over 5 years, positive RA latex serology or IgM RF ELISA, and specific joint counts and inflammatory markers. Patients on contraindicated medications will be excluded, as well as those with symptomatic vascular disease or high cholesterol levels.",
    "This sample is a phase 3 trial for patients who have undergone liver transplantation, testing the effectiveness of mycophenolate mofetil and tacrolimus as immunosuppressive treatment. The eligibility criteria include being over 18 years old, having primary liver transplantation, and being on a specific immunosuppressive treatment regimen.",
    "This sample is a phase 3 trial for patients with hypertension, testing the drug valsartan plus hydrochlorothiazide. The inclusion criteria include specific blood pressure measurements, age requirements, and written consent. The exclusion criteria are not provided in the sample.",
    "This sample is a phase 3 clinical trial for postmenopausal osteoporosis, testing the drugs arzoxifene and placebo, with inclusion criteria including age, gender, and time since last menstrual cycle, and exclusion criteria including abnormal vaginal bleeding, bone disorders, history of certain cancers, history of stroke or blood clots, and specific medications.",
    "This sample is a phase 3 trial for the treatment of obesity and overweight using the drugs naltrexone sr 32 mg/bupropion sr 360 mg/day and placebo, with specific eligibility criteria including age, body mass index, blood pressure, medication history, and various medical conditions.",
    "This sample is a phase 3 trial for children with brain tumors who are undergoing radiation therapy. The trial aims to evaluate the effectiveness of high dose and low dose dexamethasone in reducing symptoms of vomiting and headache during radiation therapy.",
    "This sample is a phase 3 trial for smoking cessation, testing the effectiveness of placebo and varenicline (cp-526,555) drugs in individuals with schizophrenia or schizoaffective disorder who are motivated to quit smoking.",
    "This sample is a phase 3 clinical trial for osteoarthritis, testing the effectiveness of diclofenac topical sodium gel 1% as a treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with hematological malignancies, testing the use of darbepoetin alpha (aranesp) and iron saccharate (venofer) to improve iron stores and marrow recovery post-transplant, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of diabetic macular edema using intravitreal triamcinolone acetonide and laser therapy, with eligibility criteria including age, diagnosis of diabetes mellitus, and willingness to provide informed consent.",
    "This sample is a phase 3 trial for diabetic foot ulcers, testing the effectiveness of daptomycin and vancomycin as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with chronic hepatitis C and evidence of liver transplantation, testing the drug ciclosporin as a treatment option. The inclusion criteria include being an adult aged 18 or over, having been included in a previous study, and having a positive qualitative PCR at inclusion. The exclusion criteria include recent treatment with peginterferon or ribavirin, severe hepatocellular failure or decompensated cirrhosis, and positive serology for HIV or HBV.",
    "This sample is a phase 3 clinical trial for patients with stage I or II non-small cell lung cancer who are current smokers, testing the effectiveness of bupropion hydrochloride and nicotine in helping them quit smoking within 30 days after registration.",
    "This sample is a phase 2/phase 3 trial for individuals with type 2 diabetes, testing the effectiveness of dapagliflozin and placebo in combination with insulin and metformin/thiazolidinedione for glycemic control, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with leukemia or graft-versus-host disease who are planning to undergo allogenic stem cell or bone marrow transplantation. The trial is testing the effectiveness of budesonide, a drug used for standard GVHD prophylaxis, in combination with other medications. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 clinical trial for Huntington's disease, testing the drugs ACR16 and placebo, with specific inclusion and exclusion criteria for eligible patients.",
    "This phase 3 trial is investigating the use of sevelamer carbonate and placebo in patients with chronic kidney disease on hemodialysis, with the goal of evaluating their impact on serum iPTH and phosphorus levels. The study has specific inclusion and exclusion criteria, and aims to assess the safety and efficacy of the drugs in this patient population.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin glulisine and insulin glargine in combination with metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for head and neck squamous cell carcinoma, testing the drugs tirapazamine and cisplatin, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is investigating the effectiveness of risperdal consta and placebo in patients with bipolar disorder, who have had at least four episodes of mood disorder in the last year that required psychiatric intervention, and meet other inclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of lurasidone hcl and risperidone in treating patients with schizophrenia or schizoaffective disorder, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of depression using memantine hcl, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 2/phase 3 trial for patients with Parkinson's disease, testing the effectiveness of pramipexole immediate release and pramipexole extended release in improving symptoms and addressing therapeutically problematic issues associated with L-DOPA therapy. The inclusion criteria include patients with a diagnosis of PD, onset at age 40 or younger, and a modified Hoehn and Yahr scale of II to IV at \"on\" time. The exclusion criteria include atypical parkinsonian syndromes, dementia, psychiatric disorders, history of psychosis, clinically significant ECG abnormalities, hypotension, other clinically significant diseases, pregnancy or breastfeeding, and certain abnormal serum levels.",
    "This sample is a phase 2/phase 3 trial for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder, where the drugs being tested are ethyl-eicosapentaenoic acid (epa) and vitamins e + c, and the eligibility criteria include being admitted to a psychiatric hospital within the previous twenty-one days and being between the ages of 18-40.",
    "This sample is a phase 3 trial for breast cancer patients receiving chemotherapy, specifically targeting those at an increased risk of febrile neutropenia, with the drug pegfilgrastim, and includes eligibility criteria such as age, prior chemotherapy, and liver function.",
    "This sample is a phase 3 trial for hypertension, testing the effectiveness of carvedilol controlled release/lisinopril and lisinopril + placebo in reducing blood pressure in patients with stage 1 or 2 hypertension. The inclusion criteria include age 18-80 years, specific blood pressure ranges, and currently receiving 0 or 1 antihypertensive medication. Exclusion criteria include taking two or more antihypertensive medications, contraindications to ACE inhibitors or alpha- or beta-blocker therapy, and having Type 1 or Type 2 diabetes.",
    "This sample is a phase 3 trial testing the effects of bifidobacterium lactis (bb-12) and placebo on healthy children aged 1-3 attending daycare or preschool centers, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the use of sodium ferric gluconate complex in sucrose for patients with non-myeloid cancer who are receiving or scheduled to receive chemotherapy and have chemotherapy-related anemia, with specific eligibility criteria related to anemia, primary hematologic disorders, and patient characteristics.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C, testing the drugs pegylated-interferon alfa-2a and ribavirin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for a drug called bc1036, which aims to treat persistent cough in patients aged 18 to 75 years with a Leicester Cough Questionnaire score of \u2264 17 at baseline and FEV \u2265 70% of predicted normal. The study has inclusion and exclusion criteria, and participants must be willing to use effective contraception during the study.",
    "This sample is a phase 3 trial for patients with ocular hypertension or open-angle glaucoma, where the drug being tested is tafluprost, and the inclusion criteria require patients to have been using latanoprost 0.005% as their prior medication and have ocular surface related symptoms and/or signs with their prior medication.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin glulisine and insulin glargine in combination with a stable insulin regimen, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with colorectal neoplasms, testing the efficacy of the drugs placebo and xaliproden in combination with an oxaliplatin-containing chemotherapy regimen, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the drug CF101, which aims to treat moderate-to-severe Aqueous-Deficient Dry Eye. The trial includes eligibility criteria such as positive corneal fluorescein staining, Schirmer Test score, and OSDI score, and excludes patients with certain conditions or recent use of specific medications.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of canagliflozin and antihyperglycemic agents compared to placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the efficacy of tivozanib and sorafenib in treating advanced renal cell carcinoma, with specific eligibility criteria for subjects, including prior nephrectomy, clear cell component of RCC, measurable disease, and ECOG performance status of 0 or 1.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of insulin degludec/insulin aspart and insulin glargine in combination with metformin for glycemic control, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of iron deficiency anemia using the drug ferumoxytol, with key inclusion criteria including low hemoglobin and transferrin saturation levels, and key exclusion criteria including allergy to IV iron and serum ferritin levels above 600 nanograms/mL.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of three different drugs (beclomethasone, budesonide, and formoterol) in reducing exacerbations and improving lung function. The inclusion criteria include a clinical diagnosis of COPD, specific lung function measurements, and a history of exacerbations, while the exclusion criteria include asthma, significant concurrent diseases, recent exacerbations, and long-term oxygen therapy.",
    "This sample is a phase 3 clinical trial for the drug safinamide in patients with idiopathic Parkinson's disease, with specific inclusion and exclusion criteria, and the study aims to evaluate the drug's effectiveness in reducing motor fluctuations and \"off\" time during the day.",
    "This sample is a phase 3 trial for patients with acute coronary syndromes, testing the drugs rosuvastatin calcium and atorvastatin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of vortioxetine and duloxetine compared to a placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of doxorubicin hydrochloride, etoposide, and ifosfamide in treating high-risk soft tissue sarcoma patients who meet specific eligibility criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of ipragliflozin and a DPP-4 inhibitor in combination therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for HIV infection, testing the effectiveness of lopinavir/ritonavir plus nucleoside drugs, with specific inclusion and exclusion criteria, including age, HIV status, medication history, and pregnancy status.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of various drugs including fluticasone furoate, fluticasone propionate, and salbutamol, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 trial is testing the effectiveness of bicalutamide, buserelin, flutamide, goserelin, leuprolide acetate, and docetaxel in treating localized prostate cancer patients with high risk of recurrence, who are eligible for chemotherapy and meet specific criteria.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) using drugs such as umeclidinium/vilanterol and fluticasone propionate/salmeterol, as well as a placebo, with specific eligibility criteria including age, smoking history, lung function, and dyspnea.",
    "This phase 3 trial is investigating the effectiveness of ir methylphenidate, modafinil, and sr methylphenidate in treating patients with brain tumors who have experienced cognitive decline, while also considering various inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs GSK573719 and GSK573719 for their effectiveness in treating COPD. The inclusion criteria include a diagnosis of COPD, a history of cigarette smoking, specific lung function measurements, and a dyspnea score. The exclusion criteria include pregnancy, other respiratory disorders, significant allergies, recent hospitalization or surgery, abnormal ECG or laboratory findings, and use of certain medications.",
    "This sample is a phase 3 trial for prostate cancer, testing the drugs rofecoxib and placebo, with eligibility criteria including regular PSA testing and study biopsies.",
    "This phase 3 clinical trial is investigating the effectiveness of liraglutide and oral anti-diabetic drugs in Japanese subjects with type 2 diabetes, who have been on monotherapy with an OAD for at least 8 weeks, and have an HbA1c between 7.0-10.0%. The study aims to assess the impact of these drugs on glycemic control and other related outcomes.",
    "This sample is a phase 3 trial for patients aged 45 to 85 with mild abnormalities of the aortic valve, testing the drugs ezetimibe (+) simvastatin and placebo, to determine their effectiveness in treating aortic stenosis.",
    "This sample is a phase 3 clinical trial for patients with non-small-cell lung carcinoma, lung cancer, or anemia, testing the drug epoetin alfa to treat anemia in patients with advanced lung cancer. The eligibility criteria include specific disease stage, hemoglobin level, and age requirements, while excluding patients with certain previous treatments or medical conditions.",
    "This phase 3 clinical trial aims to evaluate the efficacy of vincristine sulfate, carmustine, melphalan, cyclophosphamide, and prednisone in treating patients with stage I, II, or III multiple myeloma, confirmed by bone marrow plasmacytosis and ancillary criteria, with measurable disease and specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for infertility, focusing on pre-menopausal women aged 18-42 with various causes of infertility. The study includes eligibility criteria such as no previous fertility medication, specific types of infertility, and semen analysis. The exclusion criteria include contraindications to progesterone therapy, high BMI, gynecologic pathology, and previous failed IVF cycles or miscarriages. The drugs being tested are dr-2011 and crinone 8%.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease and dementia, testing the drugs mpc-7869. The study includes inclusion criteria such as having a diagnosis of probable Alzheimer's disease, being 55 years or older, and having a reliable caregiver who can understand English or Spanish. Exclusion criteria include having evidence of other causes of dementia, active malignancy within the past 24 months, and chronic or acute renal, hepatic, or metabolic disorders.",
    "This sample is a phase 3 trial for patients with melanoma, testing the drugs gsk1120212 and chemotherapy, with eligibility criteria including age, disease stage, prior treatment, and organ function.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using methylphenidate hydrochloride extended-release tablets as the drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with hypertension, testing the effectiveness of telmisartan+amlodipine fixed dose combination in reducing blood pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for HIV-1 infections, testing the effectiveness of drugs such as tenofovir disoproxil fumarate (tdf) and emtricitabine/tenofovir disoproxil fumarate (ftc/tdf) in preventing transmission between discordant heterosexual partners, with specific inclusion and exclusion criteria for both HIV-1 infected and uninfected partners.",
    "This sample is a phase 3 trial for the drug vildagliptin in patients with type 2 diabetes mellitus, with specific inclusion and exclusion criteria, such as stable metformin dose, blood glucose criteria, BMI range, and exclusion of type 1 diabetes, pregnancy, lactation, significant diabetic complications, recent cardiovascular events, laboratory abnormalities, sensitivity to pioglitazone, and other protocol-defined exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of liraglutide and exenatide in combination with oral anti-diabetic drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of velcade, thalidomide, and dexamethasone as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for posttraumatic stress disorder (PTSD) patients, testing the effectiveness of avlocardyl and placebo drugs on patients and controls who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for graft rejection in cardiac recipients, testing the drugs everolimus, mycophenolate mofetil, cyclosporine, and corticosteroids, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with end stage renal disease, testing the effectiveness of mycophenolate sodium delayed release tablets and mycophenolate mofetil as immunosuppressive agents for kidney transplantation, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of benign prostatic hypertrophy, testing the drugs cetrorelix 78+78 and cetrorelix 78 + placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for participants with chronic hepatitis C infection, testing the efficacy of peginterferon alfa-2a and ribavirin as a first treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with pulmonary hypertension, testing the drug bosentan. The inclusion criteria include patients with a documented history of sickle cell disease, symptomatic PH associated with shortness of breath, and specific hemoglobin genotype and levels. The exclusion criteria include various medical conditions and treatments, such as left ventricular ejection fraction < 40%, uncontrolled hypertension, and recent treatment with other investigational drugs.",
    "This sample is a phase 3 trial for diabetic neuropathies, testing the effectiveness of duloxetine hydrochloride and placebo in relieving pain caused by peripheral neuropathy in patients with Type I or Type II diabetes.",
    "This sample is a phase 2/phase 3 trial for patients with heart failure, congestive, using the drugs relaxin and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the effectiveness of multiple drugs (cangrelor, clopidogrel, placebo bolus & placebo infusion, placebo capsules - end of pci, placebo capsules - end of infusion) in treating atherosclerosis and acute coronary syndrome (ACS) in patients who are eligible based on specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of loteprednol etabonate and its vehicle in reducing inflammation and pain in patients undergoing routine cataract surgery, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for HIV infections, testing the effectiveness of raltegravir and placebo in patients with documented HIV-1 infection and sustained low HIV RNA levels, with various inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with soft tissue sarcoma, testing the effectiveness of doxorubicin in combination with palifosfamide-tris or placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of migraine disorders using a combination tablet of treximet (sumatriptan/naproxen sodium) and includes eligibility criteria such as age, frequency of migraine attacks, and ability to distinguish migraine from other headaches.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of docetaxel and bevacizumab in comparison to a placebo, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the drugs docetaxel and carboplatin, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for smoking cessation, using the drug nicotine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for HIV infections, testing the effectiveness of a combination of drugs including zidovudine, lamivudine, efavirenz, ritonavir, and indinavir, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic myelogenous leukemia (CML) in chronic phase, testing the effectiveness of hydroxyurea and homoharringtonine drugs as treatment options, with specific eligibility criteria including prior treatment failure and age requirement.",
    "This sample is a phase 3 trial for a drug called pf-00345439, which aims to treat moderate to severe pain caused by osteoarthritis or low back pain, and the eligibility criteria include age, pain duration, and medication history.",
    "This sample is a phase 3 clinical trial for patients with Waldenstr\u00f6m macroglobulinemia, lymphoplasmacytic lymphoma, or splenic marginal zone lymphoma, testing the effectiveness of chlorambucil and fludarabine as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of generalized social anxiety disorder using duloxetine and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for diabetes mellitus, testing the effectiveness of acarbose (glucobay, bayg5421) compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of alogliptin and pioglitazone in combination with pioglitazone alone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with Crohn's disease, testing the effectiveness of dexamethasone, a steroid, in treating steroid-dependent CD patients who have experienced a relapse in the last 12 months. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 trial for patients with painful diabetic peripheral neuropathy, testing the effectiveness of pregabalin (Lyrica) compared to a placebo, with inclusion criteria requiring patients to be receiving treatment for this condition and exclusion criteria excluding patients with other pain conditions.",
    "This sample is a phase 3 clinical trial for ovarian cancer patients who are planning to receive platinum-based chemotherapy and are fit for interval debulking surgery, with specific eligibility criteria and no concurrent or prior malignancy likely to interfere with the treatment.",
    "This sample is a phase 3 clinical trial for multiple sclerosis, testing the drug interferon beta-1b (betaseron, bay86-5046) on Chinese patients with relapsing remitting or secondary progressive multiple sclerosis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial testing the drug atorvastatin in patients with advanced cancers, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with colorectal cancer and liver metastases, testing the effectiveness of oxaliplatin+capecitabine and oxaliplatin+capecitabine+bevacizumab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 trial is testing the effectiveness of gemcitabine in treating locally advanced or regional pancreatic cancer that is unresectable, with specific eligibility criteria including histologically confirmed adenocarcinoma, age over 18, and ECOG performance status of 0-1.",
    "This sample is a phase 3 clinical trial for ovarian cancer, testing the effectiveness of liposomal doxorubicin, carboplatin, and paclitaxel as chemotherapy drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) and symptoms such as cough, sputum production, and shortness of breath. The trial aims to evaluate the effectiveness of indacaterol maleate, a drug, in improving lung function in patients with COPD. The inclusion criteria include age between 40-75 years, a smoking history of at least 10 pack years, FEV1 less than 65% of predicted normal value, and pre-bronchodilator FEV1/FVC less than 70%. The exclusion criteria include a history of asthma or COPD diagnosis before the age of 40, recent hospitalization for COPD exacerbation, respiratory tract infection within 6 weeks, use of long-term oxygen therapy, and certain medical conditions.",
    "This sample is a phase 2/phase 3 clinical trial for newly diagnosed acute myeloid leukemia (AML) patients aged 18-60 years, testing the effectiveness of a combination of drugs including cytarabine, idarubicin, etoposide, all-trans retinoic acid, and pegfilgrastim, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for diabetes mellitus and hypercholesterolemia, testing the effectiveness of atorvastatin and a placebo in patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug resatorvid and placebo in patients with sepsis, testing their effectiveness in treating systemic inflammatory response syndrome criteria and septic shock.",
    "This sample is a phase 3 clinical trial for patients with lymphoma, testing the drugs rituximab and interferon-a-2a, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of various drugs including tiotropium respimat, salmeterol hfa mdi, and placebo, with eligibility criteria including confirmed diagnosis of asthma, specific age range, and required use of inhalers.",
    "This phase 3 clinical trial is testing the effectiveness of the drug RAD001 (also known as everolimus) compared to a placebo in patients with metastatic renal cell carcinoma who have previously received sunitinib and/or sorafenib within the past 6 months. The study has specific inclusion and exclusion criteria, and patients must have a Karnofsky Performance Status of at least 70%.",
    "This sample is a phase 3 trial for multiple sclerosis patients with central neuropathic pain, testing the effectiveness of Sativex and placebo as analgesic therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of depression using risperidone and placebo comparator, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of levomilnacipran er and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung carcinoma, testing the drug Iressa (gefitinib) in combination with chemotherapy for locally advanced disease previously treated with combined therapy. The inclusion criteria include histologically confirmed non-small cell lung cancer and response to combined therapy, while the exclusion criteria include no previous treatment with ZD1839 or any other EGFR-targeted therapy, no progressive disease after combined therapy, and no presence of metastatic disease.",
    "This sample is a phase 3 trial for metastatic breast cancer, testing the drugs ct-p6, herceptin, and paclitaxel, with inclusion criteria including females with Her 2 over-expression and ECOG 0 or 1, and exclusion criteria including current CNS metastases, known infection, and pregnancy or nursing.",
    "This sample is a phase 3 clinical trial for ovarian cancer patients, testing the effectiveness of carboplatin and paclitaxel drugs, with eligibility criteria including specific disease characteristics, surgical staging, and certain patient characteristics.",
    "This sample is a phase 3 clinical trial for the treatment of epithelial ovarian cancer, primary peritoneal cancer, and fallopian tube cancer using the drugs paclitaxel and carboplatin, with specific eligibility criteria for patients to be included or excluded from the study.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec/insulin aspart and insulin glargine in combination with oral antidiabetic drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the effectiveness of enfuvirtide and an optimized background antiretroviral regimen in treating HIV infections in participants who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for patients with unresectable metastatic colorectal cancer, testing the effectiveness of bevacizumab, capecitabine, and oxaliplatin as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with stage III or IV epithelial ovarian cancer that is resistant to platinum/taxane-based chemotherapy regimens, and it will test the effectiveness of karenitecin and topotecan as potential treatments.",
    "This sample is a phase 3 clinical trial for postmenopausal women with primary invasive breast carcinoma, testing the drug letrozole as adjuvant therapy after resection, with specific eligibility criteria including hormone receptor status and prior endocrine therapy.",
    "This sample is a phase 3 clinical trial for osteoarthritis, testing the effectiveness of diclofenac and placebo in patients with documented osteoarthritis flare, who have discontinued analgesic therapy and are chronic users of nonsteroidal anti-inflammatory drugs (NSAIDs) and/or acetaminophen for OA pain.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of various drugs including high dose fdc, bi 10773 high dose, and linagliptin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of endometriosis-associated pelvic pain using the drug Visanne (sh t00660aa, bay86-5258), with inclusion criteria being female patients with endometriosis-associated pelvic pain and exclusion criteria including pregnancy, lactation, hormone dependent tumor history or suspicion, therapy resistant endometriosis, and any other conditions that forbid participation.",
    "This phase 3 trial is testing the effectiveness of high dose clonidine hcl sustained release, low dose clonidine hcl sustained release, and placebo in treating attention deficit disorder with hyperactivity in children and adolescents aged 6 to 17 years.",
    "This phase 3 trial focuses on in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) for females aged 18-36 with an indication for Controlled Ovarian Stimulation (COS), using drugs such as corifollitropin alfa and ganirelix, while excluding those with endocrine abnormalities, ovarian hyperstimulation syndrome (OHSS), and polycystic ovary syndrome (PCOS).",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of ciclesonide and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of the drugs bortezomib, lenalidomide, and dexamethasone, with specific eligibility criteria including prior exposure to bortezomib and a minimum cumulative dose of dexamethasone.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs ly450139 and placebo. The inclusion criteria include meeting specific diagnostic criteria for Alzheimer's disease, having a certain score on cognitive and depression scales, and having a recent MRI or CT scan consistent with a diagnosis of Alzheimer's disease. The exclusion criteria include not being able to swallow oral medication, having serious or unstable illnesses, not having a reliable caregiver, having a history of alcohol or drug abuse, and having received an active vaccination for Alzheimer's disease.",
    "This sample is a phase 3 clinical trial for the treatment of graft-versus-host disease (GVHD) using drugs such as cyclosporine, hydroxychloroquine, prednisone, and tacrolimus, with eligibility criteria including histologically confirmed extensive chronic GVHD and specific clinical manifestations.",
    "This sample is a phase 3 clinical trial for patients diagnosed with Restless Legs Syndrome (RLS), testing the drug ropinirole. The inclusion criteria include patients with RLS symptoms and written informed consent, while the exclusion criteria include patients with certain sleep disorders, renal failure, iron deficient anemia, pregnancy, other movement disorders, certain medical conditions, and recent participation in clinical trials.",
    "This sample is a phase 3 trial for the drug sitaxentan in patients with symptomatic pulmonary arterial hypertension (PAH), with specific inclusion and exclusion criteria related to previous exposure to endothelin receptor antagonists and blood pressure levels.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia and cognition, using the drugs sertindole and quetiapine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for irritable bowel syndrome (IBS) patients, testing the effectiveness of mesalazine and placebo drugs. The inclusion criteria require IBS patients with a positive diagnosis based on Rome III criteria, while the exclusion criteria exclude patients with any organic or metabolic disease.",
    "This sample is a phase 3 clinical trial testing the effectiveness of retapamulin ointment, 1% compared to placebo ointment in treating secondarily-infected traumatic skin lesions in subjects aged 2 months or older, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis, testing the effectiveness of abatacept and methotrexate in combination with a placebo. The eligibility criteria include having a diagnosis of RA for at least 1 year, being on a stable dose of methotrexate for at least 3 months, and not having active or latent bacterial or viral infections.",
    "This phase 3 trial aims to evaluate the efficacy of xaliproden (sr57746a), placebo, oxaliplatin, 5-fluorouracil, and leucovorin in treating metastatic colorectal neoplasms and colorectal carcinoma, with specific eligibility criteria for patients to be included or excluded from the study.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of exenatide once weekly and liraglutide in combination with other oral antidiabetic agents, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of the drug bi 1356 compared to glimepiride and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for pneumonia, testing the drugs avelox and a combination of ceftriaxone, azithromycin, amoxicillin/clavulanate, and clarithromycin, in hospitalized non-ICU patients with specific clinical signs and symptoms, radiological evidence, and eligibility criteria.",
    "This sample is a phase 3 trial testing the use of epoetin alfa, a drug used to treat anemia, in patients with chronic kidney disease, specifically those with a glomerular filtration rate between 15 and 60 mL/min per 1.73 m2. The study has inclusion and exclusion criteria related to hemoglobin levels, previous response to epoetin alfa, hypertension, iron deficiency, heart failure, infection, and recent cardiovascular events.",
    "This sample is a phase 3 clinical trial for patients with non-metastatic operable primary invasive adenocarcinoma of the breast, testing the drug lapatinib in combination with anthracycline-based chemotherapy as a targeted therapy for patients with overexpression and/or amplification of HER2 in the primary tumor.",
    "This sample is a phase 3 clinical trial for patients with metastatic breast cancer, testing the effectiveness of pegylated liposomal doxorubicin and capecitabine as chemotherapy drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for bipolar disorder, testing the effectiveness of asenapine and placebo in patients with bipolar I disorder who are currently experiencing a manic or mixed episode and are being treated with lithium or valproic acid.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using paliperidone palmitate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for Alzheimer's disease and dementia, testing the effectiveness of rivastigmine transdermal patch as a treatment option, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of anagliptin and sitagliptin in controlling blood glucose levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with Parkinson's disease, testing the efficacy of perampanel and a placebo comparator in improving motor fluctuations and response to levodopa therapy.",
    "This sample is a phase 3 clinical trial testing the effectiveness of aripiprazole and placebo in treating chronic motor or vocal tic disorder and Tourette's disorder in children and adolescents aged 6 to 18 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for HIV infections, testing the effectiveness of tenofovir df and placebo in patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the drugs quetiapine fumarate and duloxetine, with inclusion criteria including a documented clinical diagnosis of major depressive disorder and exclusion criteria including pregnancy or lactation and a current or past diagnosis of stroke or transient ischemic attack (TIA).",
    "This sample is a phase 3 trial for patients with non-insulin-dependent diabetes mellitus, testing the drugs sitagliptin phosphate and voglibose as potential treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with major depressive disorder, testing the drug saredutant succinate (sr48968c) and evaluating eligibility criteria such as age, diagnosis, and exclusion criteria.",
    "This sample is a phase 3 trial testing the drug ivabradine for the treatment of chronic stable angina pectoris, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with coronary artery disease undergoing coronary artery bypass grafting, testing the effectiveness of aspirin and clopidogrel in preventing complications.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of budesonide/formoterol (Symbicort Turbuhaler) and formoterol (Oxis Turbuhaler) as treatments. The inclusion criteria include a current clinical diagnosis of COPD, documented symptoms for more than 2 years, and a smoking history of at least 10 pack years. The exclusion criteria include a history or current diagnosis of asthma or atopic diseases.",
    "This sample is a phase 3 trial testing the effectiveness of pregabalin and placebo in treating HIV-associated Distal Symmetrical Polyneuropathy (DSP) with subjective sensory symptom of pain, specifically in the feet, in individuals with HIV-1 infection.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin lispro and insulin aspart in combination with oral anti-diabetes medications. The study includes specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of cp-751,871 (figitumumab), carboplatin, and paclitaxel in treating non-small cell lung cancer patients with predominantly squamous cell, large cell, or adenosquamous carcinoma, who have advanced or recurrent disease and have not received prior systemic treatment for NSCLC.",
    "This sample is a phase 3 trial for HIV-uninfected individuals with HSV-2 infection, testing the effectiveness of acyclovir and acyclovir placebo in preventing HIV infection, with specific inclusion and exclusion criteria for different populations.",
    "This sample is a phase 3 trial for patients with defibrillators or ventricular tachycardia, testing the effectiveness of amiodarone in preventing sudden cardiac death, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of valsartan, a blood pressure medication, in children aged 6 months to 5 years with hypertension, who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, cardiovascular disease, and kidney disease, testing the effectiveness of olmesartan medoxomil, an angiotensin receptor blocker, compared to a placebo in reducing cardiovascular risk factors.",
    "This sample is a phase 3 trial for the treatment of inflammation using the drug difluprednate, with eligibility criteria including being scheduled for unilateral ocular surgery and exclusion criteria including recent systemic administration of corticosteroids or immunosuppressive drugs.",
    "This sample is a phase 3 clinical trial for ulcerative colitis, testing the efficacy of encapsulated mesalamine granules (emg) as a treatment option, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for lupus nephritis patients who have relapsed or are resistant to previous treatment, and it aims to evaluate the effectiveness of mycophenolate sodium and cyclophosphamide as potential drugs for treatment.",
    "This sample is a phase 3 clinical trial for children with chronic hepatitis C, testing the effectiveness of ribavirin (sch 18908) as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with Parkinson's disease, testing the effectiveness of Requip PR and Mirapex drugs in comparison to standard Requip for treating the disease.",
    "This sample is a phase 3 clinical trial for patients with moderate to severe non-malignant pain, testing the effectiveness of oxycodone and naloxone as a WHO step III opioid therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with ovarian cancer, fallopian tube cancer, or primary peritoneal cavity cancer, testing the drug carboplatin, with specific eligibility criteria including disease stage, histological confirmation, and various patient characteristics.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the drugs pemetrexed and docetaxel, with inclusion criteria including prior chemotherapy and Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2, and exclusion criteria including concurrent administration of any other tumor therapy and pregnancy or breastfeeding.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma who have failed previous treatments with lenalidomide and bortezomib, and it will test the effectiveness of pomalidomide and dexamethasone as a potential treatment option.",
    "This sample is a phase 3 trial for the treatment of diabetic neuropathy, painful, using drugs such as duloxetine and pregabalin, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for subjects with allergic rhinoconjunctivitis related to grass pollen, testing the effectiveness of sublivac\u00ae grasses/placebo treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the efficacy of nva237 and indacaterol compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of beclomethasone dipropionate and albuterol sulfate in controlling symptoms, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for asthma, testing the drug fluticasone propionate/formoterol fumarate, with eligibility criteria including a history of asthma, documented use of inhaled corticosteroids, and reversible symptoms, among others.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of various inhalation powders and a placebo in improving lung function and reducing symptoms. The eligibility criteria include being a current or former smoker with a history of COPD, having a certain severity of disease, and experiencing dyspnea. There are also exclusion criteria, such as pregnancy, asthma, and other respiratory disorders, that would prevent enrollment in the study.",
    "This sample is a phase 3 trial for patients with mild to moderate essential hypertension, testing the drug aliskiren. The inclusion criteria include age between 20-75 years old, being an outpatient, and having mild to moderate essential hypertension. Exclusion criteria include pregnancy, high blood pressure levels, secondary hypertension, and suspected malignant hypertension.",
    "This sample is a phase 3 clinical trial for postmenopausal osteoporosis, testing the effectiveness of ibandronate and placebo drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for participants with type 2 diabetes mellitus, testing the drugs ly2189265, placebo, and liraglutide, with inclusion criteria including a diagnosis of type 2 diabetes, specific HbA1c values, and a BMI range, and exclusion criteria including type 1 diabetes, previous treatment with GLP-1 analogs, and certain medications or medical conditions.",
    "This sample is a phase 3 clinical trial for the drug almotriptan malate, targeting patients with a history of migraine for at least one year, experiencing 1-14 migraines per month, and taking only one migraine preventive medication.",
    "This sample is a phase 2/phase 3 trial testing the drug sodium valproate for the treatment of neuralgia and neuropathic peripheral pain, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with seasonal allergic rhinitis, testing the effectiveness of drugs such as placebo, azelastine hcl, azelastinehcl / fluticasone propionate, and fluticasone propionate, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of fotemustine and isolated perfusion in treating patients with intraocular melanoma and metastatic cancer, who have surgically incurable or unresectable liver metastases secondary to uveal melanoma and no detectable extrahepatic metastases, and meet specific eligibility criteria.",
    "This sample is a phase 3 trial for the treatment of type 1 diabetes mellitus, testing the drugs glargine, ly2605541, and insulin lispro, with eligibility criteria including having diabetes for at least 1 year, specific HbA1c and BMI values, and previous treatment with certain insulin regimens.",
    "This phase 3 trial is investigating the use of epoetin alfa in patients with gastric cancer or rectal cancer who are undergoing preoperative chemotherapy and radiation therapy, followed by surgery. The study aims to assess the impact of epoetin alfa on hemoglobin levels and overall survival.",
    "This sample is a phase 3 trial for patients with hypertension, testing the effectiveness of telmisartan and amlodipine in reducing blood pressure, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with unresectable, locally advanced or metastatic gastric cancer, testing the effectiveness of the drugs s-1/cisplatin and 5-fu/cisplatin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of ciclesonide and placebo drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the drug fluorouracil for the treatment of kidney cancer in patients who meet specific disease and patient characteristics criteria.",
    "This sample is a phase 3 clinical trial testing the use of human albumin in patients with cirrhosis, sepsis, and renal failure, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of GSK1358820 (botulinum toxin type A) compared to placebo in reducing upper limb spasticity in subjects at least 6 months post-stroke, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for major depressive disorder, testing the drug vortioxetine (lu aa21004), with inclusion criteria being patients who completed a short-term treatment study for major depressive episode, and exclusion criteria including any current psychiatric disorder other than MDD, non-use of effective contraception for female patients of childbearing potential, use of any psychoactive medication, and significant risk of suicide.",
    "This sample is a phase 3 clinical trial for patients with bladder cancer, transitional cell cancer of the renal pelvis and ureter, and urethral cancer. The study aims to evaluate the effectiveness of drugs such as carboplatin, cisplatin, doxorubicin hydrochloride, methotrexate, paclitaxel, and vinblastine in treating these cancers. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 clinical trial for postmenopausal women with osteoporosis, testing the drugs osteoform and shelcal. The eligibility criteria include specific bone density measurements and exclude women with certain medical conditions or taking certain medications.",
    "This sample is a phase 3 clinical trial for patients with hyperglycemia and leukemia, testing the effectiveness of therapeutic insulin in controlling blood sugar levels during chemotherapy treatment.",
    "This sample is a phase 3 clinical trial for patients with both symptomatic heart failure and type 2 diabetes, where the drug being tested is metformin, and the eligibility criteria include specific requirements for diabetes diagnosis, exclusion of certain comorbidities, and willingness to self-monitor blood sugars during the trial period.",
    "This phase 3 trial is testing the effectiveness of reslizumab, a drug used to treat eosinophilic asthma, compared to a placebo, in patients with a previous diagnosis of asthma who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for the treatment of metastatic melanoma using vemurafenib and dacarbazine drugs, targeting patients with BRAF V600E mutation and measurable disease, while excluding those with central nervous system metastases or severe cardiovascular disease.",
    "This sample is a phase 3 clinical trial for patients with knee osteoarthritis and pain, testing the effectiveness of tapentadol er, oxycodone cr, and placebo as analgesic medications, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for non-small cell lung cancer patients who have undergone primary chemoradiotherapy, testing the efficacy of single low dose cyclophosphamide compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of generalized anxiety disorder (GAD) using duloxetine and placebo drugs, with specific inclusion and exclusion criteria for patient selection.",
    "This sample is a phase 3 clinical trial for the treatment of open-angle glaucoma and ocular hypertension using travoprost ophthalmic solution, 0.003% and 0.004%. The eligibility criteria include a diagnosis of the specified diseases, qualifying intraocular pressure, and signing an informed consent form. Exclusion criteria include pregnancy, severe visual field loss, inflammatory eye disease, and hypersensitivity to the study medications.",
    "This sample is a phase 3 clinical trial for postmenopausal osteoporosis, testing the efficacy of disodium clodronate injections in eligible subjects with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of nocturia, a condition characterized by excessive urination at night, using the drugs desmopressin and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for osteoporosis, testing the drugs risedronate and risedronate placebo in postmenopausal women with osteopenia, and includes eligibility criteria such as age, BMI, and exclusion criteria such as evidence of osteoporosis, renal impairment, and history of bone disease.",
    "This sample is a phase 3 trial for patients with asthma, testing the drug ciclesonide, and includes eligibility criteria such as a history of persistent bronchial asthma and FEV1 between 50-90% of predicted.",
    "This sample is a phase 3 trial for Friedreich's Ataxia, testing the effectiveness of idebenone and placebo in patients aged 8-17 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 1 diabetes, testing the efficacy of insulin degludec and insulin glargine in a basal-bolus regimen with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of exenatide and placebo in combination with sulfonylurea, biguanide, or thiazolidinedione, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with inflammatory bowel disease, specifically ulcerative colitis, testing the effectiveness of balsalazide disodium in treating UC symptoms, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for osteoarthritis, testing the effectiveness of shinbaro capsule and celebrex in patients aged 35-80 with diagnosed knee OA, who have been suffering for more than 6 months and have a WOMAC scale score of more than 30.",
    "This phase 3 trial aims to evaluate the efficacy of ferric citrate, calcium acetate, sevelamer carbonate, and placebo in treating hyperphosphatemia and kidney failure in patients on thrice-weekly hemodialysis or peritoneal dialysis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial that aims to evaluate the effectiveness of eszopiclone, a drug used to treat insomnia, in patients with Parkinson's disease and sleep maintenance or sleep latency insomnia.",
    "This sample is a phase 3 clinical trial for non-Hodgkin's lymphoma and mantle cell lymphoma, testing the effectiveness of bendamustine and rituximab as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of obesity, overweight, and type 2 diabetes mellitus using the drugs naltrexone sr 32 mg/bupropion sr 360 mg/day and placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with primary hypercholesterolemia or dyslipidemia, testing the effectiveness of pitavastatin and atorvastatin in reducing cholesterol levels, with specific inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 3 trial for hypertension, testing the drug eplerenone, and includes eligibility criteria for participants aged 6-16 with high blood pressure.",
    "This sample is a phase 3 clinical trial for patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD), testing the effectiveness of indacaterol, salmeterol, and placebos in improving lung function. The eligibility criteria include specific smoking history, lung function measurements, and exclusion criteria such as pregnancy, hospitalization for COPD exacerbation, and certain medical conditions.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of the drug roflumilast compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for breast cancer patients experiencing bothersome hot flashes, where the drug being tested is pregabalin, and the eligibility criteria include a history of breast cancer or a desire to avoid estrogen.",
    "This sample is a phase 3 trial for the drug ezetimibe in patients with hyperlipidemia, with specific inclusion and exclusion criteria related to age, cholesterol levels, and medical conditions.",
    "In this phase 3 trial, the drug tiotropium/salmeterol qd is being tested along with other drugs and a placebo for the treatment of chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for major depressive disorder, testing the drug vortioxetine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for postherpetic neuralgia, testing the effectiveness of pregabalin compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with invasive breast cancer, testing the effectiveness of lapatinib and paclitaxel in combination therapy, with specific eligibility criteria including confirmation of ErbB2 amplification and measurable lesions according to RECIST.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin phosphate compared to metformin hydrochloride in controlling blood sugar levels, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of rituximab, methylprednisolone, acetaminophen, and diphenhydramine in treating systemic lupus erythematosus (SLE) patients who have previously completed a 52-week evaluation in Study U2971g.",
    "This sample is a phase 3 trial for patients with head and neck cancer, testing the drugs placebo and palifermin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with acute cortical ischemic stroke, testing the drug ono-2506, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with metastatic prostate cancer and bone metastases, testing the effectiveness of ibandronate sodium in relieving metastatic bone pain.",
    "This phase 3 trial aims to evaluate the effectiveness of risperidone, an antipsychotic drug, in treating depressive disorders, major depressive disorder, and depression, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the effectiveness of teriparatide and risedronate in ambulatory men with osteoporosis who have received glucocorticoid therapy, and the eligibility criteria include specific bone mineral density measurements and laboratory values.",
    "This sample is a phase 3 clinical trial for the treatment of diverticulitis using the drug spd476, mmx\u2122 mesalazine, 1.2g extended release tablet, and placebo, with eligibility criteria including having had an episode of acute diverticulitis that resolved without colonic resection and confirmation of diverticulosis via endoscopic evaluation.",
    "The sample is a phase 2/phase 3 trial for the treatment of dry eye using carboxymethylcellulose sodium and glycerin eye drops, with inclusion criteria of mild, moderate, or severe dry eye symptoms and reduced tear stability or tear production, and no exclusion criteria specified.",
    "This sample is a phase 3 trial for patients with Parkinson's disease who are not responding well to L-dopa therapy, and it will test the effectiveness of the drug Requip PR compared to a placebo. The eligibility criteria include being at least 30 years old, having a diagnosis of idiopathic Parkinson's disease, and providing written informed consent. Exclusion criteria include late stage advanced Parkinson's disease, presence of significant medical conditions, and recent use of dopamine agonists.",
    "This sample is a phase 3 trial for patients with multiple sclerosis, testing the effectiveness of fampridine-sr and placebo drugs, with inclusion criteria requiring patients to complete two trials of a timed 25 foot walk and exclusion criteria excluding pregnant or breastfeeding female patients.",
    "This sample is a phase 3 trial for the drug BF2.649 (Pitolisant) in patients with narcolepsy and cataplexy, who have previously participated in a narcolepsy study or are receiving BF2.649 under \"ATU nominative\" condition. The inclusion criteria include age 18 and above, diagnosis of narcolepsy, and excessive daytime sleepiness. The exclusion criteria include adverse events related to BF2.649, untreated sleep apnea syndrome, psychiatric and neurological disorders, substance abuse, significant illnesses, long QTc syndrome, severe hepatic or renal impairment, hypersensitivity to the tested treatment, and recent participation in another study.",
    "This sample is a phase 3 clinical trial for patients with spasticity due to multiple sclerosis (MS) that is not relieved by current anti-spasticity therapy. The study aims to evaluate the effectiveness of Sativex\u00ae compared to a placebo in reducing spasticity symptoms. The inclusion criteria include being diagnosed with MS for at least six months, having spasticity for at least three months, and currently receiving or previously tried anti-spasticity therapy. The exclusion criteria include having other conditions that may influence spasticity, certain medical history, significant cardiac, renal or hepatic disease, and pregnancy or planning pregnancy.",
    "This sample is a phase 3 trial for patients with uncomplicated, essential hypertension, testing the drug valsartan/amlodipine, and includes eligibility criteria such as excluding patients with severe hypertension, a history of stroke or heart disease, and certain medical conditions.",
    "This sample is a phase 3 clinical trial for osteoarthritis of the knee, testing the drugs placebo, hyruan plus, and lbsa0103, with inclusion criteria including age over 40, Kellgren & Lawrence grade I-III, and weight-bearing pain of at least 40mm, and exclusion criteria including body mass index > 32, rheumarthritis, and Kellgren & Lawrence Grade IV.",
    "This sample is a phase 3 clinical trial for the treatment of bronchiectasis using the drug azli and a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus who are currently on acarbose alone or in combination with another antihyperglycemic agent, and the study aims to evaluate the efficacy of sitagliptin phosphate, acarbose, and glimepiride compared to placebo.",
    "This sample is a phase 3 trial for the treatment of growth hormone deficiency, testing the drugs placebo and somatropin, with inclusion criteria of males and females between 18 and 65 years of age and exclusion criteria of childhood onset growth hormone deficiency and diabetes mellitus type 1 or 2.",
    "This sample is a phase 3 clinical trial for patients with mild-to-moderate Alzheimer's disease, testing the effectiveness of galantamine hydrobromide in improving cognitive function, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for venous thromboembolism, testing the drugs du-176b (edoxaban) and enoxaparin sodium 20mg, with inclusion criteria for subjects scheduled for surgery for femoral neck fracture within 10 days and exclusion criteria for subjects with hemorrhage or thrombolic risks, weighing less than 40 kg, pregnant or suspecting pregnancy, or wanting to become pregnant.",
    "The sample is a phase 3 trial for breast cancer patients receiving the AT regimen (doxorubicin/docetaxel) to study the effectiveness of chemotherapy in treating chemotherapy-induced neutropenia.",
    "This sample is a phase 3 trial for patients with bipolar I disorder, testing the drug aripiprazole, and includes eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial for major depressive disorder, testing the drug quetiapine fumarate sustained release, with inclusion criteria based on DSM-IV diagnosis and exclusion criteria related to other Axis I and II disorders and the duration of the current episode of depression.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of the drug combination mk0653a, ezetimibe (+) simvastatin compared to atorvastatin in reducing cholesterol levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for small cell lung cancer, testing the drugs pemetrexed, etoposide, and carboplatin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with acromegaly, testing the effectiveness of octreotide acetate 30 mg suspension in controlling the disease. The eligibility criteria include having biochemically documented active acromegaly, currently receiving somatostatin-analogues for at least 6 months, and having uncontrolled disease with specific GH and IGF-I levels.",
    "This sample is a phase 3 trial for patients with gastroesophageal reflux disease (GERD) or non-erosive reflux disease (NERD), testing the effectiveness of pantoprazole in reducing symptoms of heartburn, acid regurgitation, or dysphagia.",
    "This sample is a phase 3 clinical trial for patients with primary peritoneal carcinoma, epithelial ovarian carcinoma, or fallopian tube carcinoma, testing the effectiveness of gemcitabine, paclitaxel, and carboplatin as intravenous chemotherapy drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for major depressive disorder (MDD) using extended-release bupropion hydrochloride as the drug, with specific inclusion and exclusion criteria related to orgasmic function and previous antidepressant trials.",
    "This sample is a phase 3 clinical trial for narcolepsy, testing the effectiveness of armodafinil and placebo in reducing excessive sleepiness, with eligibility criteria including a current diagnosis of narcolepsy, good health, and specific sleep latency and severity ratings.",
    "This sample is a phase 3 clinical trial for patients with follicular lymphoma, testing the effectiveness of rituximab as a treatment option, with specific eligibility criteria including disease grade, symptoms, age, performance status, and hematological function.",
    "This sample is a phase 3 clinical trial for the treatment of gastroesophageal reflux disease (GERD) using the drug pantoprazole, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with non-seminomatous germ cell tumors (NSGCT) with poor prognosis, testing the effectiveness of cisplatin, etoposide, ifosfamide, oxaliplatin, and paclitaxel as treatment options. Eligibility criteria include specific disease characteristics, age over 16, certain lab values, and no prior chemotherapy or other malignancies.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of alogliptin and glipizide in achieving glycemic control, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of ipragliflozin and alpha glucosidase inhibitor drugs in combination with \u03b1-glucosidase inhibitor mono-therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with hypertension who have not responded to telmisartan 40mg, and it aims to test the efficacy of ckd-828 and telmisartan 80mg as potential treatment options.",
    "This sample is a phase 3 trial for breast cancer patients, testing the effectiveness of multiple drugs including epirubicin, paclitaxel, cyclophosphamide, methotrexate, 5 fu, and darbepoetin alfa, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for patients with breast cancer and metastases, testing the drugs larotaxel and capecitabine, with eligibility criteria including previous treatment with anthracyclines and taxanes, age of at least 18, not taking other cancer treatments, and not being pregnant.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of liraglutide and glibenclamide compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial that aims to investigate the use of moxaverine in patients with macular degeneration, glaucoma, and regional blood flow disorders, with specific eligibility criteria for each disease group.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of pancrecarb\u00ae (pancrelipase) compared to placebo in patients with cystic fibrosis and pancreatic insufficiency, based on specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with melanoma and neoplasm metastasis, testing the drug cc-5013. The eligibility criteria include having stage IV metastatic malignant melanoma, being relapsed or refractory to standard metastatic therapy, and not having active brain disease or newly diagnosed brain metastases.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the drug quetiapine fumarate, and includes inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy and safety of the drugs nva237 and placebo, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 clinical trial for patients with chronic hepatitis C and liver fibrosis, testing the efficacy of ribavirin and ribavirin-placebo in combination with interferon for antiviral treatment. The study has specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is testing the effectiveness of budesonide/formoterol, budesonide, and formoterol in treating asthma, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer who have failed prior thymidylate synthase inhibitor and oxaliplatin-containing regimens, and it aims to evaluate the efficacy of brivanib alaninate as a treatment option.",
    "This sample is a phase 3 trial for cancer patients with breakthrough pain, testing the efficacy of fentanyl as an additional analgesic to a stable background opioid regimen, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for juvenile rheumatoid arthritis (JRA) testing the drugs celecoxib and naproxen, with inclusion criteria of being 2-18 years old and having active JRA, and exclusion criteria of using other experimental meds or recent changes in arthritis meds.",
    "This sample is a phase 3 trial for diabetes mellitus, testing the drugs tak-875 and placebo, with eligibility criteria including being an outpatient and not having serious cardiac, cerebrovascular, pancreatic, or hematological diseases.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of aclidinium bromide/formoterol fumarate and formoterol fumarate as treatments. The inclusion criteria include a smoking history of at least 10 pack-years and a diagnosis of stable moderate to severe COPD, while exclusion criteria include recent hospitalization for a COPD exacerbation and clinically significant respiratory or cardiovascular conditions.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of olmesartan medoxomil, amlodipine, and hydrochlorothiazide in treating hypertension in newly diagnosed or currently medicated hypertensive subjects, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with symptomatic chronic heart failure, testing the effectiveness of ivabradine and placebo in improving heart rate and symptoms.",
    "This sample is a phase 3 trial for the treatment of migraine, with the disease being migraine and the drugs being rizatriptan benzoate and placebo. The eligibility criteria include having a history of migraine for more than one year, experiencing 1-4 migraine attacks per month, and not having more than 15 headache days per month, heart disease, or uncontrolled high blood pressure.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of anastrozole and fulvestrant drugs in postmenopausal women with metastatic or multiple sites of new disease, who are hormone receptor positive and have no brain or CNS metastases.",
    "This sample is a phase 3 trial for bipolar disorder, testing the drugs asenapine and placebo, with inclusion criteria requiring participants to have bipolar I disorder and have completed a 12-week lead-in trial, and exclusion criteria including unstable medical conditions or a primary diagnosis other than bipolar I disorder.",
    "This sample is a phase 3 clinical trial for bladder cancer, testing the drug mitomycin c (mmc) on patients with non-muscle invasive urothelial bladder carcinoma, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the use of insulin lispro protamine suspension and insulin levemir in patients with type 1 diabetes, who meet specific inclusion and exclusion criteria, to assess their effectiveness in managing blood glucose levels.",
    "This sample is a phase 3 trial for patients with HIV infections, testing the effectiveness of the drug raltegravir in combination with other antiretrovirals, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for lupus erythematosus, systemic, testing the effectiveness of atorvastatin and placebo atorvastatin in patients who meet the American College of Rheumatology diagnostic guidelines for SLE, have a weight of 25 kg or more, are outpatient, can complete self-report questionnaires in English or Spanish, are willing to comply with recommended diet, and have acceptable methods of contraception.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of exenatide and glimepiride in combination with metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) using the drug fluticasone furoate (ff)/gw642444 inhalation powder, and includes eligibility criteria such as age, COPD diagnosis, tobacco use, and severity of disease.",
    "This sample is a phase 3 clinical trial for schizophrenia, with the drug paliperidone er being tested, and includes eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for chemotherapy-induced nausea and vomiting, testing the drugs palonosetron and granisetron hydrochloride in patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type II diabetes mellitus, testing the effectiveness of the drugs asp1941 and metformin, along with a placebo, in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 3 clinical trial for small cell lung carcinoma, testing the effectiveness of two drug combinations (etoposide + cisplatin and irinotecan + cisplatin) on patients who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of fluticasone furoate/vilanterol and tiotropium inhalers in improving lung function and reducing exacerbations.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis, testing the effectiveness of DMARDs (methotrexate, chloroquine, leflunomide, cyclosporin A, sulfasalazine, om 89) as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for bipolar disorder, testing the effectiveness of geodon (ziprasidone) and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of persistent allergic rhinitis, testing the efficacy of 5-mg desloratadine and placebo tablets, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for operable breast cancer patients, testing the effectiveness of docetaxel, 5-fluorouracil, doxorubicin, and cyclophosphamide in combination as a treatment option. The eligibility criteria include having negative axillary lymph nodes, histologically proven breast cancer, and adequate hepatic, renal, and heart functions. Exclusion criteria include prior systemic anticancer therapy, prior radiation therapy for breast cancer, and pre-existing motor or sensory neurotoxicity.",
    "This sample is a phase 3 clinical trial for patients with small cell lung cancer, testing the effectiveness of carboplatin, etoposide, and thalidomide compared to carboplatin, etoposide, and a placebo, with eligibility criteria including confirmed lung cancer, age over 18, ECOG performance status 0-3, and no prior chemotherapy or radiotherapy.",
    "This sample is a phase 3 clinical trial for the treatment of follicular lymphoma using rituximab, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the use of calcium gluconate and magnesium sulfate in combination with FOLFOX chemotherapy regimens for patients with histologically confirmed adenocarcinoma of the colon or rectum, who have undergone curative resection for stage II or III disease.",
    "This sample is a phase 3 trial for patients with hypertension, testing the effectiveness of telmisartan 80 mg + hydrochlorothiazide 25 mg in controlling blood pressure, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with non-Hodgkin lymphoma, testing the effectiveness of multiple drug combinations including pixantrone, cyclophosphamide, vincristine, rituximab, prednisone, vinorelbine, oxalplatin, ifosfamide, etoposide, mitoxantrone, gemcitabine, or rituximab, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial for the drug tiotropium in patients with chronic obstructive pulmonary disease (COPD) who meet specific eligibility criteria, including stable moderate to severe airway obstruction, specific lung function measurements, smoking history, and a history of exacerbation in the past year.",
    "This sample is a phase 3 clinical trial for newly diagnosed advanced anaplastic large cell lymphoma, testing the effectiveness of a combination of doxorubicin hydrochloride, mercaptopurine, methotrexate, prednisone, vinblastine sulfate, and vincristine sulfate as treatment, with specific eligibility criteria for patients.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of the drugs placebo and linagliptin, with specific inclusion and exclusion criteria.",
    "This study is a phase 2/phase 3 trial investigating the effectiveness of various combinations of valsartan, amlodipine, and placebo in treating essential hypertension, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 3 trial for hypertension, testing the effectiveness of carvedilol phosphate modified release formulation and metoprolol succinate in patients with documented history of hypertension, triglycerides of 120-400 mg/mL, and LDLc levels not requiring lipid lowering medication.",
    "This phase 3 trial is investigating the effectiveness of chemotherapy, exemestane, tamoxifen, and triptorelin in treating patients with histologically confirmed breast cancer confined to the breast and axillary nodes, who have undergone primary breast cancer procedures within the past 12 weeks and have no known clinical residual locoregional disease.",
    "This sample is a phase 3 clinical trial for psoriatic arthritis, testing the drugs apremilast and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of two drugs, fluticasone furoate 100mcg/vilanterol 25mcg and fluticaosne propionate 500mcg/salmeterol 50mcg, in reducing symptoms and improving lung function. The eligibility criteria include being \u2265 40 years old, having a clinical history of COPD, and meeting specific spirometry criteria. Exclusion criteria include having asthma, other respiratory disorders, and certain medical conditions.",
    "This sample is a phase 3 trial for patients with type 1 diabetes, testing the effectiveness of human insulin inhalation powder, injectable insulin, and insulin glargine in managing the disease. The eligibility criteria include having type 1 diabetes for at least 24 months, specific HbA1c levels, and being a non-smoker. Exclusion criteria include certain medical conditions and high insulin dosage requirements.",
    "This sample is a phase 3 clinical trial for patients with gastrointestinal stromal tumor, testing the efficacy of imatinib mesylate as a standard of care treatment, with eligibility criteria including histologically confirmed tumor, metastatic disease, measurable disease, and specific patient characteristics.",
    "This sample is a phase 3 trial for patients with hyperlipidemia, testing the efficacy of evolocumab, ezetimibe, and their placebos in reducing LDL-C levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for psoriasis, testing the effectiveness of ustekinumab and placebo in participants with plaque type psoriasis covering at least 10 percent of total body surface area, and with a PASI score of greater than or equal to 12.",
    "This sample is a phase 3 trial for graft rejection, focusing on patients with an established cardiac allograft vasculopathy, who must be on statins and more than 12 months post-transplant. The drug being tested is everolimus, and the inclusion and exclusion criteria are specified.",
    "This sample is a phase 3 trial for patients with diffuse large B cell non-Hodgkin's lymphoma who have undergone an autologous stem cell transplant and are in complete remission. The drug being tested is rituximab, and the eligibility criteria include specific medical conditions and test results.",
    "This sample is a phase 3 clinical trial for osteoporosis, testing the effectiveness of drugs such as ed-71 and alfacalcidol, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for patients with hypercholesterolemia, testing the effectiveness of ezetimibe (+) simvastatin and comparing it to atorvastatin and rosuvastatin, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with breast cancer, testing the effectiveness of capecitabine and lapatinib (gw572016) in combination therapy, with specific eligibility criteria including disease stage, ErbB2 overexpression, prior treatments, and various medical conditions.",
    "This sample is a phase 3 trial for psoriatic arthritis, testing the effectiveness of ustekinumab and placebo in patients who have been diagnosed with psoriatic arthritis for at least 6 months and have active symptoms.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using the drug atomoxetine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of basal cell carcinoma using the drug imiquimod, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with glioblastoma or anaplastic astrocytoma, testing the effectiveness of temozolomide as a treatment option. The eligibility criteria include age, performance score, blood counts, and previous treatments, while exclusion criteria include certain medical conditions and previous participation in other studies.",
    "In this phase 3 trial, the drug \"rezular\" is being tested for its effectiveness in treating irritable bowel syndrome with diarrhea, with the inclusion criteria being the fulfillment of Rome III criteria for IBS-D and the exclusion criteria including major cardiovascular disease, psychiatric illness (except mild or moderate depression), pregnancy, presence of other GI disease that could explain IBS-like symptoms, and history of major gastric, hepatic, pancreatic or intestinal surgery or perforation.",
    "This sample is a phase 3 clinical trial for attention-deficit/hyperactivity disorder (ADHD) using extended-release guanfacine hydrochloride as the drug, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 trial aims to evaluate the effectiveness of doripenem, imipenem-cilastatin, and placebo in treating ventilator-associated pneumonia in patients who meet specific inclusion criteria, such as having new or worsening radiographic infiltrates consistent with the disease and being on mechanical ventilation for at least 48 hours.",
    "This sample is a phase 3 trial for the drug tolvaptan, which aims to treat hyponatremia, a condition characterized by low sodium levels in the blood. The study includes specific inclusion and exclusion criteria for participants, and it requires prior successful participation in a tolvaptan hyponatremia trial termination.",
    "This sample is a phase 2/phase 3 trial for patients with multiple sclerosis and cognition disorders, testing the drug memantine. The inclusion criteria include a diagnosis of multiple sclerosis, age between 18 and 65 years, and demonstrated cognitive dysfunction. The exclusion criteria include a history of major depression or psychosis, visual impairments, non-English speaking patients, recent MS exacerbation, pregnancy, renal insufficiency, history of seizures, and use of certain medications or substances.",
    "This sample is a phase 3 clinical trial for patients with ischemic stroke, testing the efficacy of rt-pa 0.9 mg/kg verum or placebo intravenous as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of technosphere insulin, metformin & secretagogues, and technosphere insulin & metformin in controlling blood sugar levels, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial testing the effectiveness of drotrecogin alfa (activated) versus placebo in severe sepsis patients with hypotension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with unresectable metastatic melanoma and concurrent visceral/soft tissue metastases, testing the drug temozolomide. Eligibility criteria include having measurable disease, no neurological symptoms, and meeting certain hematopoietic, hepatic, renal, and other health requirements.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C, focusing on patients who have not responded to prior treatment with Pegasys and ribavirin. The trial will evaluate the efficacy and safety of rebetol (ribavirin) in combination with other medications, and includes specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients at high risk of malignancy and/or chemotherapy-induced hyperuricemia, focusing on the use of rasburicase and allopurinol to lower uric acid concentrations in patients with hyperuricemia caused by non-Hodgkin's lymphoma, acute lymphoblastic leukemia, or any lymphoma or leukemia.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the drugs erlotinib (Tarceva) and placebo, with inclusion criteria including age, disease stage, and previous treatment response, and exclusion criteria including unstable systemic disease and recent malignancies.",
    "This sample is a phase 3 clinical trial for patients with recurrent and/or metastatic head and neck cancer, testing the efficacy of two different treatment arms (arm 1 and arm 2) with eligibility criteria including confirmed diagnosis, measurable disease, and Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the effectiveness of dl-alpha-tocopherol, memantine, and placebo in patients with a diagnosis of Alzheimer's disease who have a caregiver, meet certain criteria, and have been taking specific medications for at least 4 weeks prior to randomization.",
    "This sample is a phase 3 trial for breast cancer patients who are candidates for adjuvant chemotherapy, testing the efficacy of tab premarin (ethinyl estradiol) compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with epilepsy, testing the effectiveness of the drug rufinamide compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with essential hypertension, testing the effectiveness of valsartan and amlodipine in reducing blood pressure, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec/insulin aspart in combination with oral antidiabetic drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin detemir and insulin nph in controlling blood sugar levels, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Crohn's disease, testing the drugs gsk1605786a and placebo, with eligibility criteria including a diagnosis of Crohn's disease, inadequate response to previous treatments, and moderately-to-severely active disease.",
    "This sample is a phase 2/phase 3 trial for prostate cancer patients who have experienced progression following prostatectomy or radiation therapy, and it aims to evaluate the effectiveness of celecoxib, a non-steroidal anti-inflammatory drug, in slowing down the progression of the disease.",
    "This sample is a phase 3 clinical trial for chronic hepatitis C, testing the effectiveness of albumin interferon alfa-2b, peginterferon alfa-2a, and ribavirin in treatment-na\u00efve patients with genotype 1 hepatitis C virus, who have compensated liver disease and meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) using the drugs ff/gw642444 inhalation powder and gw642444 inhalation powder, with eligibility criteria including being an outpatient, having a COPD diagnosis, and a history of COPD exacerbations.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the efficacy of the drug rivastigmine transdermal patch compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with diabetic peripheral neuropathy, testing the efficacy and safety of tapentadol extended release (er) compared to placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for seasonal allergic rhinitis, testing the effectiveness of ciclesonide hfa 160 \u03bcg, ciclesonide hfa 80 \u03bcg, and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for HIV infection, testing the effectiveness of abacavir/lamivudine and atazanavir/ritonavir drugs in antiretroviral-na\u00efve patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with locally advanced, recurrent, or metastatic colorectal adenocarcinoma, testing the effectiveness of oxaliplatin, leucovorin calcium, capecitabine, and fluorouracil as treatment options. The eligibility criteria include specific disease characteristics, performance status, blood counts, liver function, kidney function, and other medical conditions.",
    "This phase 3 trial is investigating the efficacy of macitentan, a drug used to treat pulmonary arterial hypertension, in patients with systemic sclerosis and ulcers, who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of placebo + pioglitazone (30 mg) and linagliptin + pioglitazone (30 mg) as oral hypoglycemic agents, with inclusion criteria including a diagnosis of type 2 diabetes, HbA1c levels between 7.5-11%, and a BMI of \u226440 kg/m2, and exclusion criteria including recent myocardial infraction or stroke, impaired hepatic function, hypersensitivity to the investigational product, and recent use of GLP-1 analogues/agonists or insulin.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C, testing the efficacy of eltrombopag and placebo drugs in combination with peginterferon and ribavirin antiviral therapy, with specific eligibility criteria for subjects to participate in the study.",
    "This sample is a phase 3 clinical trial for patients with bipolar I disorder, evaluating the use of injectable risperidone or oral antipsychotic drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis who have had an inadequate response to methotrexate treatment. The study will test the effectiveness of ofatumumab compared to a placebo in reducing disease activity.",
    "This phase 3 trial is testing the effectiveness of ixabepilone, calcium gluconate, and magnesium sulfate in treating patients with metastatic breast cancer, neuropathy, pain, and recurrent breast carcinoma, who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for the treatment of prostatic hyperplasia using dutasteride and tamsulosin, with specific eligibility criteria including age, diagnosis, symptom severity, and previous medical history.",
    "This phase 3 trial is investigating the effectiveness of various drugs, including ezetimibe, atorvastatin, and rosuvastatin, in treating hyperlipidemia, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with locally advanced or metastatic medullary thyroid cancer, testing the drug vandetanib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with locally advanced or metastatic prostate cancer, testing the drug triptorelin (decapeptyl\u00ae) as a hormonal treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the drugs rasagiline mesylate and rasagiline mesylate, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with stage IIIA non-small cell lung cancer (NSCLC) who are eligible for surgery, and the study will evaluate the effectiveness of cisplatin and docetaxel as treatment options.",
    "This sample is a phase 3 clinical trial for subjects with type 2 diabetes, testing the efficacy of liraglutide compared to a placebo, with specific eligibility criteria including stable diabetes treatment, HbA1c range, moderate renal impairment, and BMI range.",
    "This sample is a phase 3 trial for the treatment of obesity using the drug taranabant and a placebo comparator, with eligibility criteria including a BMI between 30 and 43 kg/m\u00b2 and stable weight for at least 3 months.",
    "This sample is a phase 3 trial for patients with cancer and breakthrough pain, testing the effectiveness of nasal fentanyl as a treatment option, with specific inclusion criteria and restrictions on previous use of certain drugs.",
    "This sample is a phase 2/phase 3 trial for Alzheimer's disease using the drug talsaclidine, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with pulmonary hypertension, testing the effectiveness of inhaled iloprost, sildenafil, and bosentan compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for relapsing-remitting multiple sclerosis, testing the drugs bg00012, placebo, and glatiramer acetate, with eligibility criteria including confirmed diagnosis of RRMS, baseline EDSS between 0.0 and 5.0, and relapsing-remitting disease course.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of the drug linagliptin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Tourette's disorder and tic disorder, testing the effectiveness of aripiprazole and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for erosive esophagitis, testing the drugs tak-438, placebo, lansoprazole, and placebo, with eligibility criteria including endoscopically confirmed erosive esophagitis and exclusion criteria such as esophagus-related complications and previous surgeries affecting gastroesophageal reflux.",
    "This sample is a phase 3 clinical trial for cervical dystonia, testing the effectiveness of incobotulinumtoxina (xeomin) and placebo, with specific eligibility criteria including TWSTRS scores and previous treatment with Botulinum Toxin.",
    "This phase 3 trial is testing the effectiveness of darusentan, guanfacine, and darusentan placebo in reducing systolic blood pressure in subjects with hypertension who are receiving full doses of antihypertensive drugs from three different classes, including a diuretic.",
    "This sample is a phase 3 trial for children with a genetic risk for developing type 1 diabetes, testing the effectiveness of daily intranasal administration of insulin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for neuropathic pain, testing the effectiveness of topical analgesic and oral intake drugs in patients with controlled diabetes or post-herpetic neuralgia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the drugs pa21 and sevelamer hydrochloride for the treatment of hyperphosphatemia in patients receiving hemodialysis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of chronic primary insomnia in elderly patients, using the drug esmirtazapine compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of venous thrombosis using the drugs apixaban and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for non-small-cell lung cancer, testing the drugs docetaxel and gemcitabine, with eligibility criteria including histologically-confirmed lung cancer, stage IIIB/IV, no prior chemotherapy, and adequate organ function.",
    "This phase 3 trial is investigating the effectiveness of acetylsalicylic acid (aspirin), ibuprofen, and placebo in treating low back pain in ambulatory patients aged 18 to 70 years with a normal blood pressure, excluding those with hypersensitivity to the drugs or serious physical illnesses.",
    "This sample is a phase 3 clinical trial for participants with allergic rhinitis, testing the effectiveness of fluticasone propionate compared to a placebo, with eligibility criteria including a diagnosis of seasonal allergic rhinitis, positive skin test reaction to mountain cedar pollen, and moderate severity of symptoms.",
    "This sample is a phase 3 trial for patients with stable moderate to severe chronic obstructive pulmonary disease (COPD), testing the effectiveness of aclidinium bromide compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the drugs timolol and tafluprost, as well as a fixed dose combination of tafluprost and timolol, for the treatment of ocular hypertension and open-angle glaucoma. The eligibility criteria include specific age requirements, diagnosis of the mentioned diseases, meeting specific IOP levels and visual acuity scores, willingness to follow instructions, and providing written informed consent. There are also exclusion criteria, such as pregnancy, high IOP levels, certain types of glaucoma, contraindications or hypersensitivity to study medications, recent ocular surgery, use of contact lenses, presence of significant illnesses, and current participation in another clinical trial.",
    "This sample is a phase 3 clinical trial for patients with bladder cancer who have progressed after 1st line platinum-chemotherapy, and it will test the effectiveness of vinflunine and best supportive care as a treatment option.",
    "This phase 3 trial is investigating the effectiveness of irinotecan hydrochloride, leucovorin calcium, and fluorouracil in treating patients with metastatic colorectal cancer who have wild type KRAS and have experienced disease progression on first-line chemotherapy with bevacizumab plus FOLFOX, OPTIMOX, or XELOX.",
    "This sample is a phase 3 clinical trial for patients with small cell lung cancer, testing the effectiveness of intravenous topotecan/cisplatin and intravenous etoposide/cisplatin as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with locally advanced, metastatic, or locally recurrent gastric, esophageal, or gastro-esophageal junction adenocarcinoma. The study aims to evaluate the efficacy of lapatinib, capecitabine, and oxaliplatin in combination with a placebo in patients with ErbB2 (HER2) positive tumors. The eligibility criteria include age over 18, ECOG performance status of 2 or less, adequate organ function, and prior gastric surgery or chemotherapy meeting certain time criteria. Exclusion criteria include pregnancy, active CNS disease, uncontrolled ascites, and concurrent anti-cancer therapy.",
    "This sample is a phase 3 clinical trial for previously untreated classical Hodgkin's lymphoma, testing a combination of drugs including doxorubicin, bleomycin, vinblastine, dacarbazine, vincristine, mechlorethamine, etoposide, prednisone, and cyclophosphamide, with specific eligibility criteria for patients to be included or excluded from the study.",
    "This sample is a phase 3 trial for immune thrombocytopenic purpura (ITP) patients, testing the effectiveness of dexamethasone and prednisone as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of idiopathic pulmonary fibrosis and chronic cough using thalidomide and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with major depressive disorder (MDD) who have had an inadequate response to one antidepressant. The trial compares the drug tc-5214 to a placebo, and the inclusion criteria include signed informed consent and out-patient status at enrollment. Exclusion criteria include a history of bipolar disorder, psychotic disorder, post-traumatic stress disorder, suicide attempts in the past year, and renal insufficiency.",
    "This sample is a phase 3 clinical trial for the treatment of ulcerative colitis using mesalazine, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for contraception, testing different treatment options (flexible, fixed, and standard) using the drug Yaz (bay86-5300) in healthy women who desire contraception, with inclusion criteria of being smokers \u2264 30 years old and exclusion criteria of contraindication against hormonal contraceptives.",
    "This sample is a phase 3 trial for kidney transplantation, testing the effectiveness of mycophenolate mofetil, anti-il-2r, methylprednisolone, and cyclosporine as immunosuppressive treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with pancreatic cancer who have undergone prior surgery, and it aims to evaluate the effectiveness of fluorouracil and gemcitabine hydrochloride as treatment options based on specific eligibility criteria.",
    "This sample is a phase 3 trial for bipolar disorder, testing the effectiveness of geodon (ziprasidone) and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug adalimumab, targeting patients with interstitial cystitis, and includes specific inclusion and exclusion criteria for participation in the study.",
    "In this phase 3 trial, the drug kd019 and erlotinib are being tested for the treatment of non-small-cell lung carcinoma, with eligibility criteria including failed previous therapy, absence of active brain metastasis, and no prior use of Epidermal Growth Factor Receptors inhibitors.",
    "This phase 3 trial aims to evaluate the effectiveness of telcagepant and acetaminophen/paracetamol in treating stable coronary artery disease in patients with a history of migraine, while ensuring contraception is used throughout the study.",
    "This sample is a phase 3 trial for psoriasis, testing the drugs u0267 and vehicle, with inclusion criteria including mild to moderate plaque-type psoriasis and exclusion criteria such as allergies to calcipotriene or vitamin D analogs, history of hypercalcemia or vitamin D toxicity, and use of certain medications or therapies within specific timeframes.",
    "This phase 3 clinical trial aims to evaluate the efficacy of ziprasidone in treating schizophrenia, with inclusion criteria including age 18-65, prior treatment with ziprasidone at a dose of 160 mg/d for at least 3 weeks, and a PANSS Positive Symptom Subscale score of 4 or greater. Exclusion criteria include intolerance to ziprasidone side effects, significant cardiac disease, abnormal QT interval, and various other medical conditions.",
    "This sample is a phase 3 trial for chronic kidney disease, testing the effectiveness of n-acetylcysteine and placebo in patients with an eGFR between 30-60 ml/min, with inclusion criteria including age > 18 and no known allergies to or adverse effects from NAC.",
    "This sample is a phase 3 clinical trial for the drug MCI-186 (edaravone) and its placebo in patients with amyotrophic lateral sclerosis (ALSO), with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with diffuse large B-cell lymphoma (DLBCL) and follicular NHL grade 3b, testing the effectiveness of rituximab in combination with R-CHOP/like treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the effectiveness of paracetamol and dypirone in treating patients with fever and sepsis who meet specific inclusion criteria, while excluding those with certain medical conditions or who are pregnant.",
    "This sample is a phase 3 clinical trial for opioid-induced constipation, testing the drug n-methylnaltrexone bromide (moa-728) in adult outpatients with chronic non-malignant pain who are taking opioids, and have agreed to discontinue pre-study laxative therapy.",
    "This sample is a phase 3 trial for patients with chronic hepatitis C and HIV infections, testing the efficacy of peg interferon plus ribavirin in treating the diseases, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with chronic pain, testing the effectiveness of hydrocodone er as a treatment option, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of paliperidone palmitate as a treatment option. The inclusion criteria include meeting the diagnostic criteria for schizophrenia and being able to perform study requirements, while the exclusion criteria include having a primary, active diagnosis other than schizophrenia and a history of treatment resistance or concurrent significant or unstable diseases.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs bapineuzumab 0.5 mg/kg and bapineuzumab 1.0 mg/kg against a placebo control, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with hypertension, testing the drugs telmisartan and amlodipine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for subjects with mixed dyslipidemia, coronary heart disease, and dyslipidemia. The trial will test the effectiveness of the drugs abt-335 and simvastatin, along with a placebo, in treating these conditions. The eligibility criteria include subjects agreeing to use adequate birth control methods and adhere to the American Heart Association diet.",
    "This sample is a phase 3 clinical trial for non-small cell lung carcinoma, testing the effectiveness of the drugs nexavar (sorafenib, bay43-9006) + carboplatin + paclitaxel and carboplatin plus paclitaxel in patients with stage IIIB or stage IV NSCLC who have not received prior chemotherapy. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the efficacy of cyclophosphamide, docetaxel, epirubicin hydrochloride, and fluorouracil in combination, with specific eligibility criteria including histologically confirmed invasive breast cancer, HER2-negative disease, and various tumor size and lymph node involvement requirements.",
    "This sample is a phase 3 trial for major depressive disorder, testing the effectiveness of aripiprazole+ adt and placebo+ adt drugs in patients who have had an inadequate response to previous antidepressant trials.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin lispro protamine suspension and detemir in combination with oral antihyperglycemic medications, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the use of lamictal, a drug used to treat bipolar disorder, in children and adolescents between the ages of 10 and 17 who are currently experiencing a manic/hypomanic, depressed, or mixed mood episode. The study has specific inclusion and exclusion criteria, and the participants must be living with their custodial parent(s) or legal guardian(s).",
    "The sample is a phase 3 clinical trial for venous thrombosis, testing the effectiveness of drugs such as enoxaparin, warfarin, and apixaban, with eligibility criteria including a clinical diagnosis of DVT or PE and exclusion criteria such as contraindications for enoxaparin or warfarin and active bleeding or high risk for serious bleeding.",
    "This phase 3 trial is testing the effectiveness of telcagepant and rizatriptan in treating migraines, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for acute myocardial infraction, testing the efficacy of mesenchymal stem cell therapy compared to a control group, with specific inclusion and exclusion criteria for patient enrollment.",
    "This sample is a phase 3 clinical trial for ulcerative colitis, testing the effectiveness of mesalamin as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the effectiveness of valproate and placebo drugs on patients who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the drugs bifeprunox, placebo, and quetiapine, with inclusion criteria including a primary diagnosis of schizophrenia and stable medication for 8 weeks prior to screening.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of insulin-like growth factor, type 1 and placebo in treating amyotrophic lateral sclerosis (ALSO), with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 3 trial investigating the effects of Sativex\u00ae on peripheral neuropathic pain in patients who have previously participated in a GW clinical study, with inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial testing the drugs mipomersen sodium and placebo on patients with heterozygous familial hypercholesterolemia and coronary artery disease, who have been on stable lipid-lowering therapy and maximally tolerated statin therapy, and meet other inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for HIV infection, testing the effectiveness of the drugs efavirenz, tenofovir, and abacavir/lamivudine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with hyperlipidemia, testing the drug ezetimibe (+) simvastatin, with inclusion criteria including voluntary participation and exclusion criteria such as contraindications for statin use and hypersensitivity to active ingredients.",
    "This sample is a phase 3 clinical trial for breast cancer patients with overexpression of HER2 receptor, testing the effectiveness of parenteral chemotherapy in neoadjuvant and adjuvant settings, with specific eligibility criteria and patient characteristics.",
    "This sample is a phase 3 trial for patients with Parkinson's disease who have completed previous studies and are eligible for treatment with ropinirole xl, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with relapsed or refractory indolent non-Hodgkin's lymphoma, testing the drugs rituximab and pixantrone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the effectiveness of cinacalcet, a drug used to treat secondary hyperparathyroidism in patients with chronic kidney disease, based on specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with Hodgkin's lymphoma, testing the effectiveness of panobinostat and placebo drugs in preventing relapse after autologous peripheral blood/bone marrow stem cell transfusion. The eligibility criteria include age, histologically confirmed classical HL, complete response after transplant, and risk factors for relapse. Patients who have received allogeneic transplant or certain anti-lymphoma therapies are excluded from the study.",
    "This phase 3 trial is testing the effectiveness of losartan potassium in treating hypertension, with inclusion criteria including patients treated with valsartan or irbesartan for at least 4 weeks and having specific blood pressure ranges, and exclusion criteria including recent angina pectoris, abnormal lab results or diseases, recent myocardial infraction, and recent stroke.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of cyclophosphamide, epirubicin hydrochloride, and fluorouracil in combination, with specific eligibility criteria including tumor size, lymph node status, hormone receptor status, age, and various health parameters.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the drugs vildagliptin and gliclazide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for Parkinson's disease, testing the efficacy of tozadenant (syn115) at different doses, along with levodopa and placebo, in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of the drug combination Stribild (containing FTC, TDF, ATV, and ritonavir) in treating HIV patients with specific eligibility criteria, such as having a certain level of HIV-1 RNA, no prior use of antiretroviral drugs, and normal ECG, renal, hepatic, and hematologic function.",
    "This sample is a phase 3 trial for contraception using the drug Skyla (levonorgestrel) in females under 18 years old, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using quetiapine fumarate extended-release as a monotherapy, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial testing the effectiveness of ambroxol and placebo in treating acute viral pharyngitis, with eligibility criteria including patients between the ages of 18 and 65 who have severe throat pain and have not had symptoms for more than 3 days, among other exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of linagliptine and pioglitazone as potential drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for metastatic colorectal cancer, testing the effectiveness of 5 fluorouracil, irinotecan, levo-leucovorin, sunitinib, and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of macular degeneration using the drug ranibizumab, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for the treatment of macular degeneration using ranibizumab, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 clinical trial aims to evaluate the efficacy of preservative-free tafluprost or vehicle and preservative-free timolol maleate in participants diagnosed with primary open-angle glaucoma, pigmentary glaucoma, capsular glaucoma/pseudoexfoliation, or ocular hypertension, who have been using ocular hypotensive medication on a stable treatment regimen for at least 30 days prior to screening or are treatment-naive. The study will assess the participants' eligibility criteria, including visual acuity, ability to discontinue medication, and willingness to self-administer or have assistance with administration of study medications.",
    "This sample is a phase 3 trial for patients with deep vein thrombosis, testing the effectiveness of drugs such as rivaroxaban and unfractionated heparin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the efficacy of drugs such as nva237 and tiotropium in comparison to placebos. The eligibility criteria include specific COPD stage, smoking history, and qualifying FEV1.",
    "This sample is a phase 3 trial for insomnia, testing the effectiveness of zolpidem tartrate sublingual tablet compared to a placebo, with inclusion criteria being adults with a history of sleeplessness and exclusion criteria including allergies to the investigational drug and any conditions or medications that may interfere with the study drug evaluation.",
    "This sample is a phase 3 trial for patients with myocardial ischemia or acute coronary syndrome, testing the effectiveness of eptifibatide (integrilin) and placebo in reducing symptoms and improving outcomes. The eligibility criteria include age, ECG changes, elevated troponin or CK-MB levels, and prior history of cardiovascular disease. Exclusion criteria include pregnancy, renal dialysis, serious illnesses, stroke, bleeding disorders, and recent major surgery or trauma.",
    "The sample is a phase 3 clinical trial for the treatment of pneumonia using the drug prednisone, with inclusion criteria including clinical symptoms of pneumonia and radiological symptoms, and exclusion criteria including conditions requiring corticosteroid therapy, pregnancy or lactation, malignancy, immune-compromised patients, and pre-treatment with macrolide for >24 hours.",
    "This sample is a phase 3 trial for patients with retinal vein occlusion, testing the drug ranibizumab, and includes specific inclusion and exclusion criteria for participation in the study.",
    "This phase 3 trial aims to evaluate the effectiveness of extended release niacin, a drug used to treat hyperlipidemia, in patients with type 2 diabetes, chronic kidney disease, and hyperlipidemia. The study includes eligibility criteria for inclusion and exclusion, such as specific diagnoses and laboratory values.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of aclidinium bromide compared to a placebo, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for HIV infections, testing the effectiveness of lopinavir/ritonavir (a protease inhibitor) in patients who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This sample is a phase 2/phase 3 trial testing the effectiveness of pegylated interferon alfa-2a and ribavirin in HIV-infected patients with compensated liver cirrhosis caused by hepatitis C virus genotype 1 or 4 who have not responded to standard treatment.",
    "This sample is a phase 2/phase 3 trial for pregnant women with documented HIV-1 infection, testing the effectiveness of kaletra (lopinavir/ritonavir) and kaletra (lopinavir/ritonavir) + combivir (zidovudine/lamivudine) in preventing mother-to-child transmission of HIV. The inclusion criteria include being assessed between 20 and 24 months of pregnancy, having a CD4 count above or equal to 350 per mm3, and having a viral load under 30,000 copies per ml.",
    "This sample is a phase 3 trial for type 2 diabetes mellitus, testing the drugs phx1149t and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of dapagliflozin, a drug used to treat type 2 diabetes, in combination with other medications, for patients with inadequate glycemic control and uncontrolled hypertension.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the effectiveness of bevacizumab, erlotinib hcl, and placebo drugs in patients who have progressed after first-line chemotherapy or chemoradiotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of generalized anxiety disorder, testing the efficacy of placebo, vortioxetine, and duloxetine drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of ipragliflozin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of bronchiectasis using the drug azli and a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with acute hepatitis C, testing the effectiveness of pegylated interferon alpha2a as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for systemic lupus erythematosus, testing the effectiveness of corticosteroids, abatacept, and mycophenolate mofetil in patients with active proliferative lupus glomerulonephritis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug paliperidone er in treating autism, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for essential hypertension, testing the effectiveness of azilsartan medoxomil and chlorthalidone, as well as olmesartan medoxomil and hydrochlorothiazide, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for patients with hypercholesterolemia, testing the effectiveness of various drugs including atorvastatin and ezetimibe/simvastatin in lowering cholesterol levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) and includes the drug salmeterol 50mcg/fluticasone propionate 500mcg. The inclusion criteria require patients to have a FEV1 <60% of predicted normal and a baseline FEV1/FVC ratio <70%, as well as a smoking history of at least 10 pack-years. The exclusion criteria include a diagnosis of other respiratory disorders and a requirement for long-term oxygen therapy.",
    "This sample is a phase 3 clinical trial for colorectal neoplasms, testing the drugs cefmetazole and kanamycin/metronidazole in patients undergoing laparoscopic colorectal resection, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for renal transplantation, testing the drugs enteric-coated mycophenolate sodium (ec-mps) and prednisone, with inclusion criteria including primary donor kidney transplant and a panel reactive antibody (PRA) \u2264 20%, and exclusion criteria including multi-organ transplantation and non-heart beating donor or kidney from a non-compatible donor.",
    "This sample is a phase 3 trial for idiopathic Parkinson's disease, testing the drug rotigotine, and the eligibility criteria include completion of previous trials and exclusion of subjects with ongoing serious adverse events related to study medication.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer and metastases, testing the drug lonafarnib (sarasar) as a potential treatment option. The eligibility criteria include specific disease stage, age, performance status, and prior treatment history. Exclusion criteria include prior chemotherapy, recent surgery or radiation therapy, and certain medical conditions.",
    "This sample is a phase 3 trial for fibromyalgia, testing the effectiveness of pregabalin and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of psoriasis, testing the effectiveness of infliximab and placebo drugs on participants with plaque-type psoriasis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for type 2 diabetes mellitus, testing the efficacy of various drug combinations (alogliptin and glimepiride, alogliptin and metformin) with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for the treatment of open-angle glaucoma using the drug memantine, with inclusion criteria including glaucoma damage on examination of visual field and optic disc and good visual acuity.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the drugs rasagiline mesylate and placebo, with inclusion criteria including confirmed diagnosis of Parkinson's disease and age 35 or older, and exclusion criteria including unstable systemic medical problems or clinically significant malignancy.",
    "This sample is a phase 3 trial for patients with psoriasis, testing the effectiveness of etanercept and placebo drugs, with eligibility criteria including not receiving certain psoriasis medications during the study.",
    "This sample is a phase 3 clinical trial for patients with epilepsy who are currently receiving Levetiracetam (LEV) but experiencing nonpsychotic behavioral side effects, and the study aims to evaluate the efficacy of Brivaracetam as an alternative treatment option.",
    "This sample is a phase 2/phase 3 trial for endometriosis, where the drug being tested is pioglitazone, and the eligibility criteria include being a healthy woman aged 18-45 with regular cycles, pelvic pain for at least 3 months, negative pregnancy test, non-lactating, no prior use of hormonal therapy, no history of liver disease, suspected endometriosis and scheduled for surgery to confirm diagnosis, surgery scheduled in follicular phase, and consent to participate in the study.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, hypercholesterolemia, and pre-diabetes, testing the effectiveness of metformin hcl and colesevelam placebo, metformin hcl tablets and colesevelam tablets, and colesevelam in reducing HbA1C levels and LDL-C levels.",
    "This sample is a phase 3 trial for patients with chronic systolic heart failure, where the drug being tested is eplerenone, and the inclusion criteria include having a history of heart failure and being on optimal dose of standard heart failure medicines.",
    "This sample is a phase 3 trial for patients with essential hypertension, testing the effectiveness of the drugs lcz696, olmesartan, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for advanced colorectal cancer, testing the effectiveness of two drug combinations (21capecitabine + bevacizumab + oxaliplatin and 1capecitabine + oxaliplatin + bevacizumab + cetuximab) in patients who are not eligible for curative surgery, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the drugs razadyne and placebo for the treatment of major depression, bipolar depression, and schizoaffective disorder, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for osteoporosis, testing the effectiveness of denosumab compared to a placebo in women aged 60 to 90 with a bone mineral density T-Score less than -2.5, excluding those with a T-Score less than -4.0 or severe vertebral fractures.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C using the drugs sofosbuvir, peg, and rbv, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with bronchial asthma, testing the effectiveness of different doses of the drug Berodual\u00ae via Respimat\u00ae and placebo in improving lung function, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of zoledronic acid, dexamethasone, thalidomide, vincristine, and adriamycin in treating multiple myeloma patients who meet specific eligibility criteria, while excluding those with certain comorbid conditions or active and invasive cancers.",
    "This sample is a phase 2/phase 3 trial for patients with Parkinson's disease, testing the efficacy of three different doses of the drug CEP-1347 in improving symptoms, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for Parkinson's disease, testing the drug perampanel, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for the treatment of juvenile idiopathic arthritis, testing the efficacy of tocilizumab, placebo, non-steroidal anti-inflammatory drugs (NSAIDs), methotrexate, and corticosteroids. The study includes inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with essential hypertension, testing the drugs olmesartan, placebo, and lcz696, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for children aged 2-5 years with perennial allergic rhinitis, testing the effectiveness of triamcinolone, a glucocorticoid, in reducing nasal symptoms.",
    "This phase 3 clinical trial aims to evaluate the efficacy of mometasone furoate nasal spray (mfns) compared to a matching placebo nasal spray in subjects with allergic rhinitis, who have a positive skin prick test response to an appropriate seasonal allergen and are clinically symptomatic. The study includes specific inclusion and exclusion criteria, and it excludes subjects who have a history of severe local reactions or anaphylaxis to skin testing, recent upper respiratory tract or sinus infections, or those who have used any drug in an investigational protocol within the past 30 days. Additionally, pregnant or breastfeeding females, subjects previously randomized into the study, and family members of the investigational study staff are also excluded.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of hypertonic saline and terlipressin, as well as normal saline and norepinephrine, in treating septic shock and sepsis-associated hypotension. The study includes eligibility criteria such as SIRS criteria, known septic source, and specific hemoglobin levels, while excluding patients with certain conditions like hypernatremia, endocrine diseases, and liver disease.",
    "This sample is a phase 3 clinical trial for patients with multiple sclerosis, testing the effectiveness of Sativex\u00ae and placebo in treating lower limb spasticity, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of opc-34712 + adt and placebo + adt drugs in treating major depressive disorder, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic kidney disease (CKD) and hyperkalemia (HK), testing the effectiveness of the drug patiromer in managing serum potassium levels. The inclusion criteria include having CKD and HK, taking specific medications, and providing informed consent, while the exclusion criteria include certain medical conditions and recent surgeries.",
    "This sample is a phase 3 clinical trial for liver cancer patients who are not eligible for surgery, testing the drug megestrol acetate. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 trial for the treatment of overactive bladder, testing the drugs ym178, placebo, and tolterodine er, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin phosphate, pioglitazone hydrochloride, and metformin as antihyperglycemic agents, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of cisplatin in treating head and neck cancer, mucositis, pain, and radiation toxicity, with specific eligibility criteria including histologically proven squamous cell carcinoma, certain stage classifications, and adequate organ function.",
    "This sample is a phase 2/phase 3 trial for patients with multiple sclerosis (MS) using hydroxyurea as the drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of relapsing-remitting multiple sclerosis using the drug natalizumab, with inclusion and exclusion criteria specified.",
    "This sample is a phase 3 clinical trial for the treatment of bipolar disorder mania, testing the efficacy of aripiprazole as an adjunctive treatment to ongoing lithium or valproate therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the drug taranabant, compared to a placebo, in obese patients with a body mass index between 30 kg/m2 and 43 kg/m2, inclusive, or between 27 kg/m2 and 43 kg/m2 for those with obesity-related comorbidities.",
    "This sample is a phase 3 clinical trial for patients with non-small-cell lung carcinoma who have failed previous treatments, and it investigates the efficacy of investigator's choice of chemotherapy and bibw 2992 as potential treatment options. The eligibility criteria include specific disease stage, previous treatment history, performance score, and tumor measurement requirements, while the exclusion criteria include previous treatment with bibw 2992, recent treatments, brain metastases, gastrointestinal disorders, and cardiovascular abnormalities.",
    "This sample is a phase 3 clinical trial for chronic constipation, testing the drugs matching placebo and linaclotide, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for Crohn's disease, testing the drugs budesonide and mesalazine, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for osteoporosis, testing the drugs denosumab, placebo, and alendronate sodium hydrate, with inclusion criteria of involutional osteoporosis with prevalent fragility vertebral fractures and exclusion criteria of any underlying condition that might have resulted in abnormal bone metabolism.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of paliperidone ER or olanzapine as treatments, with specific inclusion and exclusion criteria, including previous treatment history and certain medical conditions.",
    "This sample is a phase 3 clinical trial for patients with non-squamous, non-small-cell lung cancer, testing the efficacy of tivantinib, placebo, and erlotinib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with mesothelioma and lung cancer, testing the effectiveness of vorinostat and placebo as treatments, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) and includes drugs such as indacaterol, tiotropium, and placebo. The inclusion criteria include a smoking history of at least 10 pack years, post-bronchodilator FEV1 <80% and \u226550% of the predicted normal value, and post-bronchodilator FEV1/forced vital capacity (FVC) <70%. The exclusion criteria include patients who received any corticosteroid for 3 months prior to screening.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the efficacy of aripiprazole 5mg and 2mg compared to placebo, with eligibility criteria including a history of inadequate response to antidepressant treatments and a HAM-D17 score of at least 18.",
    "This sample is a phase 3 trial for patients with acute heart failure, testing the drug tezosentan. The eligibility criteria include patients with dyspnea at rest, evidence of pulmonary congestion, and left ventricular systolic dysfunction.",
    "In this phase 3 trial, the drug iloperidone, along with an active comparator and placebo, is being tested for its effectiveness in treating schizophrenia. The study includes subjects with schizophrenia who must sign a written consent form, and excludes those with clinically significant heart, kidney, liver, or gastrointestinal diseases, as well as those with psychiatric disorders other than schizophrenia.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the drugs tc-5214 and placebo, with inclusion criteria including inadequate response to one antidepressant and exclusion criteria including a history of bipolar disorder or suicide attempts.",
    "This sample is a phase 3 trial for allergy, specifically grass pollen-related allergic rhinoconjunctivitis, testing the efficacy of a grass pollen allergen extract tablet and placebo tablet in children aged 5 to 17 years who have been sensitized to grass pollen and have experienced symptoms in previous pollen seasons.",
    "This sample is a phase 3 clinical trial for the treatment of acute bacterial sinusitis, testing the efficacy of mfns and antibiotic nasal spray compared to a placebo nasal spray plus antibiotic, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of various drugs including olodaterol, tiotropium, and placebos, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2/phase 3 trial for patients with chronic idiopathic constipation, testing the drug plecanatide. The inclusion criteria include meeting the modified Rome III criteria for constipation, having less than 3 complete spontaneous bowel movements per week, and willingness to discontinue certain medications. The exclusion criteria include having loose or watery stool, having Irritable Bowel Syndrome, and having certain gastrointestinal conditions or surgeries.",
    "This sample is a phase 3 trial for patients with gastroesophageal reflux disease (GERD), testing the efficacy of sodium alginate double action tablets and placebo in reducing heartburn symptoms. The inclusion criteria include a history of frequent episodes of GERD-related symptoms, while the exclusion criteria include various gastrointestinal diseases and recent significant weight loss.",
    "This sample is a phase 3 clinical trial for patients with metastatic melanoma, testing the combination of elesclomol and paclitaxel as a treatment option. The eligibility criteria include confirmed melanoma diagnosis, specific performance status, measurable disease, and other protocol parameters.",
    "In this phase 3 trial, the drug combination of sunitinib malate and taxotere is being tested for the treatment of breast neoplasms, specifically unresectable locally recurrent or metastatic disease in patients with Her-2 negative tumors. The eligibility criteria include excluding patients for whom docetaxel is contraindicated and those with clinical presentation of inflammatory carcinoma with no other measurable disease.",
    "This sample is a phase 3 clinical trial for patients with colorectal neoplasms, testing the effectiveness of 5fu+l-leucovorin and uft+leucovorin as adjuvant chemotherapy after tumor resection, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial for patients with active ankylosing spondylitis, testing the effectiveness of meloxicam suppository, meloxicam tablet, and indomethacin as treatment options.",
    "This sample is a phase 3 trial for the drug tak-438 in patients with erosive esophagitis, who have successfully completed a preceding study and have endoscopically healed EE, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for stage IV non-small cell lung cancer patients, testing the drugs gemcitabine and erlotinib, with eligibility criteria including histologically documented NSCLC, measurable disease, and normal hepatic function.",
    "This sample is a phase 3 clinical trial for patients with hypertension, testing the effectiveness of telmisartan and hydrochlorothiazide combination drugs in reducing blood pressure, with specific eligibility criteria for patient selection.",
    "This sample is a phase 3 trial for the treatment of pulmonary hypertension using oral treprostinil sustained release tablets, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes mellitus, testing the efficacy of the drugs viaject\u2122 and regular human insulin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with mild and moderate hypertension, testing the drugs valsartan and irbesartan, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of exenatide in combination with various other treatments, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2/phase 3 clinical trial for rheumatoid arthritis, testing the drugs sarilumab, placebo (for sarilumab), methotrexate, and folic acid, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of ischemic stroke using the drug saline, with specific inclusion and exclusion criteria, and various medical conditions that would prevent participation in the trial.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using intramuscular ziprasidone mesylate and intramuscular haloperidol in Chinese subjects aged 18-65 years who meet the ICD-10 criteria for schizophrenia.",
    "This phase 3 clinical trial aims to evaluate the efficacy of Ultrase\u00ae MT20, a pancreatic enzyme supplementation, in treating cystic fibrosis patients with exocrine pancreatic insufficiency, based on specific eligibility criteria including confirmed CF diagnosis, genotype or sweat chloride test, fecal elastase-1 concentration, clinical stability, age, nutritional status, pancreatic enzyme dose, ability to swallow capsules and follow a high-fat diet, and willingness to complete the study.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, focusing on patients with a diagnosis of paranoid, disorganized, catatonic, residual, or undifferentiated subtype with persistent negative symptoms. The study includes the drugs asenapine and olanzapine, and the inclusion criteria require a caregiver. Exclusion criteria include uncontrolled medical conditions and other psychiatric disorders.",
    "This sample is a phase 3 trial for the treatment of prostatic neoplasms using drugs such as prednisone, sunitinib, and placebo, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial for patients with advanced liver cancer who have progressed on or are intolerant to sorafenib treatment, and it will test the efficacy of everolimus compared to a placebo.",
    "This sample is a phase 3 clinical trial for the treatment of depression in patients with bipolar I disorder, testing the efficacy of armodafinil compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of vildagliptin and placebo in combination with insulin and metformin, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the efficacy of rotigotine, a dopamine agonist, compared to placebo in treating restless legs syndrome (RLS) in patients with end-stage renal disease (ESRD) requiring hemodialysis, who have previously responded to dopaminergic treatment or are treatment-naive.",
    "This sample is a phase 3 clinical trial testing the drugs apf530, dexamethasone, and palonosetron hydrochloride for the prevention of nausea and vomiting in patients receiving moderately or highly emetogenic chemotherapy. The eligibility criteria include having a histologically or cytologically confirmed malignant disease, not having head and neck cancer or upper gastrointestinal cancer, and being able to receive standardized doses of dexamethasone.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin lispro protamine suspension and insulin glargine in combination with other oral diabetes medications. The inclusion criteria include having type 2 diabetes, being between 18 and 75 years old, and taking specific medications for at least 3 months. The exclusion criteria include not using insulin regularly in the past 2 years and not having certain medical conditions.",
    "This sample is a phase 3 trial testing the effectiveness of osmotic-release methylphenidate and placebo in treating ADHD and smoking addiction, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of plaque psoriasis using the drug apremilast, along with placebo and topical treatments or phototherapy, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the treatment of psoriasis, testing the drugs cp-690,550 and placebo/cp-690,550, with eligibility criteria including a diagnosis of moderate to severe plaque psoriasis and a Psoriasis Area and Severity Index (PASI) score of 12 or greater.",
    "This phase 3 trial aims to evaluate the effectiveness of tramadol hydrochloride plus acetaminophen and placebo in managing chronic pain associated with osteoarthritis or lower back pain, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of divalproex sodium er, a drug used to treat bipolar disorder, compared to a placebo, in patients with bipolar I or II who are currently depressed. The study will assess the impact of the drug on depression scores and mania ratings, and includes specific inclusion and exclusion criteria for participant selection.",
    "This sample is a phase 3 trial testing the effectiveness of losartan potassium, amlodipine besylate, and enalapril maleate in treating proteinuria associated with chronic kidney disease in children aged 1 to 17 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of fluticasone propionate inhalation solution and budesonide suspension as treatments, with specific eligibility criteria including age, gender, asthma history, lung function, and medication usage.",
    "This phase 3 trial aims to evaluate the efficacy of ezetimibe (+) simvastatin and atorvastatin calcium compared to placebo in patients with metabolic syndrome and hypercholesterolemia at high risk for coronary heart disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic hepatitis C, testing the effectiveness of irbesartan and placebo in patients who are non-responders or relapsers to past antiviral treatment, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the efficacy of mci-196 and placebo in patients with chronic kidney disease, dialysis, and hyperphosphatemia, who are currently on a stabilised phosphorus diet and using calcium-based phosphate-binding medication only. The study includes specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of budesonide and placebo in treating patients with active, mild to moderate proctitis and proctosigmoiditis, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients diagnosed with primary or mixed dementia, testing the effectiveness of megestrol acetate and placebo in treating weight loss and malnutrition.",
    "This phase 3 trial is testing the effectiveness of darusentan, a drug used to treat hypertension, in patients with mean systolic blood pressure \u2265130 mmHg (for those with diabetes and/or chronic kidney disease) or \u2265140 mmHg (for all other subjects), who are receiving and adhering to full doses of appropriate guideline-recommended antihypertensive drugs from three different classes of antihypertensive agents, including a diuretic.",
    "This sample is a phase 3 trial for congestive heart failure, testing the effectiveness of candesartan and placebo in patients aged 18 or above, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the drug CP-690,550 in the treatment of rheumatoid arthritis, with inclusion criteria being completion of a qualifying study and exclusion criteria being serious medical conditions that could make treatment unsafe.",
    "This sample is a phase 3 clinical trial for the treatment of pharyngitis, testing the effectiveness of the drugs placebo and flurbiprofen, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial aims to evaluate the effectiveness of pilocarpine hydrochloride compared to placebo in improving quality of life for patients with oral complications resulting from opioid therapy, with specific eligibility criteria including a minimum duration of dry mouth symptoms, opioid use, and absence of certain medical conditions.",
    "This sample is a phase 2/phase 3 trial for kidney transplantation, testing the effectiveness of rituximab and placebo in renal transplant recipients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin phosphate (+) metformin hydrochloride and comparing it to pioglitazone as a treatment option. The eligibility criteria include being inadequately controlled and not on insulin or oral antihyperglycemic therapy.",
    "This sample is a phase 3 trial for HIV infections, testing the effectiveness of tipranavir and ritonavir in combination with an optimized background regimen (OBR) of other antiretroviral agents. The study includes eligibility criteria such as being HIV-1 infected, having resistance to protease inhibitors, and having a CD4+ T lymphocyte count of at least 50 cells/mm3.",
    "This sample is a phase 3 trial for fibromyalgia, testing the effectiveness of [s,s]-reboxetine and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for ovarian cancer and fallopian tube cancer, testing the effectiveness of pegylated liposomal doxorubicin, carboplatin, and paclitaxel as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes mellitus, testing the effectiveness of a new formulation of insulin glargine (hoe901) compared to the standard insulin glargine (hoe901) (lantus), with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of saxagliptin and placebo drugs. The inclusion criteria include being diagnosed with type 2 diabetes and having HbA1c levels between 7.2% and 10.0%. The exclusion criteria include recent insulin therapy and a history of type 1 diabetes or ketoacidosis.",
    "This sample is a phase 3 clinical trial for patients with glaucoma or ocular hypertension, testing the effectiveness of latanoprost 0.005% / timolol 0.5% fixed combination as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin compared to glimepiride and open-label metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of major depressive disorder using the drug duloxetine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for fibromyalgia, testing the effectiveness of pregabalin and placebo in patients who meet the ACR criteria for fibromyalgia and have a score of >40 mm on the Visual Analog Scale. Patients with inflammatory musculoskeletal disorders, rheumatic diseases other than fibromyalgia, active infections, or untreated endocrine disorders are excluded from the study.",
    "This sample is a phase 2/phase 3 trial for patients with Type 2 diabetes, testing the drugs placebo and agi-1067, with eligibility criteria including a minimum HbA1c level of \u22657.5% and stable antidiabetic medication usage.",
    "This sample is a phase 3 trial for patients with chronic hepatitis C who are non-responders to Interferon plus Ribavirin therapy. The trial will test the effectiveness of two drugs, bms-790052 (daclatasvir) and bms-650032 (asunaprevir), in treating the disease. The eligibility criteria include having a HCV RNA viral load of \u2265 100,000 IU/mL, being aged 20 to 75 years, and being excluded from or intolerant to interferon/ribavirin therapy. Patients with hepatocellular carcinoma, co-infection with Hepatitis B virus or Human Immunodeficiency Virus, and severe or uncontrollable complications are excluded from the trial.",
    "This sample is a phase 3 trial for patients with schizophrenia, testing the effectiveness of aripiprazole, olanzapine, quetiapine, or risperidone as alternative antipsychotic medications for those whose symptoms are not well controlled or who have difficulty tolerating their current medication.",
    "This sample is a phase 3 trial for hypertension, testing the drug valsartan+amlodipine, with inclusion criteria including successful completion of a core trial and specific blood pressure measurements, and exclusion criteria including previous serious adverse events and other protocol-defined criteria.",
    "This sample is a phase 3 clinical trial for the drug vilazodone in patients with major depressive disorder, with specific inclusion and exclusion criteria, and various medical and psychiatric conditions that would exclude patients from participating in the trial.",
    "This sample is a phase 3 clinical trial for previously untreated multiple myeloma patients, testing the effectiveness of thalidomide, dexamethasone, and doxil as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for lung transplantation recipients, testing the use of everolimus and mycophenolatmofetil drugs, with specific inclusion and exclusion criteria for both donors and recipients.",
    "This phase 3 trial is investigating the effectiveness of pramipexole and levodopa in combination with benserazide for treating restless legs syndrome in patients aged 25 to 85 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with renal cell carcinoma, testing the effectiveness of pazopanib and sunitinib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of juvenile idiopathic arthritis, testing the effectiveness of drugs such as infliximab plus methotrexate, combination of dmards, and methotrexate alone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with rheumatoid arthritis who have not responded to previous treatments, and it will test the effectiveness of methotrexate and rituximab in treating the disease.",
    "This sample is a phase 3 trial for a smallpox vaccine (smallpox vaccine cj-50300) in healthy Korean subjects below 60 years of age, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with diabetes mellitus, testing the effectiveness of alogliptin and pioglitazone compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with retinal vein occlusion, testing the effectiveness of ranibizumab in improving visual impairment caused by macular edema. The inclusion criteria include specific visual acuity scores and a diagnosis within the past 12 months, while exclusion criteria include pregnancy, history of stroke, uncontrolled blood pressure, and prior use of certain medications or treatments.",
    "This phase 3 clinical trial aims to evaluate the efficacy of aflibercept, placebo, docetaxel, and dexamethasone in treating locally advanced or metastatic non-small cell lung cancer patients who have experienced disease progression after one prior platinum-based anticancer therapy.",
    "This sample is a phase 3 clinical trial for the treatment of arthritis, rheumatoid in Japanese patients, using the drugs etanercept and methotrexate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for schizophrenia patients, testing the effectiveness of olanzapine and asenapine drugs, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of valsartan + amlodipine, a combination drug, in treating moderate to severe high blood pressure in patients aged 18 and older, with specific inclusion and exclusion criteria, such as excluding patients with allergies to certain medications, controlled blood pressure, autoimmune diseases, and history of drug or alcohol abuse.",
    "This sample is a phase 3 clinical trial for patients with unresectable or inoperable Stage IIIA or IIIB non-small cell lung cancer (NSCLC), testing the effectiveness of carboplatin and paclitaxel in combination, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for plaque psoriasis, testing the effectiveness of methotrexate and placebo to methotrexate in children aged 4 to 18 years who have failed to respond to topical therapy and require systemic treatment to control their disease.",
    "This phase 3 trial is investigating the efficacy of exenatide and premixed insulin aspart in treating type 2 diabetes mellitus patients who have been treated with metformin and have an HbA1c between 6.5% and 10.0%.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of liraglutide, a GLP-1 analogue, in improving glycemic control. The inclusion criteria include a diagnosis of type 2 diabetes, inadequate glycemic control on current medications, specific BMI and C-peptide levels, and a certain range of HbA1c. The exclusion criteria include a history of cancer, diabetic gastroparesis, biliary disease, pancreatitis, significant GI surgery, cardiovascular/cerebrovascular disease, hypertension, HIV infection, liver disease, alcohol/substance abuse, pregnancy/lactation, allergies to study medications, type 1 diabetes, contraindications for study medications, recent use of investigational drugs, and thyroid disease.",
    "This sample is a phase 3 clinical trial for patients with melanoma and neoplasm metastasis, testing the drugs pegintron and intron a, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for advanced hepatocellular carcinoma, testing the effectiveness of sorafenib (nexavar, bay43-9006) compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial that aims to test the effectiveness of varenicline (chantix), bupropion (zyban), and nicotine patches in helping Duke employees and their dependents quit smoking, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, testing the effectiveness of a combination drug (naproxen and omeprazole) in reducing the risk of gastric or duodenal ulcers associated with long-term NSAID therapy.",
    "This sample is a phase 3 clinical trial for patients with chronic pain, comparing the effectiveness of fentanyl buccal tablets with immediate-release oxycodone, and the eligibility criteria include having chronic pain for at least 3 months, currently using a certain dosage of opioids, and being willing to provide informed consent.",
    "This sample is a phase 3 trial for chronic hepatitis C, testing the drugs sof, rbv, placebo to match sof, and placebo to match rbv, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the efficacy of tariquidar + vinorelbine versus placebo + vinorelbine as first-line chemotherapy for patients with stage IIIB or stage IV non-small cell lung cancer, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for chronic hepatitis B patients, testing the efficacy of entecavir and pegylated interferon \u03b1-2a sequential treatment group and pegylated interferon \u03b1-2a monotreatment group, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with rheumatoid arthritis, testing the effectiveness of cnto 148, placebo, and methotrexate (mtx) as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of seasonal allergic rhinitis using the drugs mp29-02, azelastine hcl, fluticasone propionate, and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of hydrochlorothiazide (+) losartan potassium, losartan potassium, and placebos in treating hypertension in children aged 6 to 17 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for colorectal cancer, testing the drugs cediranib, bevacizumab, 5-fluorouracil, leucovorin, and oxaliplatin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of cisplatin, cyclophosphamide, dexamethasone, etoposide, and thalidomide as treatment options, with specific eligibility criteria and prior treatment restrictions.",
    "This sample is a phase 3 clinical trial for the treatment of breast cancer and climacteric symptoms using the drugs tibolone and placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for pain management after bunionectomy surgery, testing the effectiveness of three drugs (placebo, acurox 5/30 mg, and acurox 7.5/30) on patients who meet specific inclusion criteria, such as being at least 18 years old and willing to stay at the study site for at least 48 hours post-surgery.",
    "This sample is a phase 3 clinical trial for patients with bipolar I disorder, testing the effectiveness of cariprazine and placebo in treating manic episodes, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for major depressive disorder, testing the effectiveness of antidepressant + placebo and antidepressant + aripiprazole in patients who have had an inadequate response to one to three antidepressants.",
    "This sample is a phase 3 clinical trial for patients with various stages of skin melanoma, testing the effectiveness of carboplatin, paclitaxel, and sorafenib tosylate as treatment options, with specific eligibility criteria for patient inclusion.",
    "This sample is a phase 3 clinical trial for the treatment of post-traumatic stress disorder (PTSD) in children and adolescents using the drug Zoloft (sertraline). The eligibility criteria include age range and a diagnosis of PTSD based on DSM-IV criteria.",
    "This sample is a phase 3 clinical trial testing the effectiveness of liraglutide, a drug used to treat obesity, compared to a placebo, in patients with a BMI of 30.0 kg/m^2 or above, or a BMI of 27 kg/m^2 or above with co-morbidities of dyslipidemia and/or hypertension. The study has specific inclusion and exclusion criteria, and aims to evaluate the safety and efficacy of liraglutide in treating obesity.",
    "This sample is a phase 2/phase 3 trial for metastatic colorectal cancer, testing the drugs cmab009 plus irinotecan and irinotecan-only and sequential-cmab009, with specific eligibility criteria including histologically confirmed metastatic colorectal adenocarcinoma, KRAS wild-type tumors, and failure of fluoropyrimidine and oxaliplatin treatment.",
    "This sample is a phase 3 trial for HIV-positive and HCV-positive individuals, testing the effectiveness of Kaletra tablets in reducing viral load, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial testing the drugs methoxy polyethylene glycol-epoetin beta (mircera) and epoetin alfa for the treatment of chronic renal anemia in adult patients on regular hemodialysis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of a combination therapy including metformin, pioglitazone, and alogliptin, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of lopinavir/ritonavir and lamivudine in preventing HIV transmission through breastfeeding, with specific inclusion and exclusion criteria for both infants and mothers.",
    "This sample is a phase 3 clinical trial for HIV patients, testing the effectiveness of darunavir and ritonavir drugs in reducing plasma HIV-RNA levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for prostate cancer, testing the drugs lupron and casodex, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for childhood acute myeloid leukemia and other myeloid malignancies, testing the effectiveness of drugs such as asparaginase, daunorubicin hydrochloride, cytarabine, thioguanine, and etoposide, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the effectiveness of mr prednisone and placebo in patients who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This sample is a phase 3 trial for patients with prostate cancer, testing the drugs degarelix and leuprolide 7.5 mg, with eligibility criteria including histologically proven prostate cancer, baseline testosterone >1.5 ng/mL, and a life expectancy of at least 12 months.",
    "This sample is a phase 3 clinical trial for type 2 diabetes, testing the drug MP-513 against a placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the drugs zicronapine and risperidone, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for uncontrolled asthma, testing the efficacy of a fixed combination of budesonide and formoterol, as well as budesonide alone, in patients aged 18 to 77 years who are nonsmokers. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 clinical trial testing the drug aliskiren for patients with essential hypertension, with inclusion criteria of patients at least 65 years old and exclusion criteria of severe hypertension or history of secondary form of hypertension.",
    "This sample is a phase 3 clinical trial for multiple myeloma and plasma cell neoplasm, testing the effectiveness of dexamethasone, doxorubicin hydrochloride, valspodar, and vincristine sulfate as treatment options, with specific eligibility criteria for patients.",
    "This phase 3 trial is testing the efficacy of placebo and bibw 2992 in patients with non-small-cell lung carcinoma who have failed previous chemotherapy and targeted therapy, and meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for patients aged 65 years or older with epilepsy, who have been diagnosed for at least 12 months and experienced at least 2 partial-onset seizures in the 4 weeks prior to screening. The trial aims to evaluate the efficacy and safety of eslicarbazepine acetate as an add-on treatment to 1 or 2 antiepileptic drugs (AEDs) in this patient population.",
    "This sample is a phase 3 clinical trial testing the effectiveness of Ingavirin and a placebo oral capsule in treating influenza, acute respiratory infection, common cold, flu, and viral infection. The eligibility criteria include having continuous contact with an ill person, being exposed to symptoms of flu or respiratory viral infection within 48 hours, and signing informed consent to participate in the study. Exclusion criteria include recent intake of interferone or immune system-affecting substances, use of anti-virals other than the investigational drug, recent influenza vaccination, and pregnancy or lactation.",
    "This sample is a phase 3 trial for overactive bladder, testing the drugs tolterodine er and fesoterodine against a placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This phase 3 clinical trial aims to evaluate the efficacy of anamorelin hcl, a drug used to increase appetite, in patients with cachexia and non-small cell lung cancer, who have experienced involuntary weight loss and have a BMI less than 20 kg/m2.",
    "This sample is a phase 3 trial for osteoporosis, testing the drug alendronate, with inclusion criteria including non-metastatic adenocarcinoma of the prostate and a life expectancy of >12 months, and exclusion criteria including bone metastases, previous use of bisphosphonate, and hypersensitivity to LHRH.",
    "This phase 3 clinical trial is investigating the use of baclofen/amitriptyline/ketamine gel in patients with various diseases, including chronic myeloproliferative disorders, leukemia, lymphoma, and multiple myeloma, who have neurotoxic chemotherapy-induced peripheral neuropathy and pain.",
    "This sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) patients, testing the effectiveness of roflumilast and placebo drugs. The inclusion criteria include a history of COPD, specific lung function measurements, and prior treatment with tiotropium. The exclusion criteria include recent COPD exacerbation and ongoing treatment with glucocorticosteroids or antibiotics.",
    "This sample is a phase 3 trial for the treatment of erosive esophagitis using the drugs tak-438 and lansoprazole, with eligibility criteria including endoscopically confirmed erosive esophagitis and successful completion of the treatment period with endoscopically healed EE.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of saxagliptin, metformin, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for renal transplantation patients, testing the drugs sirolimus, tacrolimus, and cyclosporine a, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the drug valsartan/amlodipine for patients with uncomplicated, essential hypertension, with exclusion criteria including severe hypertension, history of stroke or heart disease, and certain allergies to medications used to treat high blood pressure.",
    "This phase 3 clinical trial is testing the effectiveness of vandetanib and pemetrexed in treating non-small cell lung cancer patients who have failed 1st line anti-cancer therapy, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with localized prostate cancer who are undergoing prostatectomy or brachytherapy, and it aims to investigate the effects of vitamin E supplementation on the disease.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia and schizoaffective disorders using the drug quetiapine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of cyclophosphamide, epirubicin hydrochloride, gemcitabine hydrochloride, and paclitaxel as treatment options. The eligibility criteria include histologically confirmed invasive breast cancer, grade 2 or 3, tumor size at least 3 cm, and no evidence of metastatic disease.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of fluticasone furoate/gw642444 inhalation powder and fluticasone furoate inhalation powder as maintenance therapy, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of fluticasone furoate/gw642444 and fluticasone propionate drugs in patients currently using moderate to high dose inhaled corticosteroid therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for constipation, testing the drug prucalopride, and includes eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for impetigo, testing the effectiveness of ozenoxacin placebo, retapamulin 1% ointment, and ozenoxacin 1% cream as topical antibiotics, with specific inclusion and exclusion criteria for patient selection.",
    "This sample is a phase 3 trial for fibromyalgia, testing the effectiveness of pregabalin and placebo in patients who meet the American College of Rheumatology criteria for fibromyalgia, have completed at least 4 pain diaries with a pain score of \u22654, and have a score of \u226540 mm on the Visual Analogue Scale.",
    "This sample is a phase 3 clinical trial for asthma patients of Asian ancestry, testing the efficacy of the drugs gw685698/gw642444 and cci18781 in combination with an inhaled corticosteroid (ICS) for at least 12 weeks prior to the study. The inclusion criteria include informed consent, age 12 or older, a diagnosis of asthma, and a best FEV1 of 40%-90% of the predicted normal value. The exclusion criteria include a history of life-threatening asthma, recent respiratory infection or exacerbation, and concurrent respiratory diseases or abnormalities.",
    "This sample is a phase 2/phase 3 trial for the treatment of diabetic macular edema using fluocinolone acetonide, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer who have previously been treated with first-line chemotherapy plus Avastin. The study aims to evaluate the efficacy of chemotherapy and bevacizumab in these patients. The eligibility criteria include age, disease progression, performance status, and exclusion criteria such as specific timeframes for disease progression and treatment history.",
    "This phase 3 clinical trial aims to investigate the effects of vitamin K supplementation on osteoporosis, vascular calcification, and inflammation in ambulatory individuals with low dietary intake of vitamin K.",
    "This sample is a phase 3 trial for patients with chronic hepatitis C, genotype 2 or 3, who are receiving PEGASYS + Copegus and have not achieved rapid viral response. The study aims to evaluate the efficacy of peginterferon alfa-2a and ribavirin in these patients.",
    "This sample is a phase 3 trial for bipolar disorder, testing the effectiveness of lithium or lamotrigine as prophylactic treatment, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with prostate cancer, testing the drugs doxorubicin hydrochloride and methylprednisolone, with eligibility criteria including hormone-refractory disease and specific patient characteristics such as age, performance status, and hematopoietic levels.",
    "This sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) using the drugs roflumilast and placebo, with specific inclusion and exclusion criteria related to COPD history and lung function.",
    "This sample is a phase 3 trial for bipolar disorder, testing the drugs aripiprazole and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for chronic pain, testing the effectiveness of tramadol hydrochloride (HCL) plus acetaminophen (JNS013) in participants whose pain cannot be controlled with oral nonsteroidal anti-inflammatory drugs (NSAIDs). The inclusion criteria include participants with chronic pain due to various conditions, while the exclusion criteria include participants with contraindications to opioids or acetaminophen, history of convulsion, alcohol or drug dependence, and pregnancy or lactation.",
    "This sample is a phase 3 trial for postoperative pain and inguinal hernia, testing the effectiveness of pregabalin and placebo as pain control medications after open unilateral inguinal herniorraphy surgery.",
    "This sample is a phase 3 clinical trial for patients with idiopathic Parkinson's disease, testing the efficacy of pramipexole extended release and pramipexole immediate release in reducing motor complications under levodopa therapy, with various inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with moderate to severe asthma, testing the effectiveness of budesonide/formoterol (symbicort) pmdi and budesonide hfa pmdi in African American individuals aged 12 and above, who have been diagnosed with asthma for at least 6 months and require treatment with an inhaled corticosteroid.",
    "This sample is a phase 3 trial for obesity, testing the drugs lorcaserin and matching placebo, with inclusion criteria including obese adults with a BMI of 30 to 45 kg/m2 or overweight adults with a BMI of 27 to 29.9 kg/m2 and at least one obesity-related comorbidity, and exclusion criteria including diabetes, pregnancy, history of heart valve disease, and serious or unstable medical conditions.",
    "This sample is a phase 3 clinical trial for head and neck cancer, testing the effectiveness of cisplatin, docetaxel, and 5-fluorouracil in combination with definitive radiotherapy for curatively resectable disease.",
    "This sample is a phase 2/phase 3 trial for patients with chronic lymphocytic leukemia, testing the effectiveness of bendamustine and fludarabine as second-line treatment for refractory or relapsed cases, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for type 1 diabetes mellitus, testing the effectiveness of technosphere\u00ae insulin with medtone c inhaler, technosphere \u00aeinsulin with gen2 inhaler, and insulin aspart in combination with a basal insulin in patients who meet specific eligibility criteria.",
    "This sample is a phase 3 trial for the treatment of psoriasis, testing the drug cp-690,550, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with rheumatoid arthritis who have not responded well to methotrexate, and it will test the effectiveness of methylprednisolone, methotrexate, and folic acid or folate compared to a placebo.",
    "This phase 3 trial is testing the effectiveness of avelox (moxifloxacin) compared to a placebo in male and female out-patients with chronic bronchitis and lung diseases, who are at least 45 years old, have a smoking history of at least 20 pack-years, and meet other inclusion criteria. Exclusion criteria include subjects with contra-indications to moxifloxacin, known bronchial carcinoma, pulmonary tuberculosis, cystic fibrosis, chronic bronchial asthma, or diffuse bronchiectasis.",
    "This sample is a phase 3 trial for patients with hypercholesterolemia, testing the effectiveness of mk0653a (ezetimibe [+] simvastatin) and various other statin drugs in lowering cholesterol levels, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for adults with Attention Deficit/Hyperactivity Disorder (ADHD), testing the effectiveness of methylphenidate hydrochloride as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with venous thromboembolism, testing the efficacy of dabigatran etexilate 150 mg twice daily (bid) compared to a matching placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with CD20-positive diffuse large B-cell lymphoma, testing the efficacy of a combination of drugs including rituximab, etoposide, carboplatin, and others, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for patients with major depressive disorder, testing the effectiveness of saredutant, escitalopram, and placebo as potential treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with atrial fibrillation, testing the effectiveness of dronedarone and amiodarone as antiarrhythmic treatments, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of rasburicase and allopurinol in preventing tumor lysis syndrome (TLS) in patients with high-risk or potential-risk diseases such as tumor lysis syndrome, cancer, and hyperuricemia. The eligibility criteria include having high-risk or potential-risk diseases, Eastern Cooperative Oncology Group (ECOG) performance status 0-3, age >= 18 years, life expectancy > 3 months, negative pregnancy test (females of childbearing potential), and signed written informed consent.",
    "This sample is a phase 3 trial testing the effectiveness of drospirenone/ethinylestradiol/methyltetrahydrofolate and drospirenone/ethinylestradiol (yaz) in preventing neural tube defects and contraception in healthy women between 18 and 40 years old, with specific exclusion criteria related to the use of steroidal oral contraceptives or drugs that could alter oral contraception metabolism.",
    "This sample is a phase 3 clinical trial for primary insomnia, testing the effectiveness of eszopiclone and placebo in improving sleep quality, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of hypercholesterolemia using lapaquistat acetate and stable statin therapy, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of droxidopa compared to placebo in patients with neurogenic orthostatic hypotension, non-diabetic autonomic neuropathy, multiple system atrophy, and dopamine beta hydroxylase deficiency, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of rheumatoid arthritis, testing the drug fostamatinib and a placebo, with specific eligibility criteria including the presence of certain symptoms and exclusion criteria such as pregnancy and liver disease.",
    "This sample is a phase 3 clinical trial for asthma, testing the effectiveness of various drugs including fluticasone furoate/vilanterol inhalation powder and fluticasone propionate/salmeterol inhalation powder, as well as placebos, on patients who meet specific inclusion criteria such as having a clinical diagnosis of asthma and currently using inhaled corticosteroid therapy.",
    "This phase 3 trial aims to evaluate the efficacy of the drugs mk-0524a, er niacin, and placebo in patients with hypercholesteremia and hyperlipidemia, based on specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for diabetic macular edema, testing the drug ranibizumab, and includes eligibility criteria such as specific visual acuity requirements and exclusion criteria such as prior laser treatments or uveitis.",
    "This sample is a phase 3 clinical trial for the treatment of fallopian tube cancer, ovarian cancer, and primary peritoneal cancer using drugs such as amg 386 and paclitaxel, with specific eligibility criteria for participants.",
    "This phase 3 trial is investigating the effectiveness of umeclidinium bromide and fluticasone propionate/salmeterol in treating chronic obstructive pulmonary disease (COPD) patients who are 40 years of age or older, have a history of smoking, and meet specific diagnostic criteria.",
    "The sample is a phase 3 clinical trial for Crohn's disease, testing the drug adalimumab, and includes inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for the treatment of type 2 diabetes mellitus, testing the drugs bi 10773, glimepiride, and placebos, with eligibility criteria including a diagnosis of type 2 diabetes, pre-treatment with metformin, specific HbA1c levels, age, and BMI, while excluding patients with uncontrolled hyperglycemia, recent cardiovascular events, liver disease, renal impairment, bariatric surgery, cancer history, blood disorders, hypersensitivity to drugs, or treatment with anti-obesity drugs.",
    "This sample is a phase 3 trial for kidney transplantation, testing different drug combinations including fty720, neoral, and corticosteroids, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the efficacy of desvenlafaxine succinate sustained release and placebo in treating vasomotor symptoms in generally healthy, postmenopausal women who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients under 21 with high-grade gliomas in first relapse, testing the effectiveness of carboplatin, etoposide, isotretinoin, and thiotepa as treatment options, with specific eligibility criteria including prior radiotherapy and certain health parameters.",
    "This sample is a phase 3 trial for narcolepsy patients, testing the drug sodium oxybate, and includes eligibility criteria such as having a history of excessive daytime sleepiness and cataplexy, as well as exclusion criteria such as taking certain medications or having certain medical conditions.",
    "This sample is a phase 3 clinical trial testing the effectiveness of casopitant, dexamethasone, placebo, and ondansetron in reducing nausea and vomiting caused by chemotherapy in patients with colorectal cancer.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of escitalopram as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for alcohol dependence, testing the effectiveness of ondansetron combined with cognitive behavioral therapy compared to a placebo combined with cognitive behavioral therapy, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial studying the use of certoparin and heparin in patients with embolism, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women, using drugs such as 50 mg qhs, 100 mg, and placebo, with eligibility criteria including a diagnosis of HSDD, a score of 15 or higher on the Female Sexual Distress Scale-Revised (FSDS-R), and willingness to try sexual activity at least once monthly.",
    "This sample is a phase 3 clinical trial testing the combination of carboplatin, glutathione, and paclitaxel in patients with various stages of fallopian tube, ovarian, and primary peritoneal cancer, who are scheduled to undergo chemotherapy treatment. The eligibility criteria include specific chemotherapy regimens, performance status, language proficiency, and certain blood test results. Exclusion criteria include pre-existing peripheral neuropathy, certain medical conditions, pregnancy or nursing, and prior chemotherapy treatment.",
    "This sample is a phase 3 clinical trial for patients with acute graft versus host disease (GVHD) who have undergone hematopoietic cell transplantation (HCT). The trial aims to evaluate the effectiveness of etanercept (Enbrel) in treating Grade I acute GVHD. The inclusion criteria include having undergone HCT, any age, and biopsy-proven Grade I acute GVHD. The exclusion criteria include pregnancy, active unresponsive infections, allergic reaction to etanercept, previous use of oral or intravenous steroids for GVHD treatment, use of etanercept for any other purpose, noncompliance with medications, and history of or current Grade II-IV GVHD.",
    "This sample is a phase 3 clinical trial for participants with essential hypertension, testing the efficacy of azilsartan medoxomil/placebo and azilsartan medoxomil - chlorthalidone as potential treatments, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with hepatitis C virus (HCV) genotype 1 or 4 who previously failed treatment with Peginterferon alfa-2a or peginterferon alfa-2b and Ribavirin (P/R). The study aims to evaluate the efficacy of asunaprevir, daclatasvir, peg-interferon alfa-2a, and ribavirin in treating HCV. The inclusion criteria include being \u2265 18 years old, having HCV RNA \u2265 10,000 IU/mL, and being seronegative for HIV and HBsAg. The exclusion criteria include prior treatment with HCV direct-acting antiviral (DATA), evidence of other chronic liver diseases, decompensated liver disease, hepatocellular carcinoma or other malignancies, uncontrolled diabetes or hypertension, and various abnormal laboratory values.",
    "This sample is a phase 2/phase 3 trial for HIV infections, testing the effectiveness of chloroquine phosphate and placebo in HIV-1 infected adults with specific inclusion and exclusion criteria.",
    "This study is a phase 2/phase 3 trial investigating the use of high dose multivitamin in patients with chronic kidney disease, cardiovascular disease, and death as the primary diseases, with specific eligibility criteria including age range, kidney transplant history, and calculated creatinine clearance.",
    "This sample is a phase 3 clinical trial for metastatic renal cell cancer, testing the effectiveness of bevacizumab, interferon alfa 2a, and placebo as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of exenatide once weekly, sitagliptin, pioglitazone, and placebos in combination with metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of esophagitis, reflux and esophagitis, peptic, using dexlansoprazole mr and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial investigating the use of lansoprazole and placebo in patients with gastroesophageal reflux and asthma, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for postmenopausal women with osteoporosis, testing the drug bazedoxifene (bza-20) and evaluating eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for the treatment of pharyngitis using amoxicillin pulsatile release multiparticulate sprinkle, with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of paliperidone palmitate injection and oral antipsychotics in reducing relapses and symptoms.",
    "This sample is a phase 3 clinical trial for the treatment of genotype 1 chronic hepatitis C in treatment-naive patients, using drugs such as ribavirin, telaprevir, and pegylated interferon alfa-2a, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the drugs abt-335, rosuvastatin calcium, and placebo on patients with mixed dyslipidemia, coronary heart disease, and dyslipidemia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for HIV-infected individuals with measurable HIV Neurocognitive Impairment (HNCI) who are considering initiating or changing their HAART regimens. The study aims to evaluate the safety and efficacy of FDA-approved antiretroviral therapy in improving neurocognitive function, with eligibility criteria including confirmed HIV infection, age 18 or older, and willingness to undergo lumbar punctures. Exclusion criteria include presence of serious illness, neurologic disorders other than HIV causing neurocognitive impairment, and active psychiatric disorders or substance use.",
    "This sample is a phase 3 clinical trial for prostate cancer patients at high risk for relapse, testing the effectiveness of a combination of drugs including bicalutamide, estramustine phosphate sodium, etoposide, flutamide, paclitaxel, luteinizing hormone releasing hormone [lhrh] agonist, and warfarin, with specific eligibility criteria for patients' disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 3 trial for patients with atrial fibrillation and stroke, testing the effectiveness of warfarin and dabigatran in reducing the risk of stroke and systemic embolism, with specific eligibility and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the drug nktr-118 and placebo in patients with opioid-induced constipation, who are receiving a stable maintenance opioid regimen for cancer-related pain. The eligibility criteria include having confirmed OIC symptoms and being on a stable opioid dose for at least 4 weeks.",
    "This sample is a phase 3 clinical trial for the treatment of insomnia and major depressive disorder using the drug eszopiclone, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the efficacy of various drugs including mometasone furoate combination mdi and fluticasone/salmeterol, with eligibility criteria including a diagnosis of asthma for at least 12 months and the use of medium or high daily doses of ICS.",
    "This sample is a phase 3 clinical trial for the treatment of sleep initiation and maintenance disorders, using the drugs eplivanserin and lormetazepam, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with locally advanced/metastatic non-small cell lung cancer, testing the efficacy of erlotinib, sunitinib, and placebo as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial testing the effectiveness of Sativex, a cannabinoid-based medication, compared to a placebo in treating neuropathic pain in patients with Type 1 or 2 diabetes mellitus and distal symmetrical diabetic neuropathy.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) to evaluate the efficacy of tiotropium and salmeterol compared to placebo in improving lung function and exercise capacity. The inclusion criteria include patients aged 40 or older with a diagnosis of COPD and specific spirometric criteria, while the exclusion criteria include patients with certain medical conditions or taking specific medications.",
    "This sample is a phase 3 trial for epilepsy, testing the effectiveness of Keppra XR in controlling seizures in subjects aged 12 to 75 years with inadequately controlled partial onset epilepsy, who are experiencing 2 to 40 seizures per 4-week period while on one or two standard AED(s).",
    "This sample is a phase 3 clinical trial for the treatment of type 2 diabetes, testing the drugs alogliptin and pioglitazone, alogliptin, and placebo, with eligibility criteria including a diagnosis of type 2 diabetes, inadequate glycemic control, and specific blood glucose and triglyceride levels.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug galantamine hydrobromide, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for heartburn, testing the effectiveness of esomeprazole, a heartburn medication, on individuals who experience heartburn at least 2 days a week and have responded to heartburn medication in the past.",
    "This sample is a phase 3 trial for bipolar disorder, testing the drugs asenapine, olanzapine, and placebo, with inclusion criteria requiring a DSMIV diagnosis of bipolar I disorder, current episode manic or mixed, and exclusion criteria excluding patients with unstable medical conditions or clinically significant laboratory abnormalities or patients who are rapid cyclers or have any other psychiatric disorder other than bipolar I disorder as a primary diagnosis.",
    "This sample is a phase 3 clinical trial for patients with colorectal cancer, testing the effectiveness of uft, usel/leucovorin, and krestin drugs in combination with surgery for eligible patients.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of a drug called aleglitazar compared to a placebo. The eligibility criteria include being over 18 years old, having type 2 diabetes mellitus, and being hospitalized for an ACS event.",
    "This sample is a phase 3 trial for melanoma, testing the drugs ipilimumab, placebo, and dacarbazine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for subjects with type 2 diabetes, testing the efficacy of insulin degludec/liraglutide and insulin degludec in combination with metformin, sulfonylurea, or glinides, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for patients with myocardial infraction, testing the drugs aliskiren and placebo, with eligibility criteria including left ventricular systolic dysfunction and stable doses of certain concomitant medications.",
    "This sample is a phase 3 trial for patients with overactive bladder, testing the drug fesoterodine fumarate, and includes inclusion and exclusion criteria for patient eligibility.",
    "In this phase 3 trial, the drug desvenlafaxine succinate (dvs) sr and placebo are being tested for their effectiveness in treating vasomotor symptoms in generally healthy, postmenopausal women who seek treatment for hot flushes, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of diabetic macular edema using ranibizumab, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of abatacept and methotrexate in treating rheumatoid arthritis, with specific eligibility criteria for participants, such as the presence of active clinical synovitis and a positive test result for anticyclic citrullinated peptides 2.",
    "This sample is a phase 3 clinical trial for patients with prostate cancer, testing the drug leuprolide acetate 22.5 mg depot, gp-pharm sa, to evaluate its effectiveness in reducing androgen levels for medical androgen deprivation therapy. The eligibility criteria include males \u226518 years of age with histologically documented prostate carcinoma, a life expectancy of at least 1 year, and a WHO/ECOG performance status of 0, 1, or 2.",
    "This sample is a phase 3 trial for patients with bipolar I disorder, testing the effectiveness of aripiprazole and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic hepatitis B and HIV infections, testing the efficacy of pegylated interferon alfa-2a, tenofovir df / emtricitabine combination therapy, and pegifn / tdf / ftc combination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of docetaxel, doxorubicin, and cyclophosphamide as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 trial aims to evaluate the effectiveness of bevasiranib and ranibizumab in treating macular degeneration, with specific eligibility criteria for patients to be included or excluded from the study.",
    "This sample is a phase 3 clinical trial for non-Hodgkin's lymphoma, testing the drug rituximab (mabthera/rituxan) in adult patients aged 60-75 with no previous treatment and active disease, with rapid progression. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 trial for the drug \"org 50081\" in patients with insomnia, with specific inclusion and exclusion criteria outlined in the criteria section.",
    "This phase 3 trial aims to evaluate the efficacy of desvenlafaxine (dvs sr) compared to placebo in peri- and postmenopausal women with major depressive disorder (MDD), using the Montgomery-Asberg Depression Rating Scale (MADRS) as the primary outcome measure.",
    "This sample is a phase 3 clinical trial for patients with sleep initiation and maintenance disorders and insomnia, testing the effectiveness of eplivanserin (sr46349) compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for dry eye syndrome, testing the efficacy of bromfenac ophthalmic solution A, bromfenac ophthalmic solution B, and a placebo comparator, with inclusion criteria of being 18 years or older and exclusion criteria of having any disease that could interfere with safety or efficacy assessment.",
    "This sample is a phase 3 trial for patients with rheumatoid arthritis, testing the drug abatacept. The eligibility criteria include completing previous studies, maintaining stable doses of concomitant medications, willingness to self-inject the study medication, and adherence to the study schedule. Exclusion criteria include starting certain treatments or therapies, having severe or uncontrolled medical conditions, abnormal laboratory test results, imprisonment or involuntary incarceration, and impairment or illiteracy.",
    "This sample is a phase 3 clinical trial for patients diagnosed with breast cancer who will receive their first cycle of non-cisplatin moderately emetogenic chemotherapy, and the study aims to evaluate the effectiveness of dexamethasone in preventing nausea and vomiting during chemotherapy.",
    "This phase 3 trial is testing the effectiveness of palifermin before and after high-dose Melphalan treatment in multiple myeloma patients undergoing autologous peripheral blood progenitor cell transplantation, with specific inclusion and exclusion criteria, and assessing visual status as an outcome measure.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C, testing the combination of pegylated interferon alfa-2b and ribavirin, with specific eligibility criteria including age, genotype, liver biopsy confirmation, and various hematological and biochemical criteria.",
    "This phase 3 trial is investigating the efficacy of pregabalin and placebo in treating generalized anxiety disorder (GAD) in adult subjects who have previously failed to respond to GAD treatment.",
    "This sample is a phase 3 clinical trial for patients with essential hypertension, testing the effectiveness of various angiotensin II receptor blockers (azilsartan medoxomil, valsartan, olmesartan) compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic hepatitis B and C, testing the efficacy of peginterferon alfa-2a plus ribavirin as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for patients with low-grade B-cell lymphoma, testing the effectiveness of rituximab in combination with standard chop or bi-weekly chop chemotherapy, with specific eligibility criteria including age, disease stage, and prior treatment history.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer (NSCLC) patients, testing the effectiveness of paclitaxel and carboplatin in combination with nov-002 injection compared to paclitaxel and carboplatin alone. The trial has specific inclusion and exclusion criteria, and patients must have a diagnosis of stage IIIb or stage IV NSCLC, an ECOG performance score of 0 or 1, and adequate bone marrow, hepatic, and renal function.",
    "This phase 3 trial is investigating the use of zoledronic acid in premenopausal or perimenopausal females with localized breast cancer, stage I or II, who are planning to undergo adjuvant chemotherapy for at least 6 months after surgery. The eligibility criteria include specific age range, hormone receptor status, renal function, bone mineral density, and prior concurrent therapies.",
    "This sample is a phase 3 clinical trial testing the effectiveness of traumeel s and placebo remedy in reducing pain and treating fractures of the neck of the femur, with specific inclusion and exclusion criteria for patient enrollment.",
    "This sample is a phase 3 clinical trial for participants with human immunodeficiency virus infection, testing the effectiveness of lopinavir/ritonavir, emtricitabine/tenofovir disoproxil fumarate, and raltegravir as antiretroviral therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of various drugs including mometasone furoate/formoterol fumarate combination mdi, mometasone furoate mdi, formoterol fumarate, and placebo, with eligibility criteria including age, duration of asthma, and specific medication usage.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of liraglutide, a GLP-1 receptor agonist, in combination with insulin therapy for patients with type 2 diabetes mellitus, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of pramipexole and placebo in patients with advanced idiopathic Parkinson's disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, schizoaffective disorder, or bipolar I disorder, testing the efficacy of aripiprazole compared to olanzapine, risperidone, or quetiapine in treating these conditions, with inclusion and exclusion criteria specified.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C, testing the efficacy of albumin interferon alfa-2b, peginterferon alfa-2a, and ribavirin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for the drug taranabant and placebo in patients with obesity, with specific inclusion and exclusion criteria related to BMI, comorbidities, and medical history.",
    "This phase 3 trial aims to evaluate the effectiveness of lurasidone and placebo in treating bipolar depression in patients who meet specific inclusion criteria, such as having a lifetime history of at least one bipolar manic or mixed manic episode and currently being treated with lithium or divalproex. The study also has exclusion criteria, such as subjects considered to be at imminent risk of suicide or injury to self, others, or property, and those with a clinically significant history of alcohol or substance abuse within the past 3 months or alcohol or substance dependence within the past 12 months.",
    "This phase 3 trial is investigating the effectiveness of pregabalin and placebo in treating peripheral neuropathic pain syndrome, including diabetic peripheral neuropathy and postherpetic neuralgia, in patients who have completed at least 4 daily pain diaries with an average pain score of \u22654 over the 7 days prior to randomization.",
    "This sample is a phase 3 trial for chronic bronchitis, testing the drugs moxifloxacin and azithromycin sr, with inclusion criteria including a diagnosis of chronic bronchitis, increased sputum production, dyspnea, cough, and at least two exacerbations of acute exacerbation of chronic bronchitis (AECB) in the past 12 months, and exclusion criteria including recent treatment with systemic antibiotics or a chest radiograph consistent with pneumonia.",
    "This sample is a phase 3 clinical trial for the treatment of uterine fibroids and anemia, using drugs such as proellex 25 mg and proellex 50 mg, with eligibility criteria including being female between the ages of 18 and 48, having a BMI between 18 and 39, and experiencing excessive menstrual bleeding.",
    "This phase 3 clinical trial is investigating the effectiveness of various drugs, including bicalutamide and docetaxel, in treating prostate cancer patients who have failed local treatments and have no evidence of disease, with specific eligibility criteria for age, performance status, hematopoietic, hepatic, renal, and cardiovascular conditions, as well as prior concurrent therapies.",
    "This sample is a phase 3 clinical trial for patients with metastatic prostate cancer, testing the effectiveness of oral satraplatin as a treatment option, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of torcetrapib/atorvastatin and atorvastatin in patients with coronary disease and diabetes mellitus, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with colorectal cancer and liver metastases, testing the effectiveness of various drugs (folfiri, folfox-4, folfiri-hd, folfox-7, folfirinox) in combination with eligibility criteria including histologically proven adenocarcinoma, unresectable metastases, and WHO performance status 0-1.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of thalidomide and dexamethasone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial testing the drugs cisplatin and etoposide for the treatment of metastatic germ cell cancer of the testes, with eligibility criteria including good-prognosis disease and no prior chemotherapy or radiotherapy.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis (RA) patients who are methotrexate inadequate responders, testing the efficacy of subcutaneous (sc) and intravenous (iv) abatacept as a treatment option.",
    "This sample is a phase 3 trial for the treatment of juvenile rheumatoid arthritis using abatacept and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with coronary artery disease, myocardial ischemia, and myocardial infraction. The trial involves the use of intravenous infusion of saline and has specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of alogliptin and metformin in reducing blood glucose levels, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with dementia of the Alzheimer's type, testing the effectiveness of memantine er compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for cystic fibrosis patients, testing the effectiveness of tobramycin inhalation powder and tobramycin solution for inhalation in improving lung function and reducing bacterial infection.",
    "This sample is a phase 3 trial for diabetes, specifically type 1 and type 2, testing the effectiveness of technosphere\u00ae insulin inhalation powder compared to usual care, with specific eligibility criteria for subjects including nonsmoking, BMI <42 kg/m2, and normal pulmonary function.",
    "This sample is a phase 3 clinical trial for the drug ziprasidone in patients with schizophrenia, with specific inclusion and exclusion criteria, and various medical conditions that would exclude subjects from the study.",
    "This sample is a phase 3 clinical trial for multiple sclerosis, testing the effectiveness of fampridine-sr compared to a placebo, with inclusion criteria including a confirmed diagnosis of multiple sclerosis and the ability to walk with or without an assistive device, and exclusion criteria including pregnancy, participation in other investigational drug trials, and previous treatment with 4-aminopyridine (4-AP).",
    "This sample is a phase 3 trial testing the effectiveness of simvastatin and placebo in treating pneumonia patients who have been on mechanical ventilation for more than 48 hours, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for multiple myeloma, testing the drugs \"a (thalidomide + dexamethasone)\" and \"b (placebo + dexamethasone)\". The inclusion criteria include having active multiple myeloma, measurable levels of myeloma paraprotein, and an ECOG performance status of 0, 1, or 2. The exclusion criteria include being pregnant or lactating, having peripheral neuropathy \u2265 grade 2, and having certain lab abnormalities.",
    "This phase 3 clinical trial aims to evaluate the efficacy of dalt\u00e9parine and chemotherapy in patients with metastatic pancreatic cancer, while ensuring they meet specific eligibility criteria such as having histologically confirmed adenocarcinoma of the pancreas, no progressive thrombo-embolic disease, and meeting certain patient characteristics like WHO performance status 0-2 and life expectancy > 12 weeks.",
    "This phase 3 trial aims to evaluate the effectiveness of valsartan and rosuvastatin in treating hypertension and hyperlipidemia, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for chronic insomnia, testing the efficacy of ramelteon and placebo in improving sleep latency and total sleep time, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of linagliptin and metformin as antidiabetic drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for Alzheimer's disease, testing the drug semagacestat, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with kidney neoplasms, testing the drugs axitinib and sorafenib as a second-line treatment option for metastatic renal cell cancer, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with hypercholesterolemia, testing the efficacy of ezetimibe, atorvastatin, and rosuvastatin in lowering cholesterol levels, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with melanoma and skin cancer, testing the effectiveness of cisplatin, dacarbazine, and vinblastine in combination with biochemotherapy, with specific eligibility criteria including age, performance status, hematopoietic, hepatic, renal, and other health conditions, and excluding prior immunotherapy, chemotherapy, concurrent steroids, and certain medications.",
    "This sample is a phase 3 trial for women with menorrhagia, testing the effectiveness of tranexamic acid tablets and placebo tablets in reducing heavy menstrual bleeding.",
    "This sample is a phase 3 trial for patients with critical limb ischemia, peripheral vascular disease, foot ulcers, and rest leg pain, testing the drug remodulin\u00ae (treprostinil sodium) injection for those with documented peripheral arterial disease and no planned interventional vascular procedures.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of lurasidone hcl as a treatment option. The inclusion criteria include meeting DSM-IV criteria for schizophrenia, being between 18 and 75 years old, and being in good physical health. The exclusion criteria include a history of alcohol or drug abuse, and any chronic organic disease of the CNS.",
    "This phase 3 trial is investigating the effectiveness of tapentadol, oxycodone, and placebo in treating non-malignant lower back pain, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with schizophrenia or bipolar disorder, testing the drug aripiprazole, and includes eligibility criteria for adolescent patients with these conditions.",
    "This sample is a phase 3 clinical trial for patients with advanced non-small-cell lung cancer (NSCLC) testing the effectiveness of docetaxel and cisplatin as treatment options. The eligibility criteria include specific disease stage, tumor size, performance status, and adequate organ function.",
    "This phase 3 trial is testing the effectiveness of darunavir (drv, tmc114), an antiretroviral drug, in simplifying and reducing toxicity of current HAART regimens for patients with HIV-1 infection, who have been on HAART for at least 24 weeks and have a plasma viral load < 50 copies/mL.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus and coronary heart disease, testing the efficacy of pioglitazone and glimepiride as antidiabetic therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with recurrent ovarian, primary peritoneal, or fallopian tube carcinoma, testing the effectiveness of carboplatin, gemcitabine, bevacizumab, and placebo as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for major depressive disorder, testing the drugs tasimelteon and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of liraglutide, glimepiride, and metformin in combination with oral antidiabetic drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C, testing the drugs boceprevir, peginterferon alfa-2b, ribavirin, and erythropoietin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis B using ribavirin and peginterferon alpha 2a, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with relapsed and advanced chronic lymphocytic leukemia (CLL), testing the effectiveness of fludarabine, cyclophosphamide, and mitoxantrone as treatment options.",
    "This sample is a phase 3 clinical trial for the treatment of seasonal allergic rhinitis using the drug \"gw685698x aqueous nasal spray\". The study includes inclusion and exclusion criteria, such as informed consent, outpatient status, diagnosis of seasonal allergic rhinitis, and exclusion of patients with significant medical conditions or allergies to the investigational product.",
    "This sample is a phase 3 trial testing the drug epoetin alfa for the treatment of anemia in patients with non-myeloid malignancy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial investigating the use of sodium bicarbonate and sodium chloride in cardiac surgical patients with risk factors for postoperative acute kidney injury. The trial includes specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial testing the effectiveness of clopidogrel (sr25990) and placebo in treating cyanotic congenital heart disease, with inclusion criteria including cyanotic congenital heart disease treated by any palliative systemic-to-pulmonary artery shunt, and exclusion criteria including active bleeding or increased risk of bleeding, allergy to 2 or more classes of drugs, inability to receive drug orally or enterically, and current clinically significant or persistent thrombocytopenia, neutropenia, severe hepatic or renal failure.",
    "This sample is a phase 3 trial for rheumatoid arthritis, testing the effectiveness of abatacept and placebo in patients who have failed anti-TNF therapy, with specific eligibility and exclusion criteria.",
    "This sample is a phase 3 trial for rheumatoid arthritis, testing the effectiveness of tocilizumab, placebo, and methotrexate in adult patients with inadequate response to methotrexate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic HBeAg negative hepatitis B, testing the drug peginterferon alfa-2a [pegasys] to evaluate its effectiveness in treating the disease.",
    "This sample is a phase 3 clinical trial testing the effectiveness of semuloparin sodium, enoxaparin sodium, and placebo in preventing venous thromboembolism in patients undergoing major abdominal surgery, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with idiopathic pulmonary fibrosis, lung disease, and pulmonary fibrosis, testing the drug interferon gamma-1b (\"actimmune\") to evaluate its effectiveness in treating the disease. The eligibility criteria include specific diagnostic findings, disease severity and progression, and exclusion criteria such as certain medical conditions and concomitant therapies.",
    "This sample is a phase 2/phase 3 trial for patients with inoperable advanced gastric adenocarcinoma, testing the efficacy of the drugs s-1 + irinotecan and irinotecan as second-line chemotherapy after first-line treatment with S-1 alone, S-1 + Cisplatinum, or S-1 + taxane.",
    "This sample is a phase 3 clinical trial for patients with inoperable locally advanced, recurrent, and/or metastatic gastric cancer. The trial focuses on patients with HER2-positive tumors and includes drugs such as trastuzumab, fluorouracil, cisplatin, and capecitabine. The eligibility criteria include age, tumor type, and exclusion of previous chemotherapy and certain medical conditions.",
    "This sample is a phase 3 trial for kidney transplantation and graft rejection, testing the drugs everolimus, mycophenolic acid (mpa), cyclosporine a (csa), basiliximab, and corticosteroids, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with relapsed ovarian cancer, testing the efficacy of treosulfan as a third regime study therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for pancreatic cancer, testing the drugs erlotinib and gemcitabine, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial testing the efficacy of estradiol/drsp (Angeliq, Bay86-4891) and placebo in Chinese postmenopausal women with moderate to severe vasomotor symptoms, excluding those with a history of steroid hormone dependent malignant disease, known or suspected malignant or premalignant disease, severe heart, liver, renal, or psychiatric disease, and hyperlipemia.",
    "This sample is a phase 2/phase 3 trial for patients with metastatic breast cancer, testing the drug capecitabine. The inclusion criteria include patients with previous treatment or no previous treatment with anthracyclines and/or taxanes, ambulatory patients with a functional ECOG < 2 status, and patients with at least one measurable lesion according to RECIST criteria. The exclusion criteria include patients with previous severe reactions to fluoropyrimidines or known sensitivity to 5-fluorouracil, patients previously treated with capecitabine, patients with organ transplants, and patients with certain diseases or severe affections such as convulsions, central nervous system diseases, psychiatric diseases, severe intellectual impairment, clinical significant cardiac disease, severe renal impairment, active infection, history of other neoplasias, and abnormal laboratory values.",
    "This phase 3 trial is investigating the effectiveness of erlotinib hydrochloride in treating high-risk stage I or stage II-IV ovarian, primary peritoneal, or fallopian tube cancer patients who have completed first-line therapy within the past 6 weeks and achieved a complete response, partial response, or stabilization of disease.",
    "This sample is a phase 3 clinical trial for postmenopausal osteoporosis, testing the effectiveness of risedronate in women aged 50 or older with low bone mineral density and vertebral fractures, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with breast cancer, testing the effectiveness of lapatinib and paclitaxel drugs in combination, with specific eligibility criteria including HER2 overexpression and certain health parameters.",
    "This sample is a phase 3 trial testing the effectiveness of the drug Rozerem compared to a placebo in treating insomnia and obstructive sleep apnea in patients over the age of 60, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for amyotrophic lateral sclerosis (ALSO) testing the drugs memantine (ebixa), riluzole, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for stroke patients, testing the effectiveness of candesartan cilexetil (AT1 receptor blocker) compared to placebo in reducing blood pressure within 30 hours of symptom onset, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with essential hypertension, testing the efficacy of a fixed dose combination of telmisartan+amlodipine and amlodipine in controlling blood pressure, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of montelukast sodium, fluticasone, and a placebo in participants with chronic asthma who smoke, and the study excludes participants with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) or emphysema.",
    "This sample is a phase 3 trial for patients with hypertension, testing the drugs aliskiren and ramipril, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic myeloid leukemia and acute lymphoblastic leukemia, testing the effectiveness of dasatinib as a treatment option for those who have resistance or intolerance to imatinib mesylate.",
    "This phase 3 trial aims to evaluate the efficacy of ferric citrate, a phosphate-binding agent, in patients with end-stage renal disease (ESRD) and hyperphosphatemia, who are on hemodialysis and meet specific inclusion criteria.",
    "This sample is a phase 2/phase 3 clinical trial for patients with locally advanced head and neck cancer, testing the effectiveness of two drug combinations (docetaxel, cisplatin, 5-fluorouracil (5-fu), radiotherapy and cisplatin, 5-fluorouracil (5-fu), radiotherapy) in combination with eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug rosiglitazone, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial is testing the effectiveness of dexamethasone and lenalidomide in treating previously untreated multiple myeloma patients, with specific eligibility criteria including disease stage, M-protein levels, and various patient characteristics.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of bevacizumab and bevacizumab with erlotinib as treatment options. The eligibility criteria include specific disease requirements, performance status, blood counts, and various medical conditions that must be met for participation.",
    "This sample is a phase 3 clinical trial for the treatment of migraine disorders and acute migraines, using the drugs treximet\u00ae, butalbital-containing combination medications (bcm), and placebo, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is investigating the use of loteprednol etabonate and its vehicle in subjects undergoing routine cataract surgery to treat ocular inflammation, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of lymphoma using the drugs bexarotene and methoxypsoralen, with specific eligibility criteria including disease stage, age, performance status, and various health parameters.",
    "This sample is a phase 3 clinical trial for the drug risperidone in patients with schizophrenia, with inclusion criteria including meeting DSM-IV criteria for schizophrenia and having a responsible person available for each visit, and exclusion criteria including mental retardation, substance dependence, low body weight, and inability to swallow oral tablets.",
    "This sample is a phase 3 clinical trial for the treatment of generalized anxiety disorder, testing the effectiveness of vortioxetine compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of post-stroke spasticity and cerebrovascular accident using the drugs gsk1358820 and placebo, with specific eligibility criteria for patients to be included in the study.",
    "This sample is a phase 3 clinical trial for patients with grass pollen-related allergic rhinoconjunctivitis, testing the effectiveness of three drugs (300 ir (4m), 300 ir (2m), and placebo) on symptoms and eligibility criteria include age, allergy history, specific IgE values, and symptom scores.",
    "This sample is a phase 2/phase 3 trial for patients with sarcoidosis and pulmonary arterial hypertension, testing the effectiveness of bosentan and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C, testing the drugs bi 201335, pegylated interferon-alpha, ribavirin, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial testing the effectiveness of dextromethorphan hydrobromide and quinidine sulfate in treating pseudobulbar affect (PBA) in patients with Amyotrophic Lateral Sclerosis (ALSO) or multiple sclerosis. The eligibility criteria include specific diagnoses and symptoms, as well as exclusion criteria related to heart conditions and drug sensitivities.",
    "This sample is a phase 3 trial for patients with histologically confirmed colon carcinoma, testing the effectiveness of capecitabine, oxaliplatin, leucovorin (lv), and 5-fluorouracil (5-fu) as adjuvant treatment after complete tumor resection.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of saxagliptin, glyburide, and metformin in controlling blood sugar levels, with specific inclusion criteria for eligibility.",
    "This sample is a phase 3 trial for narcolepsy patients who are currently taking stable doses of modafinil, and the trial will test the effectiveness of xyrem, xyrem placebo, modafinil at established dose, and modafinil placebo in treating their daytime sleepiness.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C, testing the effectiveness of drugs such as placebo, tmc435, peginterferon alpha-2a or peginterferon alpha-2b, and ribavirin. The eligibility criteria include having genotype 1 hepatitis C infection, no prior treatment for hepatitis C, recent liver biopsy confirming chronic hepatitis C infection, and agreement to use contraception during the study.",
    "This sample is a phase 3 trial for chronic myeloid leukemia, testing the drugs bosutinib and imatinib, with inclusion criteria including a cytogenetic diagnosis of chronic phase Ph+ CML diagnosed less than 6 months, and exclusion criteria including prior anti-leukemia treatment and prior stem cell transplant.",
    "This phase 3 trial aims to evaluate the efficacy of omiganan 1% gel and povidone-iodine 10% in preventing infection in patients with a new insertion of a noncuffed temporary central venous catheter, who are at least 13 years old and not pregnant. The study has various exclusion criteria, including prior treatment with certain antibiotics, requirement for topical antibiotic use near the catheterization site, and known severe neutropenia.",
    "This phase 3 clinical trial is investigating the effectiveness of a combination of drugs including doxorubicin hydrochloride, cytarabine, dexamethasone, pegaspargase, methotrexate, leucovorin calcium, mercaptopurine, cyclophosphamide, thioguanine, and vincristine sulfate in treating various types of childhood acute lymphoblastic leukemia, with specific eligibility criteria for patients to be enrolled in the study.",
    "This sample is a phase 3 clinical trial for patients with symptomatic atrial fibrillation, testing the effectiveness of omega-3-acid ethyl esters and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of cytomegalovirus infections in pediatric solid organ transplant recipients, using valganciclovir (Valcyte) as the study drug. The inclusion criteria include age range, type of transplant, ability to tolerate oral medication, and the need for contraception in females of childbearing potential. The exclusion criteria include previous participation in the study, participation in another clinical trial, severe uncontrolled diarrhea, and pregnancy or lactation.",
    "This sample is a phase 3 clinical trial for the treatment of glaucoma and ocular hypertension, testing the effectiveness of a triple combination therapy and a fixed combination solution, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with epilepsy and generalized tonic-clonic seizures, testing the drug levetiracetam, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the efficacy of mometasone furoate nasal spray (mfns) compared to a placebo nasal spray in subjects with allergic rhinitis, and the eligibility criteria include having a 2-year history of seasonal allergic rhinitis, positive skin prick test response to a seasonal allergen, and being clinically symptomatic at the screening and baseline visits.",
    "This sample is a phase 3 trial for the drug NKTR-118 (also known as naloxegol) and placebo in patients with opioid-induced constipation (OIC) who are on a stable maintenance opioid regimen. The inclusion criteria include having symptoms of OIC and confirmed diagnosis, while the exclusion criteria include cancer-related pain, recent history of cancer, and certain gastrointestinal conditions.",
    "This sample is a phase 3 clinical trial for patients with atherosclerosis, testing the effectiveness of glipizide and rosiglitazone maleate in combination with other anti-hyperglycemic therapies in improving glycemic control in patients with type 2 diabetes mellitus and coronary artery disease.",
    "This sample is a phase 3 trial for the treatment of scalp psoriasis using clobex shampoo 0.05% and clobex shampoo placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for polycystic ovarian syndrome, testing the effectiveness of cetrorelix acetate, recombinant human choriogonadotropin, and recombinant human follicle stimulating hormone in female subjects suitable for IVF/ICSI, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for diabetes, specifically type 1 diabetes, testing the effectiveness of insulin detemir and insulin aspart in patients who have completed 52 weeks of treatment with insulin detemir in a previous trial. The inclusion criteria include obtaining informed consent, while the exclusion criteria include significant concomitant diseases and pregnancy.",
    "This sample is a phase 3 clinical trial for patients with essential hypertension, testing the effectiveness of aliskiren/amlodipine and aliskiren/amlodipine/hctz drugs in reducing blood pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with prostate cancer, testing multiple drugs including degarelix and leuprolide, with eligibility criteria including completion of a previous study.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer, testing the combination of capecitabine and bevacizumab as first-line treatment, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of thalidomide and placebo drugs. The eligibility criteria include excluding patients who have previously been treated for multiple myeloma, require high dose chemotherapy with stem cell support, are women of fertile age, have psychiatric disease or mental reduction, lack consent, have a life expectancy below 3 months, or have active cancer of another etiology.",
    "This sample is a phase 3 trial for postmenopausal women with osteoporosis, comparing the effects of a test group and a reference group of drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is investigating the use of safinamide as an add-on therapy for patients with idiopathic Parkinson's disease who have been stable on a single dopamine agonist for at least 4 weeks, and the study includes eligibility criteria such as disease duration, age range, contraception requirements for female participants, exclusion criteria related to other Parkinsonism forms, substance abuse, and various medical conditions, as well as restrictions on previous treatments and medications.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung carcinoma, testing the effectiveness of zoledronic acid, taxotere, and carboplatin as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial is focused on patients with human immunodeficiency virus - type 1 (HIV-1) infection, and it will evaluate the effectiveness of darunavir (drv) and ritonavir (rtv) in patients who are not suitable for non-nucleoside reverse transcriptase inhibitors (NNRTIs) treatment.",
    "This sample is a phase 3 clinical trial for patients with major depressive disorder, testing the drug amibegron (sr58611a), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for postmenopausal women with locally advanced or metastatic breast cancer, testing the effectiveness of fulvestrant and exemestane, two drugs used in hormone therapy, after previous treatment with an aromatase inhibitor. The eligibility criteria include biopsy confirmation of breast cancer, evidence of hormone sensitivity, and written informed consent. Exclusion criteria include previous treatment with fulvestrant or exemestane, use of hormonal therapy for another medical condition after prior treatment with a non-steroidal aromatase inhibitor, and allergies to the active or inactive ingredients of the drugs.",
    "This sample is a phase 3 clinical trial for multiple myeloma, testing the drugs velcade, thalidomide, and dexamethasone, with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 3 clinical trial for Crohn's disease, testing the effectiveness of ustekinumab and placebo in patients who have not responded to or are intolerant to other medications, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug memantine hcl in patients with moderate to severe Alzheimer's disease who have a score greater than or equal to 4 on the agitation/aggression domain of NPI, and who have been on a stable dose of donepezil for 3 months. The study has exclusion criteria including other evidence of psychiatric disorders, oncologic diagnosis, and clinically significant gastrointestinal, renal, hepatic, endocrine or cardiovascular disease.",
    "This sample is a phase 3 clinical trial for the treatment of hepatocellular carcinoma (HCC) using the drugs thermodox and 5% dextrose solution, with specific eligibility criteria for patients with HCC lesions.",
    "This sample is a phase 3 clinical trial for HIV-1 infection, testing the efficacy of the drugs ftc/rpv/tdf, pi, rtv, and nrtis, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial testing the drug rivaroxaban for venous blood clot prevention in patients who have undergone elective total hip or knee replacement surgery and are currently prescribed enoxaparin. The study has specific inclusion and exclusion criteria, and the patients must be committed to remaining in the subacute unit for the duration of the study.",
    "This sample is a phase 3 clinical trial for relapsing remitting multiple sclerosis (RRMS) patients, testing a new formulation of rebif - human interferon beta-1a and interferon beta-1b drugs, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for osteoarthritis, testing the efficacy of different drugs including naproxcinod and naproxen, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for pain, with the disease being osteoarthritis and the drug being pregabalin, along with a placebo, and the eligibility criteria including age restrictions and prior use of certain medications.",
    "This sample is a phase 3 clinical trial for the treatment of skin diseases and soft tissue infections using drugs like daptomycin, vancomycin, and teicoplanin, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for the treatment of idiopathic pulmonary fibrosis, testing the effectiveness of the drugs pirfenidone and placebo. The eligibility criteria include specific age range, lung function requirements, ability to walk a certain distance, and exclusion criteria such as certain medical conditions and substance abuse.",
    "This sample is a phase 3 trial for patients with primary hypercholesterolemia or mixed dyslipidemia, testing the effectiveness of simvastatin, niacin (+) laropiprant, and atorvastatin calcium as drugs, with specific inclusion and exclusion criteria based on LDL-C values.",
    "This sample is a phase 3 clinical trial for patients with bipolar I disorder, testing the drug cariprazine, and includes inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with generalized anxiety disorder, testing the effectiveness of quetiapine fumarate as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with atrial fibrillation, testing the effectiveness of apixaban and acetylsalicylic acid in preventing stroke, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for individuals with hypercholesterolemia, testing the effectiveness of rosuvastatin, a lipid-lowering therapy, in reducing LDL-C levels, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial is testing the drug docetaxel in patients with unresectable non-small cell lung cancer, who meet specific eligibility criteria, including age, performance status, and absence of brain metastases.",
    "This sample is a phase 3 clinical trial testing the effectiveness of melatonin and placebo in treating anorexia and cachexia in patients with gastrointestinal cancer or lung cancer who have experienced involuntary weight loss, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of quetiapine extended release and risperidone in treating patients with schizophrenia or schizoaffective disorder who also have baseline depressive symptoms.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of paliperidone palmitate, and includes inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) in children aged 6 to 16 years old, where the eligibility criteria include a diagnosis of ADHD according to DSM IV, being pharmacological na\u00efve, having normal intelligence, and providing informed consent. The exclusion criteria include a history of bipolar disorder, psychosis, autism spectrum disorder, seizure disorder, significant medical conditions, alcohol or drug abuse, and concurrent use of excluded medications in the study. The drugs being tested are atomoxetine and other standard therapy for ADHD.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of melphalan/prednisone/velcade and thalidomide/prednisone/velcade as induction treatments. The eligibility criteria include being over 65 years old, recently diagnosed with symptomatic multiple myeloma, having measurable disease, and meeting certain laboratory values. Exclusion criteria include previous treatment for multiple myeloma, non-secretor myeloma, and certain medical conditions.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec and insulin glargine in combination with other diabetes medications, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug retigabine ir in patients with epilepsy, specifically those with partial-onset seizures, who meet certain inclusion criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of inhaled insulin as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using the drugs paliperidone and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with essential hypertension, testing the effectiveness of aliskiren, valsartan, and hydrochlorothiazide (hctz) as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for pancreatic cancer, testing the drugs fluorouracil, gemcitabine hydrochloride, and liposomal cisplatin, with eligibility criteria including histologically confirmed adenocarcinoma of the pancreas and specific patient characteristics.",
    "This sample is a phase 3 clinical trial for kidney transplantation, focusing on patients between 18 and 60 years old with end-stage kidney disease. The study will test the effectiveness of tacrolimus as a medication for these patients, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for HIV-1 patients, testing the drugs TMC278 and efavirenz, with specific inclusion and exclusion criteria, such as viral load, previous ARV drug use, and kidney impairment.",
    "This sample is a phase 3 trial testing the effectiveness of fondaparinux 2.5mg or placebo in treating acute symptomatic superficial thrombophlebitis of the lower limbs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for surgically incurable melanoma patients, testing the drugs dacarbazine, cp-675,206, and temozolomide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with gastrointestinal stromal tumor (GIST), testing the effectiveness of imatinib mesylate as a treatment option. The eligibility criteria include having a histologic diagnosis of primary GIST, undergoing complete gross resection of the tumor, and meeting certain laboratory values. Patients who have received post-operative chemotherapy, radiation therapy, or investigational treatment, as well as those with active infections or residual disease, are excluded from the study.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) using various drugs including ff/vi 100/25 inhalation powder ndpi, fluticasone propionate/salmeterol 250/50 inhalation powder accuhaler/diskus, and salbutamol as needed. The eligibility criteria include age, clinical history of COPD, lung function measurements, smoking history, and exclusion criteria such as asthma, other respiratory disorders, and uncontrolled diseases.",
    "This phase 3 clinical trial is testing the effectiveness of chlorambucil and fludarabine phosphate in treating Waldenstr\u00f6m macroglobulinemia, splenic lymphoma with villous lymphocytes (SLVL), or non-IgM lymphoplasmacytic lymphoma. Eligible patients must have previously untreated disease and meet specific criteria related to their disease characteristics and patient characteristics.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the effectiveness of folate, vitamin B6, and vitamin B12 in patients who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of vildagliptin, gliclazide, and metformin in combination with stable metformin dose, specific blood glucose criteria, and a BMI range of 22-45. The study has exclusion criteria such as pregnancy, lactation, type 1 diabetes, significant diabetic complications, serious cardiovascular complications, and abnormal laboratory values.",
    "This phase 3 trial is investigating the effectiveness of synvisc, bupivicaine, and kenalog injections in treating osteoarthritis in the carpometacarpal joint, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer (NSCLC) who have previously been treated with platinum-containing chemotherapy. The drug being tested is pemetrexed, and the eligibility criteria include limitations on prior systemic anti-cancer therapies and radiation therapy. Exclusion criteria include pregnancy, breastfeeding, and the inability to interrupt certain medications.",
    "This sample is a phase 3 trial for male subjects with chronic constipation, testing the effectiveness of prucalopride and placebo drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for lupus nephritis, testing the drugs mycophenolate mofetil, cyclophosphamide (maintenance and induction phases), and prednisone, with inclusion criteria of adult patients with a diagnosis of systemic lupus erythematosus and lupus nephritis (class III, IV or V), and exclusion criteria of recent cytotoxic drug use, systemic infections, and hepatitis B or C, or HIV.",
    "This sample is a phase 3 clinical trial testing the drug telmisartan (micardis\u00ae) versus placebo in patients with metabolic syndrome x, who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for osteoporosis, testing the effectiveness of alendronate and placebo in postmenopausal women or men over 60 years old with low bone density or previous vertebral fractures, who have been on bisphosphonate treatment for at least four years and have a minimum 30% risk of hip and vertebral fractures.",
    "This sample is a phase 3 trial for obesity and type 2 diabetes, testing the drug vi-0521, with specific eligibility criteria including BMI, blood pressure, triglyceride levels, metabolic criteria, and waist circumference.",
    "This phase 3 trial is testing the effectiveness of sorafenib, carboplatin/paclitaxel, and placebo in treating patients with unresectable or metastatic melanoma who have progressed after receiving at least one cycle of DTIC or TMZ containing regimen.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of phenoxodiol, carboplatin, and placebo in treating patients with fallopian tube cancer, peritoneal neoplasms, and ovarian cancer who have undergone previous platinum therapy and have relapsed within 6 months. The study includes eligibility criteria such as histologically-confirmed carcinoma, measurable disease, and adequate physiological and hematological function. Exclusion criteria include mucinous histological type, lack of response to prior platinum therapy, active infection, and certain medical conditions.",
    "This sample is a phase 3 trial for the treatment of opioid-induced constipation (OIC) using the drugs nktr-118 and usual care, with specific inclusion and exclusion criteria for patient enrollment.",
    "This sample is a phase 3 trial for individuals with type 2 diabetes, testing the effectiveness of dapagliflozin, metformin, and placebo in improving glycemic control, with specific eligibility criteria related to age, diabetes duration, medication use, C-peptide levels, body mass index, and renal function.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using the drug paliperidone er, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the effectiveness of vilanterol and salmeterol inhalation powders compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with genotype 1 hepatitis C infection, testing the effectiveness of drugs such as placebo, tmc435, peginterferon alpha-2a, and ribavirin in combination with eligibility criteria including prior treatment history, liver biopsy results, and contraception requirements.",
    "This sample is a phase 3 clinical trial for patients with squamous cell carcinoma of the thoracic esophagus, testing the effectiveness of neoadjuvant chemotherapy (cisplatin, 5-fluorouracil) in improving outcomes.",
    "This sample is a phase 3 clinical trial for patients with atherosclerosis and kidney failure, testing the effectiveness of tacrolimus, mycophenolate mofetil, prednisone, and sirolimus in preventing transplant rejection in patients with a history of dialysis, diabetes, hypertension, or vascular disease, while excluding patients with malignancy, non-renal organ transplant, active gastrointestinal disease, HIV, hepatitis B or C infection, and pregnant or breastfeeding women.",
    "This sample is a phase 3 clinical trial for Chinese patients with type 2 diabetes mellitus, testing the combination of glimepiride and metformin hydrochloride as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for relapsing-remitting multiple sclerosis (RRMS) patients, testing the effectiveness of the drug bg00012 compared to a placebo, with specific eligibility criteria including a confirmed diagnosis of RRMS according to McDonald criteria and a baseline EDSS between 0.0 and 5.0.",
    "This sample is a phase 2/phase 3 trial testing the drugs nucleomaxx and nucleomaxx placebo in HIV-infected individuals with lipoatrophy, and the eligibility criteria include having stable ART containing zidovudine or stavudine for at least 12 consecutive weeks prior to study entry, viral load of 5,000 copies/ml or less, and lipoatrophy in specific areas of the body.",
    "This sample is a phase 3 trial for obesity, testing the drugs sibutramine hydrochloride and placebo, with eligibility criteria including a BMI of 27-45 kg/m(2) or a BMI of 25-27 kg/m(2) with a waist circumference above a certain threshold, and medical history positive for preexisting cardiovascular disease or type 2 diabetes mellitus with at least one other risk factor.",
    "This sample is a phase 3 trial for patients with mild to moderate asthma, testing the effectiveness of budesonide/formoterol, an inhaled corticoid-steroid medicine, in improving current asthma treatment.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes and inadequate glycemic control, testing the drugs dapagliflozin and placebo, with inclusion criteria including a clinical diagnosis of moderate renal impairment and exclusion criteria such as severely uncontrolled diabetes and unstable or serious cardiovascular, hepatic, hematological, oncological, endocrine, psychiatric, or rheumatic diseases.",
    "This sample is a phase 3 clinical trial for patients with chronic kidney disease, testing the effectiveness of the drugs placebo and ast-120 in improving kidney function and reducing proteinuria, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for patients with relapsing-remitting multiple sclerosis (RRMS), testing the effectiveness of rebif\u00ae new formulation (ifn-beta-1a, rnf) compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for epilepsy patients with simple partial seizures or complex partial seizures, testing the effectiveness of lacosamide as a second antiepileptic drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the drug cariprazine. The inclusion criteria include patients meeting the DSM-IV-TR criteria for schizophrenia, while the exclusion criteria exclude patients with other psychotic disorders.",
    "This sample is a phase 3 clinical trial for osteoporosis, testing the drugs tibolone and placebo, with specific inclusion and exclusion criteria for postmenopausal women aged 60 to 85 years, and screening requirements for bone mineral density and other medical conditions.",
    "This sample is a phase 3 clinical trial for patients with persistent bronchial asthma, testing the drug ciclesonide (xrp1526) and evaluating eligibility criteria such as age, history of asthma, medication use, lung function, and exclusion criteria including other pulmonary diseases, steroid use, and pregnancy.",
    "This sample is a phase 3 clinical trial testing the effectiveness of ospemifene 60 mg and placebo in treating vaginal atrophy in naturally or surgically menopausal individuals with an intact uterus, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for females with locally advanced or metastatic breast cancer who have received prior anthracycline therapy, and it evaluates the efficacy of docetaxel and doxil as treatment options.",
    "This phase 3 trial is investigating the effectiveness of buprenorphine transdermal system and placebo in treating low back pain, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for subjects with type 2 diabetes mellitus, testing the effectiveness of insulin glulisine in combination with stable oral antidiabetic therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with metastatic breast cancer, testing the efficacy of capecitabine and vinorelbine tartrate as treatment options, with specific eligibility criteria including prior taxane treatment and hormone receptor status.",
    "This phase 3 trial is investigating the effectiveness of various drugs, including carboplatin, cisplatin, and paclitaxel, in treating breast cancer patients who have undergone breast conserving surgery or modified radical mastectomy. The eligibility criteria include specific disease characteristics, such as histologically proven adenocarcinoma of the breast with involved axillary and/or intramammary lymph nodes, as well as patient characteristics, such as age, sex, and performance status.",
    "This sample is a phase 3 clinical trial for the drug paliperidone er in patients with schizophrenia, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) testing the effectiveness of dexmethylphenidate, mixed amphetamine salts, er, and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of drugs such as gsk573719/gw642444 and tiotropium bromide, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of cobi, rtv, atv, ftc/tdf, cobi placebo, and rtv placebo in treating HIV and HIV infections, with specific eligibility criteria including plasma HIV-1 RNA levels, prior antiretroviral drug use, genotype sensitivity, renal and hepatic function, and contraception methods, among others.",
    "This phase 3 trial is testing the effectiveness of ustekinumab, a drug used to treat psoriatic arthritis, compared to a placebo, in patients who have had a documented diagnosis of psoriatic arthritis for at least 6 months and have active PsA with at least 5 tender and 5 swollen joints at baseline.",
    "This sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) patients, testing the efficacy of mometasone furoate/formoterol (mf/f) combination and mometasone furoate mdi (mf mdi) compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with metastatic breast cancer, testing the drug paclitaxel. The inclusion criteria include written informed consent, measurable and/or evaluable disease, and normal cardiac function. The exclusion criteria include peripheral neuropathy > grade 2 and adjuvant taxane-based therapy.",
    "This sample is a phase 3 trial that focuses on childhood cancer, aplastic anemia, and metabolic disorders. The study involves the use of heparin and normal saline in patients with a diagnosis requiring a CVC for chemotherapy, blood product support, or hematopoietic stem cell transplantation. Thrombophilia, bleeding disorders, and previous complications with CVC are exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of diabetic neuropathy, testing the drugs cg5503 and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with chronic hepatitis C, testing the efficacy of peginterferon alfa-2b plus ribavirin as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug paliperidone er in patients with schizophrenia, with specific inclusion and exclusion criteria, and focuses on patients aged 65 years or older.",
    "This sample is a phase 3 trial for patients with hypertension, testing the effectiveness of nebivolol and metoprolol er in reducing blood pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of vascular dementia and mixed dementia using the drug donepezil, with inclusion criteria requiring subjects to meet DSM-IV-TR criteria for the clinical diagnosis of Vascular Dementia or dementia due to multiple etiologies, and exclusion criteria excluding subjects with any current primary psychiatric diagnosis other than dementia of the Alzheimer's type or Vascular Dementia.",
    "This sample is a phase 3 clinical trial for essential hypertension, testing the drugs xoma 985, amlodipine besylate, and perindopril erbumine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for depressive disorder, major, testing the drugs dvs sr and paroxetine, with eligibility criteria including a primary diagnosis of MDD and a HAM D17 total score \u226520.",
    "This sample is a phase 3 trial for the management of moderate to severe malignant or nonmalignant pain in male and female patients aged 6 to 17 years, who completed a 4-week study drug treatment with oxycodone hydrochloride controlled-release tablets. The eligibility criteria include tolerating the oxycodone therapy, willingness to swallow the tablets whole, and exclusion criteria include ongoing adverse events, pregnancy or lactation, contraindications for opioids, and allergies to oxycodone or other opioids.",
    "This sample is a phase 3 clinical trial for ulcerative colitis, testing the drugs colal-pred\u00ae and prednisolone, with inclusion criteria including endoscopically confirmed diagnosis and a Disease Activity Index score of 6-10. Exclusion criteria include previous colonic surgery and other treatments for ulcerative colitis that have not been stabilized.",
    "This sample is a phase 3 clinical trial for multiple sclerosis, testing the drugs teriflunomide and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for multiple sclerosis, testing the effectiveness of the drugs laquinimod, placebo, and interferon \u03b2-1a (avonex\u00ae) in patients who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for amyotrophic lateral sclerosis (ALSO) patients, testing the drugs mci-186 and placebo of mci-186, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for small cell lung cancer with extensive disease, testing the effectiveness of topotecan + cisplatin and etoposide + carboplatin as first-line treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for chronic kidney disease, testing the drug zemplar, with inclusion criteria of eGFR 15-59 ml/m2 and exclusion criteria of current vitamin D treatment.",
    "This sample is a phase 3 trial for patients with rheumatoid arthritis who have had an inadequate response to DMARD treatment, and it involves the drugs rituximab, methotrexate, and methylprednisolone. The inclusion criteria include adult patients aged 18-80 with active disease, while the exclusion criteria include concurrent treatment with any DMARD or antiTNF-alfa and recent bone/joint surgery.",
    "This sample is a phase 3 trial for patients with acute asthma attacks, testing the effectiveness of montelukast sodium compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) using drugs such as ldx 30 mg, ldx 50 mg, ldx 70 mg, and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of lenalidomide and bortezomib in treating newly diagnosed multiple myeloma patients who have not received prior chemotherapy or radiotherapy to a large area of the pelvis, and have not been treated with bortezomib or lenalidomide before.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer (NSCLC) patients with adenocarcinoma histology, testing the effectiveness of gefitinib, carboplatin, and paclitaxel as treatment options. The eligibility criteria include locally advanced Stage IIIB or Stage IV NSCLC, with a preference for never smokers or light ex-smokers.",
    "This sample is a phase 3 clinical trial for patients with renal cell cancer, testing the effectiveness of capecitabine, interferon, and interleukin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of the drugs ckd-501 0.5mg and pioglitazone 15mg, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with moderate to severe ankylosing spondylitis, testing the effectiveness of rituximab, a drug used to treat certain autoimmune diseases, in reducing disease activity. The eligibility criteria include age range, disease severity, and stable use of certain medications, while the exclusion criteria include other chronic inflammatory diseases, infections, immunodeficiency, and certain medical conditions.",
    "This sample is a phase 3 trial for patients with primary hepatocellular carcinoma, testing the drug pi-88 against a placebo, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for breast cancer patients who have undergone preoperative chemotherapy, with the inclusion criteria including complete resection of the tumor and axillary node involvement, and the exclusion criteria including prior treatment with bisphosphonates and concurrent treatment with other experimental drugs or anti-cancer therapy. The drug being tested in this trial is zoledronic acid.",
    "This sample is a phase 3 clinical trial for patients with colorectal cancer, testing the effectiveness of capecitabine, fluorouracil, leucovorin calcium, and oxaliplatin in combination chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for ovarian cancer and primary peritoneal cavity cancer, testing the drugs cisplatin and paclitaxel, with eligibility criteria including specific disease characteristics and patient characteristics such as age, performance status, and various laboratory values.",
    "This sample is a phase 3 trial for iron-deficiency anemia, testing the drug ferric carboxymaltose, and includes eligibility criteria such as specific disease types, previous chemotherapy treatment, and certain laboratory values.",
    "This sample is a phase 3 clinical trial for participants with schizophrenia, testing the effectiveness of paliperidone palmitate and risperidone as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with ocular hypertension, testing the drug bimatoprost to lower intraocular pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with Stage II hypertension, testing the effectiveness of aliskiren/hydrochlorothiazide and aliskiren in reducing blood pressure. The eligibility criteria include age, blood pressure levels, and exclusion of certain medical conditions.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of cisplatin, gemcitabine hydrochloride, and paclitaxel in treating patients with cervical cancer who have metastatic or recurrent disease, or persistent disease after surgery or radiotherapy. Eligibility criteria include a diagnosis of primary carcinoma of the cervix, measurable disease, Zubrod performance status of 0-1, and certain renal and other health requirements. Prior concurrent therapy restrictions apply.",
    "This sample is a phase 3 trial for patients with bone marrow disease and pain, testing the drugs fentanyl, emla, l.m.x4, and propofol for bone marrow aspiration and lumbar puncture procedures in children aged 2 to 17 years with acute lymphoblastic leukemia or lymphoblastic lymphoma in remission or on the day of anticipated remission procedures.",
    "This sample is a phase 3 trial for patients with gastroesophageal reflux disease, testing the effectiveness of dexlansoprazole MR in treating the condition, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for postmenopausal osteoporosis, testing the drugs arzoxifene and raloxifene, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the efficacy of ly2216684, placebo, and selective serotonin reuptake inhibitors (SSRIs) in patients who have had a partial response to SSRI treatment, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with Parkinson's disease, testing the drug e2007. The study aims to evaluate the drug's effectiveness in reducing motor fluctuations and improving symptoms in patients with idiopathic PD who have a good response to levodopa.",
    "This sample is a phase 3 trial for the drug esomeprazole in patients with gastroesophageal reflux disease (GERD), with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for prostate cancer patients with locally advanced disease or at high risk for relapse, testing the effectiveness of bicalutamide, goserelin acetate, docetaxel, estramustine phosphate sodium, and acetylsalicylic acid as treatment options. Eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 clinical trial for patients with atrial fibrillation, testing the effectiveness of dronedarone and placebo in maintaining AF without efforts to restore sinus rhythm, with inclusion criteria including risk factors such as coronary artery disease, prior stroke, symptomatic heart failure, and exclusion criteria including paroxysmal AF and heart failure of NYHA class IV or recent unstable NYHA class III.",
    "This sample is a phase 3 trial for patients with type 2 diabetes and hyperlipidemia, testing the effectiveness of colesevelam hcl, rosiglitazone maleate, and sitagliptin phosphate in combination with metformin monotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C, testing the drugs rebetol and copegus, and includes eligibility criteria such as previous untreated adults with HCV RNA positive, genotype 1, compensated liver disease, and specific laboratory results.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of aclidinium bromide, tiotropium, and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for individuals with impaired glucose tolerance and diabetes, testing the drug Avandamet (rosiglitazone 2mg/metformin 500mg) bid, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with severe Alzheimer's type dementia, testing the effectiveness of galantamine hydrobromide in improving memory and cognitive functions, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the effectiveness of lorazepam, a drug used to treat status epilepticus and convulsions, in children who have not received any anti-convulsant therapy within 1 hour of presentation.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of alogliptin and metformin in combination with specific diet and exercise therapies, with inclusion and exclusion criteria related to metformin use and history of lactic acidosis.",
    "This sample is a phase 3 trial for patients with relapsing-remitting multiple sclerosis, testing the effectiveness of interferon beta-1b (betaseron, bay86-5046) in reducing symptoms, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of anagliptin and a placebo of anagliptin in controlling blood glucose levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for non-constipation irritable bowel syndrome, testing the effectiveness of rifaximin and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of dapagliflozin and metformin in achieving glycemic control, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus and renal insufficiency, testing the effectiveness of the drug bi 10773 compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of painful diabetic neuropathy, testing the efficacy of eslicarbazepine acetate (bia 2-093) compared to a placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for breast neoplasms, testing the effectiveness of different drug combinations (doxorubicine + docetaxel sequential, doxorubicine + cyclophosphamide sequential, doxorubicine + cyclophosphamide combined, doxorubicine + docetaxel combined) in eligible patients who meet specific inclusion criteria, such as having histologically proven breast cancer, normal cardiac function, and meeting certain laboratory requirements.",
    "This phase 3 clinical trial is investigating the effectiveness of carboplatin, cisplatin, docetaxel, and fluorouracil in treating patients with stage III or IV squamous cell carcinoma of the head and neck, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial testing the effectiveness of nitazoxanide and vancomycin in treating clostridium infections, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec and insulin glargine in combination with other diabetes medications, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of keratoconjunctivitis sicca and dry eye disease using the drugs lifitegrast and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of depressive disorder, major using the drugs duloxetine and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for gout patients, testing the effectiveness of febuxostat and allopurinol in reducing serum urate levels, with specific inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of lantus, metformin, glyburide, and thiazolidinedione in combination with stable doses of two oral antidiabetic drugs, Avandia or Actos, for at least three months. The study includes patients between 18-79 years old and excludes those with major cardiovascular events.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of alogliptin and metformin in improving glycemic control, with specific eligibility criteria including stable metformin monotherapy, BMI range, C-peptide concentration, HbA1c range, blood pressure, liver and kidney function, and exclusion criteria such as certain medical conditions, prior treatments, and medication restrictions.",
    "This sample is a phase 3 clinical trial testing the effectiveness of semuloparin sodium, enoxaparin sodium, and placebo in preventing venous thromboembolism in patients undergoing elective total hip replacement surgery or revision. The eligibility criteria include exclusion of patients with recent major orthopedic surgery, history of deep vein thrombosis or pulmonary embolism, high risk of bleeding, allergy to heparin or enoxaparin, contra-indications to venography, and end stage renal disease or on dialysis.",
    "The sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of metformin, sulphonylurea, and saxagliptin in combination with stable doses of metformin for at least 8 weeks, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer, testing the efficacy of regorafenib and placebo as treatment options, with specific eligibility criteria including prior treatment failure and measurable disease.",
    "This sample is a phase 3 trial for diabetes mellitus, testing the drugs syr-472, alogliptin 25 mg, and placebo, with inclusion criteria including being an outpatient and signing an informed consent form, and exclusion criteria including serious cardiac, cerebrovascular, pancreatic, or hematological diseases.",
    "This sample is a phase 2/phase 3 trial testing the drug simvastatin 20 mg/ezetimibe in moderately obese individuals with hyperlipidemia, with exclusion criteria including recent unstable heart or lung condition, current use of other lipid modifying drugs, hepatic disease, and pregnancy or lactation.",
    "This sample is a phase 3 clinical trial for psoriasis, testing the efficacy of calcipotriene foam and vehicle foam in treating moderate plaque-type psoriasis on the body and scalp, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with locally advanced or metastatic non-squamous lung cancer who have the ALK gene translocation or inversion. The study aims to evaluate the efficacy and safety of a treatment regimen, and includes eligibility criteria such as no prior systemic treatment, signed informed consent, and ability to comply with study procedures. Exclusion criteria include current participation in another clinical trial, prior therapy targeting ALK, and certain medical conditions.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of canagliflozin, metformin, and sulphonylurea drugs in combination with specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for breast cancer patients with ductal carcinoma in situ (DCIS) of the breast. The drug being tested is tamoxifen citrate, and the eligibility criteria include specific disease characteristics and patient characteristics.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the drug vildagliptin. The inclusion criteria include a diagnosis of type 2 diabetes for at least 6 months, meeting blood glucose criteria, and having a BMI in the range of 22-40. The exclusion criteria include a history of type 1 diabetes, use of certain medications, significant concomitant diseases or complications of diabetes, and high fasting triglycerides.",
    "This sample is a phase 3 trial testing the effectiveness of ibuprofen and placebo in treating fever secondary to an uncomplicated acute viral or bacterial infection, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with essential hypertension, testing the drug aliskiren/amlodipine/hydrochlorothiazide, and includes eligibility criteria such as specific blood pressure ranges and discontinuation of prior antihypertensive medications.",
    "This sample is a phase 3 trial for the treatment of obesity and overweight, using the drugs naltrexone sr 32 mg/ bupropion sr 360 mg/ day and placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with pulmonary arterial hypertension (PAH) and it is testing the efficacy of macitentan (act-064992) and placebo in improving symptoms and exercise capacity.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the effectiveness of abatacept compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the effectiveness of memantine and a placebo pill in patients aged 50-95 who meet specific inclusion criteria, with exclusion criteria including a history of stroke, neurological or medical conditions causing disability, Parkinson's disease, and various psychiatric disorders.",
    "This sample is a phase 3 trial for renal transplantation, testing the drugs cyclosporine, daclizumab, mycophenoate mofetil, prednisolone, and sirolimus, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the drug ambrisentan in patients with pulmonary arterial hypertension, with inclusion criteria including completion of previous studies and signed informed consent, and exclusion criteria including recent use of certain medications and presence of certain diseases.",
    "This sample is a phase 3 clinical trial for individuals with Down syndrome and Alzheimer's disease, testing the effectiveness of alpha-tocopherol (vitamin E) compared to a sugar pill, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for postmenopausal women with symptoms of menopause and postmenopausal vaginal atrophy, testing the effectiveness of estradiol, 10 mcg, in alleviating urogenital symptoms.",
    "This sample is a phase 3 trial for patients with candidemia, testing drugs such as vfend\u00e2\u00ae i.v., oral, conventional amphotericin b, and diflucan iv, oral, with inclusion criteria being patients with candidemia and exclusion criteria being neutropenia.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of indacaterol and long-acting beta2-agonist drugs in combination with current COPD bronchodilator treatment. The inclusion criteria include a diagnosis of moderate-to-severe COPD and specific lung function measurements, while the exclusion criteria include a history of asthma, current treatment with tiotropium, certain cardiovascular comorbid conditions, and diabetes Type I or uncontrolled Type II.",
    "This sample is a phase 3 clinical trial for patients with liver cirrhosis and chronic hepatitis C, testing the effectiveness of peginterferon alfa-2a and ribavirin in treating the diseases, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for breast cancer patients who have undergone radical surgery, and the study will evaluate the effectiveness of cyclophosphamide, epirubicin hydrochloride, fluorouracil, and paclitaxel as treatment options.",
    "This sample is a phase 3 clinical trial for patients with advanced biliary tract cancer, testing the effectiveness of becatecarin and 5-fluorouracil plus leucovorin as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for HIV patients, testing the effectiveness of the drug tenofovir/emtricitabine/rilpivirine in reducing CNS-related toxicity associated with efavirenz, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial aims to evaluate the effectiveness of dapagliflozin, a drug used to treat type 2 diabetes mellitus, in patients with cardiovascular disease, hypertension, and inadequate glycaemic control. The study includes specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of sitagliptin and glipizide in treating type 2 diabetes mellitus and end-stage kidney disease in participants on dialysis, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial is testing the efficacy of inhaled treprostinil and placebo inhalation solution in patients with clinically stable pulmonary arterial hypertension, who have been on a stable dose of bosentan or sildenafil for at least three months, and meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with Crohn's disease, testing the effectiveness of mesalazine (mesalamine) in treating clinically active mild to moderate small bowel CD, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of epilepsy, testing the drugs eslicarbazepine acetate 1600 mg and eslicarbazepine acetate 1200 mg, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with recurrent or metastatic head and neck cancer, testing the effectiveness of the drugs docetaxel and gefitinib, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with primary myelofibrosis and MPN-associated myelofibrosis, testing the efficacy of pomalidomide 0.5 mg compared to placebo in reducing RBC-transfusion-dependence and improving hemoglobin levels, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of alogliptin and insulin in controlling blood glucose levels, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for the drug \"flibanserin flexible dose\" in women with hypoactive sexual desire disorder (HSDD), who must meet certain inclusion criteria and not have certain exclusion criteria, such as a history of major depressive disorder (MDD) or clinically significant ECG abnormalities.",
    "This sample is a phase 3 trial for glaucoma and ocular hypertension, testing the drugs Xalacom and Xalatan, with inclusion criteria related to intraocular pressure and exclusion criteria related to previous treatments and surgeries.",
    "This sample is a phase 3 trial for the treatment of perennial allergic rhinitis, testing the effectiveness of azelastine hydrochloride nasal spray 0.15% and 0.10% compared to a placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "The sample is a phase 3 trial for the drug adalimumab in the treatment of psoriasis, with inclusion criteria including being 18 or older and having a stable medical history, and exclusion criteria including being pregnant or breastfeeding.",
    "This sample is a phase 3 clinical trial for Alzheimer's Disease, testing the efficacy of rivastigmine patches and placebos, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 3 clinical trial for patients with stage IIIA non-small cell lung cancer who have undergone complete resection. The study aims to evaluate the efficacy of carboplatin and paclitaxel as adjuvant chemotherapy.",
    "This sample is a phase 3 trial testing the effectiveness of eptacog alfa (activated) and placebo in treating acquired bleeding disorder and trauma patients with evidence of active hemorrhage refractory to blood component therapy and surgical haemostatic procedures.",
    "This sample is a phase 3 clinical trial for bladder cancer, testing the drug eflornithine, with eligibility criteria including histologically confirmed low grade transitional cell carcinoma of the bladder and no prior upper tract TCC.",
    "This sample is a phase 3 trial for the treatment of hyperkalemia using zirconium silicate and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of fentanyl and placebo in treating postherpetic neuralgia, complex regional pain syndromes (CRPS), and postoperative pain, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for obsessive compulsive disorder (OCD) patients aged 18 to 65 who have been treated with SSRI or clomipramine for at least 12 weeks. The study aims to evaluate the efficacy of quetiapine fumarate and SSRI/clomipramine in treating OCD.",
    "This sample is a phase 2/phase 3 trial for restless legs syndrome, testing the effectiveness of rasagiline and placebo in patients with moderate or severe symptoms, who are not currently receiving treatment for RLS and meet specific inclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin and metformin in combination with insulin therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for chronic hepatitis B, testing the drugs entecavir and entecavir + tenofovir, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with myelodysplastic syndrome (MDS) and it includes the drugs decitabine at 15 mg/m2 and decitabine at 20 mg/m2. The eligibility criteria include specific diagnostic requirements, Eastern Oncology Cooperative Group (ECOG) performance status, and adequate hepatic and renal function. There are also exclusion criteria, such as not having acute myeloid leukemia, not receiving recent radiotherapy, and not having certain prior cancers or conditions that could interfere with the study requirements.",
    "This sample is a phase 3 clinical trial for patients with acute myeloid leukemia (AML), testing the effectiveness of a combination of drugs including cytarabine, etoposide, gemtuzumab ozogamicin, idarubicin, and mitoxantrone hydrochloride, with specific eligibility criteria for patients aged 61 to 75 with certain disease characteristics and patient characteristics.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the effectiveness of capsules containing carbidopa, levodopa, and entacapone in patients aged 30 to 80 years with idiopathic Parkinson's disease and at least 2 cardinal signs of the disease.",
    "This sample is a phase 3 clinical trial for the treatment of seasonal allergic rhinitis using azelastine hydrochloride and placebo, with specific eligibility criteria including age, symptom scores, and allergy confirmation.",
    "This sample is a phase 3 trial for patients with seizures, where the drug being tested is pregabalin, and the eligibility criteria include having completed a previous study and showing a significant clinical response.",
    "This sample is a phase 3 trial for patients with leukemia and myelodysplastic syndromes, testing the effectiveness of cytarabine, daunorubicin hydrochloride, and gemtuzumab ozogamicin as treatment options, with specific eligibility criteria for patients' disease characteristics, age, performance status, and other medical conditions.",
    "This sample is from a phase 3 trial for patients with pulmonary arterial hypertension who have completed a previous study and tolerated bosentan, and it aims to assess the efficacy and safety of bosentan in this patient population.",
    "This sample is a phase 3 trial for contraception, testing the effectiveness of lng-ius (bay 86-5028) and 68 mg etonorgestrel implant for subdermal use (nexplanon) in healthy female subjects aged 18-35 years, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of 5-fu continuous infusion and mtx + 5-fu sequential therapy in patients with gastric cancer and neoplasm metastasis, who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for non-Hodgkin lymphoma, testing the drugs enzastaurin and placebo in patients who have recently completed R-CHOP therapy and achieved remission, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of intramuscular olanzapine depot compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the efficacy of ly2127399 and methotrexate compared to placebos, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with hypercholesterolemia, testing the effectiveness of atorvastatin, ezetimibe, and placebos in reducing LDL-C levels, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the effectiveness of gemcitabine/carboplatin and gemcitabine/carboplatin plus iniparib in treating newly diagnosed stage IV squamous cell lung cancer patients, who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) using drugs such as umeclidinium bromide and fluticasone propionate/salmeterol, with eligibility criteria including age, smoking history, severity of disease, and exclusion criteria such as pregnancy, asthma, and other respiratory disorders.",
    "This sample is a phase 3 clinical trial for patients with chronic pain, specifically chronic non-neuropathic low back pain, who are currently on stable opioid pain medication. The trial aims to evaluate the effectiveness of oxymorphone extended release as a treatment option. The inclusion criteria include being 18 years or older, having moderate to severe chronic low back pain, and requiring a minimum daily dose of 20 mg of oxymorphone ER. The exclusion criteria include various medical conditions, such as pregnancy, certain types of pain, and history of substance abuse.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of sirolimus versus mycophenolate mofetil in patients with end-stage, C-peptide-negative, type 1-diabetic nephropathy who have undergone a simultaneous pancreas/kidney transplant. The study includes specific inclusion and exclusion criteria, and the primary outcome is the impact of the drugs on patient outcomes.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the effectiveness of tiotropium in different doses, with specific eligibility criteria including age, smoking history, and pulmonary function test results.",
    "In this sample, the phase of the trial is phase 3 and the disease being studied is upper respiratory tract infection. The drug being tested is azithromycin sr, and the eligibility criteria include patients diagnosed with laryngopharyngitis, tonsillitis, or acute bacterial rhinosinusitis. Severe underlying diseases and confounding diseases are listed as exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of various drugs including placebo, canagliflozin, and metformin, with specific eligibility criteria for enrollment.",
    "This sample is a phase 3 trial for hepatitis B, testing the drugs tenofovir disoproxil fumarate (tdf) tablets and adefovir dipivoxil (adv) tablets, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 trial for HIV infections, testing the efficacy of various drugs including abacavir/lamivudine, atazanavir, efavirenz, and ritonavir, among others, in treatment-naive patients with certain eligibility criteria.",
    "This sample is a phase 3 clinical trial for a contraception study, testing the effectiveness of the drugs nomac-e2 and drsp-ee in sexually active women who are at risk for pregnancy and not planning to use condoms. The eligibility criteria include age, body mass index, good physical and mental health, and willingness to give informed consent. Exclusion criteria include contraindications for contraceptive steroids, renal and hepatic dysfunction, abnormal cervical smear, and use of certain medications.",
    "This sample is a phase 3 clinical trial for the drug alfuzosin, targeting patients with prostatic hyperplasia, and includes specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the drug ly2140023 and placebo in patients with schizophrenia, with specific inclusion and exclusion criteria, and various medical history and demographic requirements.",
    "This sample is a phase 3 clinical trial for chemotherapy-induced nausea and vomiting, testing the effectiveness of oral and intravenous palonosetron and dexamethasone as antiemetic drugs for patients receiving cisplatin-based chemotherapy.",
    "This sample is a phase 3 clinical trial for ovarian, fallopian tube, and peritoneal cancers, testing the drugs epo906 (patupilone) and doxorubicin, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of ciprofloxacin and amoxicillin in treating patients with fever, neutropenia, and cancer, who are eligible based on specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs bapineuzumab 0.5 mg/kg and bapineuzumab 1.0 mg/kg against a placebo control, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for kidney transplantation, testing the drugs tacrolimus, mycophenolate mofetil, daclizumab, and steroids, with inclusion criteria including age, end stage kidney disease, and negative pregnancy test, and exclusion criteria including high panel reactive antibody grade, allergies to study medication, and previous organ transplants.",
    "This sample is a phase 3 trial testing the effectiveness of pregabalin and placebo in treating chronic nerve pain after spinal cord injury, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with glaucoma or ocular hypertension, testing the effectiveness of bimatoprost 0.03% formulation b ophthalmic solution and bimatoprost 0.03% ophthalmic solution in lowering intraocular pressure (IOP), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for diabetic nephropathy and type 2 diabetes mellitus, testing the effectiveness of olmesartan medoxomil compared to a placebo in patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the effectiveness of creatine as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with metabolic syndrome and type 2 diabetes, testing the effectiveness of topiramate in combination with lifestyle changes in reducing weight and improving metabolic parameters.",
    "The sample is a phase 3 clinical trial for hypercholesterolemia, testing the drugs rosuvastatin and atorvastatin, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for diabetic retinopathy, testing the drugs ruboxistaurin and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for chronic hepatitis C genotype 1, testing the effectiveness of boceprevir, placebo, and ribavirin in previously untreated or failed treatment patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of panitumumab and the folfox regimen as treatments, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2/phase 3 trial for patients with Parkinson's disease and excessive daytime somnolence, testing the effects of caffeine and placebo on sleepiness levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for postmenopausal osteoporosis, testing the drugs odanacatib and placebo, with inclusion criteria of postmenopausal women over 65 years old with low bone mineral density, and exclusion criteria including not currently taking osteoporosis therapy or having a hip fracture.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the effectiveness of insulin glulisine in controlling blood sugar levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with advanced Parkinson's disease, testing the effectiveness of levodopa-carbidopa intestinal gel in managing severe motor fluctuations.",
    "This sample is a phase 3 clinical trial for breast cancer patients with HER2-overexpression, testing the efficacy of capecitabine and trastuzumab as a treatment option for patients who have progressed after previous chemotherapy and trastuzumab treatment.",
    "This sample is a phase 3 clinical trial for major depressive disorder (MDD) using extended-release bupropion hydrochloride as the drug, with specific inclusion and exclusion criteria related to orgasmic function and previous antidepressant trials.",
    "This sample is a phase 3 trial for the treatment of major depressive disorder (MDD) in patients aged 60 and above, using the drug paroxetine cr. The inclusion criteria include a diagnosis of MDD and a current major depressive episode lasting at least 2 months, while the exclusion criteria include other primary diagnoses, history of certain mental disorders, recent psychotherapy, suicidal tendencies, recent electroconvulsive therapy or transcranial magnetic stimulation, and history of seizure disorders.",
    "This phase 3 trial aims to evaluate the effectiveness of pioglitazone and placebo in treating impaired glucose tolerance and type 2 diabetes, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 3 trial is testing the effectiveness of lenalidomide, a drug used to treat myelodysplastic syndromes (MDS) with del 5q(31) cytogenetic abnormality, in reducing the need for red blood cell transfusions in patients with MDS.",
    "This sample is a phase 3 clinical trial for acute otitis media, testing the effectiveness of xylitol syrup and placebo in children aged six months to five years with a history of at least three episodes of AOM in the previous 12 months.",
    "This phase 3 clinical trial aims to evaluate the efficacy of liprotamase, a pancreatic enzyme supplementation, compared to placebo in patients with cystic fibrosis and exocrine pancreatic insufficiency, based on specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with mild to moderate hypertension, testing the drugs valsartan and lisinopril, with eligibility criteria including specific blood pressure levels and urinary albumin concentration.",
    "This sample is a phase 3 clinical trial for asthma, testing the effectiveness of fluticasone furoate, fluticasone propionate, and placebo in patients with a pre-bronchodilator FEV1 of at least 60% predicted and a FEV1 reversibility of at least 12% and 200ml.",
    "This phase 3 clinical trial is testing the effectiveness of docetaxel and prednisone in treating metastatic hormone-refractory prostate cancer patients, with specific eligibility criteria including confirmed adenocarcinoma of the prostate, metastatic disease, and castration levels of testosterone.",
    "This sample is a phase 3 trial for patients with graft rejection, kidney failure, and kidney transplantation, testing the effectiveness of cyclosporin or tacrolimus in patients with mild to moderate renal insufficiency, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of major depressive disorder (MDD) using duloxetine and placebo drugs, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer patients who have undergone surgery, testing the effectiveness of erlotinib and placebo drugs in preventing tumor recurrence, with specific eligibility criteria for patient selection.",
    "This sample is a phase 3 clinical trial for the treatment of major depressive disorder using the drugs vilazodone and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with ankylosing spondylitis, testing the efficacy of tocilizumab and placebo in patients who have had an inadequate response to previous non-steroidal anti-inflammatory drugs (NSAIDs) and tumor necrosis factor (TNF) antagonist therapy.",
    "This sample is a phase 3 clinical trial for breast cancer patients who are postmenopausal and have hormone receptor-negative disease. The study aims to evaluate the efficacy of cyclophosphamide, methotrexate, and pegylated liposomal doxorubicin hydrochloride as treatment options.",
    "This sample is a phase 3 trial for patients with pulmonary hypertension, testing the drug sildenafil citrate, and the inclusion criteria require patients to have completed a 12-week pivotal study.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the effectiveness of drugs such as placebo, czp, and methotrexate (mtx) on patients who meet specific inclusion criteria, such as being MTX naive and having moderate or higher disease activity.",
    "This sample is a phase 3 clinical trial for patients with muscle wasting and non-small cell lung cancer, testing the effectiveness of the drug gtx-024 compared to a placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with newly diagnosed chronic myelogenous leukemia in chronic phase, testing the effectiveness of busulfan, cytarabine, etoposide, hydroxyurea, and idarubicin as treatment options.",
    "This sample is a phase 3 trial for patients with asthma and lung diseases, testing the effectiveness of esomeprazole and placebo proton pump inhibitor in treating GERD symptoms, with specific inclusion and exclusion criteria for patient selection.",
    "This sample is a phase 3 trial for pediatric patients with partial onset seizures, focusing on the drug levetiracetam (lev) and excluding patients on a ketogenic diet or with certain types of seizures or epilepsy.",
    "This phase 3 trial aims to evaluate the effectiveness of telmisartan and simvastatin in treating hypertension and dyslipidemias in patients with specific cardiovascular risk factors and LDL-C levels, while excluding individuals with certain medical conditions or taking specific medications.",
    "This sample is a phase 3 trial for the treatment of plaque psoriasis using a placebo drug, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for the treatment of open-angle glaucoma and ocular hypertension using brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension, brinzolamide ophthalmic suspension, 1%, and brimonidine tartrate ophthalmic solution, 0.2%. The eligibility criteria include a diagnosis of open-angle glaucoma or ocular hypertension, specific intraocular pressure range, and exclusion criteria such as other forms of glaucoma, severe central vision loss, and ocular trauma or infection within certain timeframes.",
    "This sample is a phase 3 trial for the treatment of hepatitis C virus infection using the drugs daclatasvir, asunaprevir, ribavirin, and telaprevir, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with stage IV breast cancer, testing the effectiveness of trastuzumab, vinorelbine, paclitaxel, and docetaxel in combination, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of the drug \"pro 2000/5\" versus placebo in preventing HIV infections in women who are sexually active and meet the inclusion criteria, while also considering the exclusion criteria.",
    "In this phase 3 trial, the drug Renzapride is being tested for its effectiveness in treating irritable bowel syndrome (IBS) in females with constipation-predominant symptoms, while excluding patients with diarrhea-predominant or alternating symptom IBS and other gastrointestinal diseases that affect bowel transit.",
    "This sample is a phase 3 clinical trial for dry eye disease, testing the effectiveness of sodium hyaluronate and a vehicle as potential treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with nonorganic insomnia associated with schizophrenia and manic-depressive psychosis, testing the effectiveness of zolpidem mr, nitrazepam, and placebo as drugs, with exclusion criteria for patients with allergic reactions to zolpidem or nitrazepam, serious cardiac disorders, serious hepatic impairment, and serious renal diseases.",
    "This phase 3 clinical trial is testing the effectiveness of Velcade, a drug used to treat multiple myeloma, in recently diagnosed patients under the age of 65 who meet specific eligibility criteria.",
    "This sample is a phase 3 trial for HIV infections and hepatitis C, testing the effectiveness of lpv/r, nucleoside reverse transcriptase inhibitors, peg-ifna 2a, and ribavirin in patients with active chronic hepatitis or compensated cirrhosis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug gw406381, which aims to treat osteoarthritis of the knee in patients who use pain medication regularly, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for chronic hepatitis C infection, testing the drugs abt-450/r/abt-267, abt-333, ribavirin, and placebo for ribavirin, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for asthma patients of Asian ancestry, testing the efficacy of the drug combination gw685698/gw642444 (fluticasone furoate/vilanterol trifenatate) compared to a placebo, with eligibility criteria including informed consent, specific disease severity and reversibility, current anti-asthma therapy, and exclusion criteria such as history of life-threatening asthma and concurrent respiratory diseases.",
    "This sample is a phase 3 trial for contraception, testing the effectiveness of nomac-e2 and levonorgestrel and ethinyl estradiol as oral contraceptives for sexually active women at risk for pregnancy. The inclusion criteria include being between 18 and 50 years old, having a body mass index between 17 and 29 kg/m^2, and being in good physical and mental health. Exclusion criteria include current or recent use of hormonal treatments, contraindications for contraceptive steroids, and a history of alcohol or drug abuse.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the drugs abatacept, placebo, and methotrexate, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with colorectal cancer, testing the drug rofecoxib, and includes eligibility criteria such as specific disease characteristics, age, performance status, and various medical conditions.",
    "This sample is a phase 3 clinical trial for patients with macular edema resulting from retinal vein occlusion. The trial will test the effectiveness of two drugs, 700 \u00b5g dexamethasone and 350 \u00b5g dexamethasone, in improving visual acuity. The eligibility criteria include being 18 years or older, having a decrease in visual acuity, and not having certain medical conditions or using specific medications.",
    "This sample is a phase 3 clinical trial for stroke patients, testing the effectiveness of rosuvastatin, a statin medication, on patients with any degree of stenosis on the relevant artery of atherothrombotic origin appearing on DWI through MRA or CTA. The inclusion criteria include being over 20 years of age, having undergone an MRI within 48 hours after onset of symptoms, and being statin-na\u00efve. The exclusion criteria include having a history of hemorrhagic stroke, high-risk potential cardiac sources of embolism, major hematologic, neoplastic, metabolic, gastrointestinal or endocrine dysfunction, and other medical or psychological conditions that may compromise the subject's safety or successful participation in the study.",
    "This sample is a phase 3 trial for epilepsy patients who are taking levetiracetam in combination with a sodium channel blocking antiepileptic drug, and the study aims to evaluate the efficacy and safety of lacosamide as an adjunctive treatment.",
    "This sample is a phase 3 clinical trial for the treatment of type 1 diabetes using the drugs diapep277 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of bipolar disorder using the drug risperidone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for individuals with hypercholesterolemia or dyslipidemia, testing the effectiveness of pitavastatin and simvastatin in reducing cardiovascular disease risk factors in patients following a restrictive diet.",
    "This sample is a phase 3 clinical trial for patients with osteoarthritis of the knee and pain, testing the effectiveness of oxycodone, placebo, and tapentadol (cg5503) as analgesic medications, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for HIV infections, testing the efficacy of the drug mk-0518 compared to efavirenz, truvada, and placebos, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for osteoarthritis of the knee, testing the effectiveness of ketoprofen in diractin\u00ae, celecoxib, and a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with aggressive B-cell non-Hodgkin's lymphoma who have failed prior combination chemotherapy. The study will test the effectiveness of carboplatin, etoposide, and ifosfamide as treatment options. Eligibility criteria include histologically proven lymphoma, CD20 antigen expression, measurable disease, and no clinical evidence of CNS involvement. Patients must also meet certain age, performance status, and organ function requirements.",
    "This sample is a phase 3 clinical trial for patients with liver metastases secondary to cutaneous or ocular melanoma, testing the effectiveness of melphalan, regional chemotherapy, and systemic chemotherapy as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 3 trial testing the effectiveness of darbepoetin alfa, a drug used to treat anemia, in patients with heart failure, anemia, cardiovascular disease, ventricular dysfunction, and congestive heart failure. The eligibility criteria include specific requirements for heart failure duration, hemoglobin levels, and left ventricular ejection fraction.",
    "This sample is a phase 3 trial for the treatment of attention deficit hyperactivity disorder (ADHD) using methylphenidate hydrochloride extended release capsules, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for osteoarthritis, testing the efficacy of meloxicam test capsules and placebo capsules as a replacement for nonsteroidal anti-inflammatory drugs (NDAIDs) and/or acetaminophen for OA pain relief.",
    "This sample is a phase 2/phase 3 trial that focuses on patients with various neuroendocrine tumors, including gastrointestinal carcinoid tumor, islet cell tumor, lung cancer, neoplastic syndrome, and neuroendocrine tumor. The trial will evaluate the effectiveness of 5-fluorouracil, leucovorin, and oxaliplatin as treatment options, and it includes eligibility criteria related to disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 3 trial for bipolar disorder, testing the effectiveness of ziprasidone oral capsules compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for asthma patients aged 4-12 years, testing the efficacy of flutiform\u00ae (formoterol fumarate / fluticasone propionate) as a substitute for pre-study prescribed asthma medication.",
    "The sample is a phase 3 clinical trial for the drug topiramate in patients with migraine, with specific inclusion and exclusion criteria, such as a diagnosis of migraine, successful completion of a previous study, and compliance with study medication.",
    "This sample is a phase 3 clinical trial for patients with newly diagnosed, Stage IIIb or IV non-small-cell lung carcinoma. The study will evaluate the effectiveness of gemcitabine/eloxatin (gemox) and carboplatin/paclitaxel (cp) as treatment options. The eligibility criteria include having a measurable lesion, an ECOG Performance Status of 0 or 1, and no history of acute cardiac or CNS events within 6 months.",
    "This sample is a phase 3 trial for attention-deficit hyperactivity disorder (ADHD) using the drugs jns001 and placebo, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 3 clinical trial for patients with end-stage renal disease or kidney transplantation, testing the effectiveness of cyclosporine, sirolimus, and tacrolimus in preventing rejection episodes in children aged 20 or younger who have experienced acute or chronic rejection and have stable kidney function.",
    "This sample is a phase 3 clinical trial for breast cancer patients with HER2-positive tumors, testing the effectiveness of chemotherapy in combination with trastuzumab (Herceptin\u00ae) for metastatic or locally advanced disease, excluding patients with brain metastases or CNS disease.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the effectiveness of tocilizumab and methotrexate in reducing disease activity, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with type 1 diabetes mellitus, testing the effectiveness of ly2963016, lantus, and insulin lispro in combination with basal-bolus insulin therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with idiopathic restless legs syndrome, testing the effectiveness of pramipexole 0.125 mg and 0.5 mg tablets in relieving symptoms, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for breast cancer patients with bone metastasis, testing the efficacy of zoledronic acid and placebo in patients who have been pretreated with Zometa or Aredia for a minimum of 9 doses, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the efficacy of donepezil hydrochloride, a dementia drug, compared to placebo in patients with brain tumors or metastatic disease who have previously undergone brain irradiation, with specific eligibility criteria including age, prior treatments, performance status, and stable disease status.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of tiotropium + olodaterol, tiotropium, olodaterol, and placebo drugs, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for the treatment of obesity and overweight, testing the effectiveness of naltrexone sr and bupropion sr drugs compared to a placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic constipation, testing the effectiveness of the drugs peg 3350 plus electrolytes and prucalopride, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of dutasteride 0.5mg capsule, a 5a-reductase inhibitor, in treating benign prostatic hyperplasia (BPH) based on specific eligibility criteria, including clinical diagnosis of BPH, AUA-SI score, prostate volume, and exclusion criteria such as history of prostate cancer, hepatic impairment, and concurrent use of certain medications.",
    "This sample is a phase 3 clinical trial testing the effectiveness of aprepitant and placebo in reducing chemotherapy-induced nausea and vomiting in children and adolescents (5-18 years) with a confirmed diagnosis of malignancy and receiving highly emetogenic chemotherapy for the first time. The inclusion criteria include a weight between 15-65 kg and the ability to understand Hindi or English. Exclusion criteria include significant organ dysfunction, active infection, pregnancy, and prior exposure to highly emetogenic chemotherapeutics.",
    "This sample is a phase 3 clinical trial for the treatment of the common cold using the drug xylometazoline, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with inoperable, locally advanced, or metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. The trial will test the efficacy of bevacizumab, capecitabine, cisplatin, placebo, and 5-fluorouracil in combination therapy, and includes eligibility criteria such as age \u2265 18 years, Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2, and measurable disease or non-measurable but evaluable disease according to the Response Evaluation Criteria in Solid Tumours (RECIST).",
    "This sample is a phase 3 trial for the treatment of opioid-induced constipation, testing the drugs methylnaltrexone and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of docetaxel and epirubicin drugs in combination with specific eligibility criteria, such as tumor characteristics and absence of metastatic disease.",
    "This sample is a phase 3 trial for psoriasis, testing the effectiveness of etanercept and clobetasol propionate foam as systemic therapy or phototherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of kidney stones using the drugs silodosin and tamsulosin, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is investigating the use of rosiglitazone, a drug used to treat type 2 diabetes, in patients with type 2 diabetes and coexisting vascular disease or hypertension, who have been receiving stable statin and fibrate therapy for at least 3 months.",
    "This sample is a phase 3 trial for chronic pain, testing the effectiveness of hydrocodone er and placebo in patients with osteoarthritis or low back pain, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for fibromyalgia, testing the drug Savella, and includes eligibility criteria such as age, pain score, and discontinuation of certain medications.",
    "This sample is a phase 3 clinical trial for the treatment of acute promyelocytic leukemia (APL) using mercaptopurine, methotrexate, and tretinoin drugs, with specific eligibility criteria including disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the efficacy and safety of rapid acting intramuscular olanzapine as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of acute hepatitis C virus (HCV) using the drug ribavirin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial testing the effectiveness of 10mg rosuvastatin and placebo in male or female subjects aged 50-80 years with end-stage renal failure who have received regular haemodialysis treatment for at least 3 months. The study aims to evaluate the impact of the drugs on subjects with renal failure and assess their eligibility criteria.",
    "This sample is a phase 3 trial for HIV-1 patients, testing the effectiveness of drugs such as maraviroc, emtricitabine/tenofovir, and darunavir/ritonavir, along with placebos, in treating the disease. The eligibility criteria include specific HIV-1 RNA and CD4 count requirements, as well as the absence of certain genotypic/phenotypic resistance and CXCR4 using virus.",
    "This sample is a phase 3 clinical trial for the treatment of non-melanomatous skin cancer using the drug imiquimod, with specific eligibility criteria including histologically confirmed primary basal cell skin carcinoma and no genetic or nevoid conditions.",
    "This sample is a phase 3 trial for patients with stage IIIB or IV non-small cell lung cancer who are not candidates for combined modality therapy. The study will test the drug sunitinib malate as a potential treatment option. The eligibility criteria include histologic or cytologic documentation of primary non-small cell lung cancer, no evidence of symptomatic or untreated brain metastases, and measurable or non-measurable disease.",
    "This sample is a phase 3 trial for patients with hypercholesterolemia and dyslipidemias, testing the drug pitavastatin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of chronic migraine using the drug topiramate, with specific inclusion and exclusion criteria, such as a diagnosis of chronic migraine, previous participation in a related study, good health, ability to take medicine orally, and use of birth control for females.",
    "This sample is a phase 3 clinical trial for patients with moderate to severe refractory ulcerative colitis, testing the efficacy of tacrolimus and placebo as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of aclidinium bromide compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 1 diabetes, testing the effectiveness of insulin detemir, insulin nph, and insulin aspart in controlling blood sugar levels, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of zoledronic acid and placebo in treating osteoporosis in patients with multiple sclerosis, who meet specific eligibility criteria including having a certain EDSS score and BMD T-score, and not being on certain immunomodulatory treatments.",
    "This sample is a phase 3 trial for glaucoma and ocular hypertension, testing the effectiveness of various brimonidine and timolol ophthalmic solutions in lowering intraocular pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for osteoporosis, testing the effectiveness of smc021 oral calcitonin and smc021 placebo in postmenopausal women with osteoporosis, who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the contraceptive drug norethindrone acetate/ethinyl estradiol in healthy women at risk for pregnancy, with specific inclusion and exclusion criteria, such as regular cycles and BMI less than or equal to 35.",
    "This sample is a phase 3 clinical trial for patients with B-cell chronic lymphocytic leukemia (CLL), testing the effectiveness of cyclophosphamide and fludarabine as treatment options, with specific eligibility criteria and exclusion criteria for patient characteristics.",
    "This sample is a phase 3 trial for patients with HIV infections who have reported gastrointestinal upset and constitutional side-effects from rIL-2 treatment, and are eligible to receive further dosing with rIL-2 along with specific adjunct regimens including ondansetron, ibuprofen, paracetamol, metoclopramide, and codeine phosphate.",
    "This sample is a phase 2/phase 3 trial for patients with inoperable or stage I-III non-small cell lung cancer, testing the effectiveness of cisplatin and vinorelbine tartrate in combination with radical radiotherapy treatment.",
    "This phase 3 trial is testing the effectiveness of levetiracetam, carbamazepine controlled release, and valproate extended release in treating epilepsy, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of paliperidone palmitate, an antipsychotic drug, in reducing symptoms. The eligibility criteria include meeting DSM-IV criteria for schizophrenia, being on an adequate dose of antipsychotic medication, and having a baseline PANSS score >= 80 and CGI-S score >= 4.",
    "This sample is a phase 3 trial for patients with advanced Parkinson's disease, testing the drug istradefylline (kw-6002) to reduce OFF time in patients already receiving levodopa treatment.",
    "This sample is a phase 3 clinical trial for postmenopausal osteoporosis, testing the drug ibandronate (Bonviva/Boniva), and includes eligibility criteria such as age, postmenopausal status, and ambulatory ability.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the effectiveness of methotrexate, ocrelizumab, and placebo in patients who are naive to methotrexate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of esophagitis, reflux and esophagitis, peptic using dexlansoprazole mr, lansoprazole, and other drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial studying the effectiveness of the drugs c31g and nonoxynol-9 (n-9) as a primary method of contraception for healthy women at risk for pregnancy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of moderate to severe plaque-type psoriasis using infliximab and methotrexate, with specific eligibility criteria including a minimum Psoriasis Area and Severity Index (PASI) score and negative tuberculosis test results.",
    "This sample is a phase 3 clinical trial for patients with high-risk invasive breast cancer, testing the effectiveness of capecitabine and docetaxel drugs in reducing the risk of recurrence, with specific eligibility and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug atorvastatin, and includes eligibility criteria for participants.",
    "This phase 3 trial is testing the efficacy of nexavar (sorafenib, bay43-9006) compared to placebo in patients with hepatocellular carcinoma who have undergone surgical resection or local ablation for treatment of HCC with curative intent within 4 months from staging to potentially curative treatment.",
    "This sample is a phase 3 trial for the drug muraglitazar in patients with type 2 diabetes mellitus, with specific inclusion criteria such as stable metformin therapy, HbA1c levels, fasting c-peptide levels, body mass index, and serum triglyceride levels.",
    "This sample is a phase 3 clinical trial for patients with gastrointestinal stromal tumors, testing the drug nilotinib. The inclusion criteria include age \u226518 years, radiological confirmation of disease progression during previous therapies, and normal organ function. Exclusion criteria include previous treatment with nilotinib or other targeted therapies, impaired cardiac function, and pregnancy or lactation.",
    "This sample is a phase 3 clinical trial for chronic myeloid leukemia patients who have not responded to previous treatments, and it aims to evaluate the effectiveness of imatinib in achieving a major cytogenetic response.",
    "This sample is a phase 3 trial for patients with poorly controlled type 2 diabetes mellitus, testing the efficacy of sitagliptin phosphate compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for relapsing remitting multiple sclerosis, testing the efficacy of bg00002 (natalizumab), interferon beta-1a, and glatiramer acetate as treatments, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for major depressive disorder, testing the effectiveness of escitalopram and placebo as drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial for multiple sclerosis (MS) patients with primary progressive MS (PPMS) and includes eligibility criteria, such as disease duration, EDSS score, and CSF specimen analysis. The study will test the efficacy of rituximab and placebo as potential treatments for PPMS.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of interferon gamma-1b in treating patients with ovarian carcinoma or peritoneal carcinoma, with specific eligibility criteria including histologically confirmed epithelial ovarian or primary peritoneal carcinoma, FIGO Stage III or IV disease, and being a candidate for first-line chemotherapy.",
    "This sample is a phase 3 trial for chronic myeloid leukemia (CML) patients, testing the drugs dasatinib and imatinib, with key inclusion criteria including being 18 years or older, having Philadelphia Chromosome-positive CML, and an Eastern Cooperative Oncology Group Performance Status score of 0-2.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of vildagliptin, an oral antidiabetic agent, in reducing HbA1c levels in patients with a body mass index between 22-35 kg/m2 and no previous treatment with oral antidiabetic agents for at least 12 weeks.",
    "This sample is a phase 3 clinical trial for participants with type 2 diabetes mellitus, testing the effectiveness of lixisenatide and metformin in managing the disease. The eligibility criteria include having a stable dose of metformin for at least 3 months and excluding participants with certain medical conditions or previous treatments.",
    "This phase 3 trial aims to evaluate the efficacy of the drug tc-5214 compared to placebo in patients with major depressive disorder (MDD) who have had an inadequate response to one antidepressant, with inclusion criteria including outpatient status and signed informed consent. Exclusion criteria include a history of bipolar disorder, psychotic disorder, post-traumatic stress disorder, suicide attempts in the past year, and renal insufficiency or impairment.",
    "This sample is a phase 3 clinical trial for ulcerative colitis, testing the effectiveness of mesalamine once-daily and mesalamine twice-daily as maintenance therapy for patients with a history of successful remission and at least one flare in the past 18 months.",
    "This phase 3 trial is testing the effectiveness of tipranavir and ritonavir, two drugs used to treat HIV infections, in combination with other antiretroviral agents, in HIV-1 infected patients who are treatment-experienced and have resistance to protease inhibitors.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of policosanol, a drug, in treating patients with hypercholesterolemia and combined hyperlipidemia, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of agomelatine compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the drugs asa404, placebo, and docetaxel, with eligibility criteria including confirmed lung cancer, previous chemotherapy treatment, specific laboratory values, and exclusion criteria such as CNS metastases and certain medical conditions.",
    "This sample is a phase 2/phase 3 trial for patients with recurrent follicular lymphoma, testing the efficacy of cyclophosphamide and rituximab, filgrastim, non-myeloablative conditioning regimen, rituximab maintenance therapy, and gvhd prophylaxis, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for the drug GSK1325760A in patients with pulmonary arterial hypertension and pulmonary hypertension, with specific inclusion and exclusion criteria for participation in the study.",
    "This sample is a phase 3 clinical trial for patients with colorectal cancer, testing the effectiveness of bevacizumab and capecitabine drugs in combination, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of esophagitis, reflux and esophagitis, peptic using dexlansoprazole mr and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial that aims to evaluate the effectiveness of er niacin/laropiprant, simvastatin, and ezetimibe/simvastatin in patients with cardiovascular disease, peripheral arterial disease, diabetes mellitus, and coronary heart disease, based on specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for colorectal cancer, testing the effectiveness of celecoxib, fluorouracil, and leucovorin calcium in patients who have undergone curative radical resection within the past 6 weeks, with specific eligibility criteria related to disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This phase 3 trial is investigating the effectiveness of insulin degludec, placebo, and liraglutide in treating type 2 diabetes patients who are insulin na\u00efve and currently on metformin or metformin in combination with other medications, with specific glycemic control criteria.",
    "This phase 3 trial is investigating the effectiveness of vildagliptin and thiazolidinedione (tzd) in combination with metformin for patients with type 2 diabetes mellitus, who meet specific inclusion criteria such as age, BMI, HbA1c levels, and FPG levels, while excluding patients with type 1 diabetes, liver disease, or recent treatment with insulin or other oral anti-diabetic medications.",
    "This sample is a phase 3 trial for bipolar disorder, testing the drugs asenapine, olanzapine, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with stage III colon cancer, testing the effectiveness of irinotecan hydrochloride, oxaliplatin, leucovorin calcium, fluorouracil, and locally directed therapy as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 3 clinical trial for dyslipidemia and kidney disease, testing the drugs abt-335 plus rosuvastatin and rosuvastatin, with eligibility criteria including specific laboratory values for estimated glomerular filtration rate and fasting lipid results.",
    "This sample is a phase 3 trial for patients with irritable bowel syndrome with constipation or chronic constipation, testing the drug linaclotide, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the effectiveness of capecitabine and oxaliplatin in combination with chemoradiotherapy for the treatment of colorectal cancer in patients who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for the treatment of macular edema and retinal vein occlusion using sham injection, ranibizumab injection 0.3 mg, and ranibizumab injection 0.5 mg, with specific eligibility criteria and exclusion criteria for the study.",
    "This sample is a phase 3 clinical trial for Crohn's disease, testing the efficacy of methotrexate and placebo in patients with active symptoms requiring prednisone therapy, with various inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of tiotropium and olodaterol drugs in improving lung function, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with prostate cancer, testing the drugs zd4054 and palcebo, with eligibility criteria including confirmed diagnosis of prostate cancer, increasing PSA levels, and current treatment with surgical or medical castration.",
    "This sample is a phase 3 trial testing the effectiveness of drotrecogin alfa (activated) and placebo in adult patients with severe sepsis, with inclusion and exclusion criteria specified.",
    "This sample is a phase 3 clinical trial for patients who have undergone liver transplantation and have chronic hepatitis C or liver cirrhosis. The trial is testing the combination of pegylated interferon alfa-2b and rebetol as a treatment option. The eligibility criteria include age, time since liver transplant, stable immunosuppression, and specific liver disease criteria. Exclusion criteria include pregnancy, prior treatment for hepatitis C post-liver transplant, and certain medical conditions.",
    "This sample is a phase 3 trial testing the efficacy of tamsulosin hydrochloride/solifenacin succinate fixed dose combination in treating lower urinary tract symptoms and benign prostatic hyperplasia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the drugs ly2127399, placebo q4w, and placebo q2w, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for pediatric renal allograft recipients with biopsy proven acute rejection episodes, testing the use of rituximab for transplant rejection. The eligibility criteria include a decline in renal function, adequate liver function, negative pregnancy test, and agreement to use birth control. Exclusion criteria include recent treatment with investigational agents, previous treatment with rituximab, history of severe allergic reactions, HIV or hepatitis B/C, recurrent infections, ongoing use of high dose steroids, and various other contraindications.",
    "This sample is a phase 3 trial for rheumatoid arthritis, testing the efficacy of rituximab and methotrexate compared to placebo, with specific eligibility criteria including previous inadequate response to other treatments and stable use of certain medications.",
    "This sample is a phase 2/phase 3 trial for type 1 diabetes, testing the drugs anakinra and saline, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of diabetic neuropathy pain, testing the effectiveness of duloxetine compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of olodaterol (bi 1744) and placebo in improving lung function, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial investigating the use of arixtra (fondaparinux sodium), an anticoagulant, in patients undergoing open laparotomy gynecologic surgery to prevent venous thrombosis. The inclusion criteria include patients who are competent to self-administer injections or have caregivers/nurses who can perform injections, while exclusion criteria include patients with a medical history requiring chronic anticoagulation, contraindications to anticoagulation, contraindications to placement of ICDs, and other specific conditions.",
    "This sample is a phase 3 trial for patients with idiopathic Parkinson's disease, testing the effectiveness of safinamide and placebo in patients who have been receiving treatment with a single dopamine agonist for at least 4 weeks. The study has specific inclusion and exclusion criteria, and female patients of childbearing potential and those who have previously received safinamide are excluded from the trial.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin glargine, insulin lispro protamine suspension, and insulin lispro in combination with metformin and other oral antihyperglycemic medications. The study aims to evaluate the impact of these treatments on HbA1c levels, BMI, and overall protocol adherence.",
    "This sample is a phase 3 clinical trial for ulcerative colitis, testing the efficacy of asacol 400 mg in children and adolescents aged 5-17 years with mildly-to-moderately active UC, who do not require steroids. The eligibility criteria include specific UC activity index scores and baseline scores for rectal bleeding and stool frequency.",
    "This phase 3 trial aims to evaluate the effectiveness of arixtra alone in treating patients with cancer and thromboembolism, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for overactive bladder, testing the effectiveness of fesoterodine and placebo in reducing urinary frequency and urgency episodes, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of hypercholesterolemia and hyperlipidemia using laropiprant/niacin (mk0524a) compared to a placebo, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 3 clinical trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the drugs nva237 and tiotropium. The inclusion criteria include patients with a smoking history of at least 10 pack years and specific lung function measurements, while the exclusion criteria include patients with certain comorbid conditions and contraindications for the drugs being tested.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of repaglinide and metformin combination tablet and rosiglitazone and metformin combination tablet in controlling blood sugar levels, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial for HIV infection, testing the drugs tenofovir df and lopinavir/ritonavir with 2 nucleoside rtis, with inclusion criteria including being HIV positive, over 18 years old, having an HIV RNA count over 400 copies/mL, and being antiretroviral na\u00efve.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of drugs such as gsk573719/gw642444 and placebo in improving lung function and reducing symptoms. The inclusion criteria include a diagnosis of COPD, a history of cigarette smoking, and specific lung function measurements, while the exclusion criteria include pregnancy, other respiratory disorders, and certain medication use.",
    "This sample is a phase 3 trial for patients with stage 1 or stage 2 essential hypertension, testing the effectiveness of nebivolol and valsartan drugs, along with a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for HIV infections, testing the efficacy of dolutegravir and a placebo in ART-experienced, INI-experienced, DTG-na\u00efve patients with virological failure on raltegravir or elvitegravir regimen, and resistance to RAL or ELV.",
    "This sample is a phase 3 clinical trial for the treatment of gastric ulcer, testing the drugs pn400 (vimovo) and pn 400 (vimovo), with eligibility criteria including a history of documented gastric or duodenal ulcer and the ability to provide written informed consent.",
    "This phase 3 trial is investigating the use of ranitidine and pantoprazole in patients with dyspeptic symptoms and abnormal esophageal findings, excluding those with certain conditions such as Barrett's esophagus or severe esophagitis.",
    "This sample is a phase 3 clinical trial for patients with newly diagnosed acute myeloid leukemia (AML) who are over 60 years old. The study aims to evaluate the effectiveness of cytarabine, idarubicin, all-trans retinoic acid, mitoxantrone, and etoposide as treatment options. The inclusion criteria include being newly diagnosed with AML, excluding acute promyelocytic leukemia (APL), and having informed consent. The exclusion criteria include bleeding independent of AML, APL, uncontrolled infection, participation in another clinical study, and various medical conditions.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) and includes the drugs extended-release guanfacine hydrochloride, atomoxetine hydrochloride, and a placebo comparator. The eligibility criteria include meeting DSM-IV-TR criteria for ADHD, having specific baseline scores, being able to swallow tablets and capsules, and meeting certain blood pressure measurements.",
    "This sample is a phase 3 clinical trial for patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, testing the effectiveness of the drugs ofatumumab and ibrutinib, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for the treatment of allergic rhinoconjunctivitis, rhinitis, and conjunctivitis using various drugs such as loratadine, olopatadine, mometasone furoate, albuterol, fluticasone, and prednisone, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of drugs such as tiotropium and olodaterol in improving lung function and reducing symptoms. The eligibility criteria include a diagnosis of COPD, stable airway obstruction, and a smoking history of more than 10 pack years.",
    "This sample is a phase 3 trial for participants with schizophrenia, testing the effectiveness of paliperidone extended release (er) and aripiprazole as antipsychotic drugs, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial aims to evaluate the effectiveness of pafuramidine maleate and trimethoprim-sulfamethoxazole in treating Pneumocystis carinii pneumonia (PCP) in HIV-infected individuals, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for attention-deficit/hyperactivity disorder (ADHD) patients who have had an inadequate response to methylphenidate (MPH) treatment, and it will test the efficacy of lisdexamfetamine dimesylate and atomoxetine hydrochloride as alternative drug treatments.",
    "This sample is a phase 3 clinical trial for mood disorders, specifically targeting patients with a diagnosis of a DSM-IV mood disorder and currently displaying symptoms of depression/dysthymia or mania/hypomania. The drug being tested is quetiapine, and the eligibility criteria include age, contraception use, and exclusion of certain medical conditions and medications.",
    "This sample is a phase 3 clinical trial for the treatment of prostate cancer, osteoporosis, and fractures using toremifene citrate, with specific eligibility criteria including age, disease history, and bone density thresholds.",
    "This phase 3 trial is testing the effectiveness of fluticasone furoate/vilanterol inhalation powder, fluticasone furoate inhalation powder, and placebo inhalation powder in treating asthma in outpatients aged 12 and above, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of alogliptin and glyburide in improving glycemic control. The eligibility criteria include specific disease diagnosis, treatment history, BMI range, C-peptide concentration, HbA1c level, blood pressure, and various other factors. Exclusion criteria include certain medical conditions, history of specific treatments, and use of certain medications.",
    "This sample is a phase 3 trial for patients with myocardial infraction, testing the effectiveness of abciximab and abciximab placebo in reducing symptoms and improving outcomes, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial testing the drug tonapofylline and placebo in patients with renal insufficiency and congestive heart failure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of two drugs, mometasone furoate/formoterol (mf/f) mdi and fluticasone propionate/salmeterol (f/sc) dpi, in reducing the need for glucocorticosteroids. The eligibility criteria include a diagnosis of asthma for at least 12 months, stable use of inhaled glucocorticosteroids, and a history of asthma-related unscheduled visits.",
    "This sample is a phase 3 trial for the drug retigabine and placebo in patients with refractory epilepsy and simple or complex partial onset seizures, with inclusion and exclusion criteria specified.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of cytarabine plus daunorubicin in treating previously-untreated acute myeloid leukemia patients, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for attention deficit hyperactivity disorder (ADHD) using oros methylphenidate and placebo as drugs, with inclusion criteria including meeting DSM-IV-TR criteria for ADHD and experiencing at least moderate impairment, and exclusion criteria including current or lifetime history of psychosis and substance dependence within 3 months of screening.",
    "This sample is a phase 3 clinical trial for premenopausal women with estrogen receptor positive breast cancer, testing the effectiveness of tamoxifen, anastrazole (arimidex), and goserelin acetate (zoladex) as treatment options. The eligibility criteria include being aged 20 years and over, having operable and measurable breast cancer, and providing written informed consent. Exclusion criteria include a medical history of chemotherapy or endocrine therapy for breast cancer, treatment history of radiotherapy, and unwillingness to stop taking any drug known to affect sex hormone status.",
    "This phase 3 trial is testing the effectiveness of hzt-501 and ibuprofen in patients with peptic ulcer disease who require daily administration of a nonsteroidal anti-inflammatory drug (NSAID) for at least six months, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for kidney transplantation, focusing on patients aged 60 and above with end-stage kidney disease. The study aims to evaluate the effectiveness of tacrolimus as a medication for these patients, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of autistic disorder using d-cycloserine and placebo drugs, with specific inclusion and exclusion criteria based on age, diagnosis, behavior scores, and medical conditions.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the effectiveness of tocilizumab, placebo, and methotrexate in adult patients who have been on methotrexate for at least 12 weeks and meet other inclusion criteria.",
    "This sample is a phase 3 trial for glaucoma, testing the drugs dorzolamide hydrochloride (+) timolol maleate and their comparators, timolol maleate and dorzolamide hydrochloride, with inclusion criteria of patients with glaucoma and ocular hypertension, and exclusion criteria of recent ocular surgery and contraindication to timolol and dorzolamide.",
    "This sample is a phase 3 clinical trial for patients with thyroid cancer, testing the effectiveness of lenvatinib and placebo drugs, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for breast cancer patients who are HER2-negative, evaluating the effectiveness of docetaxel as a treatment option.",
    "This sample is a phase 3 trial for type 2 diabetes mellitus, testing the drugs vildagliptin and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial that focuses on the treatment of bacterial skin and skin structure infections, including abscesses, wound infections, diabetic foot, and ulcers, using moxifloxacin and piperacillin/tazobactam & amoxicillin/clavulanic acid drugs, with specific eligibility criteria for participants.",
    "This sample is a phase 3 trial for patients with type 1 diabetes mellitus, testing the effectiveness of insulin degludec, insulin detemir, and insulin aspart in maintaining glycemic control, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of ibandronate and zoledronic acid in reducing pain in patients with malignant bone disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for early rheumatoid arthritis, testing the effectiveness of methotrexate as a treatment option, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of exenatide once weekly and insulin glargine in combination with metformin or sulfonylurea, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with operable primary invasive breast cancer, testing the combination of bevacizumab and standard adjuvant chemotherapy as treatment options, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of intravitreal ranibizumab and photodynamic therapy in treating choroidal neovascularization and age-related macular degeneration, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with HIV infections and chronic hepatitis C. The study aims to evaluate the efficacy of ribavirin and HIV antiretroviral therapy in eradicating the hepatitis C virus in patients who have previously failed treatment.",
    "This sample is a phase 3 clinical trial for patients with acute myeloid leukemia (AML) who are not fit for combination induction chemotherapy. The trial is testing the drug tipifarnib (also known as zarnestra or r115777) as a potential treatment option. The inclusion criteria include newly diagnosed or relapsing AML with confirmation of at least 20% bone marrow leukemic blasts and an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2. Exclusion criteria include previous cytotoxic or biologic treatment for AML, acute promyelocytic leukemia (APL), central nervous system leukemia, uncontrolled systemic infection, uncompensated disseminated intravascular coagulation, symptomatic neuropathy of grade 2 or worse, and known allergy to imidazole drugs.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of indacaterol 300 \u03bcg compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for kidney transplant recipients with cardiovascular diseases, testing the effectiveness of mycophenolate mofetil in modifying the immunosuppressive regimen to reduce cardiovascular risk factors.",
    "This sample is a phase 3 clinical trial for the treatment of psoriasis vulgaris involving the face, using drugs such as calcipotriol plus hydrocortisone ointment vehicle, tacalcitol ointment, and calcipotriol plus hydrocortisone ointment. The eligibility criteria include specific clinical signs and severity of the disease, as well as exclusion criteria related to previous treatments and other medical conditions.",
    "This sample is a phase 3 trial for patients with type 2 diabetes and obesity, testing the drug bi 10773 against a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for type 2 diabetics currently receiving a stable dose of TZD monotherapy, testing the efficacy of saxagliptin, pioglitazone, rosiglitazone, and metformin in reducing HbA1c levels.",
    "This phase 3 trial is investigating the efficacy of eribulin mesylate and capecitabine in female patients with metastatic breast cancer who have received up to three prior chemotherapy regimens, and have no more than two prior regimens for advanced and/or metastatic disease.",
    "This sample is a phase 3 clinical trial for the treatment of partial seizures, testing the effectiveness of the drug zonisamide compared to a placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with locally advanced or metastatic prostate cancer, testing the drug triptorelin pamoate 11.25mg, and includes eligibility criteria such as age, testosterone level, performance status, and exclusion criteria such as prior hormonal therapy, other malignancies, and abnormal hematological, hepatic or renal functions.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin and metformin in combination with a placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the efficacy of gsk548470 and etv in treating chronic hepatitis B, with specific eligibility criteria including age, HBV infection status, liver function, and prior therapy history.",
    "This sample is a phase 3 clinical trial for patients with hypertension, testing the effectiveness of azilsartan medoxomil and olmesartan as compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for patients with chronic noncancer pain, testing the effectiveness of oros hydromorphone hcl and oxycodone in providing sufficient pain control.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of carboplatin, cisplatin, paclitaxel, and topotecan hydrochloride in treating histologically confirmed stage IIB-IV ovarian epithelial, primary peritoneal, or fallopian tube cancer patients, with specific eligibility criteria including age, performance status, hematopoietic and renal function, and absence of certain medical conditions or prior treatments.",
    "This phase 3 trial is testing the effectiveness of tiotropium+olodaterol (low dose), tiotropium + olodaterol (high dose), and placebo to tiotropium+olodaterol in patients with chronic obstructive pulmonary disease (COPD) who meet specific spirometric criteria and other eligibility criteria.",
    "This sample is a phase 3 trial testing the efficacy of metronidazole and ceftriaxone sodium in treating intra-abdominal infections, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for chronic low back pain, testing the effectiveness of duloxetine and placebo in male and female outpatients, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of bevacizumab, irinotecan, leucovorin, and fluorouracil in treating adult patients with metastatic colorectal cancer, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for atopic dermatitis, testing the effectiveness of desonide 0.1% cream and vehicle cream in patients with dry skin and xerosis, while excluding those with acute or severe forms of the disease.",
    "This sample is a phase 3 trial for the treatment of psoriasis vulgaris on the face using calcipotriol plus hydrocortisone, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for primary insomnia, testing the drugs vec-162 20 mg and vec-162 50 mg against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of binge eating disorder and obesity, using the drugs lamotrigine and placebo, with eligibility criteria including meeting DSM-IV-TR criteria for BED, having a body mass index > 30 kg/m2, and being between the ages of 18 and 65.",
    "This sample is a phase 2/phase 3 trial for type 2 diabetes mellitus, testing the drugs alogliptin and voglibose, with inclusion criteria requiring completion of a phase 2 study and exclusion criteria related to hepatic and renal impairment.",
    "This sample is a phase 3 clinical trial testing the effectiveness of the drugs abt-335, atorvastatin, and placebo in treating mixed dyslipidemia, coronary heart disease, and dyslipidemia. The eligibility criteria include subjects with mixed dyslipidemia who agree to use birth control methods and adhere to the American Heart Association diet.",
    "This sample is a phase 3 clinical trial studying the effects of the drug vorapaxar versus placebo in patients with a history of atherosclerosis, including diseases such as atherosclerosis, ischemia, myocardial infraction, cerebrovascular accident, and peripheral arterial disease. The eligibility criteria include age, specific medical history, and exclusion criteria such as bleeding disorders, hypertension, and pregnancy.",
    "This sample is a phase 3 trial for generalized anxiety disorder, testing the drugs quetiapine fumarate and paroxetine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the efficacy of paliperidone palmitate compared to a placebo, with inclusion criteria including meeting diagnostic criteria for schizophrenia, specific PANSS scores, and documented history of exposure to risperidone or paliperidone.",
    "This sample is a phase 3 clinical trial testing the effectiveness of citicoline, a drug, in treating acute stroke and cerebral infraction, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of dyspepsia using cinitapride and domperidone, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial testing the drug rosuvastatin in individuals with elevated high-sensitivity C-reactive protein (hsCRP) levels, and the eligibility criteria include age restrictions, specific cholesterol and CRP levels, and exclusion criteria related to medical history and conditions.",
    "This phase 3 trial is investigating the effectiveness of ralfinamide in treating patients with chronic neuropathic low back pain caused by compression radiculopathy or post-traumatic/post-surgical lumbar radiculopathy, who have a clear neuropathic component and meet specific inclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic plaque psoriasis, testing the effectiveness of cyclosporine a microemulsion compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for infertility, focusing on women undergoing embryo transfer following controlled ovarian hyperstimulation with a fixed GnRH antagonist protocol, and the drugs being tested are triptorelin acetate and nacl %0.9.",
    "This sample is a phase 3 clinical trial testing the effectiveness of saccharomyces boulardii and placebo in adult patients with antibiotic-associated diarrhea and clostridium difficile, who are hospitalized and receiving systemic antibiotic treatment, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of dalbavancin and vancomycin/linezolid in treating major abscess, surgical site infection, traumatic wound infection, or cellulitis caused by Gram-positive bacteria, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial studying the effectiveness of oral glycopyrrolate liquid in reducing chronic drooling in patients with cerebral palsy, neurological conditions, mental retardation, and sialorrhea.",
    "This sample is a phase 3 clinical trial for the treatment of benign prostatic hyperplasia (BPH) using dutasteride (Avodart) and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for type 2 diabetes mellitus, testing the drugs dapagliflozin and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for breast cancer patients with 0-3 positive axillary lymph nodes, testing the effectiveness of the drugs ac regimen, cyclophosphamide, doxorubicin hydrochloride, and paclitaxel, with specific eligibility criteria outlined.",
    "This sample is a phase 3 clinical trial for allergic rhinitis, testing the effectiveness of Dymista Nasal Spray and fluticasone propionate nasal spray in children aged 4 to 12 years, who have a history of allergic rhinitis and require treatment with Dymista Nasal Spray.",
    "This sample is a phase 3 trial for the treatment of acromegaly, a condition characterized by excessive growth hormone production. The study aims to evaluate the efficacy of two drugs, c2l-oct-01 pr and octreotide acetate prolonged release, in patients who meet specific inclusion criteria. The criteria include having a diagnosis of active acromegaly, stable treatment for at least 12 weeks prior to entry, and normal or acceptable levels of IGF-1 depending on the treatment received. The sample also lists exclusion criteria, such as pregnancy, previous treatment with a growth hormone receptor antagonist, recent pituitary surgery or radiotherapy, intolerance or allergy to the test article, and other conditions that affect growth hormone or IGF-1 levels.",
    "This sample is a phase 3 trial for fibromyalgia, testing the drugs xyrem\u00ae and placebo, with inclusion criteria being subjects who meet the ACR diagnostic criteria for fibromyalgia and exclusion criteria being subjects with a history of rheumatic disease or other disorders that may compromise reliable representation of subjective symptoms.",
    "This sample is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) patients who have previously used methylphenidate and are willing to take the supplied study drug as treatment, with specific inclusion and exclusion criteria, and a requirement to avoid caffeine during certain study days.",
    "This sample is a phase 3 clinical trial for the treatment of hepatitis C, testing the drugs telaprevir and ribavirin, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for major depressive disorder, testing the drug desvenlafaxine succinate, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of cytomegalovirus infections in kidney transplant recipients using valganciclovir, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of mania and bipolar disorder, using quetiapine fumarate and lithium as drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for pediatric subjects with severe forms of sickle cell anemia, testing the effectiveness of hydroxyurea in reducing transfusional iron overload and preventing stroke recurrence.",
    "This sample is a phase 2/phase 3 trial for esophageal cancer, testing the drugs capecitabine and cisplatin in patients with localized, nonmetastatic disease who are not suitable for surgery, and have specific disease and patient characteristics.",
    "This sample is a phase 3 trial for erosive esophagitis, testing the efficacy and safety of lafutidine, famotidine, and omeprazole in patients with heartburn symptoms and reflux esophagitis. The inclusion criteria include patients with grade A to D reflux esophagitis, while exclusion criteria include gastric or duodenal ulcers, Barrett's esophagus, poor response to H2RA or PPI, and other conditions that may affect efficacy and safety assessment.",
    "This sample is a phase 3 clinical trial for patients with chronic kidney disease and hyperphosphatemia, testing the effectiveness of the drug MCI-196 (colestilan, colestimide, cholebine\u00ae) compared to a placebo and another phosphate binder (sevelamer) in maintaining stable phosphate control. The inclusion and exclusion criteria are also provided.",
    "This phase 3 trial aims to evaluate the efficacy of ziprasidone compared to placebo in treating adults with Bipolar I disorder, most recent episode depressed, who have been receiving therapeutic doses of lithium, valproate, or lamotrigine for at least 4 weeks prior to randomization. The study excludes patients with ultra-fast rapid cycling, significant heart disease, and psychotic symptoms.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the drug bortezomib. The eligibility criteria include having previously been diagnosed with multiple myeloma, requiring second-, third-, or fourth-line therapy, and having measurable disease.",
    "This phase 3 trial is investigating the effectiveness of antiandrogen therapy and releasing hormone agonist therapy in patients with prostate cancer who have either experienced PSA relapse or have incurable disease, and meet specific criteria for eligibility.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the efficacy of a chemotherapy regimen consisting of epirubicin, docetaxel, capecitabine, and trastuzumab. The eligibility criteria include specific age range, performance status, absence of prior neoplasms, normal cardiac function, and various laboratory requirements. The exclusion criteria include specific disease stages, pregnancy or lactation, pre-existing neurotoxicity, prior or concomitant systemic antitumor therapy, and other serious illnesses or medical conditions.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus and moderate or severe renal impairment, testing the effectiveness of vildagliptin and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with cystic fibrosis and a lower respiratory tract infection with Pseudomonas aeruginosa. The trial aims to evaluate the efficacy of tobramycin solution for inhalation 300 mg in treating the infection. The inclusion criteria include a confirmed diagnosis of cystic fibrosis and a documented Pseudomonas aeruginosa infection, while the exclusion criteria include hypersensitivity to aminoglycosides and recent use of investigational drugs or loop diuretics.",
    "This sample is a phase 3 trial for patients with chronic malignant tumor-related cancer pain, testing the effectiveness of oxycodone cr and r331333 in providing pain relief for those dissatisfied with current treatment.",
    "This phase 3 trial is investigating the efficacy of bardoxolone methyl, a drug, in patients with chronic renal insufficiency and type 2 diabetes, who are already on ACE inhibitors and/or ARBs, and meet specific eligibility criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of different drug combinations including valsartan and nateglinide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with hypercholesterolemia, testing the efficacy of ezetimibe and various comparator drugs in managing the disease, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of budesonide/formoterol (Symbicort) pmdi and formoterol turbuhaler in reducing COPD exacerbations. The inclusion criteria include a current clinical diagnosis of COPD, a smoking history of 10 or more pack years, and a history of COPD exacerbations requiring steroids and/or antibiotics. The exclusion criteria include a history of asthma or allergic rhinitis at or after 18 years of age, subjects taking oral steroids, and any significant disease or disorder that may jeopardize safety.",
    "This sample is a phase 3 trial testing the drugs fenofibrate/simvastatin and simvastatin for the treatment of hyperlipidemia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer (NSCLC) patients who have received specific induction therapies, and it aims to evaluate the efficacy of pemetrexed and placebo as maintenance therapy after induction therapy.",
    "This phase 3 trial is investigating the effectiveness of placebo, flurbiprofen, and acetaminophen 650mg in treating pharyngitis, with eligibility criteria including a complaint of sore throat and exclusion criteria such as a history of upper gastrointestinal ulcer or chronic analgesic use.",
    "This sample is a phase 3 clinical trial for eczema, testing the effectiveness of clobetasone butyrate 0.05% cream and a base cream, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with melanoma, testing the effectiveness of dabrafenib and trametinib in treating BRAF V600E/K mutation-positive melanoma, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with hypertension, testing the drugs telmisartan+amlodipine and amlodipine, with eligibility criteria including age > 20 years, ability to stop current anti-hypertensive therapy, and written informed consent.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of acetylsalicylic acid (aspirin complex, baye4465) + pseudoephedrine and acetylsalicylic acid (aspirin, baye4465) in treating common cold and pharyngitis symptoms in male and female subjects between 18 and 65 years of age, who have experienced cold symptoms within 96 hours before study participation and have moderate sore throat and nasal congestion.",
    "This sample is a phase 3 clinical trial for multiple sclerosis, testing the drugs rnf and placebo, with eligibility criteria including specific disease characteristics, age range, and willingness to follow study procedures.",
    "This sample is a phase 3 clinical trial for the treatment of osteoarthritis in patients aged 50 and older, using the drug celecoxib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with open-angle glaucoma or ocular hypertension, testing the effectiveness of multiple IOP-lowering medications including brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension, brinzolamide 1% ophthalmic suspension, and brimonidine tartrate 0.2% ophthalmic solution, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of osteoporosis using bazedoxifene acetate, with specific inclusion and exclusion criteria, such as being at least 2 years postmenopausal and not having diseases that may affect bone metabolism.",
    "This sample is a phase 3 trial for heavy menstrual bleeding, testing the drugs levosert-20 and mirena, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 clinical trial is testing the drug gefitinib for the treatment of lung cancer in patients with adenocarcinoma of the lung, stage IIIB or IV, who are non-smokers and have good performance status, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial testing the effectiveness of duloxetine and placebo in treating chronic low back pain, with specific inclusion and exclusion criteria, and a list of icd-10 codes associated with the disease.",
    "This sample is a phase 3 trial for patients with primary hypertension, testing the efficacy of candesartan cilexetil and hydrochlorothiazide as monotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of canagliflozin and sitagliptin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with colorectal cancer, testing the effectiveness of capecitabine, 5-fluorouracil (5-fu), leucovorin calcium, and oxaliplatin as treatment options. The eligibility criteria include having undergone curative surgery within 4-8 weeks prior to randomization and having an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. Exclusion criteria include evidence of remaining tumor, certain cardiovascular diseases, and various other medical conditions.",
    "This sample is a phase 3 clinical trial for lapatinib, a drug used to treat metastatic breast cancer, specifically in patients with amplification of the ErbB2 gene or overexpression of the ErbB2 protein. The trial aims to assess the efficacy and safety of lapatinib in this patient population, and includes specific eligibility criteria such as prior treatment with taxane-containing and anthracycline-containing regimens, as well as trastuzumab plus cytotoxic chemotherapy or anti-hormonal regimen in the metastatic setting.",
    "This sample is a phase 3 clinical trial for cystic fibrosis patients who are currently receiving treatment with a pancreatic enzyme product, and it aims to evaluate the efficacy of pancrelipase delayed release compared to a placebo comparator in improving pancreatic exocrine insufficiency.",
    "This sample is a phase 3 trial for patients with attention deficit disorder with hyperactivity, testing the efficacy of double blind placebo and double blind pr oros methylphenidate drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of docetaxel, trastuzumab, epirubicin, cyclophosphamide, 5-fluoruracil, and granulocyte-colony stimulating growth factor in treating women with HER2-positive breast cancer who have undergone surgery and have no evidence of local or metastatic disease.",
    "This sample is a phase 3 clinical trial for patients with visual impairment due to macular edema following branch retinal vein occlusion (BRVO). The drug being tested is ranibizumab, and the eligibility criteria include specific visual acuity measurements and exclusion criteria related to prior treatments and eye conditions.",
    "In this phase 3 trial, the drug being tested is formoterol fumarate inhalation solution for the treatment of chronic obstructive pulmonary disease (COPD), with inclusion criteria including a medical diagnosis of COPD and a current or prior history of cigarette smoking, and exclusion criteria including a medical diagnosis of asthma and significant conditions or diseases other than COPD.",
    "This sample is a phase 3 clinical trial for patients with breast cancer and osteoporosis, testing the effectiveness of risedronate sodium in premenopausal women undergoing adjuvant or neoadjuvant chemotherapy, with specific eligibility criteria and contraindications.",
    "This sample is a phase 3 trial for patients with relapsed non-Hodgkin's lymphoma, testing the combination of galiximab and rituximab as a retreatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the drug lacosamide for the treatment of partial epilepsies and partial onset seizures, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for HIV infections and AIDS, testing the effectiveness of drugs such as enfuvirtide, emtricitabine/tenofovir, and lopinavir or efavirenz, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for kidney transplantation, focusing on patients between 5 and 65 years old with compatible ABO blood type, and the drug being tested is tacrolimus.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C. The study includes participants with genotype 1 infection and specific liver biopsy results. The drugs being tested are ribavirin, placebo, and boceprevir. The inclusion criteria include age, weight, and agreement to use contraception. The exclusion criteria include coinfection with HIV or hepatitis B, prior treatment for hepatitis C, and various medical conditions.",
    "This sample is a phase 3 clinical trial for the drug paricalcitol in patients with chronic kidney disease, focusing on eligibility criteria such as age, diagnosis, and specific laboratory values.",
    "This sample is a phase 3 trial for osteoarthritis, testing the drugs mk0663 and etoricoxib against the comparator drug celecoxib, with inclusion criteria being osteoarthritis of the knee or hip requiring pain relief medication and exclusion criteria being any known allergy to the study drugs.",
    "This sample is a phase 3 trial for patients with myocardial infraction, testing the effectiveness of enoxaparin, tenecteplase, and clopidogrel in reducing bleeding events and evaluating the study primary endpoint.",
    "This sample is a phase 3 clinical trial for patients with hypertension who have failed to respond to amlodipine monotherapy, and it aims to evaluate the efficacy of a fixed dose combination of telmisartan+amlodipine in controlling blood pressure.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, schizoaffective disorders, and psychotic disorders using the drug quetiapine ir (immediate release). The eligibility criteria include age between 18 to 65 years and the need for treatment for an acute episode of schizophrenia/schizoaffective disorder.",
    "This sample is a phase 3 trial for the drug flibanserin, targeting women with sexual dysfunctions, psychological, and includes inclusion and exclusion criteria such as age, sexual activity frequency, contraceptive use, and exclusion of certain medical conditions and medications.",
    "This sample is a phase 3 trial for age-related macular degeneration (AMD) using ranibizumab as the drug, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the effectiveness of insulin glulisine / insulin glargine and insulin glulisin / insulin detemir in controlling blood glucose levels. The study includes specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2/phase 3 trial investigating the use of zoledronic acid and alendronate in patients who have undergone heart or liver transplantation and have diseases related to bone resorption. The eligibility criteria include age, race, and exclusion of certain conditions such as hyperparathyroidism and cancer.",
    "This sample is a phase 3 trial for asthma, testing the drugs budesonide/formoterol (symbicort), fluticasone/salmeterol (advair diskus), and albuterol (ventolin) on patients who meet the inclusion criteria of having a diagnosis of asthma and receiving asthma maintenance therapy within the previous 4 weeks.",
    "This sample is a phase 3 trial for insomnia, testing the effectiveness of esmirtazapine and placebo in improving sleep quality, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of the drug bi 10773 compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of asenapine and placebo in treating the disease, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for type 2 diabetes mellitus, testing the drugs pioglitazone, placebo, and rivoglitazone hcl, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for fibromyalgia, testing the effectiveness of pregabalin and placebo drugs, with inclusion criteria requiring patients to have fibromyalgia and exclusion criteria excluding patients with other painful conditions.",
    "This sample is a phase 3 trial for essential hypertension, testing the efficacy and safety of olmesartan medoxomil, amlodipine, and hydrochlorothiazide as antihypertensive drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of elvitegravir, raltegravir, and background regimen in HIV-infected individuals with documented resistance or prior experience with antiretroviral agents, who are eligible to receive ritonavir-boosted-PIs and an allowed second agent, and meet various eligibility criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of ramosetron and granisetron in reducing vomiting and nausea symptoms in cancer patients undergoing designated chemotherapy programs, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the drug decitabine for patients with myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms, who are ineligible for intensive chemotherapy, and meet specific eligibility criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of abt-335, atorvastatin, and ezetimibe in treating mixed dyslipidemia, a condition characterized by high triglycerides and low HDL cholesterol levels, in patients with coronary heart disease and combined dyslipidemia. The trial will assess the eligibility criteria, including specific lipid level thresholds, and will exclude individuals with unstable medical conditions or those taking certain medications.",
    "This sample is a phase 3 clinical trial for the treatment of psoriasis vulgaris using drugs such as calcipotriol and betamethasone gel, leo 80185 vehicle, and tacalcitol ointment, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for patients with mild to severe atopic dermatitis, testing the effectiveness of tacrolimus ointment compared to a placebo ointment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for chemotherapy-induced nausea and vomiting, testing the effectiveness of netupitant and palonosetron, palonosetron, and dexamethasone as antiemetic drugs, with specific eligibility and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with melanoma, testing the effectiveness of dacarbazine plus genasense compared to dacarbazine plus placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of vortioxetine (lu aa21004) compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for chronic prostatitis with chronic pelvic pain syndrome and prostatitis, testing the effectiveness of botulinum toxin type A compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for diabetic macular edema, testing the effectiveness of intravitreal aflibercept injection (Eylea) in improving vision in adults with diabetes mellitus. The inclusion criteria include adults with type 1 or 2 diabetes mellitus, decrease in vision primarily due to DME, and a specific range of BCVA ETDRS letter score. Exclusion criteria include recent laser photocoagulation or corticosteroid use in the study eye, previous treatment with anti-angiogenic drugs, active proliferative diabetic retinopathy, uncontrolled diabetes mellitus, and having only one functional eye.",
    "This sample is a phase 3 clinical trial for venous thromboembolism, testing the effectiveness of enoxaparin sodium, semuloparin sodium, and placebo in preventing deep vein thrombosis or pulmonary embolism in patients undergoing surgery for fracture of the upper third of the femur.",
    "This sample is a phase 3 clinical trial for participants with schizophrenia who have previously been treated with Risperdal, Zyprexa, or Seroquel and are now poorly controlled. The study aims to evaluate the efficacy and safety of paliperidone er as a potential alternative medication. The inclusion criteria include meeting the DSM-IV diagnosis criteria for schizophrenia, previous treatment with the specified antipsychotics, and stable illness. Exclusion criteria include recent treatment with clozapine or risperidone microspheres, history of seizures (except febrile convulsion), refractory schizophrenia, recent electric shock treatment, and serious, unstable physical diseases. Female participants must meet additional criteria related to contraception and pregnancy testing.",
    "This sample is a phase 3 clinical trial for bladder cancer, testing the drug mitomycin c, and includes eligibility criteria such as tumor size, prior medical history, and concurrent therapies.",
    "This sample is a phase 3 clinical trial for patients with advanced or metastatic soft tissue sarcoma, testing the effectiveness of doxorubicin hydrochloride and ifosfamide as treatment options, with specific eligibility criteria for patients' disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C using peginterferon alfa-2a, with specific inclusion and exclusion criteria, such as quantifiable HCV RNA, liver biopsy consistent with chronic hepatitis C, and absence of liver cirrhosis.",
    "This sample is a phase 2/phase 3 trial for obesity, with the icd-10 codes E66.8, E66.9, E66.1, O99.214, O99.215, O99.210, and O99.211. The drugs being tested are cp-945,598 and sibutramine, and the eligibility criteria include specific BMI ranges and exclusion criteria for blood pressure, diabetes, eating disorders, and appetite/weight modifying drugs.",
    "This sample is a phase 3 clinical trial for patients with diabetes, specifically type 2 diabetes, who are insulin naive or have had short-term insulin treatment. The study aims to evaluate the efficacy of insulin degludec and insulin glargine in combination with metformin or other oral antidiabetic drugs in achieving glycemic control. The inclusion criteria include specific HbA1c levels, BMI, and current treatment regimens, while the exclusion criteria include recent use of certain medications, cardiovascular disease, uncontrolled hypertension, pregnancy, breastfeeding, and history of cancer.",
    "This sample is a phase 2/phase 3 trial for patients with unresectable advanced gastric carcinoma and recurrent gastric carcinoma, testing the efficacy of tegafur/gimeracil/oteracil potassium (s-1) and krestin (psk) in combination as a treatment option. The eligibility criteria include age, prior treatment history, organ function, performance status, and written informed consent. There are also exclusion criteria, such as certain medical conditions and medications, that would make patients ineligible for the study.",
    "This phase 3 clinical trial is testing the drug fluorouracil for the treatment of advanced metastatic kidney cancer, and includes eligibility criteria such as confirmed renal cell carcinoma, measurable disease, and specific patient characteristics.",
    "This sample is a phase 3 clinical trial for postmenopausal osteoporosis, testing the drugs alendronate and denosumab, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for relapsing multiple sclerosis, testing the effectiveness of the drug \"rebif new formulation + prophylactic ibuprofen\" and \"rebif new formulation + ibuprofen prn\" in patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for exercise-induced asthma, testing the effectiveness of drugs such as montelukast sodium, salmeterol xinafoate, and fluticasone propionate, with eligibility criteria including children aged 6-14 with a history of asthma and airway constriction caused by exercise.",
    "This sample is a phase 3 trial for essential hypertension, testing the drugs olmesartan medoxomil and amlodipine, with specific inclusion and exclusion criteria related to blood pressure and cardiovascular health.",
    "This phase 3 trial aims to evaluate the efficacy of tapentadol extended release and morphine sulphate controlled release in treating chronic malignant tumor-related pain in opioid-na\u00efve or dissatisfied patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with major depressive disorder, testing the drug saredutant succinate (sr48968c) to evaluate its effectiveness in reducing symptoms of depression. The inclusion criteria include being 18 to 64 years old, having a confirmed diagnosis of major depressive disorder, and a minimum total score of 22 on the Montgomery-Asberg Depression Rating Scale (MADRS). The exclusion criteria include having certain types of depressive episodes, a history of suicide attempts, and certain medical disorders.",
    "This sample is a phase 3 clinical trial for allergic rhinitis, testing the effectiveness of the drug bdp compared to a placebo, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 3 clinical trial for schizoaffective disorder, testing the effectiveness of paliperidone palmitate (a drug) compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for HIV infections, testing the drugs nevirapine ir and nevirapine xr, with eligibility criteria including HIV-1 infection, no previous antiretroviral treatment, specific CD4+ counts, adequate renal function, and willingness to follow study protocols. Exclusion criteria include active drug abuse, hepatitis B or C, pregnancy or unwillingness to use contraception, and previous use of certain medications.",
    "This sample is a phase 3 clinical trial for patients with mantle cell lymphoma (MCL) who have received multiple prior therapies, and it aims to evaluate the efficacy of temsirolimus (cci-779) and investigator's choice of treatment. The eligibility criteria include confirmation of MCL diagnosis, prior treatment with specific agents, and refractory status. Exclusion criteria include recent allogeneic hematopoietic stem cell transplant and active central nervous system metastases.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of duloxetine, and includes inclusion and exclusion criteria for participants.",
    "This phase 3 trial aims to evaluate the effectiveness of rosuvastatin, ezetimibe, and simvastatin in reducing cholesterol levels in patients with hypercholesterolemia, coronary heart disease, and atherosclerosis, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of docetaxel, epirubicin, cyclophosphamide, 5-fluoruracil, and granulocyte-colony stimulating growth factor in treating women with histologically-confirmed unilateral invasive ductal or lobular breast adenocarcinoma, who have undergone surgical excision of the primary tumor with tumor-free operation margins and have at least one axillary lymph node involvement, while meeting various eligibility criteria.",
    "This sample is a phase 3 clinical trial for primary insomnia, testing the drugs suvorexant high dose (hd), suvorexant low dose (ld), and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of indacaterol and tiotropium compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial testing the effectiveness of risperidone in treating various behavioral disorders including oppositional defiant disorder, conduct disorder, ADHD, and bipolar disorder in children aged 4 to 14 years. The inclusion criteria include specific dosage requirements and the need for a reliable adult carer, while exclusion criteria include certain psychiatric disorders and pregnancy.",
    "This sample is a phase 2/phase 3 trial for patients with cutaneous T-cell lymphoma (CTCL) who have had disease progression on or following treatment with an HDAC inhibitor. The drug being tested is lbh589, and the eligibility criteria include biopsy-confirmed stages IB-IVA mycosis fungoides or S\u00e9zary syndrome.",
    "This sample is a phase 3 trial for patients with severe persistent asthma, testing the effectiveness of omalizumab compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the drug kad-1229, and the inclusion criteria include inadequate glycemic control with diet and biguanide or DPP-4 inhibitor monotherapy.",
    "This sample is a phase 3 clinical trial for the treatment of rheumatoid arthritis using the drug adalimumab, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of thalidomide and dexamethasone as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with diabetes mellitus, testing the effectiveness of insulin glulisine, lispro, and insulin glargine in managing blood sugar levels. The eligibility criteria include having type 1 or type 2 diabetes, specific HbA1c levels, and prior insulin treatment. Pregnant women are excluded from the trial.",
    "This sample is a phase 3 trial for patients with Parkinson's disease, testing the drug E2007, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with submassive pulmonary embolism, testing the use of unfractionated heparin as a treatment option. The inclusion criteria include acute PE symptoms < 14 days, contrast-enhanced chest CT showing a filling defect in the pulmonary artery, and right ventricular dysfunction confirmed by echocardiography. The exclusion criteria include age less than 18 or greater than 80, bleeding risk, recent bleeding or surgery, allergy to heparin or contrast, and various other conditions that may increase the patient's risk.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of cyclophosphamide, docetaxel, and doxorubicin in combination with radiotherapy and surgery, with specific eligibility criteria including disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 clinical trial for male osteoporosis, testing the effectiveness of ibandronate and placebo drugs, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for the treatment of acute gouty arthritis, with the drugs indomethacin and celecoxib being tested, and the inclusion criteria requiring patients to meet the American College of Rheumatology criteria for acute arthritis of primary gout.",
    "This sample is a phase 3 clinical trial for bipolar disorder, testing the drug aripiprazole, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with advanced, incurable squamous cell carcinoma of the head and neck. The study aims to evaluate the efficacy of methotrexate and paclitaxel as treatment options for patients who are ineligible for cisplatin-based therapy due to various reasons such as hearing loss, renal insufficiency, or history of brain metastases.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the efficacy of vortioxetine compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for the treatment of open-angle glaucoma and ocular hypertension using two different eye drop solutions, brinzolamide 10 mg/ml + timolol 5 mg/ml and dorzolamide 20 mg/ml + timolol 5 mg/ml. The eligibility criteria include being 18 years or older and having a diagnosis of open-angle glaucoma or ocular hypertension.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of ly2216684, placebo, and selective serotonin reuptake inhibitors (SSRIs) in patients who have had a partial response to SSRI treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with ulcerative colitis, testing the effectiveness of budesonide, a drug used to treat inflammatory bowel disease, in achieving clinical remission. The inclusion criteria include patients who have completed a previous study and have a diagnosis of mild to moderate ulcerative colitis, while the exclusion criteria include patients with severe ulcerative colitis, infectious colitis, or certain medical conditions that may make the administration of the study drug hazardous.",
    "This sample is a phase 2/phase 3 trial for allergic rhinoconjunctivitis, testing the drugs avanz phleum pratense and placebo, with inclusion criteria including a history of grass pollen allergy and positive skin prick and Immunoglobulin E tests to grass, and exclusion criteria including other allergies overlapping the grass pollen season and severe asthma.",
    "This sample is a phase 3 clinical trial for patients with ankylosing spondylitis, testing the effectiveness of a placebo drug. The eligibility criteria include age, disease duration, disease activity, previous treatment, and stable doses of corticosteroids and NSAIDs. Exclusion criteria include recent surgery, total ankylosis of the spine, other inflammatory rheumatic diseases, active uveitis, previous TNF antagonist therapy, recent corticosteroid injections, severe allergic reactions, active or history of infections, immunodeficiency, and body weight over 150 kg.",
    "This sample is a phase 3 trial for chronic hepatitis C, testing the drug amantadine, with inclusion criteria including anti-HCV positivity, ALT/AST elevation, positive HCV-RNA, and intention to be treated, and exclusion criteria including age < 18 years, pregnancy, and other serious diseases.",
    "This sample is a phase 3 trial for patients with pulmonary embolism, testing the effectiveness of rivaroxaban, unfractionated heparin, and warfarin as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for type 2 diabetes, testing the drugs dapagliflozin and thiazolidinedione (pioglitazone) against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with diabetes mellitus and macular edema, testing the effectiveness of ranibizumab and sham injection in improving visual acuity and reducing retinal thickening.",
    "This phase 3 trial aims to evaluate the efficacy of timolol/ fdc/ placebo/ tafluprost in patients with ocular hypertension or open-angle glaucoma, based on specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of various drugs, including wal801cl dry syrup and ketotifen fumarate dry syrup, in treating perennial allergic rhinitis in children aged 15 or younger, who have a body weight of 14 kg or more and meet specific inclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of chronic low back pain using the drug alo-02, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of human immunodeficiency virus (HIV) infections using lopinavir/ritonavir (lpv/r) in combination with nucleoside reverse transcriptase inhibitors (nrtis), with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of formoterol and budesonide/formoterol drugs in treating mild and stable asthma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the drug doripenem for the treatment of complicated lower urinary tract infections or pyelonephritis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with cystic fibrosis and chronic infection with Pseudomonas aeruginosa, testing the effectiveness of liposomal amikacin for inhalation and tobramycin inhalation solution in improving lung function.",
    "This sample is a phase 3 clinical trial for an oral contraceptive drug (ee20/drsp and ethinylestradiol/desogestrel) in healthy female subjects aged 18-35 who are currently using a low-dose EE containing oral contraceptive and experiencing hormone withdrawal symptoms. The trial aims to assess the efficacy and safety of the drug in reducing these symptoms.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin, liraglutide, glimepiride, and metformin in combination with stable metformin monotherapy. The eligibility criteria include specific requirements for diabetes type, metformin dosage, and hemoglobin A1C levels, while excluding patients with certain medical conditions or history of malignancy.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of fluvastatin and standard therapy in patients with chronic nephropathy, proteinuria, and hypertension, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with non-small-cell lung carcinoma, testing the drug zd6474 (vandetanib) as a treatment option for those who are no longer eligible for standard cancer treatments. The inclusion criteria include patients who have exhausted other treatment options, while the exclusion criteria include recent standard cancer treatments and significant cardiovascular events.",
    "This sample is a phase 2/phase 3 clinical trial for the treatment of hepatitis C, using the drugs Algeron, Pegintron, and Ribavirin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients diagnosed with idiopathic Parkinson's Disease, testing the efficacy of the drugs ipx066 and cle in reducing symptoms and improving quality of life, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of salmeterol/fluticasone propionate 50/500mcg diskus as a treatment option. The inclusion criteria include having a clinical history of COPD, being a current or ex-smoker with a smoking history of at least 10 pack-years, and having reduced lung function. The exclusion criteria include having a diagnosis of any other serious disease and requiring a chest X-ray to rule out a diagnosis other than COPD.",
    "This sample is a phase 3 clinical trial for systemic lupus erythematosus, testing the efficacy of belimumab at different doses compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "In this phase 3 trial, the drug combination of fenofibrate/simvastatin is being tested for the treatment of mixed dyslipidemia in patients with cardiovascular diseases, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of migraines in females, using frovatriptan 2.5 mg, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for fibromyalgia, testing the drug Xyrem\u00ae. The inclusion criteria include completing previous studies and being able to take Xyrem\u00ae for approximately 9-1/2 months, while the exclusion criteria include early termination or experiencing serious adverse events related to the study drug in previous studies.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of risperidone as an adjunctive treatment for patients who have shown a sub-optimal response to an antidepressant.",
    "This sample is a phase 3 trial for rheumatoid arthritis, testing the drugs golimumab and methotrexate, along with a placebo, on patients who meet specific inclusion criteria, such as having a diagnosis of active RA and being on a stable dose of methotrexate.",
    "This sample is a phase 3 trial for patients with atrial fibrillation and atrial flutter, testing the effectiveness of warfarin and apixaban in reducing the risk of stroke in patients with these conditions. The eligibility criteria include age, previous stroke or transient ischemic attack, congestive heart failure, and diabetes or hypertension requiring medication.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia and schizoaffective disorder, using the drugs d-serine and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with diffuse large B-cell lymphoma (DLBCL) who have relapsed or are refractory to combination chemotherapy. The study will test the effectiveness of lenalidomide, gemcitabine, oxaliplatin, rituximab, and etoposide in treating DLBCL. The inclusion criteria include histologically proven DLBCL, measurable disease, and an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. Exclusion criteria include other lymphoma histologies, history of malignancies other than DLBCL, eligibility for autologous stem cell transplant, and neuropathy grade 4.",
    "This sample is a phase 3 clinical trial for patients with severe to very severe Chronic Obstructive Pulmonary Disease (COPD), testing the efficacy of qva149, nva237, tiotropium, and salbutamol/albuterol as potential treatments. The eligibility criteria include age, smoking history, lung function measurements, history of COPD exacerbations, and exclusion criteria such as pregnancy, other pulmonary diseases, and certain medical conditions.",
    "This sample is a phase 2/phase 3 trial for the treatment of pulmonary hypertension using the drug tadalafil, with specific eligibility criteria including biopsy proven sarcoidosis, certain pulmonary pressure measurements, lung function tests, and stable sarcoidosis treatment regimen.",
    "This sample is a phase 3 clinical trial for osteoporosis, testing the effectiveness of zoledronic acid, alendronate, and calcium/vitamin D in postmenopausal women with low bone mineral density. The inclusion criteria include a \"t-score\" of -2.0 or lower, while the exclusion criteria include previous use of certain medications.",
    "This sample is a phase 2/phase 3 trial for patients with atrial flutter, testing the effectiveness of vernakalant injection 20 mg/ml in treating dysrhythmic symptoms lasting between 3 hours and 45 days, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for gout patients, testing the drugs febuxostat and allopurinol, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for bladder cancer patients, testing the drug gefitinib, and includes eligibility criteria such as histological confirmation of transitional cell carcinoma, negative radiology for metastatic disease, and specific patient characteristics.",
    "This sample is a phase 2/phase 3 trial for major depressive disorder, testing the efficacy of drugs such as eb-1010 and SSRI active, with specific eligibility criteria including a history of inadequate response to previous SSRI or SNRI treatments and a minimum score on the Hamilton Rating Scale for Depression.",
    "This sample is a phase 2/phase 3 trial for Huntington's disease, testing the effectiveness of minocycline and a matching placebo in patients who are 18 years or older, have clinical features or a family history of HD, are independently walking and self-sufficient, and able to take medication orally.",
    "This phase 3 clinical trial is testing the effectiveness of ampicillin sodium/sulbactam sodium, an antibiotic, in treating moderate to severe community acquired pneumonia in patients aged 16 and older, who require initial intravenous therapy and hospitalization.",
    "This sample is a phase 3 trial for patients with non-valvular atrial fibrillation, testing the efficacy of idrabiotaparinux sodium, warfarin, and placebos in preventing stroke or systemic embolism in patients with risk factors such as hypertension, impaired left ventricular function, congestive heart failure, age over 75, and diabetes mellitus.",
    "This phase 3 trial is investigating the use of sorafenib tosylate and sunitinib malate drugs in patients with clear cell renal cell carcinoma, stage I-III renal cell cancer, and specific icd-10 codes, who meet various eligibility criteria including no prior anti-cancer therapy, no serious intercurrent illness, and specific tumor characteristics.",
    "This sample is a phase 3 clinical trial testing the effectiveness of cellulose sulfate vaginal gel as a microbicide for preventing HIV infections, gonorrhea, and chlamydia infections in women aged 18-35 who engage in regular sexual activity with multiple partners.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of various drugs including 62.5/25mcg, 62.5mcg, 25mcg, and placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for patients with perennial allergic rhinitis, testing the effectiveness of bilastine, cetirizine, and placebo drugs, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients diagnosed with Restless Legs Syndrome (RLS), testing the drug ropinirole as a potential treatment option. The inclusion criteria include patients with RLS symptoms and the need for written informed consent, while the exclusion criteria involve patients with other sleep disorders or movement disorders.",
    "This study is a phase 2/phase 3 trial investigating the use of fluvastatin, a statin medication, in patients undergoing renal transplantation. The eligibility criteria include specific age range, type of kidney transplantation, LDL-cholesterol levels, immunosuppression regimen, and exclusion criteria such as previous statin use and certain medical conditions.",
    "This phase 3 trial is investigating the efficacy of carboplatin, cisplatin, doxorubicin hydrochloride, methotrexate, paclitaxel, and vinblastine sulfate in treating bladder and urethral cancer patients who have undergone radical cystectomy and pelvic lymph node dissection, with specific eligibility criteria including histological confirmation, absence of distant metastatic disease, and certain pathological staging requirements.",
    "This sample is a phase 3 trial for patients with hypertension, testing the drug aliskiren/hctz, and includes eligibility criteria for participation in the study.",
    "This sample is a phase 3 clinical trial for patients with polycythemia vera, testing the effectiveness and safety of hydroxyurea as a treatment option, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of multiple drugs including gsk573719/gw642444 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the effectiveness of quetiapine sr, an antipsychotic drug, in treating anxiety disorders, specifically generalized anxiety disorder (GAD), with specific inclusion and exclusion criteria for patient selection.",
    "This phase 3 trial aims to evaluate the effectiveness of paricalcitol and maxacalcitol in treating secondary hyperparathyroidism in hemodialysis patients with chronic kidney disease stage 5, who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This sample is a phase 3 trial studying the use of FK506E in heart, liver, and kidney transplantation patients, with specific inclusion and exclusion criteria, and the drug FK506E being the focus of the study.",
    "This sample is a phase 3 trial testing the effectiveness of ivabradine and placebo in patients with coronary disease and left ventricular dysfunction, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the effectiveness of antiandrogen therapy, docetaxel, and goserelin acetate in treating metastatic prostate cancer patients who meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using paliperidone palmitate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for children with type 1 diabetes mellitus, testing the effectiveness of multiple insulin drugs (insulin glulisine, insulin lispro, insulin glargine, nph insulin) in maintaining stable blood glucose levels.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) and includes eligibility criteria such as age, smoking history, and specific diagnostic criteria. The trial compares the drug tiotropium to a placebo, and the inclusion and exclusion criteria are listed in detail.",
    "This sample is a phase 3 trial for participants with chronic myelogenous leukemia (CML) who have previously participated in specific studies and are recommended to continue with the drug peginterferon alfa-2a.",
    "This sample is a phase 3 clinical trial for patients with soft tissue sarcoma, testing the effectiveness of doxorubicin hydrochloride and ifosfamide as treatment options, with specific eligibility criteria including histological confirmation, tumor types, and measurable lesions.",
    "This phase 3 clinical trial is testing the effectiveness of oxaliplatin + 5-fluorouracil/leucovorin and doxorubicin in treating patients with unresectable hepatocellular carcinoma, and it includes eligibility criteria such as having measurable lesions and adequate organ and marrow function.",
    "This phase 3 trial is testing the effectiveness of vortioxetine, a drug used to treat generalized anxiety disorder, compared to a placebo, in patients who meet specific inclusion criteria and do not have any exclusion criteria such as other psychiatric disorders or substance abuse.",
    "The sample is a phase 3 trial for the drug bosentan in patients with pulmonary hypertension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with moderate essential hypertension, testing the effectiveness of valsartan + amlodipine in reducing blood pressure. The inclusion criteria include patients with untreated MSSBP \u2265160 and <180 mmHg, while exclusion criteria include severe hypertension and a history of cardiovascular disease.",
    "This sample is a phase 3 clinical trial for breast cancer patients who have not responded to previous hormonal treatments, and it aims to evaluate the effectiveness of fulvestrant in postmenopausal women with positive estrogen receptor hormone sensitivity.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of alogliptin and pioglitazone in combination with other antidiabetic treatments to achieve adequate glycemic control.",
    "This sample is a phase 3 trial for chronic hepatitis C infection, testing the drugs abt-450/r/abt-267, abt-333, ribavirin, and their placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for metastatic breast cancer patients, testing the effectiveness of placebo, celecoxib, and exemestane drugs, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial testing the effectiveness of capecitabine, celecoxib, and placebo in patients with metastatic colorectal cancer or breast cancer, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for patients with asthma, testing the effectiveness of tiotropium inhalation solution (tiotropium 2.5 mcg and tiotropium 5 mcg) compared to a placebo, with eligibility criteria including a history of asthma, specific lung function measurements, and symptomatic patients on low doses of inhaled corticosteroids.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of escitalopram as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of risperdal consta and paliperidone palmitate drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for newly diagnosed B-precursor acute lymphoblastic leukemia, testing a combination of drugs including cyclophosphamide, cytarabine, daunorubicin hydrochloride, and others, with specific eligibility criteria for patients aged 1 to 30.",
    "This sample is a phase 3 clinical trial for patients with CD20 and CD22-positive, follicular lymphoma, testing the efficacy of a combination treatment including inotuzumab ozogamicin, rituximab, cyclophosphamide, vincristine, prednisone/prednisolone, mitoxantrone, fludarabine, and dexamethasone, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for subjects with schizophrenia or schizoaffective disorder, testing the drugs asenapine and olanzapine. The eligibility criteria include having a diagnosis of schizophrenia or schizoaffective disorder and signing a written informed consent. Exclusion criteria include having any other psychiatric disorder as a primary diagnosis and having an uncontrolled, unstable, clinically significant medical condition.",
    "This sample is a phase 3 trial for patients with moderate to severe active rheumatoid arthritis who have had an inadequate response to a single previous or current treatment with an anti-TNF agent. The drug being tested is rituximab, and the inclusion criteria include being an adult patient between 18-80 years of age and having been on methotrexate for at least 12 weeks.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of linagliptin in combination with metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with locally recurrent or metastatic breast cancer who have received prior chemotherapeutic regimens. The study aims to evaluate the efficacy of the drugs e7389 and physician's choice in treating the disease. The eligibility criteria include specific disease characteristics, prior treatment history, and various health parameters.",
    "This sample is a phase 3 clinical trial for prostate cancer patients with radiograph-documented metastatic disease, testing the efficacy of orteronel, prednisone, and orteronel placebo in participants who have received prior chemotherapy treatments.",
    "This sample is a phase 3 trial testing the effectiveness of olmesartan medoxomil, losartan, and furosemide oral tablets in patients with essential hypertension and renal impairment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for colorectal cancer patients with resectable stage II or III adenocarcinoma of the colon, testing the effectiveness of fluorouracil, leucovorin calcium, and levamisole hydrochloride as treatment options.",
    "This sample is a phase 3 trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the efficacy of indacaterol 150 \u03bcg compared to placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of benzydamine hydrochloride 0.15% oral rinse in preventing oral and/or oropharyngeal mucositis in patients receiving radiation therapy for head and neck cancer.",
    "This sample is a phase 3 trial for HIV infections, testing the effectiveness of atazanavir/ritonavir and lpv/r in combination with 2 nrtis for patients who have been on LPV/RTV-based HAART for at least 6 months, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for primary Sj\u00f6gren's syndrome, testing the effectiveness of hydroxychloroquine compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with major depressive disorder, testing the effectiveness of saredutant (sr48968c) compared to a placebo, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of chronic plaque psoriasis using calcipotriol/betamethasone ointment and placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 trial for the treatment of hepatitis C, using drugs such as sof, rbv, and placebos, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) using atomoxetine hydrochloride and placebo as drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for individuals with mood disorders, specifically testing the effectiveness of lamotrigine, a drug used to treat epilepsy and bipolar disorder, in an orally disintegrating tablet (ODT) formulation for those who have difficulty swallowing the current compressed tablet formulation.",
    "This sample is a phase 3 clinical trial for the treatment of psoriatic arthritis, testing the drugs apremilast 20mg, apremilast 30mg, and placebo, with eligibility criteria including a documented diagnosis of Psoriatic Arthritis, meeting the Classification Criteria for Psoriatic Arthritis, and having \u2265 3 swollen and \u2265 3 tender joints.",
    "This sample is a phase 3 trial for patients with chronic HIV-1 infection, testing the efficacy of ftc/tdf + efv or lpv/r +t20 and ftc/tdf + efv or lpv/r drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for rheumatoid arthritis, testing the drug certolizumab pegol, and the eligibility criteria include moderate to severe RA, failed previous treatments, and currently receiving MTX therapy.",
    "This sample is a phase 3 clinical trial for severe sepsis, testing the drugs eritoran tetrasodium and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for epilepsy, specifically focusing on patients with tonic-clonic seizures, and the drug being tested is levetiracetam. The inclusion criteria include a confirmed diagnosis of epilepsy and previous participation in a double-blind monotherapy trial, while the exclusion criteria include the need for an additional antiepileptic drug.",
    "This phase 3 trial is testing the effectiveness of panitumumab and folfiri in treating metastatic colorectal cancer patients who have experienced disease progression after first-line chemotherapy, with specific eligibility criteria including age, tumor size, ECOG status, and availability of tumor tissue for analysis.",
    "This sample is a phase 3 clinical trial for patients with open-angle glaucoma or ocular hypertension, testing the efficacy of preservative-free tafluprost compared to timolol, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is testing the efficacy of Stribild and Atripla, antiretroviral drugs, in HIV patients with specific eligibility criteria, such as plasma HIV-1 RNA levels \u2265 5,000 copies/mL and normal electrocardiogram (ECG).",
    "This sample is a phase 3 clinical trial for patients with Parkinson's disease, testing the effectiveness of KW-6500, a drug that is self-injected, in improving symptoms and quality of life.",
    "This sample is a phase 3 clinical trial for advanced Parkinson's disease, testing the effectiveness of the drug rotigotine compared to a placebo, with eligibility criteria including a diagnosis of idiopathic Parkinson's disease, a stable dose of L-dopa, and the ability to accurately complete a Parkinson's disease subject diary.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of a combination of drugs including 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for patients with chronic schizophrenia, testing the effectiveness of escitalopram, an SSRI drug, on patients who are on stable doses of antipsychotic medications. The inclusion criteria include being under 60 years old, having a PANSS score of 50 or above, and being clinically stable. Exclusion criteria include comorbidity with mania or major depression, pregnancy, lactation, impaired renal or hepatic function, and sensitivity to cipramil or other SSRIs.",
    "This sample is a phase 2/phase 3 trial that includes patients with chronic myelogenous leukemia, malignant melanoma, and renal cell carcinoma. The trial involves the drugs pegylated interferon alfa-2a and recombinant interferon alfa 2a, and the eligibility criteria include previous completion of specific protocols and response to treatment.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of velcade administered by subcutaneous injection or intravenous infusion as a treatment option. The eligibility criteria include having measurable, secretory multiple myeloma and relapse or progression following prior systemic antineoplastic therapy.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of the drug roflumilast compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial testing the drugs fenofibrate, metformin, and placebo on patients with type 2 diabetes and dyslipidemia, with exclusion criteria of type 1 diabetes.",
    "This sample is a phase 2/phase 3 trial for systemic lupus erythematosus (SLE) using drugs such as rituximab, placebo, prednisone, acetaminophen, and diphenhydramine, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2/phase 3 trial for the treatment of depression, testing the effectiveness of trazodone and placebo in patients aged 18-65 with single episode or recurrent depression, meeting specific criteria, and excluding those with serious suicide attempts, psychotic symptoms, refractory depression, bipolar disorder, significant weight loss, or serious medical conditions.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the drugs lurasidone, olanzapine, and a placebo comparator, with eligibility criteria including meeting DSM-IV criteria for schizophrenia, being off prior antipsychotic medication, and having good physical health.",
    "This phase 3 clinical trial aims to evaluate the efficacy of netupitant and palonosetron, along with other drugs, in preventing chemotherapy-induced nausea and vomiting in patients with malignant tumors who are na\u00efve to cytotoxic chemotherapy.",
    "This sample is a phase 3 trial for children aged 6-11 with diagnosed asthma, testing the effectiveness of budesonide/formoterol pmdi 40/2.25ug + spacer and budesonide/formoterol pmdi 40/2.25 ug in improving lung function, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of perennial allergic rhinitis using the drug ciclesonide hfa 160 \u03bcg, with specific inclusion and exclusion criteria for subjects, including age, health status, and contraceptive use for females.",
    "This sample is a phase 3 trial for postmenopausal women with early breast cancer, testing the effectiveness of letrozole treatment in combination with zoledronic acid, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the effectiveness of bia 9-1067, levodopa, carbidopa, and benserazide in treating Parkinson's disease patients who have been diagnosed for at least 3 years and are experiencing \"wearing-off\" phenomenon despite optimal anti-PD therapy.",
    "This sample is a phase 3 trial for cancer patients who are opioid-tolerant and experiencing breakthrough pain, testing the efficacy of fentanyl sublingual spray compared to a placebo.",
    "This sample is a phase 3 clinical trial for prostate cancer, testing the drugs flutamide, zoladex, and lupron, with eligibility criteria including histologically confirmed locally confined adenocarcinoma of the prostate, negative nodes, and no prior hormonal therapy, radiation, or chemotherapy.",
    "This sample is a phase 3 trial for relapsing-remitting multiple sclerosis, testing the effectiveness of cladribine and placebo drugs, with specific eligibility criteria including age, medical history, and laboratory parameters.",
    "This sample is a phase 3 trial for patients with pulmonary hypertension caused by primary PAH, associated with connective tissue disease or following surgical repair of a congenital heart lesion. The drug being tested is sildenafil citrate.",
    "This sample is a phase 3 trial for the treatment of perennial allergic rhinitis using ciclesonide and mometasone as the drugs, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 clinical trial is testing the effectiveness of cisplatin, cytarabine, dexamethasone, and gemcitabine hydrochloride in treating aggressive non-Hodgkin's lymphoma, with specific eligibility criteria for patients including age range, performance status, and previous treatment history.",
    "This sample is a phase 3 trial for patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) and hemodialysis-dependent chronic kidney disease (HD-CKD) who have anemia. The trial is testing the effectiveness of ferric carboxymaltose and standard medical care in improving iron levels and hemoglobin levels in these patients. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 clinical trial for patients with essential diastolic hypertension, testing the effectiveness of valsartan/amlodipine and valsartan in reducing blood pressure, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of various drugs, including the CHOP regimen, in treating aggressive non-Hodgkin's lymphoma in patients aged 18 to 60, with specific disease characteristics and risk factors, while also considering various patient characteristics and excluding those with certain medical conditions or prior malignancies.",
    "This sample is a phase 3 clinical trial for ulcerative colitis, testing the drugs asacol 800 mg and asacol 400 mg, with eligibility criteria including age, confirmed diagnosis, and moderately active disease.",
    "This sample is a phase 3 trial for patients with breast cancer undergoing myelosuppressive chemotherapy, testing the effectiveness of the drugs ep2006 and filgrastim in preventing chemotherapy-associated neutropenia.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using paliperidone palmitate and placebo, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 3 clinical trial for bipolar disorder, testing the effectiveness of aripiprazole compared to a placebo, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of paliperidone palmitate compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for epilepsy patients with tonic-clonic seizures, testing the effectiveness of lamotrigine extended-release compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the drug bortezomib. The inclusion criteria include symptomatic myeloma diagnosis and recent autologous stem cell transplantation, while exclusion criteria include prior exposure to bortezomib and certain medical conditions.",
    "This sample is a phase 3 clinical trial for fibromyalgia patients with stable depression, testing the effectiveness of pregabalin and placebo as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for bipolar disorder, testing the effectiveness of quetiapine fumarate or valproate as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with rheumatoid arthritis, testing the effectiveness of tocilizumab, placebo, and permitted DMARDs in treating the disease, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the use of seroquel (quetiapine fumarate) tablets in patients with bipolar disorder, specifically those with the most recent episode being depressed. The study is looking for outpatients who meet the inclusion criteria and do not have certain exclusion criteria.",
    "This phase 3 trial is investigating the efficacy of doxorubicin hydrochloride and ifosfamide in treating various types of cancer, including endometrial cancer, kidney cancer, metastatic cancer, ovarian cancer, pheochromocytoma, and sarcoma, in patients who have undergone radical treatment of the primary tumor. The eligibility criteria include specific disease characteristics and patient characteristics such as age, performance status, and hematopoietic and hepatic function.",
    "This sample is a phase 3 clinical trial for patients with exocrine pancreatic insufficiency, steatorrhea, malabsorption syndromes, and cystic fibrosis, testing the effectiveness of pancrease mt 10.5 or mt 21 compared to a placebo in controlling symptoms of EPI.",
    "This sample is a phase 3 trial for the treatment of perennial allergic rhinitis, testing the effectiveness of 0.15% and 0.1% azelastine hydrochloride compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial for multiple sclerosis, testing the drug mycophenolate mofetil (cellcept), and includes eligibility criteria such as age, disease duration, prior treatments, and medical conditions.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the combination therapy of alogliptin and a rapid-acting insulin secretagogue (nateglinide or mitiglinide calcium hydrate) in patients who have been receiving basic diabetes treatment with a stable dosage regimen of the rapid-acting insulin secretagogue.",
    "This sample is a phase 3 trial for epilepsy, testing the effectiveness of topiramate and phenytoin as anti-seizure medications, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using aripiprazole depot and placebo depot, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 3 trial for diabetes, specifically type 2 diabetes, testing the drugs insulin degludec, insulin aspart, and liraglutide. The eligibility criteria include having completed a previous trial with insulin degludec once daily + metformin and adhering to the protocol for self-measurement of plasma glucose. Exclusion criteria include previous treatment with GLP-1 receptor agonists and impaired liver or renal function.",
    "This phase 3 trial aims to evaluate the effectiveness of ramipril and ramipril-telmisartan in reducing blood pressure in patients with hypertension and type 2 diabetes, who also have albuminuria.",
    "This phase 3 trial is investigating the effectiveness of montelukast sodium and aminophylline hydrate in treating acute asthma attacks in adult participants, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of carboplatin and cisplatin in treating patients with stage IIIC or IV ovarian, peritoneal, or fallopian tube carcinoma, and the eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 trial for patients with rheumatoid arthritis, testing the drug rituximab (mabthera/rituxan), with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for asthma, testing the effectiveness of fluticasone furoate 50mcg compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with chronic hepatitis C who were previously in the no-treatment arm of another protocol, and it aims to evaluate the efficacy of daily infergen (interferon alfacon-1, cifn) in combination with ribavirin for up to 48 weeks. The inclusion criteria include a <2 log10 reduction in plasma HCV RNA level or detectable plasma HCV RNA at specific time points, and patients must use effective contraception. Exclusion criteria include hepatic decompensation, unsuitability for enrollment, pregnancy or lactation, and participation in other experimental protocols or therapy during the previous study.",
    "This sample is a phase 3 clinical trial for patients with prostatic neoplasms, testing the effectiveness of docetaxel (taxotere\u00ae) chemotherapy and leuprolide acetate (eligard\u00ae) hormonal therapy in combination, with specific eligibility criteria for enrollment.",
    "This sample is a phase 3 clinical trial for the treatment of obsessive-compulsive disorder and generalized anxiety disorder using the drug memantine, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for patients with colorectal cancer, testing the effectiveness of oxaliplatin, leucovorin, and 5-fluorouracil in combination with prior irinotecan treatment.",
    "This sample is a phase 3 clinical trial for metastatic breast cancer, testing the efficacy of bevacizumab, placebo, and chemotherapy as treatment options, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug galantamine hbr on out-patients with mild to moderate probable AD, who have a MMSE score of 10-24, and live with or have regular daily visits from a responsible caregiver. The study has inclusion and exclusion criteria, and aims to evaluate the effectiveness of the drug on AD patients.",
    "This sample is a phase 3 clinical trial for patients with heart disease, arrhythmia, and atrial fibrillation, testing the effectiveness of olmesartan in reducing blood pressure and preventing cardiovascular events.",
    "This sample is a phase 3 trial for the treatment of seasonal allergic rhinitis using the drugs act-129968, placebo, and cetirizine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with chronic pain, testing the effectiveness of hydrocodone bitartrate as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of schizophrenia using the drugs asenapine and haloperidol, with eligibility criteria including currently suffering from an acute exacerbation of schizophrenia and exclusion criteria including having an uncontrolled, unstable medical condition or any other psychiatric disorder other than schizophrenia as a primary diagnosis.",
    "This sample is a phase 3 clinical trial for subjects with newly diagnosed or recurrent epilepsy, testing the effectiveness of lamictal as a treatment option, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for Crohn's disease, testing the effectiveness of 10% metronidazole ointment in patients with anorectal involvement, who have had perianal symptoms for longer than 3 months, and meet various inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with hypercholesterolemia, testing the effectiveness of atorvastatin and ezetimibe in reducing LDL-C levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug lapatinib in patients with ErbB2-overexpressing invasive breast cancer, who have undergone excision of the tumor and have specific disease staging criteria.",
    "This sample is a phase 3 trial for Alzheimer's disease, testing the efficacy of the drug rivastigmine transdermal patch on patients who meet the inclusion and exclusion criteria of the study.",
    "This sample is a phase 3 trial for patients with renal cell carcinoma, testing the drugs interferon-alfa and su011248, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer patients with specific genetic mutations, testing the effectiveness of erlotinib (tarceva) and a combination of carboplatin, gemcitabine, docetaxel, and cisplatin as treatment options, with detailed inclusion and exclusion criteria provided.",
    "This sample is a phase 3 clinical trial testing the effectiveness of pelubiprofen and celebrex in treating rheumatoid arthritis, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial testing the drug lenalidomide for the treatment of anemia in patients with low or intermediate-1 risk Myelodysplastic Syndrome (MDS) who are resistant to erythropoiesis stimulating agents (ESAs) and require red blood cell transfusions.",
    "This sample is a phase 3 clinical trial for patients with stage III-IV low-grade Non-Hodgkin's lymphoma, testing the effectiveness of cyclophosphamide, fludarabine phosphate, vincristine sulfate, and prednisone as treatment options. The eligibility criteria include specific disease classifications, baseline measurements, and various lab values.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer (NSCLC) patients who have previously received chemotherapy, and it aims to evaluate the effectiveness of icotinib and gefitinib as treatment options. The eligibility criteria include confirmed NSCLC with advanced stage, and exclusion criteria include previous usage of EGFR-TKI or antibody to EGFR.",
    "This sample is a phase 3 trial for patients with hypercholesterolemia and hyperlipidemia, testing the effectiveness of niacin (+) laropiprant and niacin in reducing the risk of heart disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of exenatide and placebo in combination with metformin or sulfonylurea therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of human insulin inhalation powder and injectable insulin in managing the disease. The eligibility criteria include having type 2 diabetes, being a non-smoker, and having normal lung function, while exclusion criteria include having pulmonary, hepatic, or renal disease, congestive heart failure, active malignancy, and systemic glucocorticoid therapy.",
    "This sample is a phase 3 trial for generalized anxiety disorder (GAD) and includes the drugs duloxetine, venlafaxine, and placebo as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for individuals with hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia, testing the effectiveness of ezetimibe (+) simvastatin in reducing cholesterol and triglyceride levels.",
    "This sample is a phase 3 clinical trial for patients with acute myeloid leukemia (AML) and includes eligibility criteria such as age between 18 to 60, performance status Zubrod 0-3, and specific hematopoietic, hepatic, renal, and cardiovascular requirements. The trial will test the effectiveness of gemtuzumab ozogamicin, cytosine arabinoside, and daunomycin as treatment options.",
    "This sample is a phase 3 clinical trial for primary insomnia, testing the efficacy of the drug circadin compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sulfonylurea compared to placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of quetiapine, an antipsychotic drug, in treating acute depressive episodes in adolescents aged 12-18 with bipolar I disorder.",
    "This sample is a phase 3 clinical trial for patients with essential hypertension, testing the efficacy of valsartan/amlodipine and amlodipine in reducing blood pressure, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for the treatment of migraine disorders, testing the efficacy of a combination product (sumatriptan succinate / naproxen sodium) compared to a placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for ovarian cancer patients who have relapsed disease, and the drug being tested is cediranib. The eligibility criteria include age, previous diagnosis, performance status, and various health parameters.",
    "This sample is a phase 3 clinical trial for the treatment of autistic disorder using aripiprazole and placebo drugs, with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of dapagliflozin, glipizide, and metformin hydrochloride in reducing HbA1c levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with stage III or IV squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx. The drug being tested is cisplatin, and the eligibility criteria include specific disease characteristics and patient characteristics such as age, performance status, and various medical parameters.",
    "This sample is a phase 3 trial for asthma patients who have been prescribed daily use of glucocorticosteroids at a dose > 320 mcg/day for at least 3 months, comparing the effectiveness of budesonide/formoterol turbuhaler versus conventional best asthma therapy. The inclusion criteria include a diagnosis of asthma for at least 3 months, while the exclusion criteria include a smoking history > 10 pack-years and recent asthma exacerbation requiring a change in treatment.",
    "This sample is a phase 2/phase 3 trial for patients with persistent asthma, testing the drug indacaterol maleate. The inclusion criteria include age range, daily treatment with a bronchodilator, and specific lung function measurements. Exclusion criteria include tobacco use, COPD, recent asthma attacks or hospitalizations, and respiratory tract infections.",
    "This sample is a phase 3 clinical trial for patients with chronic kidney disease and dialysis, testing the drugs mci-196 and placebo for the treatment of hyperphosphatemia and dyslipidemia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients infected with HIV, testing the efficacy of atazanavir+ritonavir and lopinavir+ritonavir drugs in patients who have experienced virologic failure on treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using the drug lurasidone, and the eligibility criteria include being between 18 and 75 years old, meeting DSM-IV-TR criteria for schizophrenia, and having a PANSS Total score \u2265 80.",
    "This phase 3 trial is investigating the effectiveness of desvenlafaxine sr, desipramine, and paroxetine in treating depression in healthy men and women between 18 to 55 years of age, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for multiple sclerosis, testing the drug colecalciferol, with specific inclusion and exclusion criteria related to the disease and drug.",
    "This sample is a phase 2/phase 3 trial for patients with metastatic non-small cell lung cancer, testing the efficacy of chemotherapy +/- disulfiram as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of juvenile rheumatoid arthritis, testing the effectiveness of etanercept and placebo drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with type 2 diabetes and high blood sugar, testing the drug dapagliflozin. The inclusion criteria include provision of informed consent, age \u226520 years old, and a diagnosis of type 2 diabetes with a blood sugar level between 6.5% and 10% at 1 week before treatment. The exclusion criteria include type 1 diabetes, fasting plasma glucose >240 mg/dL, unstable or rapidly progressing renal disease, severe hepatic insufficiency, significant abnormal liver function, and significant cardiovascular history.",
    "This sample is a phase 3 clinical trial for lung cancer, testing the drugs amrubicin hydrochloride and etoposide-cisplatin combined chemotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the effectiveness of atorvastatin and a sugar pill in treating obesity and dyslipidemia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for major depressive disorder (MDD) testing the effectiveness of agomelatine compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the efficacy of the drug nva237 compared to placebo in treating moderate to severe chronic obstructive pulmonary disease (COPD) in male and female adults aged 40 years and above, who are current or ex-smokers with a smoking history of at least 10 pack years. The study includes specific inclusion and exclusion criteria, and the primary outcome measure is the change in post-bronchodilator forced expiratory volume in one second (FEV1) from baseline.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin glargine, metformin, and taspoglutide in combination with eligibility criteria including age, HbA1c levels, and previous treatment history.",
    "This sample is a phase 3 clinical trial for women with locally advanced or metastatic breast cancer, testing the combination of temsirolimus and letrozole as a treatment option. The eligibility criteria include being postmenopausal and having a confirmed diagnosis of breast cancer.",
    "This sample is a phase 3 clinical trial for non-erosive gastroesophageal reflux disease, testing the drugs tak-438 and placebo, with eligibility criteria including participants with grade N or M in the modified LA classification system confirmed by endoscopy and repeated acid reflux symptoms for 2 days or more in one week.",
    "This sample is a phase 3 trial that aims to test the effectiveness of topiramate, a drug, in treating alcohol dependence and borderline personality disorder. The inclusion criteria include a diagnosis of both conditions, while the exclusion criteria include certain medical conditions, opiate dependence, and the use of specific medications.",
    "This sample is a phase 3 trial for hypoactive sexual desire disorder, testing the effectiveness of testosterone gel and placebo gel in women who have undergone hysterectomy and bilateral salpingo-oophorectomy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with pulmonary arterial hypertension, testing the efficacy of iloprost and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of hypercholesterolemia using the drug atorvastatin, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 clinical trial for attention-deficit/hyperactivity disorder (ADHD) using extended-release guanfacine hydrochloride as the investigational drug, with eligibility criteria including age, diagnosis, symptom severity, and willingness to comply with study requirements.",
    "This sample is a phase 3 trial for type 1 diabetes, testing the effectiveness of technosphere insulin and an active comparator drug, with specific eligibility criteria including duration of diabetes, BMI, HbA1c levels, lung function, and insulin dosage.",
    "This sample is a phase 3 clinical trial for patients with cystic fibrosis, testing the efficacy of tiotropium respimat\u00ae inhaler compared to placebo respimat\u00ae inhaler, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for cardiovascular diseases, specifically targeting subjects with measurable carotid plaque who are eligible for atorvastatin therapy, with exclusion criteria including subjects at higher risk for cardiovascular disease, those currently on high dose statin, and those with contraindications for MRI or statin therapy.",
    "This sample is a phase 3 trial for patients with restless legs syndrome, testing the drug xp13512 (gen), and the inclusion criteria require patients to have successfully completed one of four previous studies, while the exclusion criteria include non-compliance with the study procedures or medication administration.",
    "This sample is a phase 3 trial for congestive heart failure, testing the effectiveness of candesartan and placebo as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer, testing the drug marimastat. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the effectiveness of insulin detemir, nph insulin, and insulin aspart in managing blood sugar levels during pregnancy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of tiotropium plus salmeterol, tiotropium, and salmeterol in improving lung function. The inclusion criteria include patients with a diagnosis of COPD, aged 40 or older, with a smoking history of 10 pack-years, and able to perform pulmonary function tests. The exclusion criteria include significant diseases other than COPD, recent history of myocardial infraction, and known active tuberculosis. Pregnant or nursing women and patients currently participating in another study are also excluded.",
    "This sample is a phase 3 clinical trial for patients with ulcerative colitis, testing the efficacy of various drugs including budesonide mmx\u00ae and entocort ec\u00ae, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of duloxetine, venlafaxine, and placebo in treating generalized anxiety disorder (GAD) in male and female outpatients aged 18 and above, with specific inclusion and exclusion criteria. The trial focuses on patients with GAD and excludes those with other primary DSM-IV Axis I diagnoses, such as major depressive disorder, panic disorder, post-traumatic stress disorder, obsessive-compulsive disorder, bipolar affective disorder, psychosis, factitious disorder, or somatoform disorders. Additionally, patients with Axis II disorders or a history of antisocial behavior that may interfere with compliance are excluded.",
    "This sample is a phase 3 clinical trial for HIV-1 infection, testing the drugs ftc/rpv/tdf and efv/ftc/tdf, with inclusion criteria including specific HIV-1 RNA levels, genotype sensitivity, normal ECG, hepatic and renal function, and adequate contraception, while exclusion criteria include recent AIDS-defining condition, breastfeeding, pregnancy, hepatitis, cirrhosis, implanted defibrillator or pacemaker, substance abuse, malignancy, active serious infections, contraindicated drugs, participation in other trials, recent immunosuppressant therapy, and any other condition that would make the participant unsuitable for the study.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes and postprandial lipemia, testing the effectiveness of sitagliptin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with hepatitis, hepatitis B, chronic, and cirrhosis, testing the drugs telbivudine, lamivudine, and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of capecitabine and gemcitabine hydrochloride in treating patients with locally advanced, unresectable, or metastatic extrahepatic bile duct cancer, gallbladder cancer, or liver cancer.",
    "This sample is a phase 3 clinical trial for patients with atrial fibrillation, testing the drug candesartan for use in direct current cardioversion, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for patients with essential hypertension, testing the efficacy and safety of olmesartan medoxomil (om)+ hydrochlorothiazide (hctz) tablets and olmesartan medoxomil (om)/ hydrochlorothiazide (hctz) 20mg/25mg in European adults aged 18 years or older. The inclusion criteria include moderate to severe hypertension, while the exclusion criteria include pregnancy, lactation, serious disorders, recent cardiovascular events, abnormal laboratory values, and secondary hypertension.",
    "This sample is a phase 3 clinical trial for the treatment of benign prostatic hyperplasia using the drugs finasteride and alfuzosin, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for patients with significant nausea/vomiting, failed previous treatments, and adequate cognitive function, testing the drugs olanzapine and haldol, with exclusion criteria including current use of these drugs, drug-induced extrapyramidal symptoms, and undergoing chemotherapy or radiotherapy to specific areas.",
    "This sample is a phase 3 trial for patients with esophagitis, reflux and esophagitis, peptic, testing the effectiveness of dexlansoprazole mr and placebo in healing esophageal erosions proven by endoscopy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with non-insulin-dependent diabetes mellitus, testing the drug rosiglitazone. The inclusion criteria include having type 2 diabetes, co-existing vascular disease, and specific HbA1c levels, while the exclusion criteria include certain medication use, previous exposure to a thiazolidinedione, and various medical conditions.",
    "This sample is a phase 3 trial for patients with mild to moderate hypertension, testing the effectiveness of telmisartan and losartan in reducing blood pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for diabetic nephropathy, testing the effectiveness of sulodexide and placebo in patients with type 2 diabetes, microalbuminuria, and controlled blood pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin phosphate (+) metformin hydrochloride and metformin as oral therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the drug flibanserin, which is being tested for the treatment of sexual dysfunctions, psychological. The trial includes eligibility criteria such as age, diagnosis, questionnaire scores, and relationship status, among others.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of agomelatine (ago178c) compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for venous thromboembolism, testing the effectiveness of rivaroxaban and enoxaparin as anticoagulant drugs in patients undergoing elective total knee replacement surgery, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of perennial allergic rhinitis, testing the drugs gw685698x and mometasone furoate, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of megadose oral methylprednisolone and IV methylprednisolone in treating acute symptomatic exacerbation of multiple sclerosis in patients aged 18-50 years with relapsing form of the disease, as determined by Poser or McDonald Criteria, and an Expanded Disability Status Scale (EDSS) score between 2 and 6.5.",
    "This sample is a phase 3 trial for type 2 diabetes, testing the efficacy of dapagliflozin and placebo in patients with inadequate glycemic control and uncontrolled hypertension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for participants with type 2 diabetes mellitus, testing the effectiveness of ly2189265, insulin glargine, sulfonylureas (su), and biguanide (bg) drugs in maintaining stable blood glucose levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for obesity, testing the drug rimonabant (sr141716) against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the effectiveness of insulin lispro and insulin aspart in patients with type 1 diabetes who have been on continuous subcutaneous insulin infusion therapy for at least 6 months, and meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for ulcerative colitis, testing the effectiveness of budesonide mmx\u00ae, placebo, and 5-asa drugs in patients who have not responded to oral 5-ASA treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for asthma, testing the drugs flutiform, seretide, and flixotide, with eligibility criteria including age, asthma severity, medication use, and adequate technique in using the inhaler.",
    "This phase 3 trial is investigating the efficacy of the drug mci-196 versus placebo in patients with chronic kidney disease, dialysis, and hyperphosphatemia, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for HIV-infected pregnant women, testing the effectiveness of various anti-HIV medications such as abacavir sulfate, lamivudine, and zidovudine, lamivudine/zidovudine, and lopinavir/ritonavir, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for patients with uncontrolled or partly controlled asthma, testing the effectiveness of the drugs meptin swinghaler and berotec. The inclusion criteria include age \u226518, stability of asthma severity, and positive pulmonary function test results. Exclusion criteria include hypersensitivity to \u03b22-agonist or lactose, recent hospitalization or respiratory tract infection, and use of corticosteroids.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C virus (HCV) infection using the drugs ldv/sof and rbv, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 3 trial for a sleep disorder, testing the effectiveness of trazodone and sentra pm in comparison to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of bipolar disorder using the drug lamotrigine, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for the treatment of overactive bladder, testing the drugs mirabegron and tolterodine, as well as placebos, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of sulfonylurea and liraglutide drugs in combination with diet and exercise therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug clazosentan in patients with aneurysmal subarachnoid hemorrhage, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for the treatment of type 2 diabetes mellitus, testing the efficacy of alogliptin and placebo in subjects who have failed previous antidiabetic therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with locally advanced or metastatic colorectal cancer, testing the effectiveness of cetuximab, 5-fu, irinotecan, leucovorin, and oxaliplatin as treatment options, with specific eligibility criteria including no prior treatment for advanced or metastatic colorectal cancer, age \u2265 18 years, CTC (ECOG) performance status of 0-1, and various other medical conditions and laboratory values.",
    "This sample is a phase 3 clinical trial for patients with advanced idiopathic Parkinson's disease, testing the efficacy of pramipexole extended release and pramipexole immediate release compared to a placebo, with inclusion and exclusion criteria outlined.",
    "This phase 3 trial is investigating the efficacy of pn400 (vimovo) and diclofenac/misoprostol in treating gastric ulcer patients with a history of ulcer-related serious upper gastrointestinal events, and the eligibility criteria include having a documented history of such events, being 18 years or older, and requiring daily NSAID therapy for at least 6 months.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia using the drug lamotrigine, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial focuses on testing the drugs tiotropium and salmeterol for the treatment of pulmonary disease, chronic obstructive, with the eligibility criteria not specified.",
    "This sample is a phase 3 clinical trial for multiple sclerosis, testing the efficacy of ipx056 and encapsulated baclofen as potential treatments, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the drugs emend and placebo in combination with high-dose chemotherapy and autologous peripheral stem cell transplantation. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the effectiveness of agomelatine (ago178c) and placebo in patients who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with relapsing-remitting multiple sclerosis (RRMS) and includes eligibility criteria such as age, EDSS score, and treatment-naive status for interferon beta-1b (betaferon/betaseron) or copaxone.",
    "This sample is a phase 3 trial for HIV infection, testing the effectiveness of cellulose sulfate gel (6%) as a potential treatment, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial testing the effectiveness of ospemifene and a nonhormonal vaginal lubricant in treating postmenopausal women with symptoms of vaginal atrophy, such as dryness and pain, and includes eligibility criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the efficacy of tapentadol, oxycodone, and placebo in managing moderate to severe pain following bunionectomy surgery, with inclusion criteria including patients undergoing the specific procedure and exclusion criteria such as a history of seizure disorder, malignancy, alcohol or drug abuse, and certain medication usage.",
    "This sample is a phase 3 trial for patients with orthostatic hypotension associated with primary autonomic failure, dopamine beta hydroxylase deficiency, or non-diabetic autonomic neuropathies. The trial will test the effectiveness of the drug droxidopa compared to a placebo in treating these conditions.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes, testing the effectiveness of sitagliptin, metformin, and placebo drugs in managing the disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients following allogeneic stem cell transplantation, testing the effectiveness of valganciclovir and ganciclovir in preventing CMV infection, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for psoriatic arthritis, testing the effectiveness of apremilast and placebo in patients who have been inadequately treated by disease-modifying antirheumatic drugs (DMARDs), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for obesity, testing the effectiveness of lorcaserin and a placebo in overweight and obese individuals with or without comorbid conditions, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of migraine, using the drugs mk0974 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with gastrointestinal stromal tumors, testing the efficacy of retaspimycin hydrochloride (ipi-504) compared to placebo, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 3 trial for schizoaffective disorder and psychotic disorder, testing the drugs placebo, paliperidone er, and paliperidone er, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of ceftaroline, vancomycin plus aztreonam, and placebo in treating complicated skin and skin structure infections caused by bacterial infections, specifically those involving deeper soft tissue or requiring significant surgical intervention, or cellulitis or abscess on lower extremity occurring in subjects with diabetes mellitus or peripheral vascular disease.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis, testing the effectiveness of certolizumab pegol in combination with methotrexate (MTX) as a treatment option. The eligibility criteria include specific disease duration, active disease symptoms, and prior treatment with MTX. Various exclusion criteria are also listed, such as other inflammatory arthritis diagnoses, pregnancy, and certain medical conditions.",
    "This sample is a phase 3 clinical trial for patients with chronic pain, specifically targeting those with conditions such as diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia. The study aims to evaluate the effectiveness of oravescent fentanyl, an opioid therapy, in providing relief for breakthrough pain episodes experienced by patients already on around-the-clock opioid therapy.",
    "This sample is a phase 3 trial for the treatment of perennial allergic rhinitis (PAR) using the drugs ff and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for hypoactive sexual desire disorder in postmenopausal women, testing the efficacy of testosterone and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for attention deficit disorder with hyperactivity, testing the effectiveness of neutral salts of dextroamphetamine sulfate, usp, amphetamine sulphate, usp, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate as a treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with multiple myeloma, testing the drug pamidronate. The inclusion criteria include newly diagnosed multiple myeloma with treatment demanding disease, while the exclusion criteria include a life expectancy of less than 3 months, other active malignant diseases, and patients who cannot cooperate for monthly infusions or do not give their informed consent.",
    "This sample is a phase 3 clinical trial for patients with acute myeloid leukemia (AML) in complete remission, testing the efficacy of busulphan plus cyclophosphamide and busulphan plus fludarabine as a conditioning regimen for allogeneic stem cell transplantation. The eligibility criteria include age between 40 and 65, availability of an HLA compatible sibling or unrelated donor, and Eastern Cooperative Oncology Group (ECOG) performance status less than 3.",
    "This sample is a phase 3 trial for the drug vortioxetine in patients with major depressive disorder, who have completed a prior study and meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of schizophrenia using aripiprazole im depot, with specific inclusion and exclusion criteria for subjects participating in the study.",
    "This phase 3 trial is testing the effectiveness of bibw 2992, trastuzumab, and vinorelbine in treating HER2-overexpression breast cancer patients who have progressed on prior trastuzumab treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with metastatic renal cell carcinoma, testing the effectiveness of sunitinib (sutent) and sorafenib (nexavar) as first-line therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for restless legs syndrome, testing the drug rotigotine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic hepatitis B, testing the effectiveness of entecavir and telbivudine drugs in treating the disease. The eligibility criteria include being 18-70 years old, having documented compensated hepatitis B \"e\" antigen (HBeAg)-positive chronic hepatitis B, and being able to comply with the study regimen and provide informed consent.",
    "This sample is a phase 3 trial that aims to evaluate the effectiveness of quetiapine fumarate, lithium, and divalproex in treating bipolar I disorder with alcohol dependence, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the drug sitaxentan in patients with pulmonary hypertension, with specific inclusion and exclusion criteria related to blood pressure levels.",
    "This sample is a phase 3 trial for epilepsy, testing the effectiveness of lamotrigine extended-release as a treatment option, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the efficacy of 0.5% loteprednol etabonate ophthalmic ointment and its vehicle in patients undergoing routine cataract surgery, with the goal of achieving a postoperative pinholed Snellen visual acuity of at least 20/200 in the study eye.",
    "This sample is a phase 3 trial for patients with type 2 diabetes and renal insufficiency, testing the effectiveness of canagliflozin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of seasonal allergic rhinitis and hay fever using beclomethasone dipropionate and placebo nasal aerosol, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of loteprednol etabonate in reducing inflammation and pain in patients undergoing routine cataract surgery, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of exenatide once weekly, metformin, sitagliptin, and pioglitazone in combination with diet and exercise, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of alogliptin and glimepiride in combination with glimepiride alone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of vildagliptin and metformin in reducing HbA1c levels and FPG, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for type 2 diabetes, testing the drugs saxagliptin, placebo, metformin (blinded), and metformin (open-label), with inclusion criteria including drug-naive patients with specific HbA1c levels and fasting C-peptide levels, and exclusion criteria including recent cardiac or cerebrovascular events and elevated serum creatinine.",
    "This sample is a phase 3 clinical trial for patients with branch retinal vein occlusion, testing the effectiveness of intravitreal aflibercept injection (Eylea) in treating macular edema. The inclusion criteria include adults aged 18 and above with foveal center-involved macular edema, while the exclusion criteria include uncontrolled glaucoma, uncontrolled diabetes mellitus, and previous use of intraocular corticosteroids or anti-angiogenic drugs in the study eye.",
    "This sample is a phase 3 trial for HIV infections, testing the drug Truvada, and includes eligibility criteria such as age, negative HIV test results, willingness to comply with study procedures, and exclusion criteria for certain medications and medical conditions.",
    "This sample is a phase 3 trial for HIV patients who are currently on HAART including tenofovir and are switching to abacavir. The study aims to evaluate the efficacy of the switch in maintaining undetectable plasma HIV-1 RNA levels while also assessing bone health and resistance mutations.",
    "This sample is a phase 3 clinical trial for the treatment of acute bacterial sinusitis using moxifloxacin and placebo drugs, with specific inclusion and exclusion criteria based on radiographic and clinical symptoms.",
    "This sample is a phase 3 clinical trial for patients with gastroesophageal reflux disease, testing the effectiveness of 10 mg ilaprazole and 40mg esomeprazole in treating erosive esophagitis confirmed by esophagogastroduodenoscopy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of chronic obstructive pulmonary disease (COPD) using the drugs gsk573719/vi 62.5/25, gsk573719/vi 125/25, and placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 trial for patients with short bowel syndrome, testing the effectiveness of teduglutide at different doses compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial is investigating the effectiveness of budesonide/formoterol, fluticasone/salmeterol, and albuterol in treating asthma patients who are at least 18 years old and have been diagnosed with asthma. The study includes specific inclusion and exclusion criteria, such as the use of inhaled corticosteroids and the absence of severe asthma or sensitivity to certain drugs.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of various drugs including indacaterol and glycopyrronium, glycopyrronium, indacaterol, tiotropium, and placebo, based on specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of docetaxel, vinorelbine, carboplatin, and gemcitabine as chemotherapy drugs, with specific eligibility criteria for patient inclusion.",
    "This sample is a phase 3 trial for obesity, testing the drug mk0557, and includes eligibility criteria for obese men and nonpregnant women with a specific body mass index.",
    "This sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of fenretinide and tamoxifen citrate drugs in combination with surgery and radiotherapy, with specific eligibility criteria for age, menopausal status, and various health parameters.",
    "This phase 3 trial is testing the effectiveness of nesiritide and placebo in treating acute decompensated heart failure and chronic obstructive airway disease (COAD) in patients who meet specific inclusion criteria, while excluding pregnant women, patients with certain medical conditions, and those who have recently received an investigational new drug.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia or schizoaffective disorder, testing the effectiveness of risperidone long-acting injectable (lai) at different doses, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with acute myeloid leukemia (AML) in first relapse, testing the drugs cytarabine and laromustine. The eligibility criteria include specific disease characteristics, age, performance status, and various medical conditions.",
    "This sample is a phase 3 trial testing multiple drug combinations (amlodipine/atorvastatin) for patients with hypertension and hypercholesterolemia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial testing the effectiveness of buprenorphine, fentanyl, and placebo in treating pain, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of alogliptin and pioglitazone in combination with metformin for glycemic control. The inclusion criteria include specific requirements for BMI, C-peptide levels, blood pressure, and other health factors, while the exclusion criteria include conditions such as heart failure, history of cancer, and psychiatric disorders.",
    "This sample is a phase 3 clinical trial for the treatment of allergic rhinitis, testing the efficacy of 5-mg desloratadine compared to a placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for the treatment of otitis media and negative middle ear pressure using triamcinolone acetonide nasal spray and placebo nasal spray, with specific inclusion and exclusion criteria for enrollment.",
    "This sample is a phase 3 clinical trial for patients with chronic hepatitis C and HIV-1 infection, testing the efficacy of the drugs sof and rbv in combination therapy. The eligibility criteria include specific viral load levels, genotype confirmation, and HIV treatment requirements.",
    "This sample is a phase 2/phase 3 trial for hypertension, testing the drugs irbesartan and atenolol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with acute myeloid leukemia (AML) and includes eligibility criteria such as age, performance status, and organ function, as well as a list of drugs used in the treatment.",
    "This sample is a phase 3 trial for patients with severe motor fluctuations in idiopathic Parkinson's disease, testing the effectiveness of levodopa-carbidopa intestinal gel as a treatment option.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung carcinoma, testing the effectiveness of taxotere and pemetrexed as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for hypoactive sexual desire disorder, testing the effectiveness of testosterone gel and placebo gel in women who have undergone hysterectomy and bilateral salpingo-oophorectomy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for rheumatoid arthritis, testing the efficacy of placebo injections, placebo capsules, and methotrexate capsules in patients who meet specific inclusion criteria, such as having a diagnosis of RA for at least 3 months and having active RA with specific symptoms.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of various drugs including placebo, canagliflozin, sitagliptin, metformin, and pioglitazone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of childhood acute lymphoblastic leukemia (ALL) in remission, using drugs such as thiotepa, cyclophosphamide, tacrolimus, methotrexate, and sirolimus, with specific eligibility criteria for patients.",
    "This sample is a phase 3 clinical trial for the treatment of restless legs syndrome (RLS) using ropinirole extended release (XR), with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for obesity, testing the drug taranabant against a placebo, with specific inclusion and exclusion criteria based on BMI, psychiatric history, seizures, blood pressure, blood glucose, and triglyceride levels.",
    "This sample is a phase 3 trial for the treatment of hepatitis B, using entecavir and adefovir drugs, with specific inclusion and exclusion criteria such as Child-Pugh score and ALT levels.",
    "This study is testing the effectiveness of sitagliptin, a drug used to treat diabetes, in HIV-infected individuals with stable immunologic and virologic status, and normal blood chemistry, who do not have certain medical conditions or take specific medications.",
    "This sample is a phase 3 clinical trial for patients with bipolar disorder, focusing on the use of paliperidone er as a treatment option. The inclusion criteria include meeting DSM-IV criteria for Bipolar I Disorder, having a history of manic or mixed episodes, and taking lithium or valproate. The exclusion criteria include rapid cycling or schizoaffective disorder, significant risk for suicidal or violent behavior, recent use of certain drugs, and prolonged use of benzodiazepines.",
    "This sample is a phase 3 clinical trial for patients with glaucoma or ocular hypertension, testing the effectiveness of dorzolamide hydrochloride (+) timolol maleate and prostaglandin as compared to dorzolamide hcl/timolol maleate in reducing intraocular pressure, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the drugs dacomitinib, erlotinib, and placebos, with specific eligibility criteria including prior treatment history, biomarker analysis, and disease characteristics.",
    "This sample is a phase 3 clinical trial for patients with Parkinson's disease, testing the drug ropinirole xl (formerly cr), and the eligibility criteria include being at least 30 years old and having a diagnosis of idiopathic Parkinson's disease.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis B virus (HBV) infection, testing the efficacy of tenofovir disoproxil fumarate (TDF) compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the drug adalimumab in the treatment of ulcerative colitis, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with congestive heart failure, testing the effectiveness of carvedilol controlled release and carvedilol immediate release as a treatment option, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 clinical trial for newly diagnosed acute myeloid leukemia (AML) patients, testing the effectiveness of a combination of drugs including asparaginase, cytarabine, daunorubicin hydrochloride, etoposide, gemtuzumab ozogamicin, and mitoxantrone hydrochloride, with specific eligibility criteria for patients including age, disease characteristics, and donor criteria for transplantation.",
    "This phase 3 trial is testing the effectiveness of ldv/sof and rbv drugs in treating chronic hepatitis C virus in patients who have previously failed a NS3/4A protease inhibitor plus PEG/RBV regimen, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of nocturia, a condition characterized by excessive urination at night, using the drugs desmopressin and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the drug ropinirole in patients with moderate to severe idiopathic restless legs syndrome (RLS), with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer (NSCLC) and febrile neutropenia. The trial is testing the efficacy of pegylated rhg-csf and placebo in combination with chemotherapy for these conditions. The inclusion criteria include specific disease staging, age range, performance status, and various blood count and liver function requirements. Exclusion criteria include prior treatments and pregnancy/lactation.",
    "This sample is a phase 3 trial for patients with diabetes mellitus and vitamin D deficiency, testing the effectiveness of vitamin D3 supplements (2000 IU and 5000 IU) compared to a placebo, with specific inclusion criteria related to diabetes control and vitamin D levels.",
    "This phase 3 trial is testing the effectiveness of levodopa carbidopa intestinal gel (lcig) and levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets in treating advanced Parkinson's disease patients who demonstrate severe motor fluctuations despite optimized treatment, with inclusion criteria including idiopathic Parkinson's disease and levodopa responsiveness, and exclusion criteria including unclear diagnosis or suspicion of other parkinsonian syndromes, previous surgery for PD, contraindications to levodopa, and any neurological deficit that may interfere with study assessments.",
    "This sample is a phase 3 trial for asthma, testing the drugs salmeterol and beclomethasone hfa, with inclusion criteria including clinical history consistent with asthma and specific FEV1 measurements, and exclusion criteria including smoking history and significant unstable medical conditions.",
    "This phase 3 trial is testing the effectiveness of extended-release guanfacine hydrochloride (spd503) compared to a placebo oral capsule in treating attention deficit disorder in children and adolescents aged 6-17 years, who meet the DSM-IV-TR criteria for ADHD and have specific ADHD-RS-IV and CGI-S scores, while excluding those with certain psychiatric diagnoses, cardiac abnormalities, hypertension, and other criteria.",
    "This sample is a phase 3 trial for patients who have received a liver transplant due to chronic hepatitis B infection, with the drug entecavir being tested. The inclusion criteria include having a low HBV-DNA level and detectable HBsAg, while the exclusion criteria include certain characteristics of hepatocellular carcinoma and co-infection with other viruses.",
    "This sample is a phase 3 clinical trial for the treatment of non-Hodgkin's lymphoma using the drugs bortezomib + rituximab and rituximab, with specific eligibility criteria for enrollment in the study.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD) exacerbation, testing the effectiveness of the drug zileuton compared to a placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of the drug l50/h12.5/a5, along with other drugs and a placebo, in treating essential hypertension in participants who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for lupus nephritis, testing the effectiveness of rituximab, mycophenolate mofetil, methylprednisolone, and other drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the drug rifampicin and placebo in patients with multiple system atrophy, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for osteoporosis, testing the drugs risedronate and teriparatide, along with placebo versions of both drugs, to determine their effectiveness in treating osteoporosis in males aged 30-85 with various eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with pancreatic cancer, testing the effectiveness of gemcitabine hydrochloride and sorafenib tosylate as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of cervical dystonia using a placebo drug, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with stage IIIB or stage IV non-small cell lung cancer, testing the efficacy of tariquidar + paclitaxel/carboplatin compared to placebo + paclitaxel/carboplatin, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of chronic hepatitis C, testing the efficacy of boceprevir and ribavirin in combination with pegylated interferon alfa-2a or pegylated interferon alfa-2b, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is investigating the efficacy of prolonged release (pr) oros methylphenidate and placebo in treating attention deficit/hyperactivity disorder (ADHD) in patients who meet specific inclusion criteria, such as having a diagnosis of ADHD according to DSM-IV and a CAARS score of at least 24, while excluding patients with known non-responsiveness to methylphenidate or any clinically unstable psychiatric condition.",
    "This phase 3 trial is investigating the effectiveness of telcagepant potassium and zolmitriptan in treating migraines, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for HIV infection, testing the effectiveness of the drug mk0518 (raltegravir) compared to kaletra\u2122 (lopinavir (+) ritonavir) and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with HIV infection, testing the effectiveness of different drugs including raltegravir, lopinavir (+) ritonavir, and placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of benign prostatic hyperplasia using tadalafil and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of allergic rhinitis, testing the effectiveness of fluticasone furoate nasal spray compared to a placebo, with eligibility criteria including age, diagnosis confirmation, symptomatic status, and ability to comply with study procedures.",
    "This phase 3 trial is testing the effectiveness of mycophenolate mofetil, a drug used for chronic-graft-versus host disease (GVHD), in patients who have undergone transplantation and require systemic immunosuppressive treatment.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of lc15-0444 and placebo in reducing HbA1c levels, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of herceptin, taxol, fluorouracil, cytoxan, and epirubicin in treating patients with invasive breast cancer, specifically those with T2-3, N0-1, M0 stage tumors, and positive Her-2/neu status.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin phosphate and other comparators as add-on therapy to pioglitazone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the efficacy of drugs such as bia 9-1067, entacapone, placebo, levodopa, carbidopa, and benserazide in patients who have been diagnosed with idiopathic PD for at least 3 years and have been treated with L-DOPA/DDCI for at least 1 year. The study aims to evaluate the impact of these drugs on motor fluctuations and OFF time in patients with Parkinson's disease.",
    "This sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of the drugs ly2189265, liraglutide, and metformin in combination with metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with hypertension, testing the drugs telmisartan+amlodipine and telmisartan, with eligibility criteria including age 20 years or older, exclusion criteria such as history of stroke or transient ischemic attack within last 6 months, and various other criteria related to cardiac health, hypersensitivity, and other medical conditions.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs donepezil and vitamin e, with eligibility criteria including memory complaints, abnormal memory function, and preserved general cognition.",
    "This phase 3 trial aims to evaluate the efficacy of radium-223 dichloride (xofigo, bay88-8223) compared to placebo and best standard of care (bsoc) in patients with hormone refractory prostate cancer and bone metastases, who have multiple skeletal metastases and are not planning to use cytotoxic chemotherapy within the next 6 months. The inclusion criteria include histologically or cytologically confirmed adenocarcinoma of the prostate, known hormone refractory disease, and multiple skeletal metastases on bone scintigraphy. The exclusion criteria include treatment with an investigational drug within the previous 4 weeks, eligibility for first course of docetaxel, treatment with cytotoxic chemotherapy within the previous 4 weeks, systemic radiotherapy with specific agents for the treatment of bony metastases within the previous 24 weeks, history of other malignancy treated within the last 5 years (except non-melanoma skin cancer or low-grade superficial bladder cancer), and history of visceral metastasis or visceral metastases as assessed by imaging within the previous 8 weeks.",
    "This sample is a phase 3 trial for the treatment of chemotherapy-induced nausea and vomiting, with eligibility criteria including a diagnosis of a malignant solid tumor, specific hematologic and metabolic status requirements, and the exclusion of certain medical conditions and medications. The drugs being tested in this trial are oral casopitant, IV casopitant, IV ondansetron hydrochloride, and oral dexamethasone.",
    "This sample is a phase 3 trial for patients with active rheumatoid arthritis, testing the effectiveness of abatacept compared to a placebo, with specific inclusion criteria related to disease activity, joint erosion, synovitis, and prior treatment with methotrexate.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin phosphate and other drugs in combination with metformin and glimepiride or gliclazide, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of risperidone, an antipsychotic drug, in treating bipolar disorder and anxiety disorder in patients who meet specific inclusion criteria, such as having moderate symptoms and not currently taking certain medications.",
    "This sample is a phase 2/phase 3 trial for small cell lung cancer, comparing carboplatin plus irinotecan to carboplatin plus etoposide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for breast neoplasms, testing the efficacy of fec-docgemzar adjuvant chemotherapy, fec-doc adjuvant chemotherapy, zoledronic acid i.v. 2 years, and zoledronic acid i.v. 5 years, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of different doses of clobazam and placebo in treating patients with Lennox-Gastaut syndrome (LGS), a type of epilepsy. The trial includes patients who were under 11 years old at the onset of LGS and are currently on at least one antiepileptic drug (AED). The study has specific inclusion and exclusion criteria, such as excluding patients with progressive neurologic diseases or recent episodes of status epilepticus. The trial will assess the impact of the different doses of clobazam on seizure frequency and severity, with the goal of improving the management of LGS.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of the drugs Nexium and placebo in combination with metformin and/or sulfonylureas or diet, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the drug ambrisentan, which is being tested for the treatment of pulmonary hypertension associated with various etiologies, including PAH, lung diseases, chronic thromboembolic obstruction, and sarcoidosis. The inclusion criteria include being 18 years or older, having a stable regimen of certain therapies, and meeting specific criteria from right heart catheterization. The exclusion criteria include previous use of ambrisentan or certain other medications, abnormal liver function, and contraindications to treatment with endothelin receptor antagonist. Female participants must have a negative pregnancy test and use contraception, while male participants must be informed of potential risks associated with the drug.",
    "This phase 3 clinical trial is investigating the effectiveness of insulin degludec and insulin glargine in combination with oral anti-diabetic drugs for the treatment of type 2 diabetes mellitus, with specific eligibility criteria including HbA1c levels and BMI.",
    "This sample is a phase 3 clinical trial for Parkinson's disease, testing the efficacy of preladenant and rasagiline as potential treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer (NSCLC) patients of East Asian ethnicity, testing the efficacy of pemetrexed, cisplatin, and gefitinib as systemic therapy, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the drugs tasisulam-sodium and paclitaxel in patients with metastatic melanoma who have progressed after previous treatment, and have specific eligibility criteria including histologic diagnosis, evaluable disease, performance status, and serum albumin level.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of tiotropium + olodaterol, tiotropium, and olodaterol as treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for non-small cell lung cancer, testing the drugs amg 706, placebo, paclitaxel, and carboplatin, with eligibility criteria including confirmed stage 111B or stage IV NSCLC, ECOG performance status of 0 or 1, and various hematological, renal, and hepatic function requirements.",
    "This sample is a phase 3 trial for epilepsy, testing the drug lacosamide, with inclusion criteria of a diagnosis of epilepsy and completion of a double-blind trial, and exclusion criteria of not taking any other investigational drug than lacosamide and not meeting withdrawal criteria from the double-blind trial.",
    "This sample is a phase 3 clinical trial for patients with stage III adenocarcinoma of the colon, testing the effectiveness of the drugs folfox and cetuximab in combination with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 clinical trial for the treatment of chronic lymphocytic leukemia using obinutuzumab, rituximab, and chlorambucil, with specific eligibility criteria including age, documented CD20+ B-Cell Chronic Lymphocytic Lymphoma, and previously untreated CLL requiring treatment.",
    "This phase 3 trial aims to evaluate the effectiveness of mycophenolate mofetil and mycofenolate mofetil (mmf) compared to placebo in treating interstitial cystitis and painful bladder syndrome in participants who have failed previous therapies, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for breast neoplasms, testing the drugs epirubicin, cyclophosphamide, and docetaxel, with eligibility criteria including age, hormone receptor status, and tumor characteristics.",
    "This sample is a phase 3 clinical trial for the treatment of restless legs syndrome, testing the drugs pramipexole and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for patients with stage III or IV melanoma, testing the drugs allovectin-7, allovectin-7/dacarbazine, and dacarbazine, with eligibility criteria including no history of brain metastases and specific requirements for prior/concurrent therapy and patient characteristics.",
    "This sample is a phase 3 trial for patients with acute coronary syndrome, testing the effectiveness of rosuvastatin and atorvastatin in reducing cholesterol levels, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the effectiveness of carboplatin and pegylated liposomal doxorubicin hydrochloride in treating ovarian cancer and peritoneal cavity cancer, with specific eligibility criteria for patients and restrictions on prior treatments.",
    "This sample is a phase 2/phase 3 trial testing the drug sertraline for the treatment of depressive disorder, major, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs symbicort turbuhaler (budesonide/formoterol) and any available COPD treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with prostate cancer, testing the drug docetaxel. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 3 trial for patients with Alzheimer's disease and symptoms of delusions or hallucinations, testing the effectiveness of aripiprazole (bms-337039) compared to a placebo, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial is testing the effectiveness of amlodipine and olmesartan medoxomil plus amlodipine in treating hypertension, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial aims to evaluate the efficacy of oxaliplatin-based adjuvant chemotherapy in patients with stage II or III colorectal cancer, and assess the potential neurotoxicity of the treatment by monitoring for peripheral neuropathy.",
    "This sample is a phase 3 clinical trial for multiple sclerosis, specifically relapsing-remitting MS, testing the effectiveness of natalizumab compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for osteoarthritis of the knee, testing the efficacy of drugs such as low dose ampion and high dose ampion, along with placebo, in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of different drugs (including tiotropium respimat\u00ae and salmeterol hfa mdi) compared to a placebo, with specific eligibility criteria for patients to be included in the trial.",
    "This sample is a phase 3 clinical trial for the treatment of type 2 diabetes mellitus, testing the efficacy of ranolazine compared to placebo in patients who are treatment-na\u00efve or have received no prior antihyperglycemic therapy for at least 90 days. The eligibility criteria include specific age range, BMI, HbA1c levels, fasting serum glucose levels, and C-peptide levels. The study also excludes patients with certain medical conditions, history of surgeries, and use of specific medications.",
    "This phase 3 clinical trial aims to evaluate the efficacy of aflibercept, docetaxel, and prednisone or prednisolone in treating patients with metastatic prostate adenocarcinoma who have progressive disease while receiving hormonal therapy or after surgical castration.",
    "This sample is a phase 3 clinical trial for the treatment of diabetic retinopathy and diabetic macular edema using intravitreal triamcinolone acetonide, with eligibility criteria including age, diabetes diagnosis, eye criteria, and exclusion criteria such as chronic renal failure and history of corticosteroid use.",
    "This sample is a phase 3 clinical trial for patients with myocardial infraction (heart attack) and ST-elevation myocardial infraction (STEMI), testing the effectiveness of the drugs prasugrel and clopidogrel in combination with percutaneous coronary intervention (PCI) as a treatment option. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 3 clinical trial for the drug flibanserin, targeting women with hypoactive sexual desire disorder (HSDD), and includes eligibility criteria such as age, diagnosis, questionnaire scores, willingness to engage in sexual activity, use of an electronic diary, stable relationship, contraception use, and informed consent.",
    "This sample is a phase 3 clinical trial for patients diagnosed with epilepsy, testing the efficacy of intravenous carbamazepine (iv cbz) in patients who are already receiving a stable dose of oral carbamazepine. The eligibility criteria include age, pregnancy status, previous hypersensitivity to certain medications, and various medical conditions that may affect participation.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD) and cardiovascular disease, testing the effectiveness of fluticasone furoate/vilanterol and tiotropium bromide as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with stomach cancer or metastatic neoplasm, testing the drugs ECC and FOLFIRI, with specific eligibility criteria including age, tumor characteristics, and blood counts.",
    "This sample is a phase 3 clinical trial for patients with thyroid cancer (ICD-10 codes C73, D34, D44.0, Z85.850) testing the effectiveness of the drug XL184 compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 trial for bipolar disorder, testing the effectiveness of risperdal consta and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the effectiveness of cisplatin and gemcitabine hydrochloride in treating non-small cell lung cancer patients who are medically inoperable or unresectable, with specific disease characteristics and patient eligibility criteria.",
    "This sample is a phase 3 trial for congestive heart failure, testing the effectiveness of candesartan and placebo in patients aged 18 or above, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with rheumatoid arthritis, testing the efficacy of a placebo drug in combination with methotrexate, sulfasalazine, and/or hydroxychloroquine, and other medications, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung carcinoma, testing the effectiveness of pemetrexed and carboplatin as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with intermittent claudication and peripheral vascular disease, testing the effectiveness of niacin extended release and lovastatin tablets in reducing LDL-C and triglyceride levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with open-angle glaucoma or ocular hypertension, testing the effectiveness of two drugs, travoprost ophthalmic solution 0.004% with sofzia\u00ae preservative system (travatan z\u00ae) and latanoprost ophthalmic solution 0.005% (xalatan\u00ae), with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of metformin, bi 10773, and placebos in controlling blood glucose levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for asthma patients who have been using a high dose of inhaled glucocorticosteroid (ICS) and have experienced at least one severe exacerbation requiring oral glucocorticosteroid. The trial will test the efficacy of mometasone furoate/formoterol combination and mometasone furoate mdi in reducing asthma symptoms.",
    "This sample is a phase 3 clinical trial for chronic myeloid leukemia (CML) patients, testing the efficacy of ponatinib and imatinib drugs, with specific eligibility criteria including disease stage, cytogenetic assessment, performance status, and adequate organ function.",
    "This phase 3 trial is testing the effectiveness of golimumab and methotrexate in treating arthritis and autoimmune diseases, with specific eligibility criteria for participants, such as inadequate disease control prior to treatment and negative tuberculosis test.",
    "This sample is a phase 3 clinical trial for major depressive disorder, testing the drugs sr58611a, escitalopram, and placebo, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 3 clinical trial for the treatment of chronic hepatitis C using a combination of pegylated interferon alfa-2b and ribavirin, with specific inclusion and exclusion criteria, and the requirement for contraception during the study.",
    "This sample is a phase 3 clinical trial for the treatment of homozygous familial hypercholesterolemia using the drug aegr-733, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 trial aims to evaluate the effectiveness of clevidipine, a calcium channel blocker, in reducing systolic blood pressure in patients with intracerebral hemorrhage, specifically those with CT evidence of hemorrhage within 12 hours of symptom onset and baseline systolic blood pressure >160 mmHg.",
    "This phase 3 clinical trial is testing the effectiveness of gemcitabine and placebo in treating patients with superficial transitional cell carcinoma of the bladder, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with essential hypertension, testing the efficacy and safety of olmesartan medoxomil/hydrochlorothiazide tablets, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of schizophrenia, testing the efficacy of aripiprazole depot and oral tablets compared to placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 3 clinical trial for asthma patients, testing the efficacy of tiotropium respimat low dose and high dose compared to placebo respimat, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the efficacy of the drug qva149 and comparing it to placebos of tiotropium and formoterol. The inclusion criteria include age, smoking history, and lung function measurements, while the exclusion criteria include certain medical conditions and treatments.",
    "This phase 3 trial is investigating the efficacy of erlotinib hydrochloride and temozolomide in treating patients with non-small cell lung cancer and brain metastases, who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for plaque psoriasis, testing the effectiveness of a placebo drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using methylphenidate hydrochloride extended release capsules as the drug, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for Alzheimer's disease, testing the drugs rosiglitazone extended release 2mg and rosiglitazone extended release 8mg, with eligibility criteria including a clinical diagnosis of probable Alzheimer's disease, mild to moderate disease severity, and ongoing acetylcholinesterase inhibitor therapy.",
    "This sample is a phase 2/phase 3 trial testing the drug vortioxetine and placebo for the treatment of major depressive disorder, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 trial for the treatment of migraine disorders using the drugs map0004 and placebo, with eligibility criteria including age, history of episodic migraine, and exclusion criteria including allergies or contraindications to the study drugs or certain medical conditions.",
    "This sample is a phase 3 clinical trial for patients with stable, symptomatic Chronic Obstructive Pulmonary Disease (COPD) and includes eligibility criteria such as specific lung function measurements, smoking history, and exclusion criteria related to medical conditions and contraindications to certain medications. The study will test the efficacy and safety of the drug nva237 compared to a placebo.",
    "This phase 3 clinical trial is investigating the effectiveness of fingolimod, fingolimod, and interferon \u03b2-1a in treating multiple sclerosis in patients aged 18-55 with a relapsing-remitting disease course and an Expanded Disability Status Scale (EDSS) score of 0-5.5, while excluding patients with other chronic diseases, pregnant or nursing women, and those who cannot tolerate interferon treatment.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin degludec/insulin aspart and insulin glargine in combination with metformin and other oral antidiabetic drugs. The trial has specific inclusion and exclusion criteria, and includes both a main period and an extension period.",
    "This phase 3 trial aims to evaluate the effectiveness of corifollitropin alfa and progesterone in females undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for type 1 diabetes mellitus, testing the effectiveness of the drugs rhgad65 and placebo in patients between 10 and 20 years of age, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the effectiveness of insulin degludec, insulin glargine, and insulin aspart in managing blood glucose levels, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of gastroesophageal reflux disease (GERD) in infants, using pantoprazole and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes and high blood sugar, testing the effectiveness of dapagliflozin and placebo in reducing blood sugar levels, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for head and neck cancer, testing the drugs cetuximab and cisplatin, with specific eligibility criteria including stage III or IV disease, certain diagnostic workup requirements, and exclusion criteria such as prior chemotherapy for the study cancer and certain comorbidities.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of liraglutide, a GLP-1 receptor agonist, in treating obesity and obstructive sleep apnoea in patients who are unable or unwilling to use continuous positive airway pressure (CPAP) treatment.",
    "This sample is a phase 3 clinical trial for chronic constipation, testing the effectiveness of linaclotide and a matching placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of vildagliptin and placebo in patients aged 70 years and older with inadequately controlled HbA1c levels. The study has specific inclusion and exclusion criteria, and the primary outcome is the change in HbA1c levels.",
    "This sample is a phase 3 clinical trial for gastric cancer, testing the drugs cetuximab, capecitabine, and cisplatin, with eligibility criteria including age, histological confirmation of adenocarcinoma, and specific medical conditions.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of various drugs including umeclidinium bromide/vilanterol and fluticasone propionate/salmeterol, compared to placebos, based on specific inclusion and exclusion criteria.",
    "This phase 3 trial is investigating the use of norethindrone acetate, a hormone replacement therapy, in postmenopausal women with a history of stage 0-II breast cancer, with specific eligibility criteria related to disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 3 clinical trial for attention deficit hyperactivity disorder (ADHD) using the drug atomoxetine, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial aims to evaluate the efficacy of ezetimibe + simvastatin, simvastatin, and placebo in treating hypercholesterolemia and atherosclerosis in adults, with specific inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 2/phase 3 trial for hypertension, testing the effectiveness of olmesartan medoxomil and placebo in patients with high blood pressure, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of otamixaban, ufh, and eptifibatide in treating patients with non-ST-segment elevation Acute Coronary Syndrome (NSTE-ACS) who meet specific inclusion criteria, while excluding patients who have already undergone revascularization procedures for Acute ST-segment elevation MI or have received certain anticoagulant treatments.",
    "This phase 3 trial aims to evaluate the effectiveness of hydromorphone hcl, oxycodone hcl cr, and placebo in managing moderate to severe cancer pain in participants who are currently receiving strong oral or transdermal opioid analgesics. The study also includes eligibility criteria such as the required dosage of oral morphine, stable opioid medication, and exclusion criteria such as neuropathic pain, drug/alcohol abuse history, and pregnancy/lactation in women of childbearing potential.",
    "This sample is a phase 3 clinical trial testing the drug fentanyl ethypharm for the treatment of breakthrough pain in patients with cancer, who are already on stable background opioid treatment.",
    "This sample is a phase 3 clinical trial for patients with depression, HIV infections, and hepatitis C, testing the effectiveness of citalopram and placebos in treating these conditions, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of preladenant, rasagiline, and placebo in participants with Parkinson's disease who have completed the 12-week treatment period of the parent trial, P04938 or P07037, and meet various inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for infertility treatment, testing the effectiveness of various drugs including corifollitropin alfa, recfsh, gonadatropin releasing hormone antagonist, and human chorion gonadatropin, along with placebos, on females aged 18-36 with an indication for controlled ovarian stimulation and in vitro fertilization or intracytoplasmic sperm injection. The inclusion and exclusion criteria are also provided.",
    "This phase 3 trial is investigating the effectiveness of odanacatib and placebo for odanacatib in treating osteoporosis in males between 40 and 95 years of age, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for glaucoma, testing the drugs timolol and latanoprost, with inclusion criteria including a diagnosis of glaucoma and an IOP of 22 mmHg or above in at least 1 eye.",
    "This sample is a phase 3 trial for the drug lu aa21004 in patients with major depressive disorder, where the inclusion criteria include completing a previous study, showing improvement in CGI-S score, and appearing to benefit from long-term treatment, while the exclusion criteria include having any current psychiatric or substance-related disorder, clinically significant neurological or neurodegenerative disorder, or a DSM-IV-TR axis II disorder that might compromise the study.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of glycopyrronium bromide compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 trial for the treatment of depression in patients with chronic hepatitis C infection, testing the efficacy of escitalopram, placebo, peginterferon alfa-2a, and ribavirin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for psoriatic arthritis, testing the effectiveness of apremilast and placebo in patients who have been inadequately treated by disease-modifying antirheumatic drugs (DMARDs), with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for the treatment of hepatitis C, using drugs such as daclatasvir, peg-interferon alfa-2a, and ribavirin, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 clinical trial aims to evaluate the efficacy and safety of a combination therapy (pi, rtv, ftc/tdf, and stribild) in patients with acquired immunodeficiency syndrome (AIDS) and HIV infections, who have been on a stable antiretroviral regimen for at least 6 months and have undetectable plasma HIV 1 RNA levels. The study has specific inclusion and exclusion criteria, and participants must meet certain eligibility requirements to be enrolled.",
    "This sample is a phase 3 trial for patients with myelodysplastic syndromes and anemia, testing the efficacy of epoetin alfa compared to placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of bemiparin, a low molecular weight heparin, compared to placebo in preventing thrombosis in cancer patients with a neoplastic process and a central venous catheter for anti-tumoral treatment or any other treatment related to the neoplastic process. The study includes eligibility criteria for patient inclusion and exclusion, such as platelet count, bleeding history, surgical interventions, renal and hepatic function, hypertension, and participation in other clinical trials.",
    "This sample is a phase 3 trial testing the drug cilnidipine on patients with hypertension and stroke, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of bupropion xl, a drug used to treat depressive disorder, major, in patients who have been diagnosed with the disorder for at least 8 weeks, while excluding patients with a history of seizure disorder, brain injury, anorexia or bulimia, schizophrenia or any other psychotic disorder, myocardial infraction within 1 year, or uncontrolled hypertension or unstable heart disease within 6 months.",
    "This sample is a phase 3 clinical trial for patients with brain edema or brain tumor, testing the effectiveness of the drugs hcrf and placebo hcrf in reducing peritumoral edema symptoms, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for generalized anxiety disorder, testing the drugs pexacerfont, escitalopram, and placebo, with specific inclusion and exclusion criteria for female outpatient participants.",
    "This phase 3 trial aims to evaluate the effectiveness of tacrolimus ointment in treating moderate to severe atopic dermatitis in children aged 2 to 15 years, who are known to be responsive to topical steroids, and have not taken any prohibited medications or therapies during the study period.",
    "This sample is a phase 3 trial for heart failure patients, testing the drugs rolofylline and placebo, with eligibility criteria including a history of heart failure, impaired renal function, and exclusion criteria such as acute contrast induced nephropathy and ongoing IV therapy for heart failure with certain agents.",
    "This sample is a phase 3 clinical trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the drugs qva149 and tiotropium. The eligibility criteria include specific lung function measurements and exclude patients with certain comorbid conditions or contraindications to the drugs.",
    "This sample is a phase 3 trial for venous thromboembolism, testing the drugs rivaroxaban, enoxaparin, and placebos, with inclusion and exclusion criteria for patients undergoing elective total knee replacement.",
    "This sample is a phase 3 trial for patients with atrial fibrillation and lung cancer, testing the drug amiodarone, with inclusion criteria of resectable lung nodule or mass and exclusion criteria including allergy to amiodarone, current use of amiodarone, and various cardiac and pulmonary conditions.",
    "This sample is a phase 3 trial for patients with chronic low back pain, testing the effectiveness of OROS hydromorphone slow release as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin and metformin in combination with placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for liver transplantation patients, testing the effectiveness of Prograf-XL and Prograf (tacrolimus) in preventing host vs graft reaction, with eligibility criteria including being a primary liver transplant recipient and receiving the first dose of the drug within 48 hours of transplantation.",
    "This sample is a phase 3 clinical trial for relapsing multiple sclerosis, testing the drug fty720. The inclusion criteria include being 18-65 years old and having relapsing MS, while the exclusion criteria include having a type of MS that is not relapsing, a history of chronic immune disease, certain cancers, certain eye disorders in diabetic patients, being on certain immunosuppressive medications or heart medications, having certain heart conditions, and certain lung conditions.",
    "This sample is a phase 3 clinical trial for the treatment of hypercholesterolemia using lapaquistat acetate and current lipid-lowering treatment, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with squamous cell carcinoma of the head and neck, who have completed definitive treatment within the past 3 months. The study aims to evaluate the efficacy of tegafur-gimeracil-oteracil potassium and tegafur-uracil in these patients. Eligibility criteria include specific disease characteristics and patient characteristics such as performance status, blood counts, liver and kidney function, and absence of certain medical conditions. Concurrent therapy with biologic therapy, radiotherapy, other chemotherapy, or any other therapy is not allowed.",
    "This phase 3 trial is testing the drug carboxyamidotriazole in patients with stage III or IV non-small cell lung cancer who have previously received chemotherapy, and have specific eligibility criteria including blood counts, liver function, and expected survival of at least three months.",
    "This sample is a phase 3 trial for the treatment of schizophrenia, using the drugs asenapine and olanzapine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for diabetic macular edema, testing the effectiveness of fluocinolone acetonide in patients with diabetes mellitus types 1 or 2, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with malignant mesothelioma, testing the drugs doxorubicin hydrochloride and ranpirnase, with eligibility criteria including confirmed histology, specific disease characteristics, age, performance status, and various medical conditions.",
    "This sample is a phase 3 clinical trial for patients with cystic fibrosis, testing the efficacy of mp-376 (levofloxacin solution for inhalation) compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 3 clinical trial for patients with schizophrenia or schizoaffective disorder, testing the drug ziprasidone. The inclusion criteria include patients not currently being treated with antipsychotic medication and a diagnosis of schizophrenia or schizoaffective disorder. The exclusion criteria include patients at immediate risk of harm to self or others and current antipsychotic treatment.",
    "This sample is a phase 3 trial for neuropathic pain, testing the drug pregabalin, with inclusion criteria including Chinese outpatients aged 18 to 75 and a score of greater than 40 mm on the visual log scale of SF-MPQ, and exclusion criteria including neurologic disorders unrelated to neuropathic pain and serum creatinine clearance greater than 60 ml/min.",
    "This sample is a phase 3 clinical trial for asthma in Chinese pediatric and adolescent subjects, testing the efficacy of fluticasone propionate inhalation solution, oral prednisone, placebo inhalation solution, placebo tablet, and salbutamol as treatments, with specific inclusion and exclusion criteria outlined in the protocol.",
    "This sample is a phase 3 clinical trial for patients with non-small cell lung cancer (NSCLC) who have received one prior platinum-based chemotherapy regimen. The trial aims to evaluate the efficacy of erlotinib (Tarceva) in treating NSCLC patients with specific characteristics, such as inoperable, locally advanced or metastatic disease.",
    "This phase 3 trial is investigating the effectiveness of insulin degludec/liraglutide versus placebo in subjects with type 2 diabetes mellitus who are on a stable dose of sulphonylurea with or without metformin, and have a HbA1c level between 7.0-9.0%.",
    "This phase 3 trial is investigating the effectiveness of fluorouracil, gemcitabine hydrochloride, and leucovorin calcium in treating pancreatic cancer patients who have undergone complete resection and meet specific eligibility criteria.",
    "This sample is a phase 3 clinical trial for the treatment of chronic constipation using the drug prucalopride, with inclusion criteria including a history of chronic constipation and exclusion criteria including other organic diseases and severe cardiovascular, liver, or lung disease.",
    "This sample is a phase 3 trial for patients with essential hypertension, testing the effectiveness of nifedipine (adalat, baya1040) in reducing blood pressure despite previous antihypertensive treatment.",
    "This sample is a phase 2/phase 3 trial that focuses on cardiovascular disease, aging, and endothelial dysfunction in sedentary elderly individuals. The drug being tested is alt-711, and the eligibility criteria include being healthy, sedentary, and aged 65 years or older.",
    "This sample is a phase 3 clinical trial for patients diagnosed with Chronic Phase Philadelphia chromosome positive (CP Ph+) CML who have failed to achieve CCyR after 3-18 months of therapy with imatinib 400 mg. The study aims to evaluate the efficacy and safety of dasatinib and imatinib as treatment options for these patients.",
    "This sample is a phase 3 clinical trial for patients with heart disease, stroke, ischemic heart disease, and myocardial infraction, testing the effectiveness of aspirin and warfarin in reducing the risk of embolism, with specific eligibility and exclusion criteria.",
    "This phase 3 trial aims to investigate the effectiveness of aspirin in patients with thrombocytopenia and myocardial infraction, with specific eligibility criteria including platelet count, cardiac enzyme levels, and ability to give consent.",
    "This sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) and it is testing the effectiveness of aclidinium bromide/formoterol fumarate and placebo in improving lung function. The trial has specific inclusion and exclusion criteria, and patients must meet certain eligibility requirements to participate.",
    "This sample is a phase 3 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of regorafenib (stivarga, bay73-4506) compared to a placebo, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of technosphere\u00ae insulin and technosphere powder as a treatment option, with specific eligibility criteria for enrollment.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of rosiglitazone, sulfonylurea, and metformin in lowering glycated hemoglobin levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for schizophrenia, testing the effectiveness of paliperidone er and placebo as drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for the treatment of psoriatic arthritis using the drugs onercept and placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of fluticasone furoate and fluticasone propionate/salmeterol in improving lung function and symptoms. The inclusion criteria include being \u2265 40 years old, having a clinical history of COPD, and being a former or current smoker. The exclusion criteria include having asthma, other respiratory disorders, or poorly controlled COPD, as well as various other medical conditions.",
    "This phase 3 trial is testing the effectiveness of fluorouracil and irofulven in treating locally advanced or metastatic pancreatic cancer patients who have failed one prior gemcitabine-containing chemotherapy regimen.",
    "This sample is a phase 3 clinical trial for patients with infiltrating primary breast cancer, testing the effectiveness of various drugs including aromatase inhibition therapy, cyclophosphamide, docetaxel, and others, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This phase 3 trial aims to evaluate the efficacy of half-boosted and full-boosted fosamprenavir, antiretroviral drugs, in subjects with HIV-1 infection, while considering various inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with bipolar I disorder experiencing a major depressive episode, testing the efficacy of armodafinil and placebo as adjunctive treatment to mood stabilizers.",
    "This sample is a phase 3 trial for hypertension, testing the drug candesartan cilexetil (atacand) in children with specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for the treatment of perennial allergic rhinitis, testing the effectiveness of various drugs including ciclesonide hfa nasal aerosol and ciclesonide aqueous nasal spray, with specific eligibility criteria for subjects to be included in the study.",
    "This phase 3 clinical trial aims to evaluate the efficacy of febuxostat and allopurinol in treating gout patients with a serum urate level of 8.0 mg/dL or higher, while excluding subjects with certain medical conditions or taking specific medications.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the effectiveness of technosphere\u00ae insulin inhalation powder and 70% insulin aspart protamine suspension and 30% insulin aspart injection in improving glycemic control, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of lixisenatide, a drug used to control blood sugar levels, in combination with other medications. The eligibility criteria include having a diagnosis of type 2 diabetes for at least 1 year and insufficient control with a sulfonylurea alone or in combination with metformin.",
    "This sample is a phase 3 trial for asthma patients, testing the effectiveness of the drugs flutiform and symbicort turbohaler in combination with inhaled corticosteroids, and the eligibility criteria include age, asthma history, lung function, and willingness to use study medication.",
    "This sample is a phase 3 trial for hypertension, testing the effectiveness of amlodipine in treating untreated and treated hypertensive patients, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for Parkinson's disease, testing the drug parcopa, with inclusion criteria of stable Parkinson's disease and exclusion criteria of idiopathic PD with Hoehn and Yahr state II or III.",
    "This sample is a phase 3 clinical trial for postmenopausal women with vulvar and vaginal atrophy, testing the effectiveness of ospemifene 60mg oral tablet in improving symptoms and meeting specific inclusion and exclusion criteria.",
    "This sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of insulin human/insuman comb 25 and insulin human/novolin\u00ae 30r in combination with oral anti-diabetic drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the effectiveness of ezetimibe and simvastatin in treating hypercholesterolemia and diabetes mellitus type 2 in patients with coronary heart disease, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 3 clinical trial for osteoarthritis knee pain, testing the effectiveness of duloxetine and placebo drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 3 clinical trial for ovarian and peritoneal neoplasms, testing the efficacy of drugs such as placebo, paclitaxel, bibf 1120, and carboplatin, with specific eligibility criteria for patients to participate in the trial.",
    "This phase 3 clinical trial aims to evaluate the effectiveness of amlodipine/losartan and amlodipine in treating hypertension in patients aged 18 and over, with specific blood pressure measurements as inclusion criteria and various exclusion criteria related to medical conditions, medications, and pregnancy.",
    "This sample is a phase 3 clinical trial for patients with renal failure, testing the drugs prograf (tacrolimus) and lcp-tacro, with inclusion criteria including age between 18 and 70, negative pregnancy test, and ability to swallow tablets and capsules, and exclusion criteria including history of alcohol or recreational drug abuse, significant cardiac or pulmonary disorders, and positive serological tests for HIV, HBV, or HCV.",
    "This sample is a phase 3 clinical trial testing the effectiveness of vortioxetine, escitalopram, and placebo in treating treatment-emergent sexual dysfunction (TESD) in patients currently being treated with selective serotonin reuptake inhibitor (SSRI) monotherapy for major depressive episode (MDE).",
    "This sample is a phase 3 trial for patients with advanced colorectal cancer, testing the efficacy of capecitabine, perifosine, and placebo drugs, with specific inclusion and exclusion criteria."
]
